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Chronic venous disease (CVD) is a common problem in the western world, causes 
considerable morbidity and has a substantial impact on the health care system in terms 
of cost of treatment.  Most epidemiological research has focussed on the prevalence of 
varicose veins and ulceration.  As such, evidence on the incidence and risk factors is 
limited.  The aim of this study was to measure the incidence of C2 varicose veins, C3-C6 
chronic venous insufficiency (CVI) and venous reflux ≥ 0.5 seconds duration in an adult 
population, and to investigate risk factors associated with the development of these 
conditions.   
 
The Edinburgh Vein Study was a prospective cohort study in which 1,566 men and 
women aged 18-64 years randomly sampled from the general population underwent an 
examination comprising clinical and photographic classification of CVD, duplex 
scanning of the deep and superficial systems of both legs, and completed a 
questionnaire on lifestyle and medical history.  After a 13 year period, invitations were 
sent to the 1456 survivors to attend a follow up examination.  In total, 880 participated 






The overall incidence of C2 varicose veins was 18.2% (95% CI 15.2-21.6), equivalent to 
an annual incidence rate of 1.4% (95% CI 1.1-1.7).  There were no gender differences 
(p=0.78).  Age was associated with the development of new C2 varicose veins the 13 
year incidence rose from 9.8% in those aged 18-34 years to 25.7% in those aged 55-64 
years (p<0.001).  New cases of C3-C6 CVI developed in 9.2% (95% CI 7.0-11.9) of the 
study sample over 13 years, an annual incidence rate of 0.7% (95% CI 0.5-0.9).  There 
were no gender differences: the 13 year incidence was 10.7% (95% CI 7.2-15.5) and 
8.1% (95% CI 5.7-11.6) in men and women respectively (p=0.32).  The incidence 
increased consistently with age, from 2.1% in those aged under 35 years to 17.1% in 
those aged over 55 years (p<0.001).  Of all C3-C6 conditions, C3 corona phlebectatica 
had the highest incidence (5.3%, 95% CI 3.7-7.5).  C5-C6 venous ulceration had the 
lowest incidence, affecting only 0.5% (95% CI 0.2-1.6) of the study sample over the 13 
years.   
 
Overall, 12.7% of participants developed new venous reflux ≥0.5 seconds duration 
from baseline to follow up.  The 13 year incidence of superficial, deep and combined 
venous reflux was 8.8%, 2.6% and 1.3% respectively.  Neither age nor sex were 
associated with the incidence of venous reflux (p>0.05).  The highest incidence of reflux 
was in the great saphenous vein in the lower third of the thigh (4.2%, 95% CI 2.4-7.1).  
Venous reflux at baseline was associated with the development of new C2 varicose 
veins at follow up: the incidence creased linearly in those with no reflux, deep, 







Family history of venous disease was a significant risk factor for C2 varicose veins (age 
and sex-adjusted OR 1.7, 95% CI 1.1-2.7) while obesity was associated with the 
development of CVI (age and sex adjusted OR 4.5 (95% CI 3.3-6.9).  Pregnancy 
appeared to be associated with the development of varicose veins but the association 
was not statistically significant due to small numbers.  No risk factor was associated 
with the development of venous reflux. 
 
The Edinburgh Vein Study is one of a few cohort studies to report the incidence of C2 
varicose veins, C3-C6 CVI and venous reflux ≥0.5 seconds duration, and investigate risk 
factors associated with these conditions.  While the results on incidence are consistent 
with the limited evidence from other studies, the exact effect of risk factors remains 
unknown.  Genetic studies would help clarify whether CVD is an inherited or acquired 
condition.  For other risk factors, results of this study could be combined with other 
population-based studies in a meta-analysis.  The overall estimate of effect would 
identify the most important risk factors associated with the development of CVD and 
venous reflux.   Finally the natural history and progression of CVD needs to be assessed.  
The Edinburgh Vein Follow Up Study has examined this relationship and results will 
help to identify those most likely to progress to more severe disease and, in turn, those 
who will benefit most from treatment. Appropriate, clinically proven, effective and 
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CHAPTER 1: INTRODUCTION 
 
 
1.1 CHAPTER OUTLINE 
 
Chronic venous disease (CVD) of the legs is common in the Western world.  It causes 
considerable morbidity in the population and treatment incurs significant costs to the 
health service.  Knowledge on the epidemiology of CVD is essential in order to identify 
which patients will benefit most from treatment to slow or halt the progression of 
disease.  This chapter will provide an overview of CVD, beginning with a definition of 
the term and a brief outline on the extent of the problem, in terms of prevalence and 
health service costs of treating the condition.  (The prevalence, incidence and risk 
factors for CVD will be discussed in detail in Chapter 2, which reviews the literature).  
The anatomy of the venous system of the legs will be considered and the theories on 
the pathophysiological mechanisms of the disease discussed.   Clinical manifestations of 
CVD and the various classification systems used in its diagnosis will then be presented.  
Methods of assessment of CVD will be outlined briefly, with a detailed section on duplex 
ultrasound.  CVD has an impact on quality of life and tools used to measure this 
outcome will be presented.  Treatments for CVD will then be summarised.  Finally a 
brief synopsis of the aims, methods and results of the baseline stage of the Edinburgh 




1.2 INTRODUCTION TO CHRONIC VENOUS DISEASE 
 
1.2.1 Spectrum of chronic venous disease 
Chronic venous disease (CVD) is a term which includes the “full spectrum of 
morphologic and functional abnormalities of the venous system” (Eklöf 2004).  Leg 
symptoms associated with CVD include aching, heaviness, swelling and skin irritation 
(Bergan 2006).  Clinical signs of CVD range in severity from uncomplicated 
telangiectases (spider veins) to varicose veins, skin changes and ulceration.  A varicose 
vein, derived from the Greek word for “grape-like” (Krijnen 1997),  is defined as a 
“subcutaneous dilated vein three millimetres in diameter or larger, measured in an 
upright position” (Porter 1995).  Varicose veins are not just a cosmetic problem.  If left 
untreated, they can lead to chronic venous insufficiency (CVI), including skin changes 
and ulceration.   
 
1.2.2 Extent of the problem 
Estimates of the prevalence of varicose veins vary widely from 2-57% in men and from 
1-68% in women (Robertson 2008).  This variation is discussed in Chapter 2.  Venous 
ulceration is less common, affecting between 0.1-0.3% of the adult population (Scottish 
Intercollegiate Guidelines Network 2010).  The natural history of venous ulceration is a 
continuous cycle of breakdown and healing over years, causing considerable morbidity 
and impaired quality of life.  Pain is common, mobility and work capacity is restricted 




1.2.3 Health service utilisation 
Varicose veins pose a substantial burden on the National Health Service (NHS).  
According to the Information Services Division (ISD) in Scotland, 3,063 surgical 
procedures for varicose veins were performed in 2011/12 (www.isdscotland.org).  In 
addition to the surgical workload, patients with varicose veins represent a large 
proportion of outpatient appointments in primary and secondary care (Simpson 2004).  
Furthermore, the management of venous leg ulcers places a significant demand on 
nursing services, thus incurring further costs to the NHS.  The cost of treating leg ulcers 
is approximately £600 million per year (Scottish Intercollegiate Guidelines Network  
2010).  Each ulcer has been estimated to cost £2000-£4000 (Bosanquet 1992). 
 
1.3 VENOUS SYSTEM OF THE LEG 
 
Before the pathophysiology of CVD can be discussed, the anatomy and function of the 
venous system must be understood.  The venous system of the legs acts as “a reservoir 
to store blood and as a conduit to return the blood to the heart” (Eberhardt 2005).  
Blood is transported from the leg to the heart through a network of veins in the lower 
extremity.  Compared to arteries, veins have thinner walls (Meissner 2005) and “a 
weaker muscular layer and less elastic tissue” (Browse 1988), thus making them stiffer.  
There are three venous systems within the leg: the deep, superficial and perforating 
systems [Figure 1.1].  Leg veins are “classified according to their relationship within the 
muscular fascia and are located in either the deep or superficial compartment” 





1.3.1 Deep veins 
Deep veins lie beneath the muscular fascia.  They follow the course of major arteries as 
“venae comitantes” and, with the exception of the femoral vein, are given the same 
name as the arteries they accompany (Meissner  2005).  Approximately 90% of venous 
blood leaves the legs by the deep veins (Mitchel 1994).  There can often be significant 
variations in the deep veins, with classic anatomy observed in as little as 16% of limbs 
(Browse 1988).  The number of veins may vary and the communication with other 
veins along the way can show a variety of patterns.  However a general arrangement is 
usually apparent.  In most cases, there are five major veins of the deep venous system: 
three below the knee and two above the knee. 
 
Figure 1.2 displays the deep veins of the leg.  The three principal conducting deep veins 
below the knee are usually double channels which correspond to the three main 
arteries in the calf; the anterior tibial, posterior tibial and the peroneal (Browse 1988).  
The anterior and posterior tibial veins join at the lower end of the popliteus muscle to 
form the popliteal vein (POP).  As well as the veins from the calf and calf muscles, the 
POP vein is joined by the short saphenous vein (SSV) at the saphenopopliteal junction 
(SPJ).  It runs proximally behind the knee, ascends through the popliteal fossa and 
passes through the adductor canal to become the femoral vein (FV) (Fronek 2004).  The 
FV ascends through the thigh, and receives the deep femoral vein to form the common 
femoral vein (CFV).  The CFV passes upward through the groin crease to become the 








1.3.2 Superficial veins 
Superficial veins are large, thick-walled veins situated just under the skin within the 
superficial fascia (Simpson 2004).  Superficial veins are a complex and variable 
network of collecting veins that drain blood from the skin and subcutaneous tissue and 
direct it to the deep system via tributary or perforating veins (Somjen 1995).  The 
superficial veins of the leg are the great saphenous vein (GSV), which runs from groin 
to ankle and the small saphenous vein (SSV), which runs from ankle to knee [Figure 
1.3].  
 
 The GSV is the longest vein in the body (Chen 2009).  It originates in the medial foot, as 
part of the dorsal venous arch and runs upwards anterior to the medial malleolus 
before ascending the length of the tibial edge of the medial calf, passing behind the knee 
and forward around the medial side of the thigh (Meissner  2005).  It passes through 
the saphenous opening in the deep fascia 3cm below to join the antero-medial side of 
the common femoral vein (CFV) (Browse 1988).  The site where the GSV meets the CFV 
at the groin skin crease is termed the saphenofemoral junction (SFJ)(Caggiati 2002).  
The GSV lies within a clearly defined fascia compartment known as the “saphenous 
eye”, as it has the appearance of an Egyptian eye on ultrasound examination.  This 
distinguishable feature, particularly in the thigh region, prevents tributary veins from 
being mistaken for the GSV (Chen  2009).   The GSV is often accompanied by tributary 
veins and is prone to several anatomical variations in the thigh and knee (Ricci 1999).  





 The small saphenous vein (SSV) originates in the lateral part of the dorsal venous arch 
of the foot (Meissner  2005).  It ascends proximally behind the lateral malleolus, follows 
the lateral border of the Achilles tendon and then runs up the middle of the back of the 
lower leg.  The vein pierces the deep fascial roof of the popliteal fossa and passes 
between the two heads of the gastrocnemius muscle (Fronek  2004).  The termination 
of the SSV varies.  In around 60% of cases, the vein joins the popliteal vein in the 
popliteal fossa within 8cm of the knee joint, to form the saphenopopliteal junction 
(SPJ).  However, in 20% of cases, it joins the GSV at varying levels in the thigh; in the 
remainder of cases, it has an alternative termination e.g. by joining the superficial or 
deep femoral vein (Browse 1988).   For its entire length, the SSV lies in an inter-fascial 
compartment defined by muscular and superficial fascia.   
 
1.3.3 Perforating veins 
Most venous blood is transported from the superficial to the deep system via the two 
connecting junctions, the SFJ and the SPJ (Fronek  2004).  However, blood also travels 
between the systems through perforating veins, which are connected to superficial 
veins and pass through the deep fascia to join directly with the deep veins (Meissner  
2005).  The number of perforating veins varies but in general there are four groups 
according to location: the foot, the medial and lateral calf and the thigh [Figure 1.4].  
With the exception of the foot, all perforators direct blood from the superficial to the 





1.3.4 Venous valves 
As the blood in the legs must travel against gravity, veins contain a series of one way 
valves to prevent back flow of blood in an upright position [Figure 1.5] (Simpson 2004).  
The number of valves increases from the hip down to the calf but can vary between 
individuals (Eberhardt 2005).   From the inguinal to the popliteal fossa there can be 
between two and nine deep venous valves: the CFV and the SFJ usually contain one 
valve each, while the FV above the adductor canal usually contains at least three, and 
the distal FV and POP contain between one and two valves each (Mozes 2001).  The 
main trunk of the GSV usually has at least 6 valves while the SSV has between seven to 
ten closely spaced valves (Mozes 2001).  Perforating veins of the calf and thigh also 
possess one to three  valves that prevent the backflow of blood from the system to the 
superficial system (Meissner  2005).   
 
Valves are formed from folds of endothelium and are supported by thin sheets of 
collagen and smooth muscle (Meissner  2005).  They have two cusps which remain 
open during rest in the supine position and close through the force of the retrograde 
blood flow (van Bemmelen 1990).   Valves work in tandem with venous muscle pumps, 
which eject a sufficient force of blood up towards the heart, ensuring valve closure 





1.3.5 Calf muscle pump 
Venous muscle pumps are located in the foot, calf and thigh.  Of the three, the calf 
muscle pump has the “largest capacitance, generates the highest pressures, and is of 
greatest importance”  (Meissner  2005) and as such, is often termed the “peripheral 
heart” (Fronek  2004).  Figure 1.6 displays the mechanism of the calf muscle pump.  
During contraction, the gastrocnemius and soleus muscles drive blood into the deep 
veins, where the valves prevent backflow (Meissner 2007b).  During relaxation, blood 
is drawn from the superficial to the deep system through perforating veins (Eberhardt 
2005).  When exercise ceases, the veins slowly fill until normal resting venous pressure 
is achieved (Meissner 2007b). 
 
1.3.6 Venous reflux 
Reverse flow of blood is prevented by one-way valves in the veins which snap shut, 
holding the column of blood until the next calf muscle contraction occurs.  However, the 
valve will only shut when the gradient of the retrograde blood flow is of sufficient 
velocity to force the cusps to close completely (van Bemmelen 1990).  The normal time 
taken for the velocity to reach the required force in an upright position is less than 0.5 
seconds, during which some reverse blood flow will occur (van Bemmelen 1990).  
However if the reverse blood flow persists for longer than 0.5 seconds in an upright 
position, this is termed pathological “reflux” (Meissner  2005).   Venous reflux develops 
when “venous pressure is increased and return of blood is impaired through several 





1.4 PATHOPHYSIOLOGY OF CHRONIC VENOUS DISEASE 
 
According to an International Consensus Committee on Chronic Venous Disease, CVD is  
“an abnormally functioning venous system caused by venous valvular incompetence 
with or without associated venous outflow obstruction, which may affect the superficial 
venous system, the deep venous system, or both” (Porter 1995).  The term CVD covers 
the whole spectrum of clinical severity, from telangiectases and reticular veins to 
varicose veins, skin changes and ulcers (Meissner 2007a).  An ad hoc committee of the 
American Venous Forum determined that as spider and reticular veins are highly 
prevalent in the adult population, the term “disease” is not appropriate for these 
conditions (Eklöf 2004).  Therefore, when discussing pathophysiology, the term CVD 
will only cover varicose veins and CVI.   
 
Primary CVD is defined as “venous dysfunction of unknown cause but not of congenital 
origin”, whereas secondary refers to “an acquired condition which has led to CVD, for 
example, deep vein thrombosis” (Porter 1995).  A varicose vein is defined as a 
“subcutaneous dilated vein three millimetres in diameter or larger, measured in an 
upright position” (Porter 1995).  The term CVI does not include varicose veins but 
“refers more specifically to the spectrum of skin changes associated with sustained 
venous hypertension” (Meissner 2007a).   Venous hypertension is defined as a “failure 
to reduce venous pressure with exercise’  (Meissner 2007b), and is caused by reflux.  
Although the exact aetiology of reflux is unknown, several theories have been proposed 





1.4.1 Valvular incompetence 
The valvular incompetence theory proposes that valve failure is the initial pathological 
change that causes varicose veins.  Valve failure may be primary as a result of weakness 
in the valve, or secondary to DVT or phlebitis (Burnand  2001).  Incompetence of the 
valves in the junctions connecting the two venous systems (SFJ and SPJ) or the 
perforating veins, allows pathological reflux > 0.5 seconds duration to occur.  In turn, 
reflux causes blood stasis and increased hydrostatic pressure in the leg (Eberhardt 
2005).  Venous hypertension causes the vein wall to weaken, the vein dilates and 
becomes varicose (Lim 2009).  Furthermore, as the vein dilates, the valve cusps 
separate further, thus worsening the valvular incompetence (Lim 2009).  This constant 
state of venous hypertension can lead to hyperpigmentation, subcutaneous tissue 
fibrosis (lipodermatosclerosis), and eventual ulceration (Eberhardt 2005).  The theory 
also proposes that valvular incompetence progresses in a descending fashion, starting 
in the SFJ or SPJ and progressing down the leg (Raffetto 2008, Somers 2006).   
 
Despite the fact that reflux is often the main haemodynamic abnormality in primary 
CVD, there is little evidence to support the valvular incompetency theory.  In fact, 
evidence has shown that vein dilation often occurs before valvular incompetence 
(Meissner 2007a).  Furthermore, the theory of sequential valve failure has also been 
contradicted by evidence that varicose veins are often found below competent valves in 
the SFJ (Labropoulos 2000,  Somjen  1995).  Instead, ultrasound findings suggest that 
primary valvular incompetence is “a multicentric process the develops simultaneously 





1.4.2 Vein wall abnormality 
The vein wall theory hypothesises that the primary cause of CVD is a structural or 
biochemical abnormality of the vein wall (Meissner  2005).  Changes in the collagen, 
elastin and smooth muscle layers of saphenous varicose veins have been proposed 
(Clarke 1992, Vanhoutte 1997) and significantly reduced vein wall elasticity has been 
detected in affected patients (Raffetto 2008, Somers 2006).  This evidence suggests that 
structural changes in the vein wall precede both symptomatic varicose veins and 
valvular incompetence.  It is presumed that reflux occurs when the weakened vein wall 
dilates, causing the valve cusps to stretch and subsequent failure of the valve to close 
completely (Meissner  2005).  Consequently the high venous pressure in the leg leads 
to varicose veins and can eventually result in oedema, inflammation, skin changes and 
ulceration (Eberhardt 2005). 
 
While it is unknown whether the structural changes in the vein wall are primary or a 
consequence of a pathological process, various factors associated with haemodynamic 
abnormality have been suggested, including hypoxia, changes in enzyme activity, 
mechanical stretch, low shear stress and underlying defects in venous tone (Haardt 








1.4.3 Venous obstruction 
Venous obstruction of the deep system is a common cause of secondary CVD (Johnson 
1995).  A thrombus in a deep vein may damage the valve directly or indirectly by 
causing venous stenosis, which leads to vein-wall injury and dilatation (Eberhardt 
2005, Ibrahim 1996). Normal venous outflow of blood is restricted and the venous 
pressure within the calf increases, leading to reflux.  As a result of this process, the calf 
muscle pump can become dysfunctional (Eberhardt 2005).  Lipodermatosclerosis and 
ulceration are seen more frequently in patients with varicosities secondary to venous 
obstruction (Lees 1993),  suggesting that venous obstruction is a significant mechanism 
in the pathogenesis of CVI (Neglén 2003).  Obstruction of the popliteal vein in 
particular, has been shown as an important determinant of the severity of CVI 
(Meissner 1998). 
 
1.4.4 Dysfunction of the calf muscle pump 
While calf muscle pump dysfunction is rarely a primary cause of reflux, it is often a 
secondary outcome of severe venous reflux or obstruction (Eberhardt 2005).  An 
ineffective calf muscle pump results in blood not being emptied out of the leg, causing 
venous hypertension (Eberhardt 2005).  Evidence has shown that calf muscle pump 
dysfunction is a major mechanism for the development of superficial vein 
incompetence and venous ulcers (Araki 1994, Christopoulos 1989).  The relationship 
between calf muscle pump and ulceration can be partially explained by the reduced 





Despite the theories regarding the aetiology of venous reflux, the precise 
pathophysiology of CVD remains unknown.  It is important to consider that the venous 
system of the legs is comprised of three components: valves, vein walls and 
haemodynamics of venous blood flow (Lim 2009).  For a venous system to function 
normally, the three components must all function effectively (Ibrahim 1996).  As the 
three components are interdependent, when one is disrupted in any way, the 
functioning of the others is affected.  Any changes can further affect the initial 
dysfunction, triggering a repetitive cycle (Lim 2009).  By the time varicose veins are 
symptomatic, “all components are already disrupted, making it difficult to pinpoint the 
primary stimulus and map the sequence of pathological events” which led to the 
varicosity (Lim 2009).  
 
1.4.5 Predisposing factors 
Other, non-pathological factors may predispose to the development of CVD.  Varicose 
veins are generally accepted as being more common in women than in men and to 
increase in prevalence with age.  There is some evidence that family history of CVD, 
pregnancy and DVT are risk factors.  Other postulated risk factors include, obesity, 
prolonged standing, constipation, heavy lifting, lack of exercise and cigarette smoking.  
However, evidence on these risk factors is variable and inconclusive.  Risk factors for 






1.5  CLASSIFICATION OF CHRONIC VENOUS DISEASE 
 
1.5.1 Clinical manifestation of chronic venous disease 
The manifestations of CVD range in severity from uncomplicated telangiectases and 
reticular veins, to varicose veins and advanced skin changes. Telangiectases [Figure 
1.7], are small intradermal veins less than 1mm, while reticular veins [Figure 1.8] are 
blue sub-dermal veins 1-3mm in diameter (Eklöf 2004).  There have been various 
definitions of varicose veins but they are generally described as dilated, subcutaneous 
veins 3mm in diameter or larger, that become progressively more tortuous and 
distended [Figure 1.9] (Eklöf 2004).  Apart from the obvious cosmetic issue regarding 
the appearance of the legs, patients with varicose veins also report a dull ache or 
heaviness in the legs, particularly after periods of prolonged standing (Ibrahim 1996).   
 
Symptoms of CVI range by severity of the condition.  Mild CVI comprises submalleolar 
venous ‘flare’ at the ankle known as corona phlebectatica [Figure 1.10] and oedema 
(Eklöf 2004).  Oedema [Figure 1.11] is a swelling caused by the accumulation of fluid, 
which begins in the gaiter region and ascends up the leg (Eberhardt 2005).  Moderate 
CVI comprises cutaneous changes, including a brown discolouration in the gaiter region 
called pigmentation [Figure 1.12], eczema-like dermatitis [Figure 1.13], inflammation 
and fibrosis of subcutaneous tissue, called lipodermatosclerosis [Figure 1.14] and 
atrophic white skin, known as atrophie blanche [Figure 1.15] (Eklöf 2004).  Severe CVI 
comprises healed and active ulceration [Figures 1.16 and 1.17 respectively], defined as 
“a full-thickness defect of the skin that fails to heal spontaneously and is sustained by 





1.5.2 Basle classification 
The Basle, or Widmer classification, was the first attempt to standardise the 
classification of chronic venous disease (Widmer 1978).  Telangiectasia, reticular, and 
varicose veins were classified separately with grades 1, 2 and 3 applied to each to 
represent the severity of the condition; mild, moderate and severe.  CVI was also split 
into three categories according to severity of disease [Appendix 2].  The Basle 
classification used only clinical criteria, which was subjective as it involved assessment 
by examination of the legs without objective measurements using instruments. 
 
1.5.3 CEAP classification 
In 1994, an ad hoc committee of the American Venous Forum developed a classification 
system, in an attempt to standardise the evaluation of severity of CVD (Porter 1995).  
Since then, subsequent revisions and improvements have been made based on new 
knowledge (Eklöf 2004).  The CEAP classification system includes not only the clinical 
symptoms (C) of CVD, but also considers the etiology (E), anatomic distribution (A), 
and the pathogenic mechanism (P), and produces a score based on the severity of 
disease [Appendix 3].  Clinical signs in the affected leg are categorised into seven 
classes designated C0 to C6, which are further categorised by the presence or absence 
of symptoms.  The etiologic classification is based on congenital, primary or secondary 
causes of venous dysfunction.  The anatomical classification identifies the deep, 
superficial or perforating venous systems affected, where multiple venous segments 
may be involved.  Finally, the pathophysiological classification determines the 






CEAP is a “valuable tool in the objective valuation, providing a system to standardise 
venous disease classification, with emphasis on the manifestations, cause and 
distribution of venous disease” (Eberhardt 2005).  It is now widely accepted and is 
used in many large observational studies (Chiesa 2005, Criqui 2003, Rabe 2010, 
Schultz-Ehrenburg 1992).  Nevertheless, it has limitations.  It is a subjective measure 
and does not allow an assessment of change in response to treatment.  Other than 
clinical class, CEAP does not estimate the severity of venous disease:  varicose veins can 
be present with or without oedema, skin changes and ulceration (Meissner 2007b).  To 
complement the CEAP system and measure the severity of CVD, a committee on Venous 
Outcome Assessment of the American Venous Forum developed a venous severity 
scoring system (Rutherford 2000). 
 
1.5.4 Venous Severity Scoring System 
The Venous Severity Scoring (VSS) system provides a numeric score based on 3 
components: Venous Clinical Severity Score (VCSS), Venous Segmental Disease Score 
(VSDS) and Venous Disability Score (VDS) [Appendix 4] (Rutherford 2000). The VCSS 
consists of ten clinical characteristics of CVD (pain, varicose veins, venous oedema, skin 
pigmentation, inflammation, induration, number of ulcers, duration of ulcers, size of 
ulcers, and compressive therapy) with four grades (absent, mild, moderate, severe). 
The VSDS provides the number of venous segments with reflux or obstruction and the 
VDS is based on the ability to perform normal daily activities with or without the use of 






The venous severity scoring has been shown to be useful in evaluating the response to 
treatment, particularly superficial venous surgery (Kakkos 2003, Vasquez 2007).  
However, results the on the internal and external validity are contradictory.  One study 
reported high inter-observer and intra-observer agreement (Vasquez 2007) but 
another study measured inter- and intra-observer variability in grading CVD (Meissner 
2002).  Furthermore, a survey of angiologists determined that the VCSS was not as 
effective as CEAP in diagnosing conditions at the lower end of the CVD spectrum (CEAP 
classes C1 to C3) (Perrin 2006).   
 
1.6 QUALITY OF LIFE WITH CHRONIC VENOUS DISEASE 
 
For chronic conditions such as CVD, patient-based assessments of quality of life (QOL) 
provide important information not only on the burden of disease, but also on the 
change in illness over time  (Kahn 2004).  Furthermore, as CEAP may not accurately 
reflect the patients’ own perceptions of CVD severity, they provide a “needed adjunct to 
physician-based assessments” (Meissner 2007b).  Patient based QOL instruments 
include both generic and disease-specific surveys.  Generic surveys assess overall state 
of wellbeing, whereas disease-specific surveys focus on particular aspects of the 
disease process and are sensitive to specific outcomes (Vasquez 2010).  A combination 
of generic and disease-specific tools surveys has been advocated for measuring QOL 






1.6.1 Generic quality of life instruments  
Generic QOL instruments include the Medical Outcomes Study Short Form (SF-36), 
EuroQol, the Nottingham Health Profile and the Sickness Impact Profile.  The SF-36 is 
the most commonly used, and determines both physical and mental health (Davies 
2006).  These two health states are categorised into eight domains, including physical 
and social functioning, limitations due to physical or emotional problems, mental 
health, pain, vitality and health perceptions.  The SF-36 produces a score ranging from 
0 to 100, with higher scores indicating better general health perception (Vasquez 
2010).  For measuring the CVD, it is preferable to be combine the SF-36 with a disease-
specific QOL instrument (Meissner 2007b)   
 
1.6.2 Disease-specific quality of life instruments 
There are several disease-specific QOL instruments.  The Aberdeen Varicose Vein 
Questionnaire (AVVQ) (Garratt 1996), The Charing Cross Venous Ulceration 
Questionnaire (CXVUQ) (Smith 1999), and The Chronic Venous Insufficiency 
Questionnaire (CIVIQ) (Launois 1996), only look at specific conditions and therefore 
cannot be applied to the full spectrum of CVD.  However, an instrument, set up by the 
Venous Insufficiency Epidemiological and Economic Study (VEINES), evaluates all 
aspects of venous disease, including CEAP classes, post-thrombotic syndrome, and 






The VEINES instrument is focussed on physical symptoms rather than psychological or 
social aspects of CVD.  It consists of 35 items split into two sections.  The first is a QOL 
questionnaire (VEINES-QOL), comprising 25 items quantifying disease effect on quality 
of life.  The second section is a symptom questionnaire (VEINES-Sym), with 10 items 
measuring physical symptoms.  Patient responses are made on a 2- to 7-point scale 
rating intensity, frequency, and agreement.  A summary score is generate for each 
section, with higher scores representing a better quality of life (Lamping 2003).   The 
VEINES-QOL/Sym was tested and deemed to be an acceptable, reliable and valid tool 
(Abenhaim 1997). 
 
1.7 INVESTIGATION OF CHRONIC VENOUS DISEASE 
 
Initial assessment of a patient with CVD begins with a clinical history and physical 
examination of the legs, with the patient in an upright position to allow maximal 
distention of the veins (Eberhardt 2005).  Inspection of the legs allows the physician to 
identify the visual signs and symptoms, assess their severity and determine whether 
they are associated with CVD or another co-existing non-venous pathology.  As the 
initial examination does not always indicate the nature and extent of the underlying 
pathology, objective testing is required to confirm the diagnosis, determine the 
aetiology of disease and identify the particular vein segment affected.  This section will 
briefly review the diagnostic tests available in the assessment of venous reflux.  Tests 
are divided into two categories: non-invasive testing (venous duplex imaging, 
continuous wave Doppler ultrasound, photoplethysmography and air 





1.7.1 Duplex ultrasound 
Physics and principles 
Ultrasound refers to any sound wave of frequency higher than 20 KHz, which cannot be 
heard by the human ear (Oxford English Dictionary 2012).  In an ultrasound machine, a 
transducer containing piezoelectric crystals transmits high frequency sound waves 
through an electrical current.  When the sound waves enter the body, they are 
absorbed, attenuated or reflected back by the tissues.  As body tissues are various 
densities, they reflect the sound waves at different degrees.  Sound waves reflected 
back to the transducer are converted into electrical signals.  The electrical signals form 
a detailed image of differing shades of brightness (B-mode ultrasound) based on the 
amplitude of the reflected sound wave and the time taken to reflect back to the 
transducer (Sofferman 2011). 
 
Ultrasound uses the principle of the “Doppler effect” to measure blood flow in a vessel.  
The theory is that the “frequency of a sound wave reflected from a moving object 
changes in proportion to the velocity of the reflecting object” (Donnelly 2000).  The 
change in the frequency of the reflected sound measures the velocity of movement of 
the object (Sofferman  2011).  To measure blood flow, the transducer is coupled with 
acoustic gel to prevent sound being reflected at the air-skin surface.  The transducer is 
directed towards a vein and sound waves are reflected from the red blood cells.  
Movement of the red cells causes a change in frequency (Doppler shift) in the reflected 





Duplex ultrasound to detect venous reflux 
Venous duplex ultrasound “combines B-mode imaging of the deep and superficial veins 
with pulsed Doppler assessment” to provide anatomical and functional information on 
blood flow (Eberhardt 2005).  Specific veins in the deep, superficial and perforating 
systems can be identified and the presence, direction and velocity of blood flow at 
different locations within the vein can then be established.  The addition of colour 
frequency mapping allows the moving blood to be represented as a colour [Figure 
1.18].  The colour is dependent on the direction of the blood flow in relation to the 
transducer and the tone represents the velocity of the blood flow.  Colour systems have 
the advantage not only of rapid identification of the veins, thus reducing scanning time , 
but they also enable visualisation of blood flow and venous reflux in the veins directly 
(Donnelly 2000).    
 
High frequency linear array transducers ranging from 7-13.5 MHz are used to detect 
venous reflux (Coleridge-Smith 2006).  The examination is best done with the patient in 
a vertical position to allow gravity to demonstrate reflux (Allan 1999).  The deep veins 
of the thigh and the calf, the GSV and SSV, perforators and other communicating veins 
are assessed for reflux.  Reflux can be initiated by three methods: the Valsalva 
manoeuver, manual calf compression or pneumatic cuff compression of the calf with 
subsequent sudden release or rapid deflation (Nicolaides 2000).  Cuff measurements 
have been shown to be the most accurate in diagnosing reflux as they provide a 





Reflux is diagnosed where there is “clear reversed flow of blood occurring after the 
period of forward flow in the vein segment being scanned” (Allan  1999).  A short 
period of reverse blood flow as the cusps of the valve close is normal.  However, a 
reflux time of greater than 0.5 seconds is classified as pathological reflux.  Although 0.5 
seconds is the accepted measure of reflux, the cut-off point has been debated and a 
more refined definition with a variable cut-off based on location has been suggested.   
In particular it is recommended that the reflux cut-off value for the femoropopliteal 
veins should be greater than 1 second (Labropoulos 2003). 
 
According to a consensus committee on CVD, duplex ultrasound is considered to be the 
‘best-documented non-invasive method of quantifying reflux by measuring reflux 
duration’ (Porter 1995).  Evidence has shown that duplex ultrasound reflects the 
degree and distribution of reflux more accurately than descending venography (Neglen 
1992).  Furthermore, a study of 118 limbs determined that duplex ultrasound was 
accurate in measuring the degree and distribution of reflux correlated to the severity of 
CVD, with high sensitivity (83%) and specificity (86%) (Neglén 1993).   Duplex 
ultrasound has also been shown to produce repeatable results with 94% agreement 
between reflux measures when a cut-off point of ≥ 0.5 seconds was used and the 
patient was in a standing position (Lurie 2012).  Measurements of reflux made using an 
inflatable cuff have been shown to be more accurate than manual compression of the 








Duplex ultrasound in epidemiological studies 
Duplex scanning has been used several epidemiological studies of CVD (Allan 2000, 
Cesarone 2002, Criqui 2003).  It is non-invasive and painless.  However, the scan is time 
consuming.  Furthermore the observer must be trained in ultrasound scanning and 
understand the anatomy of the leg veins.  As epidemiological studies of reflux require 
several observers taking measurements over a long study period, they are prone to 
observer variability.  Studies often provide detailed scanning protocols and extensive 
training to reduce such variability.  It is imperative that observers are monitored 
regularly to check observer variability and ensure accuracy of reflux data. 
 
1.7.2 Continuous wave Doppler ultrasound 
Continuous wave Doppler ultrasound is a useful test for detecting reflux at the SFJ and 
SPJ.  A limitation is that it cannot insonate an individual vein as it detects flow in any 
artery or vein in the path of the ultrasound beam.  At the groin, reflux can be in the GSV, 
its tributaries or the CFV.  Doppler ultrasound cannot identify the exact site of reflux 
nor can it detect the SPJ.  For these reasons, duplex ultrasound is favoured.   
 
1.7.3 Photoplethysmography 
Photoplethysmography (PPG) is a non-invasive test where a light sensor detects 
changes in the blood flow as the veins fill and empty after calf muscle contractions.  PPG 
has several limitations.  It cannot determine the specific anatomic distribution of reflux.   
Secondly, refilling time is dependent on the size of the vein to be filled.  Deep veins are 
larger in diameter, carry a large volume of blood and therefore naturally refill quickly 
(Eberhardt 2005).  A short refilling time would incorrectly suggest venous reflux.  With 





Air plethysmography can measure venous reflux, obstruction and calf muscle pump 
dysfunction (Christopoulos 1988).  Changes in limb volume are measured by air 
displacement in a cuff while the patient performs a series of tiptoe movements to 
empty and fill the venous system (Eberhardt 2005).  A thigh cuff is rapidly inflated and 
deflated so that the adequacy of venous outflow can be measured.  Rate of refill is used 
to determine the presence and severity of venous reflux, while the ejection fraction 
corresponds to the calf muscle pump function.   
 
1.7.5 Phlebography 
Phlebography was the “gold standard” but has been replaced by non-invasive imaging.  
Dye is injected into the foot or at the groin, allowing visualisation of the vein and blood 
flow.  Phlebography measures the extent of reflux in the superficial or deep veins, 
provides information on valves, and differentiates primary from secondary disease 
(Meissner 2007a).   However, it is an invasive procedure associated with complications 
including allergic reaction, infection, vein damage and exposure to radiation.   
 
1.7.6 Ambulatory venous pressure 
Ambulatory venous pressure (AVP) is the gold standard in detecting venous 
hypertension in the leg (Masuda 2001, Nicolaides 1986).  It is an invasive technique in 
which a needle is inserted into the vein in the foot to measure the change in pressure 
between rest and exercise.  AVP can also distinguish deep from superficial reflux 
(Eberhardt 2005).  As it provides information on haemodynamics only, it supplements 




1.8 TREATMENT OF CHRONIC VENOUS DISEASE 
 
Treatment of CVD is based on severity of disease and reflux imaging results.  At first, all 
patients are treated conservatively and advised to elevate their legs to prevent oedema.     
If conservative measures fail or provide an unsatisfactory response, then further 
treatments, including interventional or surgical procedures, are considered based on 
anatomical and pathophysiological features of the disease.  Patients with CEAP classes 
4 to 6 are often referred to a vascular specialist and undergo invasive treatment in an 
attempt to slow or stop progression of disease.   
 
1.8.1 Conservative treatment 
Conservative measures aim to “reduce symptoms and help prevent the development of 
secondary complications and the progression of disease” (Eberhardt 2005).  The 
preferred form of treatment is compression therapy.  Compression stockings oppose 
the hydrostatic forces of venous hypertension, thus reducing venous reflux and 
improving venous pumping (Kurz 1999, Partsch 1999).  Worn compliantly, they have 
been shown to reduce pain, oedema and skin changes (Motykie 1999), improve calf 
muscle pump function and reduce reflux in vein segments (Ibegbuna 2003, Zaijkowski 
2002), and heal and prevent the recurrence of ulcers (Mayberry 1991).  Other 
conservative treatments include venoactive drugs for the relief of symptoms of CVD 





1.8.2 Interventional treatment 
Sclerotherapy is the injection of an irritant into an empty vein, resulting in complete 
venous destruction (Worthington-Kirsch 2005).  According to a consensus statement, it 
is the preferred treatment for obliterating telangiectases and reticular veins without 
reflux (Baccaglini 1997).  Although sclerotherapy can treat varicose veins, it cannot 
cure the underlying pathology and therefore cannot prevent new varices forming 
(Baccaglini 1997).  As a result, it is often used in conjunction with surgical procedures 
in the correction of CVD (Eberhardt 2005).  Complications of sclerotherapy include 
hyperpigmentation of the surrounding skin over the thrombosed vein and 
thrombophlebitis (Simpson 2004). 
 
Recent advances in interventional treatment include endovascular radiofrequency or 
laser therapy ablation, in which controlled thermal energy, damages the vein wall 
leading to thrombosis, fibrosis and vein obliteration (Eberhardt 2005).  This technique 
can be used an alternative to surgery when there is reflux in the GSV.  Both techniques 
have reported high obliteration rates and improvement of symptoms (Merchant 2002, 
Min 2003).  Furthermore, two randomised controlled trials determined that they are 
associated with fewer complications and a faster recovery time than surgery (Darwood 










1.8.3 Surgical treatment 
Surgical treatment of superficial reflux involves removing the saphenous vein (Bergan 
2004).  Methods of removing the GSV include “ligation alone, ligation with groin to knee 
stripping and ligation with ankle to groin stripping” (Meissner 2007a).  Ligation 
without stripping has been deemed inadequate as the competent vein left in the thigh 
continues to reflux (Cheatle 2005).  Ligation and stripping of the GSV has been shown 
to improve venous haemodynamics, eliminate concomitant deep venous reflux, provide 
symptomatic relief and assist in ulcer healing (MacKenzie 2004, Padberg 1996).  
However, approximately one-third of patients develop recurrent varicose veins after 
surgery (Fischer 2001).  Neovascularisation in the groin causes recurrence after 
saphenous stripping and is commonly seen following this procedure (Fischer 2002).   
 
1.8.4 Management of venous leg ulcers 
There is wide variation in the management of venous leg ulcers including hospital and 
primary care clinics and home visits.  Aggressive wound care is required to minimise 
infection.  A variety of hydrocolloids and foam dressings control wound fluid drainage 
and resultant maceration of the skin.  In the presence of an infected ulcer, silver-
impregnated dressings have been effective in controlling infection and restoring tissue 
integrity.  Surgical repair of deep venous valves is an effective procedure in patients 
with a non-healing ulcer (Meissner 2007a), with high rates of healing success  at 5 







1.9 THE EDINBURGH VEIN STUDY 
 
The Edinburgh Vein Study was the first large scale study in the United Kingdom to 
measure CVD in the general population.  It was a cross-sectional survey which 
measured the prevalence of varicose veins and CVI.  Additionally, it aimed to establish a 
cohort of men and women in the general population as a basis for future studies to 
examine the natural history, estimate the incidence and identify risk factors associated 
with the development of CVD. 
 
Between 1994-1996 men and women aged 18-64 years were randomly sampled from 
the registers of twelve general practices in Edinburgh.  In total, 1,566 people took part 
and underwent a clinical examination of their legs.  The examination included a self-
administered questionnaire, height and weight, leg examination and classification of 
CVD using the Basle system, plus photographs, duplex scanning of the deep and 
superficial systems of both legs.   
 
The age-adjusted prevalence of trunk varices (grades 1-3) was 39.7% in men and 
32.2% in women.  The majority of affected subjects had mild (grade 1) trunks.  
Telangiectases and reticular varices were very common, each affecting over 80% of 
subjects.  The age-adjusted prevalence of CVI was 9.4% in men and 6.6% in women.   
Risk factors measured included pregnancy, family history of venous disease, smoking, 
mobility at work, obesity and fibre intake.  No consistent association was shown with 
any risk factor.  Results suggested that obesity might to be a risk factor for varicose 





1.10 CHAPTER SUMMARY 
 
This chapter has outlined the symptoms and pathophysiology of CVD, its diagnosis and 
treatment.  The Edinburgh Vein Study was one of the first large-scale studies of venous 
disease in a UK population.  Results on the prevalence of CVD and associated risk 
factors have been presented previously (Evans 1999, Lee 2001).  The study was 
designed with the aim that participants at baseline would form a cohort who could be 
followed up, in order to measure the incidence of CVD and identify factors that 
predispose individuals to this condition.  This PhD thesis is based on the design and 














FIGURE 1.1 VENOUS SYSTEMS OF THE LOWER LIMB 
 
 





FIGURE 1.2 DEEP VEINS OF THE LEG 
 
 





FIGURE 1.3 SUPERFICIAL VEINS 
 
 
Figure reprinted with permission from Total Vein Care. 
 
Footnote:  
(a) Long saphenous vein now termed great saphenous vein 





FIGURE 1.4 PERFORATING VEINS OF THE LEG 
 
 







FIGURE 1.5 VENOUS VALVES 
 
 
Figure reprinted with permission from Nucleus Medical Media. Inc. 
 
Footnote:  
(a) Upward blood flow through an open valve 
(b) Competent valve with the cusps fully closed preventing reverse blood flow 
(reflux) 
(c) Incompetent valve where the cusps fail to close completely resulting in reverse 
blood flow (reflux) 
 
 




FIGURE 1.6 ACTION OF THE CALF MUSCLE PUMP 
 
 
Figure reprinted with permission from Queen’s Printer for Ontario. 
 
Footnote:  
(a) Calf muscle is relaxed, the valve is open and blood accumulates in the vein 
(b) Calf muscle contracts squeezing blood into the vein, the valves are closed 
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FIGURE 1.8 C1 RETICULAR VEINS 
 
 





FIGURE 1.9 C2 VARICOSE VEINS 
 
 





FIGURE 1.10 C3 CORONA PHLEBECTATICA 
 
 




FIGURE 1.11 C3 OEDEMA 
 
 




FIGURE 1.12 C4a  PIGMENTATION 
 
 




FIGURE 1.13 C4a  VENOUS ECZEMA 
 
 




FIGURE 1.14 C4b LIPODERMATOSCLEROSIS 
 
 




FIGURE 1.15 C4b ATROPHIE BLANCHE 
 
 




FIGURE 1.16 C5 HEALED VENOUS ULCER 
 
 





FIGURE 1.17 C6 ACTIVE VENOUS ULCER 
 
 




FIGURE 1.18 COLOUR FLOW DUPLEX ULTRASOUND IMAGE 
 
 




CHAPTER 2: LITERATURE REVIEW 
 
 
2.1 CHAPTER OUTLINE 
 
This chapter reviews the available evidence from the literature on the epidemiology of 
CVD.  Firstly the search strategy used to retrieve relevant will be briefly outlined.  The 
prevalence of C2 varicose veins and C3-C6 chronic venous insufficiency from various 
studies will then be reviewed and variations according to age, gender and race 
discussed.  Evidence on proposed risk factors for C2 varicose veins and C3-C6 CVI will 
also be summarised. 
 
2.2 SEARCH STRATEGY 
 
A literature search was conducted.  Electronic databases searched included Medline, 
Embase, Cinahl and Current Contents.  Keywords used included “varicose veins”, 
“chronic venous insufficiency”, “chronic venous disease/disorder”, “venous ulceration”, 
“venous reflux” and “risk factors”.  In addition, the reference lists of articles were hand 
searched for relevant studies.   Various health services research resources such as NHS, 
National Institute for Clinical Effectiveness (NICE), Scottish Intercollegiate Guidelines 
Network (SIGN), Health Technology Assessment (HTA), and the Cochrane Library were 




2.3 VARICOSE VEINS 
 
2.3.1 Prevalence of varicose veins 
The prevalence of varicose veins ranges from 2% to 57% in men and from <1% to 68% 
in women [Table 2.1].  This variation can be partly explained by differences in the study 
samples in terms of age, gender and race.  In the majority of studies, a minimum age of 
15-18 years was used, although one study included children of 10 years (Coon 1973).  
Some used specific age groups (Carpentier 2004, Ducimetiere 1981, Kontosic 2000, 
Laurikka 1993, Leipnitz 1989) while two only included patients over 60 years old 
(Canonico 1998, Komsuoglu 1994).  Many used selected populations such as 
occupational groups (Ducimetiere 1981, Guberan 1973, Hirai 1990, Malhotra 1972, 
Mekky 1969, Sam 2007, Stvrtinova 1991), or of hospital patients (Franks 1992, Hirai 
1990, Jawien 2003, Komsuoglu 1994, Maffei 1986, Pospíšilová 2008, Richardson 1977).  
Some studies completed in New Guinea (Stanhope 1975) or Tanzania (Richardson 
1977) may not be generalisable to the wider population. 
  
Population surveys including the whole study population or a stratified random 
sample, are considered to be the most accurate method of measuring the true 
prevalence of a disease (Petrie 2000).  If the sample is representative, generalisations 
can be made in relation to the wider population (Bowling 1997).  To date, fifteen 
general population surveys of varicose veins have been conducted (Abramson 1981, 
Canonico 1998, Carpentier 2004, Chiesa 2005, Coon 1973, Criqui 2003, Evans 1999, 
Franks 1992, Komsuoglo 1994, Jawien 2003, Laurikka 2002, Preziosi 1999, Rabe 2003, 
Sisto 1995, Widmer 1978).  Table 2.2 compares the prevalence from these surveys by 




Four surveys used self-administered questionnaires to determine the prevalence of 
varicose veins.  Three of these relied on the participant’s own observations (Franks 
1992, Komsuoglo 1994, Laurikka 2002).  Self-diagnosis of varicose veins is a method of 
data collection proven to be prone to error (Krijnen 1997, Weddell 1969).  The fourth 
was based on the participant’s report of a previous diagnosis of varicose veins made by 
a doctor (Sisto 1995).  The prevalence in this study was 6.8% in men compared to 
24.6% in women.  The significantly lower prevalence observed in men could be due to 
the fact that they may be more reluctant to consult their doctor about varicose veins. 
 
In the other eleven surveys, patients were examined for the presence of varicose veins 
(Abramson 1981, Canonico 1998, Carpentier 2004, Chiesa 2005, Coon 1973, Criqui 
2003,, Evans 1999, Jawien 2003, Preziosi 1999, Rabe 2003,  Widmer  1978).  Three of 
these surveys were conducted before the introduction of the CEAP classification and 
the prevalence ranged from 10-56% (Abramson 1981, Coon 1973,  Widmer  1978).  
These estimates may be less precise due to the lack of uniform measurement of 
varicose veins.  In the seven surveys that used the C2 CEAP definition of varicose veins, 
the prevalence was more constant, ranging from 10-39% in men and 15-50% in women 
(Carpentier 2004, Chiesa 2005, Criqui 2003, Evans 1999, Jawien 2003, Preziosi 1999, 
Rabe 2003).  One survey did not used CEAP to measure varicose veins, but instead 
defined them as “any reticular or truncal visible varicosity” (Canonico 1998).  As 
reticular veins are classified as C1 according to CEAP, the results of this study are not 
comparable with other studies which used the C2 CEAP definition of varicose veins.  
Furthermore, as reticular veins are relatively common in the general population, their 





2.3.2 Prevalence of varicose veins by age  
Evidence on the association between age and varicose veins is relatively conclusive, as 
the majority of studies suggest that the prevalence increases with increasing age 
(Abramson 1981, Arnoldi 1958, Canonico 1998, Carpentier 2004, Chiesa 2005, Coon 
1973, Criqui 2003, Evans 1999, Franks 1992, Guberan 1973, Hirai 1990, Komsuoglu 
1994, Laurikka 1993,  Malhotra  1972, Mekky 1969, Novo 1988, Preziosi 1999, Sadick 
1992, Sisto 1995, Stvrtinova 1991,  Weddell  1969).   
 
At baseline in the Edinburgh Vein Study, the overall prevalence of C2 varices increased 
from 11.5% in 18-24 year olds to 55.7% in those aged 55-64 years (p=0.001) (Evans 
1999).  The San Diego population study reported a prevalence of 16.9% in subjects 
aged less than 50 years which rose to 29.9% in subjects aged over 70 years (Criqui 
2003).  In a population study with a random sample of 1,319 men and women aged 
over 65 years, the prevalence of varicose veins did not increase significantly beyond 
this age (p=0.75) (Canonico 1998).  
 
2.3.3 Prevalence of varicose veins by gender 
Many studies have shown that varicose veins are more common in women than in men 
(Abramson 1981,  Arnoldi  1958, Beaglehole 1975, Canonico 1998, Carpentier 2004, 
Coon 1973, Criqui 2003, Franks 1992, Jawien 2003, Komsuoglu 1994, Kontosic 2000, 
Laurikka 1993, Leipnitz 1989, Maffei 1986, Novo 1988,  Pospíšilová  2008, Preziosi 
1999, Rabe 2003, Sisto 1995,  Weddell  1969) [Tables 2.1 and 2.2].  In a population-
based study in Italy, the prevalence of was twice as high in women as in men 
(p<0.0001) but only participants aged over 65 years were included in the study 




Selection bias may have occurred in some of these studies.  Aesthetically, women may 
be more aware of their varicose veins than men and may consider them to be more of a 
problem for cosmetic reasons.  Consequently, women may be more likely to participate 
in varicose vein research.  It is also important to consider than many of the results from 
these studies have not been adjusted for age, pregnancy and hormonal factors. 
 
There are several studies which found a higher prevalence in men.  In the Edinburgh 
Vein Study, the age-adjusted prevalence of trunk varices in men was 40% compared to 
35% in women (p=0.01).  In the Bochum Study, by the age of 18-20 years, the male 
schoolchildren had a higher prevalence of varicose veins than females (Schultz-
Ehrenburg 1992).  However statistical tests of significance were not reported for these 
results.   
 
In addition to selection bias, methods of assessing varicose veins may also introduce 
bias in prevalence figures.  Studies relying on self-assessment (Franks 1992, 
Komsuoglu 1994, Laurikka 1993) or previous diagnosis by a doctor (Sisto 1995) may 
have under-reported the prevalence in men, as they may be less likely to report 
varicose veins or consult their doctor about them than women.  This hypothesis is 
supported by findings from the baseline Edinburgh Vein Study (Evans 1999).  Prior to 
examination, only 10% of men reported a previous diagnosis of varicose veins made by 
a doctor compared with 17% of women, despite the fact that men were subsequently 





2.3.4 Prevalence of varicose veins by race 
Geographical variations in the prevalence of varicose veins suggest a possible 
correlation with race [Table 2.1].  Several studies demonstrate that varicose veins are 
rare in Africa compared with Western countries (Abramson 1981, Richardson 1977,  
Stanhope  1975).  A study in Jerusalem found that men born in North Africa had a 
significantly lower age-adjusted prevalence than immigrants from Europe, America and 
Israel (Abramson 1981).  Another study comparing female cotton workers in England 
and Egypt observed a significantly increased prevalence in English women compared 
with Egyptian women (Mekky 1969).   In Brazil, a large study of 1,755 participants 
diagnosed using the Basle classification system, showed a significantly higher 
prevalence of varicose veins in Caucasians than non-Caucasians (Maffei 1986).  Other 
variations include a higher prevalence in railroad workers from the South compared to 
the North of India (Malhotra  1972) and a lower prevalence in women of Southern 
Europe compared with Northern Europe (Guberan 1973).  This finding was 
contradicted by the 24-cities Cohort Study in Italy where the prevalence of varicose 
veins was 26% in Northern Italy compared to 42% in Southern Italy (Chiesa 2005). 
 
Authors have suggested a possible etiologic role of lifestyle or behavioural patterns in 
the countries of origin.  Ethnic or social factors, diabetes, the habit of sitting in a chair 
and food fibre intake are other contributing factors proposed in the relationship 








2.3.5 Incidence of varicose veins 
The incidence of varicose veins refers to the development of new cases over a period of 
time in a population initially free of disease.  Few studies have measured the incidence 
of varicose veins.  The Framingham Study was a longitudinal study that followed up 
men and women living in Framingham, USA (Brand 1988).  Every two years from 1966 
over a 16-year period, participants were examined for varicose veins, defined as ‘the 
presence of distended and tortuous veins, clearly visible on the lower limbs with the 
subject standing’.  Over the 16 years, 396 of 1720 men and 629 of 2012 women initially 
free of disease developed varicose veins.  On average, the two-year incidence rate of 
varicose veins was 39.4 per 1000 for men and 51.9 per 1000 for women.   
 
The Bochum study in Germany examined schoolchildren on three occasions over an 8 
year period (Schultz-Ehrenburg 1992).  At the first examination, none of the children 
aged 10-12 years, had trunk varices, although there was already venous reflux present 
in the great and small saphenous veins in 2.5% of the children on Doppler examination.    
At age 14-16 years, 1.7% of the children had trunk varices and 0.8% had varices of the 
tributary veins while 12.3% had saphenous reflux.  This prevalence of trunk and 
tributary varices increased to 3.3% and 5.0% by age 18-20 years, with a prevalence of 
19.8% for saphenous reflux on Doppler examination.  The Bonn Vein Study examined 
1,978 participants and the incidence of C2 varices was 13.7% over the 6.6 year follow 








2.4      C3-C6 CHRONIC VENOUS INSUFFICIENCY 
 
2.4.1 Prevalence of CVI 
There have been many studies on the prevalence of leg ulceration and several on CVI. 
The sex-stratified estimates of prevalence of CVI in different studies, is presented in 
Table 2.3.  The wide variation in prevalence may be due to the different sampling 
methods, ages of the sample population, and definitions of chronic ulceration.   
 
2.4.2 Prevalence of CVI by age 
Evidence suggests that the prevalence of CVI increases with age.  At baseline in the 
Edinburgh Vein Study, the prevalence of CVI increased linearly with age for both sexes 
(Evans 2002).  The prevalence of all CVI was 25% (95% CI 19.3-31.6) in men and 12.3 
(95% CI 8.2-17.2) in women aged 55-64 years (p<0.001).   In a cross-sectional study of 
a multi-ethnic sample of 2,211 men and women in San Diego, Criqui et al, reported the 
prevalence of trophic skin changes in all subjects < 50 years, 50-59 years, 60-69 years 
and ≥70 years were 2.3%, 4.0%, 8.8% and 10.2%, respectively (Criqui 2003).  In a case-
control study, Scott et al observed a 6% increase in risk of CVI per one year increase in 
age (OR 1.1, 95% CI 1.0-1.1) (Scott 1995).  In Tecumseh, USA the prevalence of venous-
related oedema and skin changes increased from 1.8% in women aged 30-39 years to 









2.4.3 Prevalence of CVI by gender 
While the occurrence of varicose veins is usually reported to be more common in 
women, results with respect to CVI have been inconsistent [Table 2.3].  The prevalence 
appears to vary according to the severity of disease.  For stage C3 including corona and 
oedema, three studies (Carpentier 2004, Chiesa 2005, Rabe 2003) reported a higher 
prevalence in woman. For C4 trophic skin changes including eczema and 
lipodermatosclerosis, the prevalence was higher in women three studies (Coon 1973, 
da Silva 1974, Komsuoglu 1994) but higher in men in five studies (Carpentier 2004, 
Chiesa 2005, Criqui 2003, Rabe 2010,  Widmer  1978).  Gender differences on 
prevalence for healed and active venous ulceration were conflicting with six studies 
reporting a higher prevalence in men (Carpentier 2004, Chiesa 2005, Coon 1973, Criqui 
2003, da Silva 1974, Franks 1992), two studies reporting a higher prevalence in women 
(Arnoldi  1958, Komsuoglu 1994) and two reporting no difference in prevalence by 
gender (Rabe 2010,  Widmer  1978).  At the baseline stage of the Edinburgh Vein Study, 
the prevalence of CVI was higher in women up to 45 years of age and then was more 
frequent in men (Evans  2002).  Among those aged 55-65 years, the overall prevalence 
of CVI in men was double that in women (25.3% versus 12.3%, p<0.001).  In Tecusmeh, 
USA, 37% of women and 3.0% of men had skin changes (Coon 1973).  The marked 
gender difference was not demonstrated by the Edinburgh Vein Study which found that 









2.4.4 Incidence of CVI 
Very little research has been done on the incidence of CVI in healthy populations.  The 
Bonn Vein Study II examined 1978 participants after a 6.6 year follow up and reported 
an incidence of 13.0% for CVI (Rabe 2010).   However authors do not stipulate the class 
of CVI nor how the incidence was measured.  It is unclear if the incidence was based on 
participants free of C2 varices or C3-C6 CVI at baseline.  It is important to know if a 
participant in this study who had C3 CVI at baseline but progressed to C4 CVI at follow 
up, was included in this incidence calculation.  Such an example is a measure of disease 
progression rather than incidence. 
  
2.5      RISK FACTORS FOR VARICOSE VEINS AND CVI 
 
Predisposing factors for venous disease are difficult to establish due to the interplay of 
environmental and genetic elements.  Consequently the question over whether varicose 
veins are due to an inherited defect or to some environmental influence remains.  
Family history of venous disease and pregnancy may both be factors in the 
development of varicose veins.  A case also exists for the role of weight.  Aggravating 
factors such as diet and long hours spent standing have been emphasised.  These risk 
factors will now be discussed. 
 
2.5.1 Family history 
There is a general consensus that defective valves are the cause of varicose veins.  This 
can be an inherited problem where people are born with too few valves or valves that 
do not function properly.  Others can be born with abnormalities of the vein wall 
causing the valves to separate and become leaky. 
70 
 
Several studies have reported that the risk of varicose veins is higher in those with a 
family history of venous disease (Carpentier 2004, Cornu-Thenard 1994, Criqui 2007, 
Dindelli 1993, Hirai 1990, Komsuoglu 1994, Kröeger 2004, Laurikka 2002, Lee 2003, 
Mekky 1969,  Sadick  1992, Schultz-Ehrenburg 1992, Scott 1995, Stvrtinova 1991,  
Weddell  1969) [Table 2.4].   
 
Two studies examined family members to clinically diagnose varicose veins (Cornu-
Thenard 1994,  Weddell  1969).  One study examined 134 families: 67 varicose veins 
cases and their parents, and 67 controls and their parents (Cornu-Thenard 1994).   In 
total, 402 participants were examined for varicose veins defined as “the presence of a 
permanent dilatation of a subcutaneous vein of the lower limb visible and tortuous”.  
The prevalence of varicose veins was 90% in those with a history of varices in both 
parents, 25% in males and 62% in females with one parent affected, and 20% in those 
with no family history.  Only 76 families were included in the second study and it is 
probably too small to draw any meaningful conclusions (Weddell  1969). 
 
The remaining studies relied on self-reporting of family history.  In the Edinburgh Vein 
Study, the odds ratios for varicose veins were 1.5 (95% CI 1.0-2.3) in men and 2.2 (95% 
CI 1.4-3.4) in women with a positive family history (Lee 2003).  Three other large 
cross-sectional studies reported higher odds ratios.  Carpentier et al. studied 835 
participants and measured odds ratios of 3.5 (95% CI 1.9-6.5) and 3.5 (95% CI 2.4-5.1) 
for men and women respectively (Carpentier 2004). In the San Diego Population Study 
of 2,211, the odds ratios were 2.9 (95% CI 1.8-4.6) in men and 2.3 (95% CI 1.8-3.1) in 
women (Criqui 2007).  Finally The Tampere Study estimated an odds ratio of 4.9 (95% 





In a study of 541 Japanese women, 42% of subjects with varicose veins reported a 
positive family history compared with just 14% of women without disease (Hirai 
1990).  However, this difference diminished with increasing age.  Another study 
reported that patients with varicose veins were 21.5 times more likely to report a 
positive family history compared with controls (p=0.0001) (Scott 1995).  A study in the 
Czech republic reported that 87% of varicose veins patients had a positive family 
history of venous disease (Pospíšilová  2008).  However, participants in this study were 
patients at a phlebology clinic and were selected on the basis that they had varicose 
veins.  There was no control group. 
 
There is less evidence regarding family history and CVI and it is inconsistent.  One 
study reported an odds ratios of 7.2 (95% CI 4.6-11.0) in men and 7.7 (95% CI 5.9-9.9) 
in women for CVI with a positive family history (Gourgou 2002).  A case-control study 
of 102 cases with venous ulcer and 200 controls with no ulcer reported that family 
history of maternal venous insufficiency was a risk factor for venous ulcer (adjusted OR 
6.9, 95% CI 1.9-24.3) but paternal history was not (adjusted OR 1.2, 95% CI 0.5-2.9) 
(Bérard 2002).  Interestingly the case-control study by Scott et al. which reported a 
high risk for varicose veins, showed no association between family history and CVI 
(Scott 1995). 
 
The results of studies relying on self-reported family history must be interpreted with 
caution.  Varicose veins are a common problem and therefore, a large proportion of 
study subjects would report a positive family history.  Those with venous disease 
would probably be more aware of the occurrence of disease among family members 





It has been hypothesised that the increase in intra-abdominal pressure, combined with 
the direct pressure exerted on the iliac veins by the uterus during pregnancy, obstructs 
venous return from the leg.  Consequently venous valves rupture, reflux develops and 
varicose veins form (Cordts 1996).  However, this has been refuted as the majority of 
varices appear during the first three months of the pregnancy (McCausland 1939, 
Mullane 1952, Rose 1986) when the uterus is not large enough.  Furthermore, varicose 
veins often disappear after birth (Evans 1994).  Two studies using ultrasound, 
confirmed that the diameters of competent and incompetent great and small saphenous 
veins increase significantly during the first trimester of pregnancy (p<0.001) but return 
to baseline values during the postpartum period (Boivin 2000, Cordts 1996).   
 
The association between pregnancy and varicose veins may have a hormonal 
component.  Saphenous veins contain oestrogen and progesterone receptors and 
although their function is unknown, it has been postulated that the increase in 
hormones circulating through the blood in pregnancy may cause these receptors to 
mediate venous dilation and cause valve failure (Masiah 1999).  Contrary to this theory, 
the number of pregnancies in developing countries is far higher than Westernised ones, 
yet the prevalence of varicose veins is lower in the former.  It remains unclear whether 
pregnancy is an independent risk factor for varicose veins or whether it simply 








The majority of studies show an association between varicose veins and pregnancy 
(Abramson 1981, Carpentier 2004, Chiesa 2005, Criqui 2007, Dindelli 1993, Guberan 
1973, Hirai 1990, Komsuoglu 1994, Laurikka 2002, Maffei 1986, Mekky 1969, 
Richardson 1977, Sisto 1995, Stvrtinova 1991,  Weddell  1969,  Widmer  1978) [Table 
2.5].  The Edinburgh Vein Study found no association between pregnancy and varicose 
veins (Lee 2003).  However, in the same study, pregnancy was implicated as a risk 
factor for venous reflux (Fowkes 2001). 
 
Several studies report that women with at least one pregnancy have a higher 
prevalence of varicose veins than childless women (Abramson 1981, Carpentier 2004, 
Chiesa 2005, Dindelli 1993, Komsuoglu 1994, Maffei 1986, Stvrtinova 1991,  Widmer  
1978).  A study of 611 women in Italy reported an age-adjusted odds ratio of 2.0 (95% 
CI 1.3-2.9) with one or more pregnancies (Dindelli 1993).  Three large population-
based studies on a total of 7,279 female participants confirmed the association between 
pregnancy and varicose veins (Carpentier 2004, Chiesa 2005,  Widmer  1978).  The 
Basle Study of 2,264 female employees demonstrated a significantly higher age-
adjusted prevalence of trunk varices in parous women (Widmer  1978) while in a 
French study of 558 female participants, the odds ratio of varicose veins was twofold in 
women with at least one pregnancy compared to nulliparous women (p=0.007) 
(Carpentier 2004).  Finally, in the Italian 24-Cities Cohort Study of 4,457 female 
participants, the prevalence of varicose veins was 20%, 35% and 50% in women with 
0, 3 and 4 pregnancies respectively.  Crucially, in these three studies, all patients were 






Evidence also suggests a positive relationship between prevalence of varices and an 
increasing number of pregnancies (Chiesa 2005, Dindelli 1993, Laurikka 2002, Sisto 
1995), although only in one study was the effect independent of age (Sisto 1995).  In 
the Tampere study of 3,101 women, the prevalence of varicose veins with 0, 1, 2, 3, and 
4 or more pregnancies were 32%, 38%, 43%, 48%, and 59%, respectively (Laurikka 
2002) while in the Mini-Finland Health Survey the odds ratio for varicose veins was 1.4 
(95% CI 1.0-1.9) in women with one pregnancy and 3.0 (95% CI 2.3-4.1) in women 
with five pregnancies (Sisto 1995).  However, in both studies, women self-diagnosed 
varicose veins through a questionnaire and no validation of this method of assessment 
was performed.  The Tecumseh Community Health Study (Coon 1973), the 
Framingham Study (Brand 1988), and several other studies (Abramson 1981, Hirai 
1990, Richardson 1977, Scott 1995) failed to show a rising prevalence with increasing 
number of pregnancies.   
 
Evidence on the association between pregnancy and CVI is limited.  A case control 
study of 102 cases with venous ulcer and 200 controls without determined that 
pregnancy was associated with venous ulceration (OR 1.2, 95% CI 1.0-1.5) (Bérard 
2002).  However the odds ratio was not adjusted for age, a confounding factor in 
venous leg ulceration.    A case-control study by Scott reported that women with CVI 
had more pregnancies than those with varicose veins but this association disappeared 








2.5.3 Oral contraceptives 
Very few studies have investigated the effect of oral contraceptives on varicose veins.  
One case-control study reported that women with varices were more likely to use oral 
contraceptives than women free of varices ( Sadick  1992).  In contrast, the Basle Study 
(Widmer  1978), the Mini-Finland Health Survey (Sisto 1995) and a case-control study 
in North America (Scott 1995), all reported no association between varicose veins and 
oral contraceptive use.  It should be noted that the oral contraceptive pill was 
introduced in Switzerland only four years before the Basle Study and therefore the 
exposure period was very short.  A limitation of studies measuring the relationship 
between oral contraceptives and varicose veins is selection bias.  The risk of the pill on 
venous disorders such as deep vein thrombosis is well known and may influence a 
woman’s decision to participate in the research study.   
 
2.5.4 Hormone replacement therapy 
Results of studies on the association between postmenopausal hormone replacement 
therapy (HRT) and varicose veins are inconsistent.  In the Mini-Finland Health Survey 
the age-adjusted prevalence of varicose veins in women aged over 50 years was 35% in 
women taking HRT compared with 27% in those not taking it.  The result was 
statistically significant but this survey diagnosed varicose veins by a questionnaire  
(Krijnen 1997).  Two population-based studies investigated the use of HRT but neither 
found it to be associated with varicose veins (Carpentier 2004, Lee 2003).  One 
population-based study reported that varicose veins developed after the menopause in 
38% of 759 female participants (Canonico 1998).  However, participants were aged 






It has been postulated that in obese patients, fat tissue augments surrounding veins 
thus impeding the normal exchange of blood between deep and superficial veins 
(Lemaire 1988).  One study which measured the cross-sectional area of the 
saphenofemoral and great saphenous veins, reported significant associations with 
increased BMI for both veins (p<0.0001) (Kröeger 2003).  It should be noted that the 
association was only tested in those with C0 CEAP.   
 
Several studies have shown that BMI is associated with varicose veins.  However not all 
studies showed an association (Dindelli 1993, Hirai 1990).  The Basle Study ( Widmer  
1978), Framingham Study (Brand 1988) and a study of 4,488 participants in Jerusalem 
(Abramson 1981) all reported a significant association between trunk varices and BMI 
but no comparable effect in men.  In an Italian study, the prevalence of varicose veins 
increased significantly with BMI for women (p<0.0001) but not for men (p=0.54) 
(Canonico, 1998 70 /id).  The Edinburgh Vein Study confirmed these findings (Lee 
2003).  A study of 104 postmenopausal women in Italy found that obesity, measured as 
BMI > 30 kg/m2, was significantly associated with varicose veins (OR 5.8, 95% CI 1.2-
28.2) after adjusting for age and sex hormones (Iannuzzi 2002).  This study also 
reported that varicose veins were associated with increased hip and thigh 
circumference (p = 0.04) but not waist circumference (p=0.21) supporting the theory 
that excess fat may impact venous circulation in the lower limbs.  Since it is unlikely 
that obesity is a risk factor for one sex and not the other, it may be the case that being 
overweight merely accelerates the development of varicose veins in individuals already 





Additionally, the association was maintained across increasing grades of severity in 
women.  The weight of women with grades 0, I, II and III varicose veins increased 
linearly from 66kg, 68 kg, 73 kg and 74 kg (p≤0.0001) while the corresponding BMI 
also increased linearly from 25, 26, 27 and 28 kg/m2 (p≤0.0001).  However there was 
no association for height.  This is supported by several other studies who found obesity 
to be a risk factor in women only (Brand 1988, Canonico 1998, Gourgou 2002, Kontosic 
2000, Mekky 1969, Sisto 1995).  Seidell et al. found that moderately overweight women 
(BMI = 25.0-29.9 kg/m2) were more likely to have varicose veins (OR 1.5, 95% CI, 1.2-
1.9) than women of a normal weight.  Furthermore, obese women (BMI = ≥ 30.0 kg/m2) 
were three times more likely to have varicose veins (Seidell 1986).  In a female 
population in Switzerland, although there was an increased prevalence of varicose 
veins with increasing body weight, the association was not significant after adjusting 
for age (Guberan 1973) 
 
Evidence suggests that obesity is particularly associated with the more severe forms of 
varicose veins, especially in women (Brand 1988, Lee 2003,  Widmer  1978).  However 
these studies did not adjust for parity and given the fact that parous women tend to 
have a higher average body weight than nulliparous women, this may have been a 
confounding factor in the association between obesity and varicose veins. 
 
There are fewer studies on CVI and obesity.  One case control study found no 
association between BMI > 27 kg/m2 and venous ulceration (Bérard 2002).  Scott et all 
reported an age-adjusted odds ratio of 1.06 kg/m2 (95% CI 1.0-1.1) for CVI patients 
versus controls with no venous disease and an age-adjusted odds ratio of 1.07 kg/m2 




2.5.6 Mobility at work 
Certain occupations, in particular those involving prolonged standing and/or heavy 
lifting at work, have been proposed as risk factors for varicose veins.  Standing for 
prolonged periods of time results in increased hydrostatic pressure which leads to 
impeded blood flow and stasis in the leg veins.   Increase in pressure can also impair 
the function of the calf muscle pump, which is important for the venous return of blood.  
The calf muscle pump does not suffer during walking because of the activation of the 
leg muscle pump (Krijnen 1997) 
 
Several studies reported that a standing occupation is associated with an increased 
prevalence of varicose veins (Abramson 1981, Brand 1988, da Silva 1974, Gourgou 
2002, Kakande 1981, Lee 2003, Mekky 1969, Pinto 1995,  Sadick  1992, Scott 1995, 
Sisto 1995, Stvrtinova 1991).  A few studies however, found no association (Canonico 
1998, Guberan 1973, Maffei 1986,  Malhotra  1972, Weddell  1969).  A community 
study of 4,488 men and women in Jerusalem, Israel reported an odds ratio of 1.6 for 
standing at work compared to little standing and the association remained significant 
after adjusting for age and sex (p<0.01) (Abramson 1981).  One study found that, while 
there was no association with standing at work, there was a correlation with heavy 
lifting.  The prevalence of varicose veins was significantly higher in men who lifted 
heavy objects at work (43%) compared to those who did not (21%).  The same was 
true for women, where the prevalence of varicose veins was 59% in those who lifted 
heavy objects compared to 33% who did not.  Both associations were statistically 






In the Framingham Study, authors reported that the number of hours spent each day in 
sedentary activities was significantly associated with the incidence of varicose veins in 
women (Brand 1988).  When incidence rates were adjusted based on type of work that 
was done, women with four or less hours a day of sedentary activities had a 2-year 
adjusted incidence rate of varicose veins of 57/1,000.  Women with eight or more 
hours a day of sedentary activity had a 2-year adjusted incidence rate of 74/1,000.  In 
men the differences (44/1,000 and 48/1,000 respectively) were not significant.   
 
One large population-based 12-year follow up study in Denmark analysed 
hospitalisations due to varicose veins according to ICD and national hospital registers.  
In total 40 men and 71 women were admitted to hospital requiring treatment for 
varicose veins.  For those who stood for prolonged periods of time (defined as seldom 
or never sitting) the pooled estimate of the adjusted relative risk was 1.8 (95% CI 1.2-
2.7) while adjusted relative risk was 1.7 (95% CI 0.9-3.3) among men and 1.8 (95% CI 
1.1-2.9) among women (Tüchsen 2005).   
 
Care should be taking in drawing conclusions from studies on mobility at work given 
the difficulty in retrospectively ascertaining participants’ workplace posture, 
particularly over many years of work.  In the Edinburgh Vein Study, mobility was 
measured in relation to the amount of time spent sitting, standing, walking or heavy 
lifting at work.  Although standing may be an aggravating factor for venous disease, it is 
unlikely to be a primary cause.  For example, there is no evidence that Africans stand 
for less time than Europeans, yet the prevalence of venous disease in the former is 





2.5.7 Physical activity 
Physical activity has also been suggested as a risk factor for venous disease due to the 
functional changes that occur during exercise.  The Framingham Study reported that 
men and women with varicose veins were less physically active than those with no 
varices (Brand 1988).  In contrast, a study of women working in a department store in 
Slovakia, found no significant association between the prevalence of varicose veins and 
physical activity levels (Stvrtinova 1991).  Conversely, a case-control study carried out 
in America found that cases with varicose veins reported the highest frequency of 
exercise compared with a control group with no varices but this association diminished 
after adjusting for age (Scott 1995).  It is important to consider that the presence of 
distended varicose veins are often painful and thus may influence the level of activity 
chosen by the individual.  As such, physical activity levels may have diminished as a 
result of this rather than the lack of physical activity causing the initial varicosity.   
 
One case control study of 102 cases with venous ulcers and 200 controls reported an 
odds ratio of 8.9 (95% CI 1.1-72.0) for ulceration in people who had engaged in 
vigorous exercise (e.g. running, football squash).  The odds ratio was not adjusted for 
age but given that the prevalence of leg ulceration is increased in older people who are 
less likely to engage in strenuous physical activity, this is an unexpected finding.   
Physical activity was ascertained for a 20-year period before the study.  There are 
always difficulties in measuring exercise levels over such a long period.  Furthermore, 
study participants may feel like they are being judged and therefore over-report their 







A diet deficient in fibre-rich foods has been proposed as a risk factor for varicose veins.  
It is considered that the lack of fibre causes constipation and the subsequent straining 
to pass a stool, produces an increase in intra-abdominal pressure which, over a period 
of time, causes the leg veins to dilate and changes to occur in the superficial or deep 
venous system (Burkitt 1972).  Another theory is that an overloaded colon could press 
on the iliac veins and obstruct venous return from the legs (Cleave 1959)  
 
Few studies have examined the dietary habits and most are of limited use because they 
often make no allowance for confounding factors.  Constipation was found to be a 
positive risk factor among a study of Sicilian people (Novo 1988).  However, in an 
Israeli population, constipation was shown to have only a weak association with 
varicose veins in women and no association in men.  Two studies found no association 
(Canonico 1998, Mekky 1969).  Results from the Edinburgh Vein Study showed an 
increased risk of saphenous trunk varices in men who reported that they strained at 
the initiation of a bowel movement (Lee 2003) .  In women, there was a suggestion of 
an inverse relationship.  However, fibre intake was unrelated to the prevalence or 
severity of varicose veins in men and women.   
 
2.5.9 Smoking 
Smoking leads to a decrease fibrinolytic activity which has been suggested as a possible 
mechanism for changes in the vein walls (Browse 1977, Cleave 1960).  In the Aachen 
study, increased viscosity and blood clotting was found in patients with venous 





The Framingham Study noted a correlation between cigarette smoking and varicose 
veins in men, but not in women (Brand 1988).  Similarly, a study on French male 
employees (Ducimetiere 1981), a German cohort study (Leipnitz 1989), and an 
American case-control study (Scott 1995) all reported a positive association.  In a study 
by Scott, the association with years smoked diminished after adjusting for age.  
However, not all studies found an association (Abramson 1981, Canonico 1998, 
Carpentier 2004, Franks 1992, Hirai 1990, Komsuoglu 1994, Lee 2003).  Indeed a 
cross-sectional study in Finland study showed that varicose veins were less prevalent 
in women who smoked (Sisto 1995).   Furthermore, a  German study indicated  a 
protective effect of smoking in both genders (Kröeger 2004). 
 
A case-control study in France analysed the effect of smoking in 1,806 cases with lower 
limb venous insufficiency, matched by gender and in 10-year age bands to 1806 
controls with no venous insufficiency (Gourgou 2002).   After adjusting for other risk 
factors, results showed a significant association with smoking.  The odds ratio for 
developing venous insufficiency was 1.8 for those who smoked 10-19 cigarettes a day 
(95% CI 1.4-2.2) and 2.4 for those who smoked 20 or more cigarettes a day (95% CI 
1.8-3.1) (both p<0.001).   
 
Smoking appeared to have a protective effect on venous ulceration in one case-control 
study in Canada (Bérard 2002).  This association disappeared after adjusting for 
exercise levels as smokers were less active than non-smokers.   However this 
contradicts the earlier association reported in the same study that vigorous exercise is 





2.5.10 Social class 
The finding regarding varicose veins and social class have been inconsistent.  One study 
showed a higher prevalence of varicose veins in the lower social classes (Ducimetiere 
1981) whilst others have shown no effect (Scott 1995, Sisto 1995).  At baseline in the 
Edinburgh Vein Study, there was no obvious relationship between social class and the 
prevalence of trunk varices.  The age- and sex-adjusted prevalence was higher in 
manual workers (social classes IIIM-V) than non-manual workers (social classes I-IIIM) 
but the difference did not reach statistical significance (Lee 2003) .  Other studies have 
shown that venous disease is related to other socioeconomic measures such as family 
income and level of education (Abramson 1981, Scott 1995). 
 
2.6 CHAPTER SUMMARY 
 
Although numerous epidemiological studies of CVD have been conducted, the exact 
prevalence remains difficult to determine.  Estimates of the prevalence of varicose 
veins vary widely due to differences in variability of the study populations including 
age, race and gender and method of measuring disease.  Venous ulceration is less 
common, affecting approximately 0.3% of the adult population.  Very little data is 
available on the incidence of CVD.  A universal finding in epidemiological studies is that 
the prevalence of CVD increases with age.  Evidence on the difference in prevalence 
between men and women is less conclusive.  Family history of CVD and prolonged 
standing have been proposed as risk factor but both are prone to bias in research 
studies.  Obesity and pregnancy have been suggested but they may be aggravating 
factors rather than primary causes. Other postulated risk factors include hormonal 





TABLE 2.1 PREVALENCE OF VARICOSE VEINS BY SEX IN STUDIES FROM DIFFERENT COUNTRIES 
 
     PREVALENCE  
FIRST AUTHOR YEAR a  LOCATION STUDY SAMPLE  SAMPLE SIZE MALE (%)  FEMALE (%) 
Arnoldi 1958 Denmark Clinic attendees aged > 25 years 536 40.7 73.2 
Bobek 1966 Bohemia General population aged > 15 years 15,060 6.6 14.1 
Weddell 1966 UK General population aged > 15 years 289 31.0 36.0 
Mekky 1969 Egypt Female cotton workers aged 15-74 years 467 - 5.8 
Mekky 1969 England Female cotton workers aged 15-74 years 504 - 32.1 
Malhotra 1972 India (South) Male railroad workers aged 18-65 years 323 25.1 - 
Malhotra 1972 India (North) Male railroad workers aged 18-65  years 354 6.8 - 
Coon 1973 United States General population aged > 10 years 6,389 12.9 25.9 
Guberan 1973 Switzerland Female store employees aged ≥ 15 years 610 - 29.0 
Beaglehole 1975 Cook Island General population aged 15-64 years 377 2.1 4.0 
Beaglehole 1975 Cook Island General population aged 15-64 years 417 15.6 14.9 
Beaglehole 1975 New Zealand General population aged 15-64 years 721 33.4 43.7 
Beaglehole 1975 Tokelau Island General population aged 15-64 years 786 2.9 0.8 
a
 Year of publication 
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TABLE 2.1 PREVALENCE OF VARICOSE VEINS BY SEX IN STUDIES FROM DIFFERENT COUNTRIES (CONTINUED) 
 
     PREVALENCE 
FIRST AUTHOR YEAR a  LOCATION STUDY SAMPLE  SAMPLE SIZE MALE (%) FEMALE (%) 
Stanhope 1975 New Guinea Rural villagers aged ≥ 20 years 1,457 5.1 0.1 
Richardson 1977 Tanzania Clinic outpatients aged ≥ 18 years 1,000 6.1 5.0 
Abramson 1981 Israel General population aged ≥ 15 years 4,802 10.4 29.5 
Ducimetiere 1981 France Male employees aged 42-53 years 7,425 26.2 - 
Maffei 1986 Brazil Patients aged > 15 years 1,755 37.9 50.9 
Novo 1988 Italy Villagers 1,122 19.3 46.2 
Leipnitz 1989 Germany Random sample aged 45-65 years 2,821 14.5 29.0 
Hirai 1990 Japan Hospital patients and staff aged ≥ 15 years 541 - 45.0 
Stvrtinova 1991 Slovakia Female workers in a department store 696 - 60.5 
Franks 1992 England General practice patients aged 35-70 years 1,338 17.4 31.6 
Laurikka 1993 Tampere, Finland General population aged 40-60 years 5,568 18.4 41.7 
Komsuoglo 1994 Turkey Hospital patients aged > 60 years 856 34.5 38.3 
Sisto 1995 Finland General population aged 40-60 years 8,000 6.8 24.6 
a






TABLE 2.1 PREVALENCE OF VARICOSE VEINS BY SEX IN STUDIES FROM DIFFERENT COUNTRIES (CONTINUED) 
 
     PREVALENCE 
FIRST AUTHOR YEAR a LOCATION SAMPLE TYPE SAMPLE SIZE MALE (%) FEMALE (%) 
Krijnen 1997 The Netherlands Male employees with a standing occupation 387 58.0 - 
Canonico 1998 Italy Random sample aged > 65 years 1,319 17.0 35.2 
Evans 1999 Edinburgh, Scotland General population aged 18-64 years 1,566 39.7 32.2 
Preziosi 1999 France SUVIMAX cohort participants  aged 35-60 years 3,065 10.8 18.1 
Kontosic 2000 Croatia Working population 1,324 18.9 34.6 
Criqui 2003 San Diego, USA University staff aged 40-79 years 2,211 15.0 27.7 
Rabe 2003 Bonn, Germany General population aged 18-79 years 3,072 12.4 15.8 
Jawien 2003 Poland Clinic outpatients aged 16-97 years 40,095 28.0 35.0 
Carpentier 2004 France General population aged 42-53 years 8,000 30.0 51.0 
Sam 2007 UK Asian men attending mosque, mean age 67 years 100 33.0 - 
Pospíšilová 2008 Czech Republic Phlebology clinic patients aged 16-80 years 319 36.0 54.0 
a




TABLE 2.2 PREVALENCE OF VARICOSE VEINS BY SEX FROM SURVEYS OF THE GENERAL POPULATION 
 
       PREVALENCE (%) 
AUTHOR a YEAR b LOCATION SAMPLE SIZE AGE c VARICOSE VEIN DEFINITION DIAGNOSIS 
d MALE FEMALE 
Coon 1973 USA 6,389 > 10 
Prominent superficial veins in the lower 
extremities 
Examination 12.9 25.9 
Widmer 1978 Switzerland 4,422 25-74 Dilated subcutaneous veins Examination 56.0 55.0 
Abramson 1981 Israel 4,802 > 15 
Distended and tortuous subcutaneous 
veins, excluding very small veins  
Examination 10.4 29.5 
Franks 1992 England 1,338 35-70 
Asked “Have you ever had large veins or 
varicose veins in your legs?” 
Questionnaire 17.0 31.0 
Laurikka 1993 Finland 5,568 40-70 
Clearly visible, dilated, tortuous veins of 
lower extremities 
Questionnaire  18.4 41.7 
Komsuoglu 1994 Turkey 850 > 60 
Dilated, tortuous and elongated veins of 
the lower extremities 
Questionnaire 35.4 38.2 
a
 First author 
b
 Year of publication 
c
 Age in years 
d
 Method of varicose vein diagnosis  
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TABLE 2.2 PREVALENCE OF VARICOSE VEINS BY SEX FROM SURVEYS OF THE GENERAL POPULATION (CONTINUED) 
 
       PREVALENCE (%) 
AUTHOR a YEAR b LOCATION SAMPLE SIZE AGE c VARICOSE VEIN DEFINITION DIAGNOSIS d MALE FEMALE 
Sisto 1995 Finland 8,000 > 30 Varicose veins diagnosed by a doctor Questionnaire 6.8 24.6 
Canonico 1998 Italy 1,319 > 65 
Any reticular or truncal visible varicosity 
of the lower limb 
Examination 17.0 35.2 
Evans 1999 Scotland 1,566 18-64 
Dilated subcutaneous tortuous trunk 
veins (C2 CEAP) 
Examination 39.7 32.2 
Preziosi 1999 France 3,065 35-60 
Dilated, tortuous and visible veins of the 
lower extremities (C2 CEAP_ 
Examination 10.8 18.1 
Criqui 
 
2003 USA 2,211 40-79 
Dilated subcutaneous tortuous trunk 
veins (C2 CEAP) 
Examination 15.0 27.7 
Jawien 
 
2003 Poland 40,095 16-97 
Dilated subcutaneous tortuous trunk 
veins (C2 CEAP) 
Examination 28.0 35.0 
a
 First author 
b
 Year of publication 
c
 Age in years 
d
 Method of varicose vein diagnosis   
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TABLE 2.2 PREVALENCE OF VARICOSE VEINS BY SEX FROM SURVEYS OF THE GENERAL POPULATION (CONTINUED) 
 
       PREVALENCE (%) 
AUTHOR a YEAR b LOCATION SAMPLE SIZE AGE c VARICOSE VEIN DEFINITION DIAGNOSIS d MALE FEMALE 
Rabe 2003 Germany 3,072 18-79 
Dilated subcutaneous tortuous trunk vein 
(C2 CEAP) 
Examination 12.4 15.8 




Enlarged, tortuous subcutaneous veins 
(C2 CEAP) 
Examination 30.1 50.5 
Chiesa 2005 Italy 5,187 18-90 
Dilated subcutaneous tortuous trunk 
veins (C2 CEAP) 
Examination 29.3 29.4 
a
 First author 
b
 Year of publication 
c
 Age in years 
d




TABLE 2.3   PREVALENCE OF CHRONIC VENOUS INSUFFICIENCY (CVI) BY SEX IN DIFFERENT STUDIES   
 
      PREVALENCE (%) 
AUTHOR a YEAR b LOCATION STUDY SAMPLE SAMPLE SIZE CVI DEFINITION MALE FEMALE 
Arnoldi 1958 Denmark  
Clinic attendees aged > 
25 years 
n = 1,981 Active or healed ulcer 1.9 5.5 
Bobek 1966 Czechoslovakia  
General population aged  
> 15 years 
Males = 6,540 
Females = 8,520 
Hyper-depigmented areas 








Female cotton workers 
English = 504 
Egyptian = 467 
Hyperpigmentation, ulcer, 





General population > 10 
years 
Males = 3,026 
Females = 3,363 
Stasis skin change* 










Males = 3,744 
Females = 785 
Skin changes** 





Franks 1992 UK  
Men and women from 
general practices  
n = 1338 Active or healed ulcer 4.7 4.0 
a
 First author 
b
 Year of publication 





TABLE 2.3   PREVALENCE OF CHRONIC VENOUS INSUFFICIENCY (CVI) BY SEX IN DIFFERENT STUDIES (CONTINUED) 
 
      PREVALENCE (%) 
AUTHOR a YEAR b LOCATION STUDY SAMPLE SAMPLE SIZE CVI DEFINITION MALE FEMALE 
Komsuoglo 1994 Turkey  Hospital patients aged  > 
60 years 
n = 850 Hyperpigmentation 
Eczema 







Ruckley 2002 Edinburgh, 
UK 
General population aged 
18-64 years 
Males = 699 
Females = 867 
Hyperpigmentation 





Criqui 2003 San Diego, 
USA 
Employees of the 
University of California 
Males = 780 
Females = 1431 






Rabe 2003 Bonn,  
Germany 
General population aged 
18-79 years 
Males = 1,350 














 First author 
b
 Year of publication 




TABLE 2.3   PREVALENCE OF CHRONIC VENOUS INSUFFICIENCY (CVI) BY SEX IN DIFFERENT STUDIES (CONTINUED)   
 
      PREVALENCE (%) 
AUTHOR a YEAR b LOCATION STUDY SAMPLE SAMPLE SIZE CVI DEFINITION MALE FEMALE 
Carpentier 2004 France Patients of primary care 
physicians 
Males = 277 













Chiesa 2005 Italy Volunteers from general 
population, aged > 18 
years 
Males = 730 










Sam 2007 UK Asian men attending a 
mosque, mean (IQR) age 
67 (62.3-72.8) years 








 first author 
b




TABLE 2.4 SUMMARY OF STUDIES EXAMINING THE ASSOCIATION BETWEEN FAMILY HISTORY AND VARICOSE VEINS 
AUTHOR a YEAR b LOCATION STUDY TYPE STUDY SAMPLE FAMILY HISTORY c ASSOCIATION d 
Mekky 1969 UK Cross-sectional 504 females  aged 15-74 years Self-reported p<0.001 
Dindelli 1989 Italy Cross-sectional 611 women  aged 15-47 years Self-reported OR 5.8 (95% CI 3.8-8.9) 
Stvrtinova 1991 Slovakia Cross-sectional Store workers aged < 19-60+ years Self-reported p<0.01 
Sadick 1992 USA Cross-sectional Clinic patients aged 18-74 years Self-reported p<0.0001 
Schultz-
Ehrenberg 
1992 Germany Follow -up  Schoolchildren aged 10-12 years Self-reported p<0.05 (aged 18-20 y) 
Cornu-
Thenard 
1994 France Cross-sectional 
67 varicose vein cases + 134 parents,  
67 controls + 134 parents. 
Examination p<0.001 
Komsuoglu 1994 Turkey Cross-sectional 
856 general population aged ≥ 60 
years 
Self-reported p=0.001 





1,566 men and women aged 18-64 
years 
Self-reported 
OR 1.5 (95% CI 1.0-2.3) P* 
OR 2.2 (95% CI 1.4-3.4) M** 
a First author 
b Year of publication 
c Method of determining family history of venous disease 
d Association between family history of venous disease and varicose veins 
p = p value < 0.05 denotes statistical significance 
OR = odds ratio (95% confidence interval), *Paternal family history, **Maternal family history 
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TABLE 2.4 SUMMARY OF STUDIES EXAMINING THE ASSOCATION BETWEEN FAMILY HISTORY AND VARICOSE VEINS (CONTINUED) 
a
 First author 
b 
Year of publication 
c 
Method of determining family history of venous disease 
d
 Association between family history of venous disease and varicose veins 
p = p value < 0.05 denotes statistical significance 
OR = odds ratio (95% confidence interval) 
*Paternal family history 
**Maternal family history  
AUTHOR a YEAR b LOCATION STUDY TYPE STUDY SAMPLE FAMILY HISTORY c ASSOCIATION d 
Laurrika 2002 Tampere Cross-sectional 
3,284 men and 3,590 women aged 
40-60 years 
Self-reported OR 4.9 (95% CI 4.2-5.7) 
Carpentier 2004 France Cross-sectional 8,000 men and women Self-reported 
OR 3.5 (95% CI 1.9-6.5)  P* 
OR 3.5 (95% CI 2.4-5.1)  M** 
Kroeger 2005 Germany Cross-sectional 
4,250 men and 2,380 women civil 
employees 
Self-reported 
OR 3.7 (95% CI 3.0-4.6)  P* 





2,211 university employees aged 40-
79 years 
Self-reported 
OR 2.9 (95% CI 1.8-4.6)  P* 
OR 2.3 (95% CI 1.8-3.1)  M** 
Pospíšilová 2008 Czech Clinic-based 
319 phlebology patients aged 16-80 
years 
Self-reported 






TABLE 2.5 SUMMARY OF STUDIES EXAMINING THE ASSOCIATION BETWEEN PREGNANCY AND VARICOSE VEINS 
 
AUTHOR A YEAR B LOCATION STUDY TYPE STUDY SAMPLE ASSOCIATION C 
Mekky 1969 England + Egypt Cross-sectional 504 women aged 15-74 years Prevalence higher in 15-34 year olds 
Widmer 1978 Switzerland Cross-sectional 785 female employees Prevalence higher in multiparous women 
Abramson 1981 Israel Cross-sectional 2,257 women 
Age-adjusted OR 0.17 ever pregnant 
No association with no. of pregnancies 
Maffei 1986 Brazil Cross-sectional 1,312 women aged > 15 years Prevalence increased with no. of pregnancies 
Dindelli 1989 Italy Hospital-based 611 women aged 15-47 years OR 2.0 (95% CI 1.3-2.9) ≥ 1 pregnancy 
Hirai 1990 Japan Cross-sectional 541 women aged 15-90 years 
Prevalence higher in multiparous women but 
association only significant in younger women 
Stvrtinova 1991 Slovakia Cross-sectional 696 women Prevalence increased ≥ 1 pregnancy (p<0.001) 
Komsuoglu 1994 Turkey Cross-sectional Women aged > 60 years Prevalence increased ≥ 1 pregnancy 
Sisto 1995 Finland Cross-sectional 3,456 women 
OR 1.4 (95% CI 1.0-1.9) 1 pregnancy 
OR 3.0 (95% CI2.3-4.1) 3 pregnancies 
a
 First author 
b 
Year of publication 
d
 Association between pregnancy and varicose veins 
p = p value < 0.05 denotes statistical significance 





TABLE 2.5 SUMMARY OF STUDIES EXAMINING THE ASSOCIATION BETWEEN PREGNANCY AND VARICOSE VEINS (CONTINUED) 
AUTHOR A YEAR B LOCATION STUDY TYPE STUDY SAMPLE ASSOCIATION C 
Laurrikka 2002 Finland Cross-sectional 
3,590 women aged 40-60 
years 
OR 1.8 (95% CI 1.2-2.8) increasing number of 
births 
Criqui 2003 San Diego Cross-sectional 1,431 women aged 15-70  OR 1.14 (95% 1.03-1.27) ever pregnant 
Carpentier 2004 France Cross-sectional 
558 subsample women from 
8000 study participants 
OR 1.98 (95% CI 1.20-3.25) (p=0.007) ≥ 1 
pregnancy 
Chiesa 2005 Italy Cohort 4,457 women 
Prevalence 19.6%, 35.0% and 50.0% with 0,3 
and 4 pregnancies respectively 
Weddell 1969 UK Cross-sectional 160 women aged ≥ 15 years No association (p>0.20) 
Guberan 1978 Switzerland Cross-sectional  
Prevalence increased with number of children 
but not significant when adjusted for age 
Richardson 1977 New Zealand Cross-sectional  No association 
Scott 1995 USA Case-control 
129 varicose vein cases and 
113 controls 
No association after adjusting for age 
Lee 2003 Edinburgh, UK Cross-sectional 867 women aged 18-64 years No association (p>0.05) 
a
 First author 
b 
Year of publication 
d
 Association between pregnancy and varicose veins 
p = p value < 0.05 denotes statistical significance 





TABLE 2.6 SUMMARY OF STUDIES EXAMINING THE ASSOCIATION BETWEEN VARICOSE VEINS AND MOBILITY AT WORK 
 
AUTHOR a YEAR b LOCATION STUDY TYPE STUDY SAMPLE MOBILITY c ASSOCIATION d 
Guberan 1992 USA Clinic-based 1,000 women aged 18-74 
years 
Standing Yes 
Pinto 1995 Italy Outpatients 48 men and 152 women,  
Aged > 15 years 
Standing Yes 
Sisto 1995 Finland Cross-sectional 3,895 women, aged > 30 
years 
Standing Yes 
Laurikka 2002 Tampere, 
Finland 
Cross-sectional 5,580 men and women 
aged 40-70 years 
Sitting/standing OR 1.6 (95% CI 1.4-
1.8) for standing 
Lee 2003 Edinburgh, UK Cross-sectional 1,566 men and women 
age 18-64 years 
Sitting/standing/walking/heavy 
lifting 
Standing at work in 
women only (P<0.05) 
a
 First author 
b 
Year of publication 
c 
Measure of mobility at work
 
d
 Association between mobility at work and varicose veins
 
p = p value < 0.05 denotes statistical significance 






TABLE 2.6 SUMMARY OF STUDIES EXAMINING THE ASSOCIATION BETWEEN MOBILITY AT WORK AND VARICOSE VEINS (CONTINUED) 
 
AUTHOR a YEAR b LOCATION STUDY TYPE STUDY SAMPLE MOBILITY c ASSOCATION d 
Maffei 1986 Brazil Clinic-based 1,000 women aged 18-74 years Sitting/standing/walking No 
Stvrtinova 1991 Slovakia  696 female store workers  Sitting/standing No 
Scott 1995 USA Case-control 23 men and 106 women 
Mean (SD) age 43.7 (1.3) years 
Standing No 
Canonico 1998 Italy Cross-sectional 560 men and 759 women 
Age 66-96 years 
Lifetime occupation No association after 
adjusting for sex 
a
 First author 
b 
Year of publication 
c 
Measure of mobility at work
 
d
 Association between mobility at work and varicose veins
 
p = p value < 0.05 denotes statistical significance 







TABLE 2.7 SUMMARY OF STUDIES EXAMINING THE ASSOCIATION BETWEEN OBESITY AND VARICOSE VEINS 
 
AUTHOR a YEAR b LOCATION STUDY TYPE STUDY SAMPLE OBESITY c ASSOCIATION d 
Abramson 1981 Israel Cross-sectional 2,245 men and 2,557 women Weight (kg) Varicose vein patients mean 
3.8 kg heavier after adjusting 
for age and sex (p<0.001) 
Canonico 1998 Italy Cross-sectional 560 men and 759 women 
aged 66-96 years 
BMI<23 kg/m2 
BMI 23-28 kg/m2 
BMI > 28 kg/m2 
p<0.001 for BMI>28 kg/m2 in 
women. 
No association in men 
Iannuzzi 2002 Italy Cross-sectional 104 women aged 48-65 years BMI > 30 kg/m2 OR 5.8 (95% CI 1.2-28.2) after 
adjusting for age and sex 
hormones 
Dindelli 1989 Italy Hospital based 611 women aged 15-47 years Weight 20% 
greater than ideal 
OR 1.0 (95% CI 0.5-1.8) 
a
 First author 
b 





 Association between obesity and varicose veins 
BMI = body mass index 
p = p value < 0.05 denotes statistical significance 





CHAPTER 3: AIMS AND OBJECTIVES 
 
 
3.1 AIMS OF THE THESIS 
 
This thesis presents some of the results from the Edinburgh Vein Follow Up Study.  This 
thesis focusses on the incidence of C2 varicose veins, C3-C6 chronic venous 
insufficiency and venous reflux ≥ 0.5 seconds duration at follow up, and risk factors 
associated with the development of these conditions.  The aims of this thesis are as 
follows: 
 
1. To estimate the prevalence of C1-C6 chronic venous disease at follow up 
2. To measure the incidence of C2 varicose veins and C3-C6 CVI at follow up 
3. To estimate the prevalence of venous reflux ≥ 0.5 seconds duration at follow up 
4. To measure the incidence of venous reflux ≥ 0.5 seconds duration at follow up 
5. To examine the relationship between the prevalence of venous reflux ≥ 0.5 
seconds duration at baseline and the incidence of C2 varicose veins and C3-C6 
CVI at follow up. 
6. To determine the association between risk factors at baseline and the incidence 
of C2 varicose veins and C3-C6 CVI at follow up. 
7. To determine the association between risk factors at baseline and the incidence 





3.3 OBJECTIVES OF THE THESIS 
 
The specific objectives to be addressed in this thesis are as follows: 
 
1. To determine the incidence and severity of C2 varicose veins at follow up by: 
 age and sex 
 leg 
 social class 
 
2. To determine the incidence and severity of C3-C6 chronic venous insufficiency 
at follow up by: 
 age and sex 
 leg 
 social class 
 
3. To determine the prevalence  of venous reflux ≥ 0.5 seconds at follow up by: 
 venous system 
 vein segment 
 age and sex 
 
4. To determine the incidence of venous reflux ≥ 0.5 seconds at follow up by: 
 venous system 
 vein segment 





5. To examine the relationship between the presence of reflux ≥ 0.5 seconds at 
baseline and the incidence of C2 varicose veins at follow up by: 
 venous system 
 vein segment 
 number of vein segments 
 severity of disease 
 
6. To examine the relationship between the presence of reflux ≥ 0.5 seconds at 
baseline and the incidence of C3-C6 CVI at follow up by: 
 venous system 
 vein segment 
 number of vein segments 
 severity of disease 
 
7. To measure the association of risk factors at baseline with the incidence of C2 
varicose veins at follow up, including: 
 body mass index 
 family history of venous disease 
 history of medical conditions associated with chronic venous disease 
 pregnancy, oral contraceptive and hormone replacement therapy use 
 mobility at work 
 smoking 






8. To measure the association of risk factors at baseline with the incidence of C3-
C6 chronic venous insufficiency at follow up, including: 
 body mass index 
 family history of venous disease 
 history of medical conditions associated with chronic venous disease 
 pregnancy, oral contraceptive and hormone replacement therapy use 
 mobility at work 
 smoking 
 bowel habit 
 
9. To measure the association of risk factors at baseline with the incidence of 
venous reflux ≥ 0.5 seconds at follow up, including: 
 body mass index 
 family history of venous disease 
 history of medical conditions associated with chronic venous disease 
 pregnancy, oral contraceptive and hormone replacement therapy use 
 mobility at work 
 smoking 







CHAPTER 4: METHODS 
 
 
4.1 CHAPTER OUTLINE 
 
The Edinburgh Vein Study is the first large population-based study in the UK and one of 
a few in the world, to investigate chronic venous disease (CVD) using duplex ultrasound 
to measure venous reflux.  The study comprises two stages: baseline and follow up.  
The baseline study conducted from 1994-1996, measured the prevalence of CVD and 
established a cohort of participants to study over time.  The follow up study conducted 
from 2007-2009, measured the incidence, progression and risk factors associated with 
CVD.  This thesis is focussed on the follow up study, in particular, the incidence of C2 
varicose veins, C3-C6 CVI and venous reflux ≥ 0.5 seconds duration, and risk factors 
associated with the development of these conditions.  The specific aims and objectives 
of this thesis have already been discussed (Chapter 3).   
 
This chapter will describe the methodology used in the Edinburgh Vein Study.  Firstly a 
summary of the baseline study methods will be provided.   The rest of this chapter will 
focus on the methodology used in the follow up study.  The process of tracing and 
recruiting participants will be outlined.   A detailed account of the study measurements, 
including the clinical examination of the legs and questionnaire, will be given.  Lastly, 
statistical analysis of the study data will be summarised.  Quality control measures 
were undertaken throughout the course of the study but the methods and results will 




4.2 BASELINE STUDY  
 
4.2.1 Sample size 
The baseline study was a cross-sectional survey of a random sample of the general 
population of Edinburgh.  The sample size at baseline was based on the number of 
participants required to estimate the prevalence of CVD with precision.  The sample 
size also had to be sufficient enough to enable a subsequent follow up study to be 
conducted.  The prevalence of varicose veins and CVI was assumed to be 20%.  
Therefore, 1,500 participants were required to give this prevalence a precision of ±2%.  
If 50% of the 1,500 baseline participants were followed up, assuming a 10% incidence 
of varicose veins and CVI, an odds ratio of 1.5 or more could be detected.  These 
calculations assumed a 5% significance level with 90% power (Evans 1997). 
 
4.2.2 Sample recruitment 
Participants were selected from computerised age-sex registers of twelve general 
practices, distributed geographically and socioeconomically throughout the city of 
Edinburgh.  They were divided into 10-year age bands for sex, and random sampling 
was carried out within each age-sex group.  Invitation letters were sent to 4,103 
prospective participants.  Of those, 1,155 had moved away (n=618) or were 
uncontactable (n=537).  Of the 2,948 living in Edinburgh and thus eligible to 
participate, 998 refused and 348 withdrew, resulting in a study population of 1,566 and 





4.2.3 Study measurements 
The study measurements at baseline comprised an examination of the legs for signs of 
CVD, duplex ultrasound to measure venous reflux, a questionnaire, measures of height 
and weight, blood sampling and a 3-day diary of bowel habit.  Classification of CVD was 
based on the Basle system, which was the only available classification system at the 
time.  Photographs of the legs were also taken to document evidence of CVD and allow 
comparisons between observers.  The duplex ultrasound scan measured venous reflux 
at eight points along the deep and superficial veins in both legs.  The self-administered 
questionnaire enquired about venous history, reproductive history, smoking, dietary 
fibre and mobility at work.   Precise details of the examination procedure at baseline 
have been published (Evans 1997). 
 
4.3 FOLLOW UP STUDY DESIGN 
 
The follow up study design was a population-based prospective cohort in which the 
study sample already examined at baseline underwent a 13 year follow up 
examination.  Prospective cohorts are particularly useful in determining the incidence 
of a disease and associated risk factors.  People free of disease are studied 
longitudinally to observe how many develop the disease (incidence) and exposure to 
risk factors measured.  The study was funded by the Chief Scientist Office, part of the 
Scottish Government Health and Social Care Directorate and approved by the Lothian 







4.4 FOLLOW UP STUDY POPULATION 
 
The study population comprised the cohort of 1,566 men and women aged 18-64 who 
took part in the Edinburgh Vein Study.  Before the follow up study was undertaken, a 
preliminary search of the Lothian Community Health Index was conducted to assess 
how many baseline participants were alive and living in Edinburgh.  A search for every 
10th participant (n=156) revealed that 85% of the baseline participants would 
potentially be eligible to participate in the follow up.  It was expected that the response 
to follow up would be higher than the 54% response achieved at baseline, as 
participants were known volunteers and previous participation should not have been 
unpleasant or uncomfortable.   
 
4.4.1 Sample recruitment 
Prior to recruiting participants for the follow up study, it was necessary to identify 
those who had died or changed address since taking part at baseline.  A list of names, 
addresses and dates of birth of the 1,566 baseline participants, was sent to the 
Practitioner Services Division (PSD) of the NHS National Services Scotland (NHS NSS).  
PSD aids the transfer of medical records between general practitioner (GP) practices to 
ensure that patient registers are accurate and up to date.  Staff at PSD linked each 
participant’s details to the Community Health Index (CHI), a register containing health 
information of all patients in NHS Scotland, identified by a unique number.  This linkage 
provided up to date information including any deaths, changes to name and address, 






Patients who had died since participating at baseline were subsequently removed from 
the list of those invited to take part in the follow up study.  Where a patient no longer 
resided in Scotland but still lived in the UK, PSD referred to the General Register Office 
for Scotland (GROS).  GROS has an established National Health Services Central Register 
(NHSCR), which holds patient details such as NHS number, CHI number and health 
authority based on GP registration.  Using the unique CHI number, a search of the 
NHSCR identified the name of the local health authority in which the patient was 
registered with a GP.  Public health consultants were identified for each health 
authority, contacted by telephone and notified about the study.  Due to data protection, 
health authorities were not allowed to disclose patient addresses, so an invitation pack 
was forwarded to the patient by them at our request.   
 
A letter of invitation signed jointly by the research fellow and principal investigator 
was sent to each baseline participant, inviting them to take part in the follow up study 
and attend a research clinic for an examination of their legs [Appendix 5].   Travel and 
accommodation expenses were offered and it was stated that participants’ GPs would 
be notified of the examination results.  Enclosed with the invitation letter was a patient 
information sheet which outlined the purpose of the study, detailed what participation 
in the study would involve, highlighted data confidentiality and stated where the study 
results would be published [Appendix 6].  A newsletter summarising the results from 
baseline [Appendix 7], a reply form [Appendix 8] and a pre-paid envelope were also 







A detailed summary of the process of recruiting participants living in Scotland is 
provided in Figure 4.2.  After sending the initial letter of invitation, a period of four 
weeks was given for the participant to reply.  If a reply had been not received within 
this time period, a second letter of invitation was sent.  For those who did not respond 
to the second invitation, a minimum of three attempts were made to contact them by 
telephone, where numbers were available.  Those who could not be contacted by 
telephone were deemed “no response”.  Those whose letters were returned either by 
the Post Office or a subsequent occupier, were counted as “returns” and a further check 
was carried out by PSD using the CHI for identification [Figure 4.2]. 
 
Upon receiving an affirmative reply, an appointment at a time and date suitable for the 
participant, was arranged by telephone.  A confirmation letter [Appendix 9], map of the 
research clinic [Appendix 10] and questionnaire [Appendix 11] were sent.  One week 
before, participants were contacted by telephone to remind them of their appointment.  
Those who did not attend were offered another appointment by telephone.  A 
maximum of three appointments were offered.  Those who withdrew from the study or 
ultimately failed to attend after agreeing to participate were counted as “withdrawals” 
[Figure 4.2].  Those who refused to participate in the follow up study, or who initially 
agreed to attend but then subsequently withdrew, were sent a one page questionnaire 
[Appendix 12].  Questions inquired about previous diagnosis and treatment of varicose 
veins.  They were asked whether they themselves thought they had varicose veins and 
were given a number of options to state as a reason why they did not want to 






4.4 FOLLOW UP STUDY MEASUREMENTS 
 
Clinical examinations were held at the Wellcome Trust Clinical Research Facility 
(WTCRF) at the Western General Hospital, Edinburgh from September 2007 to October 
2009.  The WTCRF is a clinic dedicated to conducting research and employs nurses 
with experience of taking repeated, standardised study measurements.  Before any 
measurements were taken, each participant was asked to read a consent form and sign 
two copies [Appendix 13].  One copy was given to the participant and the other was 
kept in their file.  Participants were also asked to provide details of an emergency 
contact and notes were made regarding any health conditions and current medication.  
Data from the examination were documented on specially designed recording forms 
with the participant’s unique study reference number and the initials of the research 
staff member conducting the appointment [Appendix 14].    
 
Participants were examined by one member of the research team, which comprised 
two WTCRF research nurses, the research fellow (and author of this thesis) and the 
study assistant.  All four were specially trained in the methods of classification of CVD 
and duplex ultrasound scanning to assess venous reflux in the legs (Training in 
classification of CVD and duplex ultrasound will be discussed in sections 4.4.3 and 4.4.4 
respectively).  The study examination included a measure of height and weight, 
questionnaire, leg examination and photographs, and duplex ultrasound of the leg veins 





4.4.1 Height and weight 
Participants’ height was measured once to the nearest 5mm, without shoes, using a free 
standing stadiometer.  Weight, without shoes or outdoor clothes, was measured to the 
nearest 100g on a digital scale.  The stadiometer and scales were periodically calibrated 
against another instrument.  Body mass index (BMI) was calculated using the following 
equation: 
BMI = weight in kilograms / (height in metres)2 
 
Participants with a BMI of < 18.5 kg/m2 were classified us “underweight”, 18.5-24.99 
kg/m2 as “normal weight”, 25 to <30 kg/m2 as “overweight” and ≥ 30 kg/m2 as “obese”, 
in accordance with the World Health Organization’s criteria (WHO 2000). 
 
4.4.2 Questionnaire 
A self-administered questionnaire was completed by all participants prior to their 
examination and checked by the research staff at the appointment [Appendix 11].  The 
questionnaire was amended from that at baseline to identify changes in exercise and 
other lifestyle factors during the follow up years.  In addition, questions from the 
VEINES-QOL/Sym (Lamping 2003) were also included.  The VEINES-QOL/Sym has 
been discussed in Chapter 1, Section 1.6.2.  It is modelled on the SF-36 but is specific to 
CVD.  Responders are asked about symptoms, daily limitations, and psychological 
impact of CVD within the past 4 weeks, rated on a 2-point to 7-point scale of intensity, 







Topics covered in the study questionnaire include the participant’s general health, leg 
problems and symptoms, past relevant medical history including details of treatment 
for varicose veins and venous ulcers, family history of CVD, smoking history and 
physical exercise.  Mobility at work, measured by the proportion of time spent sitting, 
standing, walking or heavy lifting, was also documented.  An obstetric history and use 
of oral contraceptives and hormone replacement therapy was obtained for all female 
participants.  In addition, the research staff recorded participant’s ethnic origin as one 
of the following: White Caucasian, African, Indian, Chinese or other (to be specified). 
 
4.4.3 Classification of chronic venous disease 
The classification system used in the follow-up study was slightly different to that 
adopted at baseline.  At baseline, the classification of CVD was based on the Basle 
System, with telangiectases, reticular veins, varicose veins and CVI split into 3 grades 
according to severity [Appendix 1].   However, the CEAP classification has since become 
universally accepted as the most appropriate for venous research and clinical practice 
[Appendix 2].  In order to permit comparison with the baseline study and ensure 
comparison with other studies using CEAP, both the Basle and CEAP classifications for 
CVD were used in the follow up study.  For CEAP classes C1 (telangiectases and 
reticular veins) and C2 (varicose veins), varices were divided into grades 1-3 for 
severity, according to the Basle classification.  Classification of CVI was based on the 
CEAP classification alone with C3 (corona phlebectatica or oedema), C4 (skin changes 
such as C4a pigmentation, C4a eczema, C4b lipodermatosclerosis and C4b atrophie 






The four members of the research team were trained in the Basle and CEAP 
classification systems.  The original slides from both the Basle and baseline EVS studies 
were used to provide examples of grades of severity of CVD based on the Basle 
classification system.  Additionally, images showing the CEAP C1-C6 classes of CVD 
were analysed and definitions of each class studied.  Periodically during the study, the 
research staff re-examined photographic evidence of the Basle and CEAP classifications, 
to remind them of the original standard of classification and to try to increase observer 
reliability.  Several quality control measures were adopted during the study to increase 
observer reliability in the classification of CVD.  These measures and results will be 
discussed in detail in Chapter 5. 
 
Leg examination 
All participants had their legs examined for signs of CVD using the Basle and CEAP 
classifications discussed above.  Participants stood on a raised platform with their feet 
in three standard positions: facing towards the observer with heels together and 
forefeet spread apart [Figure 4.3], facing away from the observer with heels together 
and forefeet spread apart [Figure 4.4] and facing away from the observer with feet 
parallel [Figure 4.5].  A mat with pre-designated foot positions was used to ensure 
consistency.  Participants were asked to stand for a minimum of two minutes in order 
to allow the blood to pool in their legs prior to classification.  Any scars and notable 








Photographs of the legs 
Participants had their legs photographed in the Medical Photography studio at the 
Western General Hospital.  Three photographs were taken while the participant stood 
on the raised platform in the three examination positions described previously [Figures 
4.3-4.5].  The camera was positioned at a distance so that the photograph allowed 
visualisation of the leg from the foot to the groin.  Camera and light adjustments were 
made by the medical photographer, according to skin colour of the participant.  For 
identification purposes, each participant was photographed beside their unique five 
digit study number.  The photographs were saved as a digital image on compact discs in 
subfolders arranged by the participant’s study number. 
 
The digital photographs were subsequently analysed by two members of the study 
team who had not examined the participant in the clinic.  They independently graded 
the photos according to the Basle/CEAP classification system described above.  If the 
classifications of the two observers viewing the photographs differed, discussion 
between these observers achieved a consensus classification for each participant.  If a 
consensus could not be reached, the photographs were reviewed by a vascular surgeon 
who made the final classification.  The process of classifying CVD upon examination and 
subsequent analysis of photographs resulted in two independent classifications of CVD 







4.4.4 Duplex ultrasound for venous reflux 
The research team underwent extensive training in duplex ultrasound scanning of the 
leg veins.  Training was conducted by a consultant radiologist and two vascular 
scientists.  A range of volunteers were recruited so that the staff could practise 
scanning leg veins.  Staff sat a practical test where they conducted a complete scan of 
the veins segments, assessed by a vascular scientist.   Only when all four researchers 
were deemed competent in duplex ultrasound, did the study examinations begin.  A 
specific scanning protocol was devised to ensure that the scans were performed in the 
same way for each participant [Appendix 15]. 
 
The duplex ultrasound scans were performed with a real-time, pulsed, Doppler colour 
flow imaging Philips ATL HDI 5000 Sono CT duplex scanner (Mount International 
Ultrasound Services Ltd, Gloucester, England).  An L7-4 broadband linear array probe 
with an operating frequency range of 4-7MHz was used.  Reflux was induced using a 
cuff placed around the calf, which was rapidly inflated and deflated using a Hokansen 
E20 cuff inflator and an AG-101 air source (P.M.S Instruments Ltd, Berkshire, UK).  
There were two cuff sizes depending on the diameter of the calves (cuff width 10cm, 
length 50cm or 65cm).  A pressure of approximately 110mmHg was used to rapidly 
inflate the cuff.  A minimum time of 5 seconds was given between compressions to 
ensure that the legs refilled with blood.  For vein segments where the compression did 
not produce sufficient forward flow to measure reflux, a manual squeeze of the calf was 
employed.  For vein segments below the calf (GSV lower calf) a foot squeeze was 






Before the scan commenced, all participants were asked about their history of varicose 
vein operations, experience of recurrent fainting or blackouts, and current use of 
hypotensive drugs.  Each participant was examined on a tilting couch (Mount 
International Ultrasound Services Ltd, Gloucester, England) at an angle of 45°.  This 
position was chosen to provide support to participants and thus prevent fainting 
during the procedure, while allowing gravity to act on blood within the leg.  Where 
participants felt faint at an angle of 45°, the tilt table was reduced to an angle of 30°.  
For scanning veins in the thigh and the calf, participants stood with their back to the 
tilting table and were encouraged to take most of their weight onto the opposite leg and 
relax the leg to be scanned out to the side, with the knee slightly bent.  For scanning 
veins behind the knee, the participant stood facing the scanner with their side against 
the tilting table, the leg to be scanned slightly bent at the knee and the weight mainly on 
the opposite leg (Evans 1997).   
 




1. Common femoral vein (CFV) proximal to the sapheno-femoral junction (SFJ). 
2. Femoral vein (FV) approximately 2cm distal to the confluence with the 
profunda femoris vein 
3. FV in the lower third of the thigh. 
4. Popliteal (POP) vein above the knee crease. 






6. Great saphenous vein (GSV) distal to the SFJ 
7. GSV in the lower third of the thigh. 
8. GSV in the upper calf. 
9. GSV in the lower calf. 
10. Small saphenous vein (SSV) distal to the sapheno-popliteal junction (SPJ). 
 
When venous flow was induced in the leg being scanned, reflux was identified on the 
Doppler spectrum [Figure 4.6].  Two spectra were selected at each vein segment and 
the duration of reflux was measured by placing the cursors at the beginning and end of 
the period of reflux (Evans 1997).  Reflux time was calculated to the nearest hundredth 
of a second.  The mean of the two reflux times at each vein segment was used in all 
analysis.   
 
In cases where the participant had an unusual venous anatomy and the observer 
wanted a second opinion, the participant was invited to return for a second scan 
performed by a vascular scientist, using the same duplex ultrasound machine. If the 
scan results differed considerably, the reflux measurements of the second scan were 
used in the analysis.  Periodically during the course of the study, duplex scans were 
performed by two observers on the same participant, or by one observer on the same 
participant, to allow inter- and intra-observer comparison of results and identification 
of any problems.  The methods and results of these observer variability checks will be 






4.5 DATA ENTRY  
 
Data from recording forms and questionnaires were entered into a specifically 
designed Microsoft Access database by the research fellow.  The database was 
password protected and data was only identifiable by the participant’s unique study 
number.  All data was entered onto a second identical database by the study assistant.  
Comparison of the two databases revealed any discrepancies which were subsequently 
checked and corrected.  Once the data had been checked, a report summarising the 
examination results was generated and sent to each participant’s GP [Appendix 16]. 
 
4.6 STATISTICAL ANALYSIS 
 
Data files were transferred to the Edinburgh University computing network for analysis 
using the SPSS-X software (SPSS INC., Chicago III).   Univariate statistical analysis was 
conducted to test the association between incidence and risk factors.  The chi squared 
(χ2) test was used for nominal categorical data, the χ2 test for linear trend was used for 
ordered categorical data and the Student’s t-test was used for continuous data.  A P 
value of <0.05 was used to denote statistical significance throughout.  Unadjusted and 
adjusted odds ratios with 95% confidence intervals were calculated for the incidence.  
Risk factors that were statistically significant on univariate analysis were entered into a 
stepwise logistic regression model adjusted for age and sex, to determine which factors 
were independently associated with the incidence of C2 varicose veins, C3-C6 CVI and 






Data from the clinical examination at baseline and at follow-up were compared to 
measure the:   
 Prevalence of CVD in the follow up sample (C1-C6 CVD) 
 Incidence of C2 varicose veins and C3-C6 CVI in the follow up sample 
 Prevalence of venous reflux ≥ 0.5 seconds duration in the follow up sample  
 Incidence of venous reflux ≥ 0.5 seconds duration in the follow up sample  
 Association between venous reflux ≥ 0.5 seconds duration at baseline and 
incidence of C2 varicose veins and C3-C6 CVI at follow up 
 Association between risk factors at baseline and incidence of C2 varicose veins 
and C3-C6 CVI at follow up 
 Association between risk factors at baseline and incidence of venous reflux ≥ 
0.5 seconds duration  at follow up 
 
Incidence refers to the number of new cases of disease in a population.  The incidence 
of C2 varicose veins is calculated by dividing the number of participants who developed 
C2 varicose veins at follow up by the number of participants free of C2 varices at 
baseline.  Similarly, incidence of C3-C6 CVI is based on the number of participants with 
C3-C6 CVI at follow up divided by the number of participants free from C2 varicose 
veins and C3-C6 CVI at baseline.  This thesis does not deal with progression of venous 
disease.  Therefore any participant with C2 varicose veins at baseline who had C3-C6 
CVI at follow up would not be included as an incident case as this is not an occurrence 
of new venous disease but rather progression of existing venous disease.  Incidence of 
venous reflux is measured by dividing the number of participants who developed reflux 
≥ 0.5 seconds duration in any vein segment at follow up by the number of participants 




Participants free of C2 varices, C3-C6 CVI or venous reflux at baseline may have 
developed either of these conditions and had subsequent treatment during the 13 year 
follow up period.  Consequently any symptoms and signs of C2-C6 disease or venous 
reflux may not have been evident at the follow up examination.  The questionnaire 
administered at follow up enquired about varicose vein treatment including surgery, 
sclerotherapy and the year that the procedure was carried out.  In order to measure the 
true incidence, any participant free from disease at baseline who had subsequent 
treatment during the follow up but had no symptoms of C2 varicose veins or C3-C6 CVI 
at the follow up examination, was included as an incident case.  
 
4.7 CHAPTER SUMMARY 
 
 The Edinburgh Vein Follow Up Study was a population cohort study in which survivors 
of 1,566 individuals aged 18 to 64 years from the general population examined at 
baseline, were invited to have a 13 year follow up examination.  Participants were 
identified through NHS services and strenuous efforts were undertaken to recruit as 
many participants as possible.  Study examinations were held at a research clinic by 
one of four trained staff members.  The examination comprised a clinical classification 
of the legs to check for signs of CVD and photographs to document the evidence.  A 
duplex ultrasound scan was conducted at ten vein segments in the deep and superficial 
systems in both legs to detect the presence of venous reflux.  Participants completed a 
standardised questionnaire which gathered information on past medical history, family 
history and previous treatment of CVD, smoking status, physical activity and mobility at 
work.  An obstetric history was documented for all female participants.  Symptoms of 




Statistical analysis of the data was performed to measure the incidence of C2-C6 CVD 
and venous reflux at follow up and risk factors associated with the development of 
these conditions.  Several quality control measures were employed during the study 
and they will be discussed in the next chapter. 
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PSD = Practitioner Services Division,  
NHSCR = National Health Service Central Register 
PSD search Community Health 
Index (CHI) 
Patient deceased Patient living in Scotland Patient living in England 
Removed from list invited to 
participate in follow up study 
Follow up study invitation letter 
sent to patient 
NHSCR identified health authority 
where patient registered with GP 
Recruitment process                
(Figure 4.2) 
 
Invitation letter to Public Health 




FIGURE   4.2 RECRUITMENT CYCLE FOR THE EDINBURGH VEIN FOLLOW UP STUDY 
“Returns” = baseline participants whose letters were returned by post office or subsequent occupier. 
“Unable to trace” = baseline participants with whom no contact was made, despite two invitations and three 
telephone calls. 
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CHAPTER 5: QUALITY CONTROL 
 
 
5.1 CHAPTER OUTLINE 
 
Research studies reporting physical examination findings or results of diagnostic tests, 
often rely on some degree of subjective interpretation by observers.  The Edinburgh 
Vein Follow up Study employed four different research staff who conducted complex 
duplex ultrasound examinations to assess venous reflux and followed a strict 
classification system to diagnose CVD.  It was therefore imperative that the reliability of 
the observers was assessed to ensure that the study data were as accurate as possible.  
This chapter summarises the methods used to assess observer reliability during the 
follow up study and presents results of these checks.  Four aspects of the classification 
of CVD were assessed: 1) comparison of classification between baseline and follow up 
observers, 2) inter-observer reliability at follow up, 3) intra-observer reliability at 
follow up and 4) comparison of classification based on examination versus 
photographic evidence at follow up.  Two assessments were made regarding venous 
reflux measurements: inter- and intra-observer reliability at follow up.  For reporting 
comparisons between observers or methods, results are presented as level of 
agreement (%) with a kappa statistic (K) where possible.  A detailed description of the 





5.2 CLASSIFICATION OF CHRONIC VENOUS DISEASE 
 
5.2.1 Comparison of baseline and follow up observers 
In order to compare the inter-observer variability between observers at baseline and 
observers at follow up, a sub-sample of 100 baseline participants was created by 
selecting every 15th from the 1,566 baseline participants.  Baseline photographs of the 
sub-sample were independently classified by two observers participating in the follow 
up examination.  The observers at follow up were unaware of the CVD classification 
made by the observers at baseline.  If the classification of the two observers viewing the 
photographs differed, discussion between two observers was held until a consensus 
classification for each participant was achieved.  The overall consensus classifications 
for the follow up observers were compared to the classifications made at baseline to 
check for any differences in observer variability between the observers at baseline and 
follow-up.  Table 5.1 displays the results. 
 
There was good agreement between the observers at baseline and follow up for C1 
telangiectases (88%) and reticular veins (92%).  For C2 varicose veins, the level of 
agreement was 96% (K=0.90).  For C3-C6 CVI, the level of agreement for corona 
phlebectatica was 99% (K=0.88) while for oedema and pigmentation there was 100% 
agreement (K=1.00) for both conditions.  These results suggest that, while some 
observer variability would be expected between the observers at baseline and follow 
up, the differences were tolerable, thus permitting a comparison to be made of findings 





5.2.2 Inter-observer reliability at follow up 
In order to assess reliability between observers at follow up, a random sample of 49 
follow up participants were invited for a second clinical examination, a minimum of 12 
weeks after their first follow up examination.  Due to time constraints at the research 
facility, only observers 3 and 4 classified the legs.  The two observers classified the legs 
independently of each other.  Classification data for both observers were entered into a 
quality control database, double checked, and statistical analysis was conducted to 
assess the level of agreement and kappa statistic.  Results of this analysis are presented 
in Table 5.2. 
 
There was good inter-observer agreement (80.8%) for C1 telangiectases (K=0.69).  For 
C1 reticular veins, the kappa value of 0.58 suggested a moderate level of reliability but 
the level of agreement between observers was 82.6%.  For C2 varicose veins, the kappa 
value could not be calculated as one observer awarded a grade 3 varicose vein while 
the highest grade awarded by the other observer was a grade 2 varicose vein.  
Nevertheless the level of agreement between the two observers was almost 77%.  For 
C3-C6 CVI, the inter-observer reliability was high with kappa values ranging from 0.78-







5.2.3 Intra-observer reliability at follow up 
For the assessment of intra-observer reliability, a random sample of 35 follow up 
participants underwent a second clinical examination and had their legs classified by 
the same observer who conducted the first examination.  This was performed for 
observers 3 and 4 only.  Venous disease classification for examinations 1 and 2 were 
compared in order to measure the level of agreement for each observer.  Results of the 
intra-observer reliability are presented in Table 5.3.    
 
Observer 3 re-examined 21 participants and there was a good agreement between 
classifications at examinations 1 and 2, with kappa values between 0.64-1.00 and level 
of agreement ranging between 76-100%.  Within the random sample of 21 participants, 
there were no cases of C3-C6 CVI except for C4a venous eczema.  Observer 4 examined 
14 participants.  For C1-C2 conditions, kappa values between 0.48 and 0.64 indicated 
moderate to good reliability and levels of agreement ranged from 71-78%.  For C3-C4 
CVI including corona, oedema, pigmentation and eczema, the level of agreement was 
higher, ranging from 85-100%.  There was no evidence of C4b lipodermatosclerosis, 
C4b atrophie blanche or C5 or C6 ulceration within the sample of participants 







5.2.4 Prevalence of venous disease by observers at follow up 
A comparison of the clinical classifications for all participants was made to check for 
differences in prevalence rates between the four observers.  Given that 880 
participants were examined at follow up, the prevalence of the C1-C6 classes of CVD 
would be expected to be similar between observers.  This analysis highlighted two 
suspected observer errors.  Observer 3 reported fewer mild (grade 1) C2 varicose veins 
on examination of the participants (prevalence 15.3% versus mean prevalence of 
19.5% for other 3 observers).  However, when her classification based on photographic 
evidence was compared to the other three observers, no difference in the prevalence of 
grade I varicose veins was found (prevalence 22.6% versus mean prevalence of 21.8% 
for other 3 observers), suggesting an under reporting on examination only.   
 
The second observer error was that when observer 2 examined the subject in the clinic, 
she reported a higher prevalence of C4a eczema compared to the other three observers 
(prevalence 7.8% versus mean prevalence of 2.4% for other 3 observers).  Discussion 
with this observer and examination of her written records indicated that she had 
different clinical criteria for assigning eczema to a participant.  She classified any dry 
skin on the leg as C4a venous eczema.  However, the CEAP definition is “erythematous 
dermatitis most often located near varicose veins” (Eklöf 2004).  The fact that this 
observer did not look for redness, inflammation and eczema near the varicose vein 







5.2.5 Examination versus photographic classification at follow up 
Classifications of CVD on examination were compared to classifications based on 
analysis of the photographs.  Measures of agreement for the two methods were 
obtained for individual participants, taking the leg with the higher CEAP class or grade 
of severity as the participant’s disease status.  Results of the reliability checks are 
presented in Table 5.4.  C1 telangiectases and reticular veins and C3 corona 
phlebectatica were more likely to be classified at a higher grade from the photographic 
evidence, while C2 varicose veins were more likely to be classified at a higher grade by 
the examination method.   
 
5.2.6 Changes made to the data set 
Although the preference was to use examination rather than photographic data 
because the former was more complete (880 participants were examined but only 676 
had their legs photographed), the results of the variability checks indicated that the 
following amendments would improve the accuracy of the data to be included in the 
statistical analysis: 
 
1. Classification of C1 telangiectases and reticular veins were based on 
photographic evidence, where available, as this was considered to be the most 
accurate because the classification was based on consensus between two 








2. Classification of C2 varicose veins was based predominantly on the examination 
classification.  For participants examined by observer 3 who underreported on 
examination, a grade 0 at clinical examination was corrected to a grade 1 
(mild), if that was the finding on photographic evidence.  Of 490 participants 
examined by observer 3, 51 (10.4%) participants had varicose veins corrected 
from absent to mild, based on the photographic evidence.  As a result of these 
adjustments, the prevalence of mild C2 varicose veins for observer increased 
from 15.3% (uncorrected) to 25.7% (corrected for known underreporting).  
 
3. Classification of C3-C6 CVI was based predominantly on examination 
classification with the following adjustments for photographic findings for C3 
corona phlebectatica and C4a eczema.  C3 corona was seen more frequently in 
photographs than it was at examination and, as the photographs were 
independently classified by two observers, it was considered that the data from 
the photographs was more accurate.  C4a venous eczema was based on 
photographic evidence for observer 2 as it was known that she had over-
reported this condition on examination.  Initially, observer 2 had classified 25 
(7.8%) participants out of 180 examined as having C4a venous eczema.  
However after reviewing photographic evidence, it was confirmed that only 16 
participants had this condition and therefore 9 (5%) participants had venous 








5.3 VENOUS REFLUX MEASUREMENTS AT FOLLOW UP 
To assess observer reliability of reflux measurements, 49 participants underwent a 
second ultrasound scan.  For inter-observer reliability the participant had the same leg 
scanned by two different observers.  The observers performed the scan independently 
and were unaware of the results obtained by the other observer.  For intra-observer 
reliability, the participant had one leg scanned by the same observer who conducted 
the first scan, with a minimum of 12 weeks between the scans.  All reflux data were 
entered into a database and double checked.  Statistical analysis was performed to 
measure level of agreement and kappa values for inter- and intra-observer reliability. 
 
5.3.1 Inter-observer reliability at follow up 
For inter-observer reliability, observers were grouped into pairs for logistical purposes 
and to simplify the comparisons to be made.  Observers 1 and 2 were paired together 
and in total they examined 19 participants.  Observers 3 and 4 examined 30 
participants.  Results of the inter-observer reliability analysis are shown in Table 5.5.  
For deep vein segments such as the CFV and the FV, the prevalence of reflux was very 
low and the kappa statistic could not be calculated.  However, overall the level of 
agreement for all observers was 98% for these vein segments.  Venous reflux in the 
POP vein was more common.  Kappa values of approximately 0.5 indicated moderate 
reliability but levels of agreement ranging from 83-94% suggested that the inter-
observer reliability was higher than the kappa value would suggest.  For the superficial 
vein segments, kappa values for all four observers were all greater than 0.5 indicating 
moderate agreement.  With levels of agreement between 79-95%, the inter-observer 
reliability for all four observers was acceptable.  There were no differences in kappa 




5.3.2 Intra-observer reliability at follow up 
Table 5.6 displays the results of intra-observer reliability checks for reflux 
measurements at follow up.  Although the kappa scores for observers 1 and 4 were 
lower, the levels of agreement for both observers were all greater than 70% indicating 
good intra-observer reliability.  All four observers reported similar levels of agreement 
ranging from 70-100%, which suggests that each observer achieved similar reflux 
results at two different examinations. 
 
5.4 CHAPTER SUMMARY 
 
This chapter has discussed the various quality control checks which were applied 
during the course of this follow up study.  Such measures were put in place to ensure 
that the data obtained was as valid, reliable and generalisable as possible.  Analysis 
showed that overall, the inter- and intra-observer reliability for classification of CVD 
and measurement of venous reflux were high.  Despite these results, the quality control 
checks did highlight a few minor errors.  Consequently appropriate changes were made 





TABLE 5.1  COMPARISON OF CHRONIC VENOUS DISEASE CLASSIFICATION BETWEEN 
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CEAP = CEAP classification of chronic venous disease (Eklof 2004) 
N = number of participants assigned C class of disease by observers at baseline and follow up 
b
 Observers at the baseline stage of the Edinburgh Vein Study 
c
 Observers at the follow up stage of the Edinburgh Vein Study 
d
 Agreement = proportion of participants identified at the same grade of clinical disease by observers at baseline 
and follow up 
e




TABLE 5.2 INTER-OBSERVER RELIABILITY FOR CEAP CLASSIFICATION OF CHRONIC 
VENOUS DISEASE AT FOLLOW UP 
 
 OBSERVERS 3 AND 4 
CEAP a AGREEMENT (%) b KAPPA c 
C1   TELANGIECTASES 80.8 0.69 
C1   RETICULAR VEINS 82.6 0.58 
C2   VARICOSE VEINS 76.9 - 
C3   CORONA PHLEBECTATICA 100.0 + 
C3   OEDEMA 100.0 1.00 
C4a PIGMENTATION 100.0 + 
C4a ECZEMA 96.1 0.78 
C4b LIPODERMATOSCLEROSIS 100.0 + 
C4b ATROPHIE BLANCHE 100.0 + 
C5   HEALED ULCER 100.0 + 
C6   ACTIVE ULCER 100.0 + 
a 
CEAP = CEAP classification of chronic venous disease (Eklof 2004) 
Based on 49 participants randomly selected for a second examination 
b 
Agreement = proportion of participants identified at the same CEAP class between two observers. 
c
 Kappa statistic: <0.20 = poor, 0.21-0.40 = fair, 0.41-0.60 = moderate, 0.61-0.80 = good, 0.81-1.00 = very good 
- Kappa statistic could not be calculated as cross tabulation of CEAP condition by the two observers was 
asymmetrical 








TABLE 5.3 INTRA-OBSERVER RELIABILITY FOR CEAP CLASSIFICATION OF CHRONIC VENOUS DISEASE AT FOLLOW UP 
 
 OBSERVER 3 (n=21)  OBSERVER 4 (n=14) 
CEAP a AGREEMENT (%) b KAPPA c AGREEMENT (%) b KAPPA c 
C1 TELANGIECTASES 76.2 0.64 71.4 0.48 
C1 RETICULAR VEINS 85.7 - 78.6 0.64 
C2 VARICOSE VEINS 90.5 0.84 78.6 0.63 
C3 CORONA PHLEBECTATICA 100.0 + 92.9 - 
C3 OEDEMA 100.0 + 100.0 1.00 
C4a PIGMENTATION 100.0 + 92.9 - 
C4a ECZEMA 100.0 1.00 85.7 - 
C4b LIPODERMATOSCLEROSIS 100.0 + 100.0 + 
C4b ATROPHIE BLANCHE 100.0 + 100.0 + 
C5 HEALED ULCER 100.0 + 100.0 + 
C6 ACTIVE ULCER 100.0 + 100.0 + 
a 
CEAP = CEAP classification of chronic venous disease (Eklof 2004) 
b
 Agreement = proportion of participants identified at the same grade of clinical disease by the same observer at two different examinations. 
c
 Kappa statistic: <0.20 = poor, 0.21-0.40 = fair, 0.41-0.60 = moderate, 0.61-0.80 = good, 0.81-1.00 = very good 
- Kappa statistic could not be calculated as cross tabulation of CEAP class rated by the same observer on two different examinations was asymmetrical 





TABLE 5.4 PREVALENCE OF CHRONIC VENOUS DISEASE AT FOLLOW UP, BASED ON 
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All measures based on 676 participants for whom photographs were available 
a 
CEAP = CEAP classification of chronic venous disease (Eklof 2004) 
b
 Classification of CVD based upon examination of the participant 
c
 Classification of CVD based on photographic evidence 
N (%) = number (%) of participants with CEAP class and Basle grade of disease 
d
 Agreement = proportion of participants identified at the same grade of clinical disease between examination 
and photographic classification method 
e




TABLE 5.4 PREVALENCE OF CHRONIC VENOUS DISEASE AT FOLLOW UP, BASED ON 
























32 (4.7%) 105 (15.6%) 83.9 0.29 
C3 OEDEMA 28 (4.1%) 29 (4.3%) 96.6 0.58 
C4a PIGMENTATION 34 (5.0%) 52 (7.7%) 94.4 0.53 
C4a ECZEMA 13 (1.9%) 13 (1.9%) 99.4 0.84 
C4b 
LIPODERMATOSCLEROSIS 
9 (1.3%) 15 (2.2%) 98.5 0.58 
C4b ATROPHIE BLANCHE 3 (0.4%) 2 (0.3%) 99.6 0.40 
C5 HEALED ULCER 4 (0.6%) 7 (1.0%) 99.0 0.36 
C6 ACTIVE ULCER 1 (0.1%) 1 (0.1%) 100.0 1.00 
All measures based on 676 participants for whom photographs were available, except C3 corona phlebectatica 
which was based on 675 participants. 
a 
CEAP = CEAP classification of chronic venous disease (Eklof 2004) 
b
 Classification of CVD based upon examination of the participant 
c
 Classification of CVD based on photographic evidence 
N (%) = number (%) of participants with CEAP class and Basle grade of disease 
d
 Agreement = proportion of participants identified at the same grade of clinical disease between examination 
and photographic classification method 
e








OBSERVERS 1 AND 2 (n=19) OBSERVERS 3 AND 4 (n=30) ALL OBSERVERS (n=49) 
AGREEMENT (%) a KAPPA b AGREEMENT (%) a KAPPA b AGREEMENT (%) a KAPPA b 
CFV 94.7 - 100.0 + 98.0 - 
FV ORIGIN 94.7 - 100.0 + 98.0 - 
FV LOWER THIGH 94.7 - 100.0 + 97.9 - 
POP ABOVE KNEE 94.7 - 93.3 0.63 93.9 0.54 
POP BELOW KNEE 84.2 0.62 83.3 0.59 83.7 0.51 
GSV ORIGIN 100.0 1.00 93.3 0.71 95.9 0.83 
GSV LOWER THIGH 94.7 0.88 90.0 0.73 91.8 0.80 
GSV UPPER CALF 78.9 0.55 80.0 0.52 79.6 0.54 
GSV LOWER CALF 94.7 0.87 93.3 0.71 93.9 0.81 
SSV 94.7 0.64 86.7 0.50 89.8 0.54 
CFV = common femoral vein 
FV = femoral vein  
POP = popliteal vein  
GSV origin = great saphenous vein  
SSV = small saphenous vein 
a
 Agreement = proportion of participants identified as having venous reflux ≥ 0.5s between observers 
b
 Kappa statistic: <0.20 = poor, 0.21-0.40 = fair, 0.41-0.60 = moderate, 0.61-0.80 = good, 0.81-1.00 = very good 
- Kappa statistic could not be calculated as the presence of venous reflux ≥ 0.5s between the two observers was asymmetrical 
+ Kappa statistic could not be calculated as there was no evidence of venous reflux ≥ 0.5 s for that vein segment on either examination by different observers 
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OBSERVER 1 (n=10) OBSERVER 2 (n=9) OBSERVER 3 (n=11) OBSERVER 4 (n=19) 
AGREEMENT  
(%) a 
KAPPA  b AGREEMENT  
(%) a 
KAPPA  b AGREEMENT  
(%) a 
KAPPA  b AGREEMENT 
(%) a 
KAPPA  b 
CFV 90.0 - 88.9 - 100.0 + 89.8 - 
FV ORIGIN 100.0 + 100.0 + 100.0 + 100.0 + 
FV LOWER THIGH 100.0 + 100.0 + 100.0 + 100.0 + 
POP ABOVE KNEE 100.0 + 88.9 - 81.8 - 89.5 0.60 
POP BELOW KNEE 100.0 + 88.9 - 90.9 - 78.9 0.22 
GSV ORIGIN 90.0 0.62 100.0 1.00 90.9 0.74 89.5 0.64 
GSV LOWER THIGH 90.0 0.74 88.9 0.77 100.0 1.00 88.9 0.60 
GSV UPPER CALF 70.0 0.29 100.0 1.00 90.9 0.81 83.3 0.56 
GSV LOWER CALF 80.0 - 100.0 1.00 72.7 0.54 77.8 0.20 
SSV 90.0 - 100.0 1.00 100.0 + 84.2 0.08 
CFV = common femoral vein 
FV = femoral vein  
POP = popliteal vein,  
GSV = great saphenous vein  
SSV = small saphenous vein 
a
 Agreement = proportion of participants identified as having venous reflux ≥ 0.5s between observers 
b
 Kappa statistic: <0.20 = poor, 0.21-0.40 = fair, 0.41-0.60 = moderate, 0.61-0.80 = good, 0.81-1.00 = very good 
- Kappa statistic could not be calculated as the presence of venous reflux ≥ 0.5s by the same observer on 2 different examinations was asymmetrical 




CHAPTER 6: RESPONSE AND REPRESENTATIVENESS OF THE STUDY SAMPLE 
 
 
6.1 CHAPTER OUTLINE 
 
In health services research, it is important to ensure that study participants on whom 
data are obtained, are similar to individuals not in the study.  If a representative sample 
is achieved, then the study findings can be extrapolated and generalised to the wider 
population.  There are two issues in determining the generalisability of study results.  
Firstly, the study sample must be representative of the target population.  In this study, 
the target population comprised the population of Edinburgh.  Secondly, the study 
sample should be representative of the study population.  In this follow up cohort, the 
study population comprised the 1,566 baseline participants.   
 
This chapter begins by detailing the response to the follow up phase of the Edinburgh 
Vein Study.  Categories of response are analysed by age and sex.  Using demographic 
population data, comparisons are made to determine if the follow up study sample are 
representative of the Edinburgh population in terms of age, sex, social class and 
ethnicity.  Participants of the follow up study are then compared to the study 
population at baseline.  More specifically, lifestyle factors, medical history and 
symptoms, treatment and family history of CVD are compared between follow up 




6.2 RECRUITMENT AND RESPONSE 
 
The recruitment process of the follow up phase of the Edinburgh Vein Study is shown 
in Figure 6.1.  The target study population comprised 1,566 participants who were 
examined at baseline.  During the 13-year follow up period, 101 (6.4%) baseline 
participants died and 9 (0.6%) emigrated.  Thus, 1,456 men and women were eligible 
to take part in the follow up study.  Of these, 14 (0.9%) were identified as living in 
another health authority.  The health authorities failed to provide the contact details of 
either the participant or their general practitioner, and these people were deemed 
“unable to trace”.   
 
Invitation letters were sent to the remaining 1442 baseline participants, of whom 172 
(11.0%) replied and refused to take part in the follow up study (“refusals”).  A further 
321 (20.5%) baseline participants could not be reached despite two invitation letters, 
three attempts at contacting them by telephone and a subsequent re-check of their 
details on the Community Health Index register.  These people were classified as “no 
response”.  The remaining 949 subjects agreed to participate but of these, 69 (4.4%) 
subsequently withdrew prior to their appointment, and were termed “withdrawals”.  
This resulted in a final study sample of 880 participants, giving a response rate of 
60.4% (880 out of 1,456).   Of the 172 participants who refused to take part, 50 
completed the refusal questionnaire.  The most common reason for not taking part was 
that the individual did not have venous disease (58%), followed by lack of time (22%).  
Of the 50 who completed a questionnaire, 8 had venous disease, 4 of whom had 
previous surgery but felt there was no point in taking part in the study as varicose 




6.2.1 Response by age 
Figure 6.2 displays the follow up response by age group at baseline.  Non-participant 
refers to any baseline participant who was eligible to take part in the follow up study 
but did not participate.  Non-participants include those who refused to take part, did 
not respond, withdrew or were unable to trace (n=576).  Follow up study participants 
were older than non-participants (mean age 46.6 years vs. 41.8 years, p<0.001).  Of the 
people who took part in the follow up study, 4.9% and 13.5% were aged 18-24 and 25-
34 years at baseline compared to 12.7% and 22.7% of non-participants in these 
respective age groups.  The proportion of participants and non-participants aged 35-44 
years at baseline were similar (21.6% and 23.6% respectively).  The greatest difference 
in response was that 32.3% of participants and 19.9% of non-participants were aged 
45-54 years at baseline.  Finally, 27.7% of participants and 23.1% of non-participants 
were aged between 55 and 64 years at baseline.   
 
A more detailed analysis of the category of response by age at baseline is presented in 
Table 6.1.  Participation was highest was in those aged 45-54 years at baseline, with 
73.6% of participants in this age group at the initial stage of the study, examined at 
follow up.  Those aged between 18 and 24 years at baseline were least likely to 
participate in the follow up study (37.1%).  The refusal rate was highest in those aged 
55-64 years (17.2%) and lowest in those aged 25-34 years at baseline (6.8%).  The rate 
of no response was highest in those aged between 18 and 24 years at baseline (41.4%).  
Furthermore, this age group also had the highest withdrawal rate (8.6%) whilst the 




6.2.2 Response by sex 
The response to follow up by sex is summarised in Table 6.2.  Excluding 110 people 
who had died or emigrated, 1,456 baseline participants were eligible to take part in the 
follow up study.  Of these, 43.5% were men and 56.5% were women.  The response was 
similar in men and women, with 61.5% and 59.6% of male and female baseline 
participants agreeing to take part in the follow up study (p=0.46).  The refusal rate was 
slightly higher in women than in men (13.3% and 9.9% respectively) (p=0.05). There 
were no significant differences between men and women with regards to the rate of no 
response (p=0.15) and the withdrawal rate (p=0.13).  Similarly, while the numbers of 
men and women who were deemed “unable to trace” were small, there was no 
statistically significant difference between the two groups (p=0.95). 
 
6.2.3  Social class 
At baseline, social class was measured according to the occupation of the participants, 
using the Standard Occupational Classification (Office of Population Censuses and 
Surveys 1991).  There were six categories of social class ranging from professional to 
skilled and unskilled work.  Table 6.3 presents a summary of social class of the 
participants and non-participants of the follow up study.   Data on social class was 
available for 782 participants and 504 non-participants.  A higher proportion of 
participants were in social classes I and II, professional and managerial jobs 
respectively, while a higher proportion of non-participants were in social classes IIIM-
V.  When analysed by non-manual (I-IIIN) and manual (IIIM-V) labour, a significant 
difference was found between the two groups.  Participants in the follow up study were 
more likely to be non-manual workers than non-participants (77.7% and 68.3% 
respectively) (p<0.001).   
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6.3 REPRESENTATIVENESS OF STUDY SAMPLE TO THE POPULATION OF EDINBURGH 
 
Using population data from various sources, including the National Records of Scotland 
(NRS), Scottish Census (General Register Office for Scotland (GROS)), and Scottish 
Index of Multiple Deprivation (SIMD), the demographic characteristics of the follow up 
study participants are now compared to the general population residing in Edinburgh.   
 
6.3.1 Age 
The age of follow up study participants was compared to the age of the population of 
Edinburgh using the National Records of Scotland (last published, 19/05/2011).  The 
age groups of participants had to be adjusted so that they matched the age groups 
quoted in the above publication.  One of the age groups in the published distribution for 
Edinburgh was over 75 years.  In our study, the maximum age of participants at 
baseline was 64 years.  Given that the follow up period was 13 years, the eldest a study 
participant could be at follow up was 78 years.  Therefore, proportionately there would 
be fewer study participants in this age group compared to Edinburgh.   
 
The follow up study sample was significantly older than the population of Edinburgh 
[Figure 6.3].  The final study sample included a smaller proportion of people aged 
between 30-44 years (12.7%) than the proportion of people this age living in 
Edinburgh (23.0%).  The proportion of participants and the population of Edinburgh 
aged between 45 and 59 years were 32.3% and 18.1% respectively.  The difference in 
age was most marked for those aged 60-74 years, with 45.2% of participants aged in 
this group at follow up compared to just 12.1% of the population of Edinburgh.  Finally, 
9.8% of follow up study participants were aged over 75 years compared to 7.3% of 





According to the General Register Office for Scotland, figures published in 2011 showed 
that 48.4% of the population of Edinburgh were male and 51.6% were female.  The EVS 
follow up participants included 390 men (44.3%) and 490 women (55.7%).  Therefore, 
the study sample contained a higher proportion of women than the population of 
Edinburgh.   
 
6.3.3 Social class 
Social class of participants in the follow up study was compared to the population of 
Edinburgh.  The postcodes of the 880 follow up study participants were linked to the 
Scottish Index of Multiple Deprivation (SIMD 2009), to generate a deprivation score for 
each participant based on the postcode where they resided.  Deprivation scores were 
grouped into 5 quintiles according to the SIMD guidelines, with 1 being the most 
deprived and 5 being the least deprived.  The quintiles for the 880 study participants 
were compared to the SIMD quintiles for 12,429 postcodes within the City of 
Edinburgh.   The results are presented in Figure 6.4.  Participants in the follow up study 
tended to be less deprived than the population of Edinburgh, although the difference 
was not significant (52.2% of study participants were classified in the least deprived 
group, while the corresponding proportion for the population of Edinburgh was 
44.1%). When social class was analysed as a continuous variable, no difference was 
found with the mean quintile of Edinburgh Vein Study follow up participants 3.9 





6.3.4 Ethnic group 
Of the 880 participants in the follow up study, 99.5% were Caucasian, 0.1% Indian, 
0.2% Chinese and 0.1% mixed race.  At the 2001 Scottish Census, published by the 
General Register Office for Scotland (GROS), 95.9% of the population of Edinburgh 
were Caucasian, 0.5% Indian, 0.8% Chinese and 0.6% mixed race.  Therefore the study 
sample was representative of the population of Edinburgh in terms of ethnic groups. 
 
6.4 REPRESENTATIVENESS OF THE STUDY SAMPLE TO THE STUDY POPULATION 
 
To measure the representativeness of the EVS follow up study sample to the study 
population, data from baseline will be compared between participants and non-
participants of the follow up study.  Lifestyle factors such as body mass index, medical 
history of clinical risk factors, smoking and mobility at work will be examined.  Social 
class will then be compared.  Finally, CVD at baseline, including severity and symptoms 
of disease, previous treatment, family history and prevalence of venous reflux are 
presented. 
 
6.4.1 Body mass index 
There was no significant difference between participants and non-participants in terms 
of BMI at baseline.  Follow up study participants had a mean BMI of 25.6 kg/m2 at 
baseline compared to 25.4 kg/m2 in non- participants (p=0.22).  The proportion of 
participants and non-participants who were normal weight (51% and 52%), 




6.4.2 Medical history 
Medical history of associated venous diseases and possible clinical risk factors at 
baseline are presented in Table 6.4.  Participants were more likely to have suffered 
haemorrhoids at baseline (32.2% compared to 22.6% of non-participants (p<0.001).     
The occurrence, at baseline, of other possible medical risk factors for CVD, including 
deep vein thrombosis, pulmonary embolism, hernia, phlebitis, fractured leg or swollen 
legs post operatively or post pregnancy, did not differ significantly between 
participants and non-participants in the follow up study (all p ≥ 0.05). 
 
6.4.3 Smoking 
Smoking status at baseline was compared in participants and non-participants. Of the 
participants in the follow up study, 80.3% were non-smokers at baseline compared to 
65.8% of non-participants (p<0.001).  Smoking was split into three groups according to 
the following status at baseline: current smoker, ex-smoker and never smoked, the 
results of which are presented in Figure 6.5.  Results show that participants in the 
follow up study were more likely to have given up smoking or indeed, never smoked at 






6.4.4 Mobility at work 
At baseline, participants were asked to record the proportion of time spent sitting, 
standing, walking or heavy lifting as never, up to half or over half the working day.  
Results were compared between participants and non-participants in the follow up 
study.  No significant differences were found in the amount of time spent sitting, 
standing or walking at work (all p ≥ 0.05).  However, participants in the follow up study 
spent less time doing work which involved heavy lifting (23.3%) compared to non-
participants (26.3%).  Moreover, 4.7% of participants spent over half the day doing 
heavy work at baseline compared to 6.5% of non-participants (p=0.03).  This 
observation could be explained by the fact that, according to the social class based on 
occupation, participants were less likely to be manual workers than non-participants.   
 
6.4.5 Severity of chronic venous disease  
Baseline data on the classification of CVD was compared between participants and non-
participants in the follow up study.  The results of this comparison are displayed in 
Table 6.5.   From the data it is evident that there is little difference in the distribution of 
CVD between participants and non-participants, except that slightly more non-
participants were free of telangiectases and reticular veins.  Of the follow up study 
participants, 92.1% had evidence of telangiectases at baseline compared to 86.2% of 
non-participants (p=0.01).  The same was true for reticular veins, with 90.2% of follow 
up participants presenting with this condition at baseline compared to 86.6% of non-
participants (p=0.02).  There were no significant differences between the baseline 
prevalence of varicose veins (p=0.40) or CVI (p=0.82) in participants and non-





6.4.6 Symptoms of chronic venous disease  
Symptoms of CVD measured in the baseline questionnaire, were compared between 
participants and non-participants of the follow up study [Table 6.6].  There were no 
significant differences in the frequencies of these symptoms at baseline between those 
who did and did not take part in the follow up study. 
 
6.4.7 Previous treatment for chronic venous disease 
Participants in the follow up study were more likely to have had previous surgery for 
varicose veins than non-participants (7.8% and 4.5% respectively) (p=0.02).  The same 
was true for sclerotherapy, with 4.6% of participants reporting this treatment at 
baseline compared to 2.6% of non-participants (p=0.04).   
 
6.4.8 Family history of chronic venous disease 
Family history of CVD was defined as varicose veins or venous ulceration in any one of 
the mother, father, grandparents or siblings at the baseline stage of the study.  Family 
history of CVD did not differ significantly between participants and non-participants of 
the follow up study.  Sixty two per cent of those of who took part in the follow up study 
reported a family history of CVD at baseline compared to 58.7% of non-participants 





6.4.9 Venous reflux  
Figure 6.5 displays the prevalence of reflux at baseline, in participants and non-
participants of the follow up study.  Venous reflux was defined as reflux ≥ 0.5 seconds 
in any one of the veins assessed.  Deep system reflux comprised reflux in any one of the 
CFV, FV and POP veins while superficial system reflux comprised reflux in the GSV or 
SSV.  If a participant had reflux in a deep and superficial vein, they were classified as 
having reflux in both systems.  There were no significant differences in the prevalence 
of reflux in the deep (p=0.32), superficial (p=0.75) and combined systems (p=0.58) 
between participants and non-participants of the follow up study. 
 
6.5 CHAPTER SUMMARY 
 
The response rate for the follow up phase of the Edinburgh Vein Study was 60.4% and 
was similar in men and women.  Follow up study participants tended to be older than 
both non-participants, and the population of Edinburgh.  The study sample contained a 
higher proportion of women than the proportion of females in Edinburgh.   Participants 
were similar to the population of Edinburgh in terms of social class. However, those 
who took part in the follow up study were more likely to have non-manual jobs.   There 
were no differences in the baseline prevalence of varicose veins or CVI between 
participants and non-participants, but the former reported a higher rate of varicose 
vein treatment at baseline, including both surgery and sclerotherapy.  Furthermore 
participants of the follow up study were also more likely to have had haemorrhoids at 
baseline.  Finally, those who took part in the follow up study were more likely to be 
non-smokers than those who did not take part.  
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FIGURE 6.1 RECRUITMENT IN THE FOLLOW UP OF THE EDINBURGH VEIN STUDY 
 
 
Unable to trace = baseline study participants who had moved to another health authority and whose address 
could not be traced. 
Refusals = baseline study participants who replied and refused to take part in the follow up study. 
No response = baseline study participants who did not reply despite 2 invitation letters and 3 attempts to 
contact them by telephone. 
Withdrawals = baseline study participants who initially agreed to participate in the follow up study but 
subsequently withdrew or failed to attend 
 
1,566 participants examined at 
baseline phase of the study 
Invitation letters sent to remaining 
1442 subjects 
949 agreed to participate in follow 
up 
101 deceased (6.4%) 
9 emigrated (0.6%) 
 
172 refusals (11.0%) 
321 no response (20.5%) 
69 withdrawals (4.4%) 
880 participants examined at follow 
up 
1,456 subjects eligible to participate 
in follow up study 




FIGURE 6.2 AGE DISTRIBUTION OF PARTICIPANTS AND NON-PARTICIPANTS IN THE EDINBURGH VEIN STUDY FOLLOW UP BY AGE AT BASELINE 
Participants = baseline participants who took part in the follow up study and underwent clinical examination (n=880) 










% of study 
population 
18-24 25-34 35-44 45-54 55-64 




TABLE 6.1  CATEGORIES OF RESPONSE TO THE EDINBURGH VEIN STUDY FOLLOW UP BASED ON AGE DISTRIBUTION AT BASELINE 
 
 CATEGORIES OF RESPONSE 














18-24  43 (37.1) 11 (9.5) 48 (41.4) 10 (8.6) 4 (3.4) 116 (8.0) 
25-34  120 (48.0) 17 (6.8) 91 (36.4) 15 (6.0) 7 (2.8) 250 (17.2) 
35-44  189 (58.0) 33 (10.1) 85 (26.1) 18 (5.5) 1 (0.3) 326 (22.4) 
45-54  285 (73.6) 46 (11.9) 44 (11.4) 11 (2.8) 1 (0.3) 387 (26.6) 
55-64  243 (64.4) 65 (17.2) 53 (14.1) 15 (4.0) 1 (0.3) 377 (25.9) 
TOTAL 880 (60.4) 172 (11.8) 321 (22.0) 69 (4.8) 14 (1.0) 1456 (100) 
N (%) = number and percentage within each group based on response at follow up 
Examined = baseline study participants who agreed to take part in the follow up study and underwent clinical examination 
Refusals = baseline study participants who replied and refused to take part in the follow up study. 
No response = baseline study participants who did not reply despite 2 invitation letters and 3 attempts to contact them by telephone. 
Withdrawals = baseline study participants who initially agreed to participate in the follow up study but subsequently withdrew or failed to attend. 




TABLE 6.2 CATEGORIES OF RESPONSE TO THE EDINBURGH VEIN STUDY FOLLOW UP BASED ON SEX 
 
 
CATEGORY OF RESPONSE 
MALES 






EXAMINED 390 (61.5) 490 (59.6) 880 (60.4) 0.46 
REFUSALS 63 (9.9) 109 (13.3) 172 (11.8) 0.05 
NO RESPONSE 151 (23.8) 170 (20.7) 321 (22.0) 0.15 
WITHDRAWALS 24 (3.8) 45 (5.5) 69 (4.7) 0.13 
UNABLE TO TRACE 6 (1.0) 8 (0.9) 14 (1.0) 0.95 
TOTAL 634 (43.5) 822 (56.5) 1456 (100) - 
N (%) = number and percentage within each sex based on category of response at follow up 
Examined = baseline study participants who agreed to take part in the follow up study and underwent clinical examination 
Refusals = baseline study participants who replied and refused to take part in the follow up study 
No response = baseline study participants who did not reply despite 2 invitation letters and 3 attempts to contact them by telephone 
 Withdrawals = baseline study participants who initially agreed to participate in the follow up study but subsequently withdrew or failed to attend 
Unable to trace = baseline study participants who had moved to another health authority and whose address could not be traced 
















SOCIAL CLASS I a 84 (10.7) 49 (9.7) 133 (10.3) 
SOCIAL CLASS II a 335 (42.8) 156 (30.9) 491 (38.2) 
SOCIAL CLASS IIIN a 189 (24.2) 139 (27.6) 328 (25.5) 
SOCIAL CLASS IIIM b 101 (12.9) 89 (17.7) 190 (14.8) 
SOCIAL CLASS IV b 46 (5.9) 40 (7.9) 86 (6.7) 
SOCIAL CLASS V b 27 (3.5) 31 (6.2) 58 (4.5) 
TOTAL 782 504 1286 
N (%) = number and percentage within each group based on social class at baseline 
Participants = baseline participants who took part in the follow up study and underwent clinical examination (n=880) 
Non-participants = baseline participants who did not take part in the follow up study i.e. refusals + no response + withdrawals + unable to trace (n= 576) 
* 
Social class determined at baseline using the Standard Occupational Classification (Office of Population Censuses and Surveys, 1991) 
a
 Social classes I-IIIN = non-manual workers 
b




FIGURE 6.3 AGE AND SEX DISTRIBUTION FOLLOW UP STUDY PARTICIPANTS COMPARED TO THE POPULATION OF EDINBURGH 
Participants = baseline participants who took part in the follow up study and underwent clinical examination (n=880) 







% of population 
30-44 45-59 60-74 75+ 
Age at follow up (years) 
Male participants Male City of Edinburgh 
Female participants Female City of Edinburgh 
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FIGURE 6.4 DEPRIVATION SCORES FOR EDINBURGH VEIN STUDY FOLLOW UP PARTICIPANTS AND THE POPULATION OF EDINBURGH. 
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TABLE 6.4 HISTORY OF MEDICAL RISK FACTORS AT BASELINE, IN PARTICIPANTS AND 
NON-PARTICIPANTS OF THE EDINBURGH VEIN STUDY FOLLOW UP 
 







DEEP VEIN THROMBOSIS 22 (2.5) 9 (1.6) 0.23 
HERNIA 53 (6.0) 23 (4.0) 0.09 
PULMONARY EMBOLISM 5 (0.6) 6 (1.0) 0.36 
FRACTURED LEG 81 (9.3) 43 (7.5) 0.24 
SWOLLEN LEG POST-OPERATIVELY 53 (6.3) 25 (4.5) 0.17 
SWOLLEN LEG POST-PREGNANCY 140 (36.3) 96 (44.0) 0.06 
PHLEBITIS 41 (4.7) 16 (2.8) 0.07 
HAEMORRHOIDS 283 (32.2) 130 (22.6) <0.001 
N (%) = number and percentage within each group with condition at baseline 
Participants = baseline participants who took part in the follow up study and underwent clinical examination 
(n=880) 
Non-participants = baseline participants who did not take part in the follow up study i.e. refusals + no response 
+ withdrawals + unable to trace (n= 576) 
*P value from chi square test for differences in medical history at baseline between participants and non-




FIGURE 6.5 SMOKING STATUS AT BASELINE IN PARTICIPANTS AND NON-PARTICIPANTS OF THE EDINBURGH VEIN STUDY FOLLOW UP 
Participants = baseline participants who took part in the follow up study and underwent clinical examination (n=880) 
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TABLE 6.5 CATEGORIES AND SEVERITY OF CEAP CHRONIC VENOUS DISEASE AT 
BASELINE IN PARTICIPANTS AND NON-PARTICIPANTS OF THE EDINBURGH 































































CEAP = CEAP classification of chronic venous disease (Eklof 2004) 
N (%) = number and percentage within each group with CEAP class and severity of venous disease at baseline 
Participants = baseline participants who took part in the follow up study and underwent clinical examination 
(n=880) 
Non-participants = baseline participants who did not take part in the follow up study i.e. refusals + no response 
+ withdrawals + unable to trace (n= 576) 
b
 Grade based on Basle classification for severity: 1 (mild), 2 (moderate) and 3 (severe)   
c 
C3 CEAP = corona phlebectatica and venous oedema 
d
 C4 CEAP = C4a pigmentation, C4a venous eczema, C4b lipodermatosclerosis and C4b atrophie blanche 
e 
C5-C6 CEAP = C5 healed and C6 active venous ulceration 
*P value from chi square linear trend test for differences in prevalence of CVD by participants and non-






TABLE 6.6 SYMPTOMS OF CHRONIC VENOUS DISEASE, MEASURED AT BASELINE, IN 
PARTICIPANTS AND NON-PARTICIPANTS OF THE EDINBURGH VEIN STUDY 
FOLLOW UP 
 








HEAVY LEGS 190 (21.6) 144 (25.1) 0.13 
SWOLLEN LEGS 160 (18.2) 85 (14.9) 0.09 
ACHING LEGS 375 (42.8) 260 (45.4) 0.33 
RESTLESS LEGS 248 (28.2) 159 (27.7) 0.81 
NIGHT CRAMPS 328 (37.4) 224 (39.0) 0.54 
ITCHING 196 (22.3) 127 (22.1) 0.94 
TINGLING 153 (17.4) 106 (18.4) 0.62 
N (%) = number and percentage within each group reporting symptoms of CVD at baseline 
Participants = baseline participants who took part in the follow up study and underwent clinical examination 
(n=880) 
Non-participants = baseline participants who did not take part in the follow up study i.e. refusals + no response 
+ withdrawals + unable to trace (n= 576) 
*P value from chi square test for differences in symptoms of CVD at baseline between participants and non-





FIGURE 6.6 VENOUS REFLUX ≥ 0.5 SECONDS DURATION MEASURED AT BASELINE, IN PARTICIPANTS AND NON-PARTICIPANTS OF THE 
EDINBURGH VEIN STUDY FOLLOW UP 
Participants = baseline participants who took part in the follow up study and underwent clinical examination (n=880) 
Non-participants = baseline participants who did not take part in the follow up study i.e. refusals + no response + withdrawals + unable to trace (n= 576) 
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CHAPTER 7: PREVALENCE AND INCIDENCE OF CHRONIC VENOUS DISEASE 
 
 
7.1 CHAPTER OUTLINE 
 
This chapter presents the prevalence and incidence of CVD from the Edinburgh Vein 
Study (EVS) follow up.  Firstly prevalence of CVD at follow up will be reported and 
compared to the prevalence at baseline, to examine changes during the two stages of 
the study.  Prevalence of CVD at follow up by sex, age, right or left leg and social class 
will also be explored.  Incidence of varicose veins and CVI at follow up will then be 
presented by sex, age, left or right leg and social class.  In this thesis, the prevalence and 
incidence of CVD is based on the clinical examination with adjustments made based on 
photographic evidence, as previously discussed in Chapter 5. 
 
7.2  PREVALENCE OF C1-C6 CHRONIC VENOUS DISEASE AT FOLLOW UP 
 
The prevalence of a disease is the total number of cases of disease in the population at a 
given time, divided by the number of individuals in the population.  The prevalence in 
the Edinburgh Vein Study is the number of participants with evidence of CVD at follow 
up, divided by the number of participants who took part in both the baseline and follow 
up stages of the study.  The leg assigned the highest CEAP class or Basle grade for 




7.2.1  Prevalence of C1-C6 chronic venous disease at baseline and follow up 
The prevalence of C1-C6 CVD at the baseline and follow up are shown in Table 7.1.  At 
follow up, fewer participants had C1 telangiectases and reticular veins than at baseline.  
Although the number of participants with grade 2 and 3 telangiectases increased, the 
overall prevalence of telangiectases decreased from 92.2% (95% CI 90.2-93.8) to 
85.2% (95% CI 82.7-87.4) (p<0.001).  The prevalence of grade 2 and 3 reticular veins 
also increased, but the overall prevalence decreased from 90.2% (95% CI 88.1-92.0) at 
baseline to 70.1% (95% CI 67.0-73.1) at follow up.  The prevalence of C2 varicose veins 
increased slightly from 36.9% (95% CI 33.8-40.2) at baseline to 39.2% (95% CI 36.0-
42.5) at follow up (p<0.001).  There were fewer mild C2 varices at follow up and more 
classed as moderate to severe. 
 
The prevalence of C3 corona phlebectatica increased almost three fold, from 5.9% 
(95% CI 4.5-7.7) at baseline to 16.7% (95% CI 14.4-19.3) at follow up (p<0.001).  On 
the other hand, the prevalence of C3 oedema decreased from 11.6% (95% CI 9.6-13.9) 
at baseline to 4.4% (95% CI 3.3-6.0) at follow up (p<0.001).   C4a pigmentation showed 
a statistically significant increase from 1.3% (95% CI 0.7-2.2) at baseline to 5.5% (95% 
CI 4.1-7.2) at follow up (p<0.001).  Other C4 CEAP conditions including C4a venous 
eczema, C4b lipodermatosclerosis and C4b atrophie blanche were also more prevalent 
at follow up, although the increase was not statistically significant (all p≥0.05).  The 
prevalence of both C5 healed and C6 active venous ulceration increased from baseline 
to follow up, although the numbers are too small to estimate the prevalence of these 






7.2.2  Prevalence of C2 varicose veins and C3-C6 CVI by age 
The prevalence of C2 varicose veins according to age at follow up is shown in Table 7.2.  
For all participants, regardless of sex, the prevalence of C2 varices increased linearly 
with age from 14.3% (95% CI 4.0-40.0) in those aged 25-34 years to 50.6% (95% CI 
45.3-55.9) in those aged over 65 years at follow up (P trend<0.001).  When analysed by 
sex, the prevalence of C2 varices increased linearly with age for male participants from 
15.4% (95% CI 7.3-29.7) in those aged 35-44 years to 47.4% (95% CI 39.6-55.3) in 
those aged 65 years and older (P trend<0.001).  For female participants, the prevalence 
also increased linearly with age (P trend<0.001) but only from aged 45 years onwards. 
 
Table 7.3 shows that, with the exception of those aged 35-44 years, the overall 
prevalence of C3-C6 CVI increased linearly with age (P trend<0.001).  The prevalence in 
participants aged over 65 years was 32.6% (95% CI 27.9-37.8), four times higher than 
in those aged 25-34 years, (7.1%, 95% CI 1.3-31.5).  It should be noted only 4 of the 102 
participants aged younger than 45 years had C3-C6 CVI at follow up.  Therefore, the 
sample is too small to determine the prevalence of CVI in these age groups with 
precision.  When analysed by gender, the prevalence of C3-C6 CVI remained 
significantly associated with age for both males and females.  The prevalence increased 
from 12.3% (95% CI 6.9-21.3) in men aged 45-54 years to 36.8% (95% CI 29.6-44.8) in 
men aged 65 years and older (P trend<0.001).  In women the prevalence of CVI rose 
from 10.8% (95% CI 5.8-19.3) in those aged 45-54 years to 29.3 (95% CI 23.2-36.1) in 




7.2.3  Prevalence of C1-C6 chronic venous disease by sex 
Table 7.4 displays the prevalence of C1-C6 CVD at follow up in male and female 
participants.  The prevalence of C1 telangiectases was significantly higher in women 
(90.2%, 95% CI 87.3-92.5) than in men (79.0%, 95% CI 74.7-82.7) (p<0.001).  Men had 
a higher prevalence of mild (grade 1) telangiectases (P=0.001) but women had a higher 
prevalence of moderate (grade 2) and severe (grade 3) telangiectases (both p≤0.001).  
There was no significant sex difference in the overall prevalence of C1 reticular veins 
(p=0.11). However, moderate (grade 2) reticular veins were more common in women 
(p=0.02).  The prevalence of C2 varicose veins was similar in men (40%, 95% CI 35.3-
44.5) and women (38.6%, 95% CI 34.4-42.9) (p=0.67).  When analysed by severity, no 
significant sex differences emerged for C2 varicose veins (all p>0.05).   
 
The prevalences of C3 CVI conditions including corona phlebectatica and venous 
oedema, were similar between men and women (both p>0.05).  Furthermore, there 
were no significant differences in the prevalences of C4 conditions by sex (all p>0.05).  
The prevalence of C5 healed ulceration was identical: 0.8% (95% CI 0.2-2.2) in men and 
0.8 (95% CI 0.3-2.1) in women (p=0.62).  The prevalence of C6 active ulceration was 
0.1% (95% CI 0.1-0.6), with only one male participant presenting with this at the follow 
up examination (p=0.44).  The number of cases of C4b atrophie blanche, C5 healed and 
C6 active venous ulceration in the study sample is very small and therefore the 





7.2.4  Prevalence of C2 varicose veins and C3-C6 CVI by leg 
The prevalence of unilateral and bilateral C2 varices at follow up was 20.1% (95% CI 
17.6-22.9) and 19.1% (95% CI 16.6-21.8) respectively.  C2 varices of any severity were 
more prevalent in the left leg, 29.6% (95% CI 26.7-32.8) than the right leg, 28.7% (95% 
CI 25.9-31.8) (p<0.001) [Table 7.5].  When analysed by severity, mild varicose veins 
were more common in the left leg (p<0.001) while moderate varicose veins had a 
higher prevalence in the right leg (p<0.001).  The prevalence of severe varicose veins 
was similar in the right and left legs (p=0.57).  There were no significant sex differences 
in the prevalence of C2 varices by leg.   The prevalence in the right leg was 30.8% (95% 
CI 26.4-35.5) in men and 27.1% (95% CI 23.4-31.3) in women (p=0.24) and the left leg 
was 29.5% (95% CI 25.2-34.2) and 29.8% (95% CI 25.9-34.0) in men and women 
respectively (p=0.92). 
 
The prevalence of unilateral and bilateral C3-C6 CVI at follow up was 6.9% (95% CI 5.4-
8.8) and 13.7% (95% CI 11.6-16.2) respectively.  When all classes of CVI were grouped 
together, the prevalence was higher in the left leg, 17.6% (95% CI 15.2-20.3) than in 
the right, leg 16.7% (95% CI 14.4-19.3) (p<0.001) [Table 7.5].  When CVI was split by 
classes, C3 CVI (corona phlebectatica and oedema), was more prevalent in the left leg 
(p<0.001).  For C4-C6 CVI, no significant differences were found with regards to 
prevalence by leg (all p≥0.05).  There were no significant sex differences in the 
prevalence of CVI by leg.  Of the male participants, 18.2% (95% CI 14.7-22.3) had CVI in 
their right leg at follow up compared to 15.5% (95% CI 12.6-19.0) of women (p=0.29).  
For the left leg, 18.2% (95% CI 14.7-22.3) of men compared to 17.1% (95% CI 14.1-
20.7) of women had CVI at the follow up examination (p=0.68).   
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7.2.5  Prevalence of C2 varicose veins and C3-C6 CVI by social class 
The prevalence of C2-C6 venous disease at follow up by social class, determined at 
baseline, is shown in Table 7.6.  The prevalence of C2 varices was lowest in professional 
occupations, (33.3%, 95% CI 24.2-43.9) and highest in unskilled workers (51.9%, 95% 
CI 34.0-69.3).  Merging the six social classes into two groups based on non-manual and 
manual occupations, did not produce any statistically significant difference, with 
prevalences of 38.2% (95% CI 34.4-42.1) and 42.0% (95% CI 34.5-49.4) respectively 
(p=0.37).  There was no difference in the prevalence of CVI by social class (p=0.79). 
 
7.3  INCIDENCE OF C2 VARICOSE VEINS AND C3-C6 CVI AT FOLLOW UP 
The incidence of a disease is the number of new cases arising in a given period of time, 
in a population initially free of disease.  In this study, the incidence of C2 varicose veins 
is the number of new cases of C2 varices at follow up, divided by the number of 
participants free of C2 varices at baseline.  Similarly, the incidence of C3-C6 CVI is the 
number of new cases of C3-C6 CVI divided by those free of C2 varices and C3-C6 CVI at 
baseline.  Participants with C2 varices at baseline but C3-C6 CVI at follow up are not 
included in the incidence of C3-C6 CVI as they are not cases of new venous disease but 
whose existing venous disease has progressed in severity during the study.  The 
incidence rate is calculated by dividing the incidence by the average follow up period of 
13.38 years.  Results on incidence are based on findings from the clinical examination 
and photographs of participants in the follow up study as discussed in Chapter 5.  C1 
telangiectases and reticular veins are not considered when calculating incidence.  The 
leg assigned the highest CEAP class or Basle grade of severity was used for each 





7.3.1  Incidence of C2 varicose veins and C3-C6 CVI 
Table 7.7 presents the incidence of C2 varicose veins at follow up.  At baseline, 555 
participants were free of C2 varices.  At follow up, 101 of these participants had 
developed new cases of C2 varicose veins, resulting in an incidence of 18.2% (95% CI 
15.2-21.6).  The annual incidence rate was 1.4% (95% CI 1.1-1.7).  The majority of 
affected subjects (87%) had mild varicose veins.  The incidence of mild (grade 1), 
moderate (grade 2) and severe (grade 3) C2 varicose veins was 15.7% (95% CI 12.9-
18.9), 2.3% (95% CI 1.4-4.0) and 0.2% (95% CI 0.1-1.0) respectively.   The annual 
incidence rates of mild, moderate and severe C2 varices were 1.17% (95% CI 0.95-
1.44), 0.17% (95% CI 0.1-0.3) and 0.01% (95% CI 0-0.08) respectively.   Of the 555 
participants free from C2 varices at baseline, only 2 had varicose vein surgery during 
the follow up period.  However, both of these participants had C2 varicose veins at 
follow up and therefore were correctly included as incident cases.   
 
Of 880 participants examined at follow up, 546 had no C2 varicose veins nor C3-C6 CVI 
at baseline.  The most common CVI condition was C3 corona phlebectatica, which had 
an incidence of 5.3% (95% CI 3.7-7.5) over the 13 year follow up period and an annual 
incidence rate of 0.40% (95% CI 0.28-0.57) [Table 7.7].  New cases of C3 oedema, C4a 
pigmentation, C4a eczema and C4b lipodermatosclerosis were found in 2.6% (95% CI 
1.5-4.3), 2.2% (95% CI 1.3-3.8), 1.8% (95% CI 1.0-3.3) and 1.1% (95% CI 0.5-2.4) of the 
follow up participants respectively.  Only one participant developed C4b atrophie 
blanche at follow up (0.2%, 95% CI 0.1-1.0).  The incidence of C5 healed ulceration was 
0.5% (95% CI 0.2-1.6) and C6 active ulceration was 0.2% (95% CI 0.1-1.0).   Of the 546 
participants with no signs of C2-C6 disease at baseline, 2 had subsequent treatment 
during the follow up period.  However, both of these participants had C3-C6 CVI at 




Analysis was completed to determine the incidence of C2 varicose veins alone, C3-C6 
CVI alone and both conditions together.  The respective incidences were 13.9% (95% CI 
11.0-17.3), 5.2% (95% CI 3.6-7.5) and 3.8% (95% CI 2.4-5.8).  When analysed by 
severity, the majority of participants with C2 veins only had mild varices (91%), 8% 
were moderate and 1% was severe.  In those with isolated CVI, 62% were classed as C3, 
34% were C4 and 3% were C5.  Of those participants with both conditions at follow up, 
67% had mild varices combined with C3 CVI in 33%, C4 CVI in 24% and C5 CVI in 10%, 
while 33% had moderate varices combined with C3 in 57% and C4 in 43%.   
 
7.3.2  Incidence of C2 varicose veins and C3-C6 CVI by age 
The incidence of C2 varices increased significantly in a linear fashion, from 9.8% (95% 
CI 5.9-15.8) in those aged 18-34 years at baseline to 25.7% (95% CI 18.5-34.4) in those 
aged 55-64 years (p trend<0.001) [Table 7.8].  The incidence appeared to increase with 
age more consistently in women than in men.  In women the incidence increased with 
every baseline age group (p trend<0.001) so that the incidence in those aged over 55 
years was three times higher than in those aged 18-34 years.  On the other hand, in 
men the rate increased with age but was lower in those aged ≥55 years, so that overall 
the trend was not statistically significant (P trend=0.23).  It is important to note that 
the confidence intervals around the incidences in men aged 45-54 years and ≥55 years 
overlap considerably, indicating that the true incidence of C2 in these age groups may 








The incidence of C3-C6 CVI increased significantly with age, from 2.1% (95% CI 0.7-6.0) 
in those aged less than 35 years to 17.1% (95% CI 11.2-25.2) in those aged over 55 
years at baseline (p trend<0.001) [Table 7.9].  When analysed by sex, the incidence 
remained significantly associated with age for both males and females (p trend=0.003 
and p trend=0.001 respectively).  Similar to the findings on the incidence of varicose 
veins, male participants aged over 55 years at baseline appeared to have a lower 
incidence of CVI at follow up than those aged 45-54 years.  However the overlap in the 
confidence intervals suggests that the true incidence of CVI may not be significantly 
different in these two age groups.  Female participants aged 35-44 years had a lower 
incidence than those aged 18-34 year but with only 5 cases of CVI in these two age 
groups, the sample is too small to estimate the precise incidence of CVI.   
 
7.3.3 Incidence of C2 varicose veins and C3-C6 CVI by sex 
The incidence of C2 varicose veins and C3-C6 CVI by sex is presented in Table 7.10.  The 
total incidence of C2 varicose veins was slightly higher in women (18.6%, 95% CI 14.8-
23.1) than in men (17.6%, 95% CI 13.2-23.2) but this difference was not statistically 
significant (p=0.97).  After adjusting for age, the incidence was 15.2% (95% CI 10.4-
20.0) in men and 17.4% (95% CI 13.1-21.7%) in women (p=0.97).  When C2 varicose 
veins were examined by severity, no difference between sexes was found (all p≥0.5).  
The incidence of all CVI was 10.7% (95% CI 7.2-15.5) in men compared to 8.1% (95% 
CI 5.7-11.6) in women (p=0.32).    For each CEAP class of CVI, the incidence was higher 
in men but this did not reach statistical significance (all p≥0.5).  The incidence of C2 
varices alone, CVI alone and both conditions together was 12.1% (95% CI 8.1-17.5), 
5.1% (95% CI 2.7-8.9) and 5.6% (95% CI 3.0-9.5) respectively in men and 16.4% (95% 




7.3.4  Incidence of C2 varicose veins and C3-C6 CVI by leg 
Of the 101 new cases of C2 varicose veins, 71 were in one leg only (70.3%) and 30 were 
bilateral (29.7%).  The incidence of unilateral and bilateral C2 varicose veins was 
12.8% (95% CI 10.3-15.8) and 5.4% (95% CI 3.8-7.6) respectively.  As shown in Table 
7.11, the incidence of C2 varicose veins was similar in the right and left legs (p=0.57) 
and remained so when analysed by severity.   When men and women were compared, 
the incidence of C2 varicose was similar between sexes for the right and left legs 
(p=0.94 and p=0.97 respectively) 
  
The incidence of unilateral and bilateral C3-C6 CVI at follow up was 2.6% (95% CI 1.5-
4.3) and 6.6% (95% CI 4.8-9.0) respectively.  Of the 50 new cases of CVI, 14 were in one 
leg only (28.0%) and 36 were in both legs (72.0%).   The incidence of C3-C6 CVI did not 
differ by leg and this remained true when CVI was analysed by CEAP class (p>0.05) and 
by gender.  Of the male participants, 7.9% (95% CI 5.0-12.3) had C3-C6 CVI in their 
right leg at follow up compared to 6.6% (95% CI 4.4-9.9) of women (p=0.29).  For the 
left leg, 8.8% (95% CI 5.7-13.4) of men compared to 8.2% (95% CI 5.7-11.6) of women 
had C3-C6 CVI at the follow up examination (p=0.68).   
 
7.3.5  Incidence of C2 varicose veins and C3-C6 CVI by social class 
Table 7.12 presents the incidence of C2 varicose veins and C3-C6 CVI by social class, 
determined at baseline.  Incidence of C2 varicose veins was lowest in skilled manual 
workers (Social class IIIM), 12.9% (95% CI 6.7-23.4) and highest in unskilled workers 
(Social class V), 30.8% (95 % CI 12.7-57.7).  However, the difference was not 





When the six social classes were grouped together according to non-manual (Social 
class I to IIIN) and manual (social class IIIM to V) occupations, the overall incidence of 
C2 varicose veins was similar between the two groups: 18.6% (95% 15.1-22.8) in non-
manual workers and 18.4% (95% CI 12.1-27.0) in manual workers (p=0.97).  The 
incidence of C3-C6 CVI did not differ between manual and non-manual workers: 10.1% 
(95% CI 5.6-17.6) and 9.0 (95% CI 6.6-12.3) respectively (p=0.75).  Within manual 
workers, unskilled workers (social class V) in particular were most likely to develop 
CVI, with 16.7% (95% CI 4.7-44.8) of this group presenting with CVI at follow up.   
 
7.4 CHAPTER SUMMARY 
 
Almost 40% of the study population had C2 varicose veins and over 20% had C3-C6 CVI 
at the follow up phase of the Edinburgh Vein Study.  Prevalence of CVD did not differ by 
sex.  The prevalence of all CEAP classes of CVD increased with age.  There was no 
significant association between prevalence of C2 varices or C3-C6 CVI and social class.  
The incidence of C2 varicose veins was 18.2% over the 13 year follow up period.  
Therefore, approximately 1.4% of the study population initially free of varicose veins at 
baseline, developed new C2 varices each year.  C3-C6 CVI had an overall incidence of 
9.2% and an annual incidence rate of 0.7% per year.  There was no significant gender 
difference for the incidence of either varicose veins or CVI.  However, the incidence of 
both conditions did increase with age.  The development of C2 varices and C3-C6 CVI 







TABLE 7.1 PREVALENCE OF C1-C6 CHRONIC VENOUS DISEASE IN 880 PARTICIPANTS 
AT BASELINE AND FOLLOW UP OF THE EDINBURGH VEIN STUDY 
 
 BASELINE FOLLOW UP P VALUE * 
CEAP a % (95% CI) n % (95% CI) n  
C1 TELANGIECTASES b 
Grade 1  
Grade 2  





















C1 RETICULAR VEINS b 
Grade 1  
Grade 2  





















C2 VARICOSE VEINS b 
Grade 1  
Grade 2  
























































































CEAP = CEAP classification of chronic venous disease (Eklof 2004) 
% (95% CI) = % (95% confidence interval) in each group with CEAP class of disease at follow up  
n = number in each group with CEAP class of disease at follow up. 
* P value based on Chi squared test for association between prevalence at baseline and follow up 
b
 Grade based on Basle classification for severity: 1 (mild), 2 (moderate) and 3 (severe)   
Leg assigned the highest CEAP class or Basle grade of severity used for each participant. 
* P value = chi square test for difference in prevalence of condition between baseline and follow up 
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TABLE 7.2 PREVALENCE OF C2 VARICOSE VEINS BY AGE AND SEX, IN 880 PARTICIPANTS OF THE FOLLOW UP PHASE OF THE EDINBURGH VEIN 
STUDY 
 
AGE AT FOLLOW UP 
 (YEARS) 
MEN (N=390) WOMEN (N=490) TOTAL (N=880) 
% (95% CI) n (N) % (95% CI) n (N) % (95% CI) n (N) 
25-34 0 (0) 0 (3) 18.2 (5.1-47.7) 2 (12) 14.3 (4.0-40.0) 2 (15) 
35-44 15.4 (7.3-29.7) 6 (39) 17.2 (9.6-28.9) 10 (58) 16.5 (10.4-25.1) 16 (97) 
45-54 38.3 (28.4-49.2) 31 (81) 22.9 (15.2-33.0) 19 (83) 30.5 (24.0-37.9) 50 (164) 
55-64 40.9 (32.3-50.0) 47 (115) 38.9 (31.5-46.9) 58 (149) 39.8 (34.1-45.8) 105 (264) 
≥ 65 47.4 (39.6-55.3) 72 (152) 53.2 (46.1-60.2) 100 (188) 50.6 (45.3-55.9) 172 (340) 
P VALUE* <0.001  <0.001  <0.001  
% (95% CI) = % (95% confidence interval) in each group with C2 varicose veins at follow up  
n = number in each group with C2 varicose veins at follow up. 
N = number in each age group at follow up. 
Leg assigned the highest CEAP class or Basle grade for severity used for each participant
  
* P value = chi square test for linear trend for association between prevalence of C2 varicose veins and age 
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TABLE 7.3 PREVALENCE OF C3-C6 CHRONIC VENOUS INSUFFICIENCY (CVI) BY AGE AND SEX, IN 880 PARTICIPANTS AT THE FOLLOW UP PHASE 
OF THE EDINBURGH VEIN STUDY 
 
AGE AT BASELINE  
(YEARS) 
MEN (N=390) WOMEN (N=490) TOTAL (N=880) 
% (95% CI) n (N) % (95% CI) n (N) % (95% CI) n (N) 
25-34 0 0 (3) 9.1 (1.6-37.7) 1 (12) 7.1 (1.3-31.5) 1 (15) 
35-44 2.6 (0.5-13.2) 1 (38) 3.4 (0.9-11.7) 2 (58) 3.1 (1.1-8.7) 3 (97) 
45-54 12.3 (6.9-21.3) 10 (81) 10.8 (5.8-19.3) 9 (83) 11.6 (7.5-17.4) 19 (164) 
55-64 20.0 (13.7-28.2) 23 (115) 16.1 (11.1-22.8) 24 (149) 17.8 (13.7-22.9) 47 (264) 
≥ 65 36.8 (29.6-44.8) 56 (152) 29.3 (23.2-36.1) 55 (188) 32.6 (27.9-37.8) 111 (340) 
P VALUE* <0.001 <0.001 <0.001 
 % (95% CI) = % (95% confidence interval) in each group with C3-C6 CVI at follow up  
n = number in each group with C3-C6 CVI at follow up. 
N = number in each age group at follow up. 
Leg assigned the highest CEAP class or Basle grade for severity used for each participant
  
CVI includes C3, C4, C5 and C6, with the limb assigned the highest value used for each participant. 




TABLE 7.4 PREVALENCE OF C1-C6 CHRONIC VENOUS DISEASE IN MEN AND WOMEN 




MEN (N=390) WOMEN (N=490) P VALUE* 
% (95% CI) N % (95% CI) N  
C1 TELANGIECTASES b 
Grade 1  
Grade 2  





















C1 RETICULAR VEINS b 
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C2 VARICOSE VEINS b 
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CEAP = CEAP classification of chronic venous disease (Eklof 2004) 
% (95% CI) = % (95% confidence interval) in each group with class of disease at follow up  
N = number in each group with class of disease at follow up 
Leg assigned the highest CEAP class or Basle grade for severity used for each participant
  
b 
Grade based on Basle classification for severity: 1 (mild), 2 (moderate) and 3 (severe)   
* P value = chi square test for difference in prevalence of condition between men and women
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TABLE 7.5 PREVALENCE OF C2 VARICOSE VEINS AND C3-C6 CVI (BY SEVERITY) IN THE RIGHT AND LEFT LEGS AT THE FOLLOW UP PHASE OF THE 
EDINBURGH VEIN STUDY 
 
CEAP a RIGHT LEG LEFT LEG P VALUE* 
% (95% CI) (N) % (95% CI) (N)  
C2 VARICOSE VEINS b 
Grade 1  
Grade 2 





















C3-C6 CVI  
C3 CVI c 
C4 CVI d 






















CEAP = CEAP classification of chronic venous disease (Eklof 2004) 
% (95% CI) = % (95% confidence interval) in each group with C2 varicose veins/ CVI at follow up  
N = number in each group with C2 varicose veins/ CVI at follow up. 
Leg assigned the highest CEAP class or Basle grade for severity used for each participant
  
b
 Grade based on Basle classification for severity: 1 (mild), 2 (moderate) and 3 (severe) 
c
 C3 = corona phlebectatica and venous oedema 
d
 C4 = C4a pigmentation, C4a venous oedema, C4b lipodermatosclerosis and C4b atrophie blanche 
e
 C5-C6 = C5 healed and C6 active venous ulceration  





TABLE 7.6 PREVALENCE OF C2 VARICOSE VEINS AND C3-C6 CHRONIC VENOUS 
INSUFFICIENCY (CVI) AT THE FOLLOW UP PHASE, DETERMINED BY SOCIAL 
CLASS AT THE BASELINE PHASE OF THE EDINBURGH VEIN STUDY 
 
 C2 VARICOSE VEINS* C3-C6 CVI 
SOCIAL CLASS a % (95% CI) n (N) % (95% CI) n (N) 
I  33.3 (24.2-43.9) 28 (84) 16.7 (10.2-26.1) 14 (84) 
II 39.4 (34.3-44.7) 132 (335) 22.1 (18.0-26.8) 74 (335) 
IIIN 38.1 (31.5-45.2) 72 (189) 21.2 (15.9-27.5) 40 (189) 
IIIM 36.6 (27.9-46.4) 37 (101) 18.8 (12.4-27.5) 19 (101) 
IV 47.8 (34.1-61.9) 22 (46) 23.9 (13.9-37.9) 11 (46) 
V 51.9 (34.0-69.3) 14 (27) 18.5 (8.2-36.7) 5 (27) 
*C2 varicose veins include all Basle grades for severity: 1 (mild), 2 (moderate) and 3 (severe). 
CVI includes all CEAP classes: C3, C4, C5 and C6. 
% (95% CI) = % (95% confidence interval) in each group with C2 varicose veins or C3-C6 CVI at follow up  
n = number in each group with C2 varicose veins or C3-C6 CVI at follow up 
(N) = number in each social class group at baseline 
a
 Social class based on occupation at baseline.  I: professional, II: managerial/technical, IIIN: skilled (non-
manual), IIIM: skilled (manual), IV: partly skilled, V: unskilled, VI: other  













TABLE 7.7 13 YEAR INCIDENCE OF C2 VARICOSE VEINS AND C3-C6 CVI AT FOLLOW UP 
IN PARTICIPANTS FREE OF DISEASE AT THE BASELINE PHASE OF THE 
EDINBURGH VEIN STUDY 
 
 INCIDENCE ANNUAL INCIDENCE RATE 
CEAP a % (95% CI) N % (95% CI) 




























C4 CVI  
C4a Pigmentation 
C4a Eczema  
C4b Lipodermatosclerosis 

















C5 Healed ulcer 











CEAP = CEAP classification of chronic venous disease (Eklof 2004) 
% (95% CI) = % (95% confidence interval) in each group with C2 varicose veins/ CVI at follow up  
N = number in each group with C2 varicose veins/ CVI at follow up. 
Leg assigned the highest CEAP class or Basle grade for severity used for each participant
  
b
 Grade based on Basle classification for severity: 1 (mild), 2 (moderate) and 3 (severe) 
Incidence of C2 varicose veins based on the number of new cases of C2 varicose veins at follow up divided by 
the number of participants free from C2 varicose veins at baseline. 
Incidence of C3-C6 CVI based on the number of new cases of C3-C6 CVI at follow up, divided by the number of 
participants free from C2 varices and C3-C6 CVI at baseline. 
Participants with C2 varicose veins at baseline and C3-C6 CVI at follow up are not counted as incident cases of 
C3-C6 CVI as they are cases where existing venous disease has progressed rather than cases where new venous 




TABLE 7.8 13 YEAR INCIDENCE OF C2 VARICOSE VEINS AT FOLLOW UP BY AGE AND SEX, IN 555 MEN AND WOMEN WITH NO C2 VARICOSE 
VEINS AT THE BASELINE PHASE OF THE EDINBURGH VEIN STUDY 
 
AGE AT BASELINE  
(YEARS) 
MEN (N=221) WOMEN (N=334) TOTAL (N=555) 
% (95% CI) N % (95% CI) N % (95% CI) N 
18-34 10.0 (4.4-21.4) 5 9.7 (5.2-17.4) 9 9.8 (5.9-15.8) 14 
35-44 18.2 (10.2-30.3) 10 15.4 (9.0-25.5) 12 16.5 (11.2-23.8) 22 
45-54 22.9 (14.6-33.9) 16 20.9 (13.9-30.0) 20 21.7 (16.1-28.6) 36 
≥ 55 17.4 (9.1-30.7) 8 31.4 (21.5-43.2) 21 25.7 (18.5-34.4) 29 
P VALUE * 0.23  <0.001  <0.001  
% (95% CI) = % (95% confidence interval) in each group with C2 varicose veins at follow up  
N = number in each group with C2 varicose veins at follow up 
C2 varicose veins includes all Basle grades for severity: 1 (mild), 2 (moderate) and 3 (severe) 
Leg assigned the highest CEAP class or Basle grade for severity used for each participant
  
* P value = chi square linear test for trend for association of incidence of C2 varicose veins with age  






TABLE 7.9 13 YEAR INCIDENCE OF C3-C6 CHRONIC VENOUS INSUFFICIENCY AT FOLLOW UP BY AGE AND SEX, IN 546 PARTICIPANTS WITH NO 
CLINICAL SIGNS OF C2 VARICOSE VEINS OR C3-C6 CVI AT THE BASELINE PHASE OF THE EDINBURGH VEIN STUDY 
 
AGE AT BASELINE  
(YEARS) 
MEN (N=215) WOMEN (N=331) TOTAL (N=546) 
% (95% CI) N % (95% CI) N % (95% CI) N 
18-34 0 (0) 0 3.3 (1.1-9.2) 3 2.1 (0.7-6.0) 3 
35-44 7.3 (2.9-17.2) 4 2.6 (0.7-9.0) 2 4.5 (2.1-9.6) 6 
45-54 19.7 (11.9-30.8) 13 9.5 (5.1-17.0) 9 13.7 (9.2-19.8) 22 
≥ 55 13.6 (6.4-26.7) 6 19.4 (11.7-30.4) 13 17.1 (11.2-25.2) 19 
P VALUE * 0.003  0.001  <0.001  
% (95% CI) = % (95% confidence interval) in each group with C3-C6 CVI at follow up  
N = number in each group with C3-C6 CVI at follow up 
Leg assigned the highest CEAP class or Basle grade for severity used for each participant
  
* P value = chi square linear test for trend for association of incidence of C3-C6 CVI with age  
Incidence of C3-C6 CVI based on the number of new cases of C3-C6 CVI at follow up, divided by the number of participants free from C2 varices and C3-C6 CVI at baseline. 
Participants with C2 varicose veins at baseline and C3-C6 CVI at follow up are not counted as incident cases of C3-C6 CVI as they are cases where existing venous disease has 






TABLE 7.10 13 YEAR INCIDENCE OF C2 VARICOSE VEINS AND C3-C6 CHRONIC VENOUS INSUFFICIENCY AT FOLLOW UP, IN MEN AND WOMEN 




MEN WOMEN TOTAL P VALUE * 
% (95% CI) (N) % (95% CI) (N) % (95% CI) (N)  

































































CEAP = CEAP classification of chronic venous disease (Eklof 2004) 
% (95% CI) = % (95% confidence interval) in each group with C2 varicose veins/ C3-C6 CVI at follow up  
(N) = number in each group with C2 varicose veins/ C3-C6 CVI at follow up. 
Leg assigned the highest CEAP class or Basle grade for severity used for each participant
  
b
 Grade based on Basle classification for severity: 1(mild), 2 (moderate) and 3 (severe).  Measured in men (n=221), women (n=334) 
c
 C3 = corona phlebectatica and venous oedema.  Measured in men (n=215), women (n=331) 
d
 C4 = C4a pigmentation, C4a venous oedema, C4b lipodermatosclerosis and C4b atrophie blanche. Measured in men (n=215), women (n=331) 
e 
C5-C6 = C5 healed and C6 active venous ulceration. Measured in men (n=215), women (n=331) 
*P value = chi square test for the difference in incidence of C2 varicose veins or C3-C6 CVI between men and women 
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TABLE 7.11 13 YEAR INCIDENCE OF C2 VARICOSE VEINS AND C3-C6 CVI (BY GRADE) IN THE RIGHT AND LEFT LEGS AT THE FOLLOW UP PHASE OF 




RIGHT LEG LEFT LEG P VALUE* 
% (95% CI) (N) % (95% CI) (N)  











































CEAP = CEAP classification of chronic venous disease (Eklof 2004) 
% (95% CI) = % (95% confidence interval) in each group with C2 varicose veins/ C3-C6 CVI at follow up  
(N) = number in each group with C2 varicose veins/ C3-C6 CVI at follow up. 
Leg assigned the highest CEAP class or Basle grade for severity used for each participant
  
b
 Grade based on Basle classification for severity: 1 (mild), 2 (moderate) and 3 (severe).  Measured in men (n=215), women (n=331) 
c
 C3 = corona phlebectatica and venous oedema.   
d
 C4 = C4a pigmentation, C4a venous oedema, C4b lipodermatosclerosis and C4b atrophie blanche.  
e 
C5-C6 = C5 healed and C6 active venous ulceration.  





TABLE 7.12 13 YEAR INCIDENCE OF C2 VARICOSE VEINS AND C3-C6 CHRONIC VENOUS 
INSUFFICIENCY (CVI) AT FOLLOW UP, DETERMINED BY SOCIAL CLASS IN 
PARTICIPANTS WITH NO C2 VARICOSE VEINS OR C3-C6 CVI AT THE 
BASELINE PHASE OF THE EDINBURGH VEIN STUDY 
 
 C2 VARICOSE VEINS (N=555) C3-C6 CVI (N=546) 
SOCIAL CLASS * % (95% CI) N % (95% CI) N 
I 23.7 (14.7-36.0) 14 8.5 (3.7-18.4) 5 
II 18.3 (13.6-24.1) 38 9.3 (6.0-14.1) 19 
IIIN 16.8 (11.3-24.3) 21 8.9 (5.0-15.2) 11 
IIIM 12.9 (6.7-23.4) 8 9.8 (4.6-19.8) 6 
IV 25.0 (12.7-43.4) 7 7.7 (2.1-24.1) 2 
V 30.8 (12.7-57.4) 4 16.7 (4.7-44.8) 2 
C2 varicose veins includes all Basle grades: 1 (mild), 2 (moderate) and 3 (severe) 
% (95% CI) = % in each group with C2 varicose veins or C3-C6 CVI at follow up (95% confidence interval) 
N = number in each group with C2 varicose veins or C3-C6 CVI at follow up 
* Social class based on occupation at baseline.  I: professional, II: managerial/technical, IIIN: skilled (non-
manual), IIIM: skilled (manual), IV: partly skilled, V: unskilled, VI: other  
Incidence of C2 varicose veins by social class based on a total of 495 participants and incidence of C3-C6 CVI by 
social class based on a total of 486 participants. Excluded = housewives (44), students (14), and members of 
armed forces (2) 
Incidence of C2 varicose veins based on the number of new cases of C2 varicose veins at follow up divided by 
the number of participants free from C2 varicose veins at baseline. 
Incidence of C3-C6 CVI based on the number of new cases of C3-C6 CVI at follow up, divided by the number of 
participants free from C2 varices and C3-C6 CVI at baseline. 
Participants with C2 varicose veins at baseline and C3-C6 CVI at follow up are not counted as incident cases of 
C3-C6 CVI as they are cases where existing venous disease has progressed rather than cases where new venous 




CHAPTER 8: PREVALENCE AND INCIDENCE OF VENOUS REFLUX 
 
 
8.1 CHAPTER OUTLINE 
 
Duplex ultrasound scanning is considered to be the gold standard for assessment of 
venous reflux as it evaluates anatomical and functional haemodynamics to quantify 
reflux in deep and superficial veins (Labropoulos 2005).  This chapter presents reflux 
data on the Edinburgh Vein Study follow up participants.  The prevalence of reflux by 
vein segment, venous system, age and sex at both the baseline and follow up phases of 
the study will be presented.  The incidence of venous reflux at follow up by vein 
segment, venous system, age and sex will then be measured.    
 
8.2 ASSESSMENT OF VENOUS REFLUX 
 
The assessment of venous reflux was discussed in Chapter 4.  Two measures of reflux 
were made in each vein segment, with the mean used in the final reflux measure.  For 
all vein segments, if there was no blood flowing through the vein or the segment could 
not be visualised or correctly identified, it was recorded as a missing value rather than 
assuming there was no reflux present in the segment.  
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Data on reflux is presented by vein segment and also by venous system.  Venous system 
reflux is categorised into three groups: (1) deep reflux only, (2) superficial reflux only 
and (3) combined deep and superficial reflux.  Deep reflux only is defined as reflux ≥ 
0.5 seconds in one or more deep vein segments but not in any superficial segments.  
Superficial reflux only is defined as reflux ≥ 0.5 seconds in one or more superficial vein 
segments but not in any deep segments.  Combined deep and superficial reflux is 
defined as reflux ≥ 0.5 seconds in one or more deep segments and reflux ≥ 0.5 seconds 
in one or more superficial segments.   In determining reflux by system, if one deep 
segment was missing, deep system reflux is classified as present if one or more other 
deep segments had reflux.  If all other deep segments had no reflux, then the deep 
system reflux is classified as missing.  The same was true for superficial system reflux.  
Combined deep and superficial reflux is assigned if one or more deep and superficial 
segments had reflux in either leg.  Where reflux measurements for both deep and 
superficial segments were missing and all other segments had no reflux, combined 
reflux is classified as missing.    
 
 8.3 PREVALENCE OF VENOUS REFLUX AT BASELINE 
 
Of the 880 participants who took part in both stages of the study, reflux status at 
baseline was successfully determined in 759 participants.  Reflux could not be 
measured in 121 participants.  Two scans were abandoned, 4 examinations were 
performed at home, in 4 patients there was no blood flow in the vein and in 111 
participants the vein could not be imaged.  Of the 759 participants with valid reflux 
measurements, 443 had some evidence of reflux at baseline (58.4%).  
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8.3.1 Prevalence of venous reflux by vein segment 
Table 8.1 displays the prevalence of venous reflux ≥ 0.5 seconds for individual vein 
segments in the right, left, and both legs together, at the baseline phase of the study.  
There was no significant difference in the prevalence of reflux in any individual vein 
segment between the right and left legs (all p≥0.05).  The GSV in the lower third of the 
thigh was the most common site of reflux, with a prevalence of 17.9% (95% CI 15.1-
21.0) in the right leg, 16.8% (95% CI 14.2-19.8) in the left leg and 6.9% (95% CI 5.2-
8.9) in both legs.  Within the superficial system, the prevalence of reflux was lowest in 
the SSV.  For deep vein segments the POP vein above the knee crease had the highest 
prevalence of reflux, 12.6% (95% CI 10.4-15.1) in the right leg, 11.9% (95% CI 9.8-
14.3) in the left leg and 4.2% (95% CI 3.0-5.8) in both legs.  Reflux was least common in 
the FV origin, with a prevalence of 6.0% (95% CI 4.5-7.8), 4.8% (95% CI 3.5-6.4) and 
1.7% (95% CI 1.0-2.8) in the right, left and both legs respectively.    
 
8.3.2 Prevalence of venous reflux by venous system 
Of the 759 participants with a complete set of reflux measurements at baseline, 41.6% 
(n=319) had no reflux.  The prevalences of deep reflux only, superficial reflux only and 
combined reflux at baseline were 22.2% (95% CI 19.0-25.7), 16.3% (95% CI 13.6-19.4) 
and 19.9% (95% CI 16.9-23.2) respectively.  Of those with deep reflux only, 39.9% 
were in the right leg, 31.5% in the left, and 28.6% in both legs.  The prevalence of 
superficial reflux only was 37.6% in the right leg 41.6% in the left leg and 20.7% in 
both legs.  Of the 151 participants with combined reflux at baseline, 97% had deep and 
superficial reflux in the same leg while only 3% had deep reflux in one leg but 
superficial reflux in the other leg.  
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8.3.3 Prevalence of venous reflux by age 
The prevalence of reflux ≥ 0.5 seconds in any leg by age group at baseline is presented 
in Table 8.2.   The prevalence of reflux increased with age in four vein segments; the 
CFV, FV origin, GSV origin and GSV in the lower third of thigh.  Although, the number of 
participants aged 18-24 years with reflux in the CFV or FV origin at baseline was small, 
the prevalence increased significantly with age for both segments (p trend=0.003 and p 
trend=0.03 respectively).   For the GSV, the prevalence of reflux in both the origin and 
in the lower third of the thigh, increased with every age group so that in participants 
aged 55-64 years, the prevalence was approximately three times higher than in those 
aged 18-24 years (both P trend<0.001). 
 
When reflux at baseline was analysed by venous system, over half (55.3%) of 
participants aged 18-24 years at baseline had no reflux compared to 31.1% of 
participants aged 55-64 years (p trend<0.001) [Table 8.3].   The prevalence of reflux in 
the deep system only, increased from 16.3% (95% CI 7.1-32.2) in those aged 18-24 
years to 25.4% (95% CI 18.9-33.4) in those aged 35-44 years. However, in the older age 
groups, the prevalence decreased so that in participants aged 55-64 years, the 
prevalence was lower than in those aged 18-24 years (p trend=0.047).   The prevalence 
of reflux in the superficial system only, increased significantly with age from 10.5% 
(95% CI 3.3-25.4) in those aged 18-24 years to 22.6% (95% CI 16.9-29.8) in those aged 
55-64 years (p trend<0.001).  Age was also significantly associated with combined deep 
and superficial venous reflux.  The prevalence increased from 14.3% (95% CI 5.8-29.7) 
to 26.3% (95% CI 20.2-33.6) in participants aged 18-24 years and 55-64 years 
respectively (p trend=0.001).    
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8.3.4 Prevalence of venous reflux by sex 
The prevalence of reflux in individual vein segments in men and women at baseline is 
displayed in Figure 8.1.  For all five deep vein segments assessed, the prevalence of 
reflux was significantly higher in men than women (p<0.05).  For the superficial vein 
segments, the prevalence of reflux appeared to be slightly higher in women however 
this finding was not statistically significant for any segment (all p≥0.05).  Figure 8.2 
shows the prevalence of reflux by system in men and women at baseline.  Men had a 
significantly higher prevalence of deep reflux only (25.2%, 95% CI 20.6-30.6) 
compared to women (14.4%, 95% CI 11.3-18.1) (p<0.001).  Conversely, a significantly 
higher proportion of women (20.3%, 95% CI 16.3-25.1) than men (11.6%, 95% CI 8.4-
15.6) had superficial reflux only (p=0.002).  The prevalence of combined deep and 
superficial reflux at baseline did not differ significantly between male (20.0%, 95% CI 
15.8-25.0) and female study participants (16.5%, 95% CI 37.1-58.0) (p=0.22). 
 
 8.4  PREVALENCE OF VENOUS REFLUX AT FOLLOW UP 
 
Of the 880 study participants, reflux status at follow up could not be determined in 30 
as the scan was abandoned in 11 participants, there was no blood flow in the vein in 4 
and in 15 participants the vein could not be imaged.  Among the 850 participants in 
whom reflux status at follow up could be determined, 58.8% (n=500) participants had 
no reflux whilst 41.2% (n=350) had evidence of venous reflux at the follow up 





8.4.1 Prevalence of venous reflux by vein segment 
Table 8.4 displays the prevalence of reflux ≥ 0.5 seconds at follow up, by individual vein 
segments in the right and left legs separately and both legs together.  There were no 
significant differences in the prevalence of reflux in any vein segments between the 
right and left legs (all p≥0.05).   As at baseline, the prevalence was highest in the GSV in 
the lower third of the thigh, with 21.6% (95% CI 18.7-24.9) of follow up participants 
with reflux in this segment in the right leg, 17.2% (95% CI 14.5-20.2) in the left leg and 
9.6% (95% CI 7.7-11.9) in both legs.  Within the superficial system, the SSV was the 
least affected with a prevalence of 8.4% (95% CI 6.6-10.4) in the right leg, 3.8% (95% 
CI 3.3-6.2) in the left leg and 1.1% (95% CI 0.5-2.0) in both legs.  Within the deep 
system, the reflux was most common in the POP vein, particularly above the knee 
crease, with a prevalence of 7.2% (95% CI 5.6-9.1) in the right leg, 5.8% (95% CI 4.3-
7.6) in the left leg and 2.3% (1.4-3.5) in both legs.   
  
8.4.2 Prevalence of venous reflux by venous system 
The prevalences of deep reflux only, superficial reflux only and combined reflux at 
follow up were 6.5% (95% CI 4.9-8.3), 23.8% (95% CI 20.7-27.3) and 11.0 (95% CI 9.0-
13.5) respectively.  Of those with reflux in the deep veins only, 41.8% were in the right 
leg. 43.6% in the left leg and 14.6% in both legs.  For superficial veins, the prevalence of 
reflux was 38.4%, 28.2% and 33.4% in the right, left and both legs respectively.  Of 
those with combined reflux, 97% had reflux in the deep and superficial veins of the 
same leg and only 3% had reflux in the deep veins in one leg and the superficial veins of 
the other leg.    
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8.4.3 Prevalence of venous reflux by age 
The prevalence of venous reflux categorised by age group at follow up, is displayed in 
Table 8.5.  When individual vein segments were analysed, prevalence in the GSV was 
the only vein which showed an association with age.  Reflux in the origin of the GSV was 
prevalent in 6.7% (95% CI 0.0-3.3) of participants aged 25-34 years and increased 
more than five times to 34.3% (95% CI 28.3-41.2) in those aged over 65 years at follow 
up (p trend<0.001).  Reflux in the GSV in the lower third of the thigh was also 
significantly associated with increased age.  The prevalence of reflux rose from 13.8% 
(95% CI 7.7-23.0) in those aged 35-44 years and increased three fold to 44.3% (95% CI 
37.6-52.0) in those aged over 65 years at follow up (p trend<0.001).   
 
When analysed by venous system, 73.3% of participants aged 25-34 years had no reflux 
compared to 47.2% of those aged over 65 years at the follow up examination (p 
trend<0.001) [Table 8.6].  The prevalence of deep only and superficial only reflux was 
the same in participants aged 25-34 years (6.7%, 95% CI 0.33-32.9).  However, while 
the prevalence of superficial reflux only increased with age (p trend<0.001), the 
prevalence of deep reflux only did not (p trend=0.46).  Reflux confined to the superficial 
veins increased almost five fold, from 6.7% (95% CI 0.33-32.9) in those aged 25-34 
years to 32.6% (95% CI 26.8-39.3) in those aged over 65 years at follow up (p 
trend<0.001).  The prevalence of combined deep and superficial reflux showed no 




8.4.4 Prevalence of venous reflux by sex 
Figure 8.3 displays the prevalence of venous reflux ≥ 0.5 seconds in individual vein 
segments in either leg, in male and female follow up participants.  For all deep veins, 
men had an equal or higher prevalence of venous reflux than women, but the difference 
did not reach statistical significance for any segment (all p≥0.05).  Conversely, women 
had a higher prevalence of reflux in all the superficial veins, although the sex difference 
was not statistically significant for any segment (all p≥0.05).   Prevalence of reflux by 
system in men and women is shown in Figure 8.4.  There was no significant difference 
in the prevalence of reflux in the deep system only, between men (6.8%, 95% CI 4.5-
9.8) and women (6.2%, 95% CI 4.3-8.8) (p=0.75).  Reflux confined to the superficial 
veins only, was more prevalent in women (28.1%, 95% CI 23.6-33.3) than in men 
(18.4%, 95% CI 14.4-23.1) (p<0.001).   The prevalence of combined in the deep and 
superficial systems, did not differ by sex (p=0.06).   
 
8.5 INCIDENCE OF VENOUS REFLUX FROM BASELINE TO FOLLOW UP 
 
The incidence of venous reflux at follow up is defined as the number of new cases of 
venous reflux ≥ 0.5s at follow up, divided by the number of participants with no reflux 
at baseline.  To measure the incidence, participants with no venous reflux ≥ 0.5 s in any 
deep or superficial vein at baseline were selected.  In total 306 participants had no 




      
8.5.1 Incidence of venous reflux by vein segment 
The 13 year incidence of reflux ≥ 0.5 seconds at follow up in vein segments in the right 
and left legs separately and together is shown in Table 8.7.  The most common vein 
segment to develop reflux was the GSV in the lower third of the thigh.  The incidence of 
reflux in this vein segment was 4.6% (95% CI 2.6-7.5) in the right leg, 3.9% (95% CI 
2.1-6.7) in the left leg and 0.3% (95% CI 0.02-1.6) in both legs.  The incidence of venous 
reflux in the deep system was very low.  Only two participants developed reflux in the 
CFV (0.7%, 95% CI 0.1-2.2).  One participant developed reflux in the FV in the lower 
thigh (0.3%, 95% CI 0.01-1.6) while there were no new cases of reflux in the FV origin 
at follow up.  The incidence of reflux in the POP vein below the knee crease was 2.3% 
(95% CI 1.0-4.5) and 1.0% (95% CI 0.2-2.7) for the right and left legs respectively, 
whilst above the knee crease the incidence of reflux was lower still with 1.3% (95% CI 
0.4-3.1) and 0.7% (95% CI 0.1-2.2) of the right and legs developing reflux at follow up.   
 
8.5.2 Incidence of venous reflux by venous system 
Of the 306 participants free of any type of reflux at baseline, 39 (12.7%) presented with 
new reflux at follow up.  The incidences of deep reflux only, superficial reflux only and 
combined reflux were 2.6% (95% CI 1.2-4.9), 8.8% (95% CI 5.9-12.7) and 1.3% (95% 
CI 0.4-3.2) respectively.  Of the 8 participants with deep reflux only, 4 were in the right 
leg, 3 in the left leg and 1 had deep reflux in both legs.  Twenty seven participants had 
superficial reflux only, 14 in the right leg, 12 in the left leg and 1 in both legs.  Only 4 
participants had combined reflux at follow up, all of whom and deep and superficial 
reflux in the same leg.  
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8.5.3 Incidence of venous reflux by age 
The incidence of reflux ≥ 0.5 seconds in any leg, by individual vein segment, venous 
system and age group at baseline is summarised in Table 8.8.  Age was not associated 
with increased incidence of reflux in any individual vein segment (all p trend>0.05).  
When analysed by venous system, no significant association was observed between the 
incidence of venous reflux and age (all p trend>0.05) [Table 8.9].  It should be noted 
that the number of new cases of venous reflux was very small and thus the true 
incidence within these age groups cannot be estimated with precision. 
 
8.5.4 Incidence of venous reflux by sex 
There were no sex differences in the incidence of reflux in any leg by individual veins 
segment (all p>0.05).  For both sexes, the highest incidence was in the GSV in the lower 
third of the thigh, with 6.1% (95% CI 2.8-11.5) of male and 9.6% (95% CI 5.8-15.0) of 
female participants developing reflux in this segment at follow up (p=0.26).  The POP 
vein below the knee crease was the most common deep vein where reflux developed in 
both sexes.  The incidence in this segment was 3.8% (95% CI 1.4-8.5) and 2.2% (95% CI 
0.7-5.4) in men and women respectively (p=0.31).  When analysed by system affected 
in any leg, the incidence of deep reflux only at follow up was 3.1% (95% CI 1.0-74.0) in 
men and 2.3% (95% CI 0.7-5.4) in women (p=0.45).  The incidence of superficial reflux 
only was 6.1% (95% CI 2.8-11.6) in men and 10.9% (95% CI 6.7-16.6) in women 
(p=0.15).  Combined deep and superficial reflux developed in 1.5% (95% CI 0.3-5.1) 
and 1.1% (95% CI 0.2-3.8) of male and female participants respectively (p=0.57).  As 
stated previously, the size of the sample with new reflux, particularly in the deep veins, 
may be too low to estimate the incidence by sex with precision.  
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8.6 CHAPTER SUMMARY 
 
The EVS study sample comprised 880 participants who were examined at baseline and 
follow up.  At both stages of the study, the prevalence of reflux ≥0.5s was highest in the 
GSV located in in the superficial system.  The prevalence of superficial reflux increased 
with age and was more common in women than in men.  The incidence of venous reflux 
≥0.5s at follow up was very low.  Only 12.7% of those with no reflux at baseline 
developed reflux at follow up, the majority of which was in the superficial venous 

















TABLE 8.1 PREVALENCE OF REFLUX ≥ 0.5 SECONDS DURATION IN THE RIGHT AND LEFT LEGS SEPARATELY AND IN BOTH LEGS TOGETHER AT 
BASELINE   
 
 
REFLUX AT BASELINE 
RIGHT LEG LEFT LEG BOTH LEGS 
TOTAL a % (N) TOTAL a % (N) TOTAL b % (N) 
DEEP SYSTEM       
CFV 874 8.4 (73) 874 8.4 (73) 874 2.6 (23) 
FV origin 873 6.0 (52) 874 4.8 (42) 873 1.7 (15) 
FV lower thigh 873 6.6 (58) 873 6.8 (59) 873 2.1 (18) 
POP above knee crease 874 12.6 (110) 874 11.9 (104) 874 4.2 (37) 
POP below knee crease 874 12.2 (106) 874 10.4 (91) 874 3.9 (34) 
SUPERFICIAL SYSTEM       
GSV origin 838 9.3 (78) 831 10.6 (81) 815 4.2 (34) 
GSV lower thigh 811 17.9 (145) 826 16.8 (139) 784 6.9 (55) 
SSV 754 4.5 (34) 771 5.3 (41) 699   1.1 (8) 
a 
Missing data for the following reasons: vein segment could not be imaged, absence of blood flow in the vein segment, subjects unable to undergo all or part of the scan due to feeling 
faint or the examination being performed in their home 
% (N) = % (number) with venous reflux ≥ 0.5 seconds duration at baseline
  
b 
Reflux in both legs calculated as a percentage of participants who had valid reflux measurements for that vein segment in both legs at baseline 
CFV = common femoral vein 
FV = femoral vein 
POP = popliteal vein 
GSV = great saphenous vein 
SSV = small saphenous vein 
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TABLE 8.2 PREVALENCE OF REFLUX ≥ 0.5 SECONDS IN INDIVIDUAL VEIN SEGMENT AT BASELINE BY AGE GROUP 
 
 AGE GROUP AT BASELINE  
 
REFLUX AT BASELINE 
18-24 YEARS  
% (N) 
25-34 YEARS  
% (N) 







VEIN SEGMENT       
CFV 7.0 (3) 8.5 (10) 13.8 (26) 13.4 (38) 19.1 (46) <0.05 
FV origin  2.4 (1) 7.6 (9) 7.4 (14) 9.5 (27) 11.6 (28) 0.03 
FV lower thigh  9.5 (4) 12.7 (15) 11.1 (12) 8.5 (24) 14.5 (35) 0.51 
POP above knee crease 14.0 (6) 20.3 (24) 22.2 (42) 17.3 (49) 23.2 (56) 0.41 
POP below knee crease 16.3 (7) 20.3 (24) 22.2 (42) 14.8 (42) 20.3 (49) 0.81 
GSV origin  7.3 (3) 9.4 (11) 11.3 (21) 16.7 (45) 24.4 (52) <0.001 
GSV lower thigh  15.0 (6) 15.9 (18) 22.4 (41) 27.7 (72) 43.1 (93) <0.001 
SSV 14.3 (5) 4.5 (4) 7.3 (11) 8.0 (19) 14.2 (28) 0.07 
% (N) = % (number) with venous reflux ≥ 0.5 seconds duration at baseline  
*P value based on linear test for trend for association between age and prevalence reflux ≥ 0.5 seconds duration in individual vein segment at baseline  
CFV = common femoral vein  
FV = femoral vein 
POP = popliteal vein 
GSV = great saphenous vein 




TABLE 8.3 PREVALENCE OF REFLUX ≥ 0.5 SECONDS IN VENOUS SYSTEM AT BASELINE BY AGE GROUP 
 
 AGE GROUP AT BASELINE  
 












VENOUS SYSTEM       
No reflux 55.3 (21) 48.5 (47) 41.1 (67) 46.2 (115) 31.1 (66) 0.001 
Deep only 16.3 (7) 23.7 (28) 25.4 (48) 16.6 (47) 15.8 (38) <0.05 
Superficial only  10.5 (4) 8.2 (8) 12.9 (21) 17.3 (43) 22.6 (48) <0.001 
Deep and superficial  14.3 (6) 12.5 (14) 15.0 (27) 15.9 (44) 26.3 (60) 0.001 
% (N) = % (number) with venous reflux ≥ 0.5 seconds duration at baseline  
*P value based on linear test for trend for association between age and prevalence reflux ≥ 0.5 seconds duration in venous system at baseline  
Deep only = reflux ≥0.5 seconds duration in CFV, FV or POP and no reflux ≥ 0.5 seconds duration in GSV or SSV in any leg at baseline 
Superficial only = reflux ≥0.5 seconds duration in GSV or SSV and no reflux ≥ 0.5 seconds duration in CFV, FV or POP in any leg at baseline 
Deep and superficial reflux = reflux ≥0.5 seconds duration in CFV, FV or POP and reflux ≥ 0.5 seconds duration in GSV or SSV in any leg at baseline 
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*P<0.05.  P value based on chi square test for differences in reflux ≥ 0.5 seconds duration by vein segments at baseline in men and women. 
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*P < 0.05.  P value based on chi square test for differences in venous system reflux at baseline in men and women. 
Deep only = reflux ≥ 0.5 seconds duration in CFV, FV or POP and no reflux ≥ 0.5 seconds duration in GSV or SSV in any leg at baseline 
Superficial only = reflux ≥ 0.5 seconds duration in GSV or SSV and no reflux ≥ 0.5 seconds duration in CFV, FV or POP in any leg at baseline 
Deep and superficial = reflux ≥ 0.5 seconds duration in CFV, FV or POP and reflux ≥ 0.5 seconds duration in GSV or SSV in any leg at baseline 
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TABLE 8.4 PREVALENCE OF REFLUX ≥ 0.5 SECONDS IN RIGHT AND LEFT LEGS SEPARATELY AND IN BOTH LEGS AT FOLLOW UP 
 
 RIGHT LEG LEFT LEG BOTH LEGS 
REFLUX AT BASELINE TOTAL (N) a                                 % (N) TOTAL (N) a                                 % (N) TOTAL (N) b                                 % (N) 
DEEP SYSTEM       
CFV 876 1.6 (14) 870 2.1 (18) 868 0.5 (4) 
FV origin 877 1.6 (14) 875 1.4 (12) 875 1.4 (12) 
FV lower thigh 877 2.5 (22) 869 2.0 (17) 869 0.3 (3) 
POP above knee crease 879 7.2 (63) 864 5.8 (50) 864 2.3 (20) 
POP below knee crease 875 6.9 (60) 860 5.5 (47) 860 1.7 (15) 
SUPERFICIAL SYSTEM       
GSV origin 876 15.0 (131) 801 11.7 (94) 801 5.2 (42) 
GSV lower thigh 875 21.6 (189) 821 17.2 (141) 821 9.6 (79) 
SSV 874 8.4 (73) 833 3.2 (27) 833 1.1 (9) 
a
 Missing data: vein segment could not be imaged, absence of blood flow in the vein segments or subjects unable to undergo all or part of the scan due to feeling faint. 
b 
Reflux in both legs calculated as a percentage of participants who had valid reflux measurements for that vein segment in both legs at follow up. 
% (N) = % (number) with venous reflux ≥ 0.5 seconds duration at follow up  
CFV = common femoral vein 
FV = femoral vein 
POP = popliteal vein 
GSV = great saphenous vein 
SSV = small saphenous vein 
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TABLE 8.5 PREVALENCE OF REFLUX ≥ 0.5 SECONDS BY INDIVIDUAL VEIN SEGMENTS BY AGE GROUP AT FOLLOW UP 
 
 AGE GROUP AT FOLLOW UP  
 









≥ 65 YEARS 
% (N) 
P VALUE* 
VEIN SEGMENT       
CFV 6.7 (1) 3.2 (3) 4.3 (7) 2.3 (6) 3.3 (11) 0.59 
FV origin  6.7 (1) 2.1 (2) 0 (0) 1.5 (4) 2.1 (7) 0.81 
FV lower thigh  6.7 (1) 2.1 (2) 1.9 (3) 4.2 (11) 5.7 (19) 0.07 
POP above knee crease 20.0 (3) 3.2 (3) 7.9 (13) 9.7 (25) 14.6 (49) 0.05 
POP below knee crease 6.7 (1) 7.4 (7) 6.2 (10) 11.2 (29) 13.6 (45) 0.01 
GSV origin  6.7 (1) 10.8 (10) 14.7 (24) 15.3  (27) 34.3 (109) <0.001 
GSV lower thigh  20.0 (3) 13.8 (13) 23.9  19.8 (51) 44.3 (145) <0.001 
SSV 6.7 (1) 9.7 (9) 10.1 (16) 10.2 (26) 13.5 (44) 0.15 
% (N) = % (number) with venous reflux ≥ 0.5 seconds duration at follow up  
*P value based on linear test for trend for association between age prevalence reflux ≥ 0.5 seconds duration in vein segment at follow up 
CFV = common femoral vein 
FV = femoral vein 
POP = popliteal vein 
GSV = great saphenous vein 




TABLE 8.6 PREVALENCE OF REFLUX ≥ 0.5 SECONDS IN VENOUS SYSTEM BY AGE GROUP AT FOLLOW UP 
 
 AGE GROUP AT FOLLOW UP  
 









≥ 65 YEARS 
% (N) 
P VALUE* 
VENOUS SYSTEM       
No reflux 73.3 (11) 68.1  65.9 (108) 65.0 (165) 47.2 (154) <0.001 
Deep reflux only 6.7 (1) 8.4 (8) 4.3 (7) 9.3 (24) 4.8 (16) 0.46 
Superficial reflux only  6.7 (1) 17.6 (16) 20.9 (34) 17.8 (45) 32.6 (105) <0.001 
Deep and superficial reflux 13.3 (2) 5.5 (5) 9.2 (15) 7.9 (20) 15.9 (51) 0.05 
% (N) = % (number) with venous reflux ≥ 0.5 seconds duration at follow up  
*P value based on linear test for trend for association between age and prevalence reflux ≥ 0.5 seconds duration in venous system at follow up 
Deep reflux only= reflux  ≥ 0.5 seconds duration in CFV, FV or POP and no reflux ≥ 0.5 seconds duration in GSV or SSV in any leg at follow up 
Superficial reflux = reflux  ≥ 0.5 seconds duration in GSV or SSV and no reflux ≥ 0.5 seconds duration in CFV, FV or POP in any leg at follow up 
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System reflux at follow up 
% with reflux 
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 * 
*p<0.001.  P value based on chi square test for difference in system reflux at follow up between men and women. 
Deep reflux = reflux ≥ 0.5 seconds duration in CFV, FV or POP and no reflux in GSV or SSV in any leg at follow up 
Superficial reflux = reflux ≥ 0.5 seconds duration in GSV or SSV and no reflux in CFV, FV or POP in any leg at follow up 
Deep and superficial reflux = reflux ≥ 0.5 seconds duration in in CFV, FV or POP and reflux ≥ 0.5 seconds duration in in GSV or SSV in any leg at follow up 
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TABLE 8.7 13 YEAR INCIDENCE OF REFLUX ≥ 0.5 SECONDS AT FOLLOW UP IN THE RIGHT AND LEFT LEGS SEPARATELY AND IN BOTH LEGS 
TOGETHER  
 
 RIGHT LEG LEFT LEG BOTH LEGS 
 REFLUX AT FOLLOW UP TOTAL (N) a                                 % (N) TOTAL (N) a                                 TOTAL (N) a                                 % (N) TOTAL (N) a                                 
DEEP SYSTEM       
CFV 306 0 (0) 305 0.7 (2) 305 0 (0) 
FV origin 306 0 (0) 305 0 (0) 305 0 (0) 
FV lower thigh 306 0.3 (1) 305 0 (0) 305 0 (0) 
POP above knee crease 306 1.3 (4) 305 0.7 (2) 305 0.3 (1) 
POP below knee crease 306 2.3 (7) 305 1.0 (3) 305 0.3 (1) 
SUPERFICIAL SYSTEM       
GSV origin 306 2.0 (6) 303 2.3 (7) 303 0.3 (1) 
GSV lower thigh 306 4.6 (14) 305 3.9 (12) 305 0.3 (1) 
SSV 306 2.3 (7) 302 1.3 (4) 302 0 (0) 
% (N) = % (number) with venous reflux ≥ 0.5 seconds duration at follow up
  
a 
Missing data for the following reasons: vein segment could not be imaged (following vein stripping); absence of blood flow in the vein segments or subjects unable to undergo all or 
part of the scan due to feeling faint.  
b 
Reflux in both legs calculated as a percentage of participants who had valid reflux measurements for that vein segment in both legs at follow up 
CFV = common femoral vein 
FV = femoral vein 
POP = popliteal vein 
GSV = great saphenous vein 
SSV = small saphenous vein 
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TABLE 8.8 13 YEAR INCIDENCE OF REFLUX ≥ 0.5 SECONDS DURATION IN INDIVIDUAL VEIN SEGMENTS  AT FOLLOW UP, BY AGE AT BASELINE 
 
 AGE GROUP AT FOLLOW UP  
 









≥ 65 YEARS 
% (N) 
P VALUE* 
VEIN SEGMENT       
CFV 5.0 (1) 0 (0) 0 (0) 0 (0) 1.6 (1) 0.54 
FV origin  0 (0) 0 (0) 0 (0) 0 (0) 0 (0) - 
FV lower thigh  0 (0) 2.1 (1) 0 (0) 0 (0) 0 (0) 0.20 
POP above knee crease 0 (0) 0 (0) 1.5 (1) 1.8 (2) 3.1 (2) 0.73 
POP below knee crease 0 (0) 2.1 (1) 1.5 (1) 4.4 (5) 3.1 (2) 0.62 
GSV origin  5.0 (1) 2.1 (1) 6.1 (4) 1.8 (2) 6.3 (4) 0.78 
GSV lower thigh  15.0 (3) 2.1 (1) 6.1 (4) 3.6 (4) 20.0 (13) 0.06 
SSV 5.0 (1) 4.3 (2) 1.5 (1) 1.8 (2) 7.9 (5) 0.50 
% (N) = % (number) with venous reflux ≥ 0.5 seconds duration at follow up 
*P value based on linear test for trend for association between age and incidence of reflux ≥ 0.5 seconds duration in vein segment at follow up 
CFV = common femoral vein 
FV = femoral vein 
POP = popliteal vein 
GSV = great saphenous vein 




TABLE 8.9 13 YEAR INCIDENCE OF REFLUX ≥ 0.5 SECONDS DURATION IN VENOUS SYSTEM AT FOLLOW UP BY AGE AT BASELINE 
 
 AGE GROUP AT FOLLOW UP  
 









≥ 65 YEARS 
% (N) 
P VALUE* 
VENOUS SYSTEM       
No reflux 0 (0) 0 (0) 0 (0) 0.9 (1) 4.8 (3) 0.13 
Deep reflux only 5.0 (1) 4.3 (2) 1.5 (1) 3.6 (4) 0 (0) 0.30 
Superficial reflux only 15.0 (3) 6.4 (3) 7.6 (5) 5.5 (6) 15.6 (10) 0.52 
Deep and superficial reflux 20.0 (4) 10.6 (5) 9.1 (6) 10.1 (11) 20.3 (13) 0.48 
% (N) = % (number) with venous reflux ≥ 0.5 seconds duration at follow up 
*P value based on linear test for trend for association between age and incidence of reflux ≥ 0.5 seconds duration at follow up 
Deep reflux only = reflux ≥ 0.5 seconds duration in CFV, FV or POP and no reflux ≥ 0.5 seconds duration in GSV or SSV in any leg at baseline 
Superficial reflux only = reflux ≥ 0.5 seconds duration in GSV or SSV and no reflux ≥ 0.5 seconds duration in CFV, FV or POP in any leg at baseline 
Deep and superficial reflux = reflux ≥ 0.5 seconds duration in CFV, FV or POP and reflux ≥ 0.5 seconds duration in GSV or SSV in any leg at baseline
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CHAPTER 9: PREVALENCE OF VENOUS REFLUX AND INCIDENCE OF CHRONIC 
VENOUS DISEASE 
 
9.1 CHAPTER OUTLINE 
 
Evidence suggests that venous reflux, thought to occur as a result of damaged valves, 
causes veins to enlarge and become varicose.  Venous reflux is a progressive condition 
and if left untreated, can lead to more severe disease.  This chapter examines the 
association between the prevalence of reflux ≥ 0.5 s at baseline and the incidence of C2 
varicose veins and C3-C6 CVI at follow up.  The incidence of varicose veins and CVI will 
be presented separately and analysed according to reflux in specific vein segments, 
number of segments and venous system affected.  The association between reflux and 
severity of C2 varices will be measured.  Due to the low incidence of CVI at follow up, it 
was not possible to examine the association between reflux and severity of CVI.   
 
The incidence reported in this chapter is leg-specific.  Therefore only cases where 
reflux at baseline and the development of C2 varices or C3-C6 CVI occurred in the same 
leg are considered.  In determining the incidence of C2 varices at follow up, the leg with 
the highest Basle grade for severity was chosen.  For measuring the incidence of CVI, 
the highest C3-C6 CEAP class was chosen.  Within the C4 class, which is split into two 
categories, the most severe condition was chosen.  For C2 varices and CVI, if the 
severity of disease was equal in both legs, then either the right or left leg was selected 
at random and included in the analysis.   
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9.2 PREVALENCE OF VENOUS REFLUX AND INCIDENCE OF C2 VARICOSE VEINS 
 
9.2.1 Any reflux 
To examine the relationship between prevalence of venous reflux ≥ 0.5s at baseline and 
incidence of C2 varicose veins at follow up, participants free of C2 varices at baseline 
were selected (n=555).  Ninety four participants with missing reflux data were 
excluded from the analysis.  Of 461 participants with valid reflux data, 204 (44.3%) had 
some reflux at baseline, 48 of whom developed C2 varices at follow up, resulting in a 
13-year incidence of 23.5% (95% CI 17.5-30.9).  This was significantly higher than the 
incidence of C2 varices in those with no reflux at baseline 12.8% (95% CI 9.0-17.8) 
(P=0.004).  When analysed by leg, the 13-year incidence was 20.0% (95% CI 11.8-31.8) 
in the right leg, 18.6% (95% CI 10.3-31.0) and 13.0% (95% CI 5.7-25.6) in both legs. 
 
9.2.2 Reflux by venous system 
Tables 9.1 and 9.2 show the 13 year leg-specific incidences of C2 varicose veins 
according to system reflux at baseline, for the right and left legs respectively.  Reflux 
confined to the deep veins only was not associated with the development of C2 varices 
in either leg (both p>0.05).  However reflux in the superficial system at baseline was 
associated with increased incidence of C2 varices and this was significant for both legs 
(both p<0.05).  After adjusting for age and sex, the odds of developing C2 varices if 
reflux was present in the superficial system were 4.4 (95% CI 1.8-10.8)  in the right leg 
and 2.6 (95% CI 1.2-6.0) in the left leg.  The odds ratios for C2 varices in those with 
combined deep and superficial reflux were higher still at 7.3 (95% CI 2.6-22.6) and 4.0 




9.2.3 Reflux by vein segment 
The 13-year leg-specific incidence of C2 varicose veins of any severity in the right leg by 
reflux ≥ 0.5 s in individual vein segments at baseline is shown in Tables 9.3.  Of the deep 
veins scanned, reflux in the FV in the lower thigh and in the POP vein above and below 
the knee crease, were all significantly associated with increased incidence of C2 varices 
(all p<0.05).   After adjusting for age and sex, participants with reflux in these segments 
were between 2.7 and 3.7 times more likely to develop C2 varices than those with no 
reflux in these segments at baseline.  Reflux in the GSV was also significantly associated 
with an increased incidence of C2 varices (p<0.001).  The age- and sex-adjusted risk of 
developing C2 varices was 5.8 (95% CI 1.2-27.3) fold in those with reflux in origin of 
this vein and higher still at 7.1 (95% CI 3.1-16.3) in those with reflux in this vein in the 
lower third of the thigh. 
 
Table 9.4 presents the 13-year leg-specific incidence of C2 varices in the left leg by 
reflux in individual vein segments at baseline.  The only deep vein significantly 
associated with an increased incidence of C2 varices was the POP vein below the knee 
crease.  After adjusting for age and sex, participants with reflux in this segment at 
baseline were 2.6 (95% CI 1.0-6.2) times more likely to have C2 varices at follow up.  
Reflux in the GSV origin and in the lower third of the thigh was also significantly 
associated with the incidence of C2 varices (p=0.006 and p=0.003 respectively).  When 
reflux was present in either of these two segments at baseline, the risk of developing C2 
varices over the 13 year follow up period was three to fourfold (both p<0.05)  Reflux in 





9.2.4 Reflux by number of vein segments 
Tables 9.5 and 9.6 presents the leg-specific incidence of C2 varices according to the 
number of vein segments with reflux at baseline in the right and left legs.  In the right 
leg, the incidence of C2 varices of any severity was 9.5% (95% CI 6.9-12.7) in those 
with no reflux and increased with number of segment affected so that in those with 
reflux in 3 or more deep segments, the incidence was 35.3% (95% CI 14.3-73.4) (P 
trend<0.01).   For superficial veins, the incidence of C2 varices was over 7 fold in those 
with reflux in 2 segments (42.9%, 95% CI 10.9-116.6) compared to those with no reflux 
(8.8%, 95% CI 6.3-12.0) (p trend<0.001).   In the left leg, there was no significant 
association between number of refluxing deep segments and incidence of C2 varices (p 
trend<0.15).  However, for superficial veins the incidence of C2 varices increased 
linearly from 10.7% (95% CI 7.9-14.1), to 21.2% (95% CI 9.3-41.9) to 37.5% (95% CI 
15.2-78.0) in those with 0, 1 and 2 refluxing segments respectively (p trend<0.001).  
Statistical tests on the severity of C2 varices must be interpreted with caution due to 
the small sample with grade 2 and 3 varices. 
 
Analyses on the severity of C2 varices at follow up, according to reflux ≥ 0.5s in specific 
vein segments at baseline in the right and left legs are displayed in Table 9.7 and 9.8 
respectively.  Again the statistical tests must be interpreted with caution.  The majority 
of new cases of C2 varices at follow up were classified as mild (grade 1).  As very few 
participants with reflux at baseline developed moderate (grade 2) and severe (grade 3) 
C2 varices at follow up, the sample is too small to estimate the incidence with precision 
and therefore conclusions cannot really be drawn from the results.    
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9.3 PREVALENCE OF VENOUS REFLUX AND INCIDENCE OF C3-C6 CVI 
 
9.3.1 Any reflux 
To determine the incidence of C3-C6 CVI by reflux at baseline, participants free of CVI at 
baseline were selected (n=546).  Reflux data was available for 454 participants, of 
whom 198 had reflux.  Of those, 20 participants developed new C3-C6 CVI at follow up, 
resulting in a 13-year incidence of 10.1% (95% CI 6.3-15.3).  The incidence of CVI in 
those without reflux at baseline was not significantly different (9.8%, 95% CI 6.4-14.2) 
(p=0.59). 
 
9.3.2 Reflux by venous system 
The 13-year leg-specific incidences of C3-C6 CVI at follow up by venous system reflux ≥ 
0.5 s at baseline are presented in Tables 9.9 and 9.10.  Deep, superficial nor combined 
reflux were significantly associated with increased incidence of CVI in either leg at 
follow up (all p>0.05).   However, the number of participants with reflux and CVI was 
very small and thus it is difficult to draw any meaningful conclusions. 
 
9.3.3 Reflux by specific vein segments 
Reflux in superficial vein segments was not associated with incidence of CVI (all 
p>0.05) [Tables 9.11 and 9.12].  Unlike C2 varicose veins, reflux in the GSV had no 
significant association with the development of CVI.  The age- and sex-adjusted odds 
ratios were 1.5 (95% CI 0.2-13.5) and 1.4 (95% CI 0.4-4.9) in the GSV origin and in the 
lower third of the thigh respectively.  It is important to note that the number of 
participants with reflux at baseline who subsequently developed CVI at follow up is too 
small to estimate the incidence with precision. 
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9.4 CHAPTER SUMMARY 
The analysis in this chapter has shown that those with venous reflux, particularly in the 
GSV of the superficial system, were at significantly increased risk of developing C2 
varicose veins at follow up.  Additionally, those with combined reflux in the deep and 
superficial systems were at greatest risk of acquiring C2 varices.  The presence of reflux 
appeared to have no significant effect on the incidence of CVI.  However, the number of 
participants who developed CVI was too small to precisely estimate the incidence of 
this condition.  The chapter has presented univariate analyses on the association of 
reflux at baseline and incidence of C2 varicose veins and C3-C6 CVI at follow up.  The 
next chapter will present univariate analyses on the association of risk factors at 
baseline and incidence of C2 varicose veins and C3-C6 CVI at follow up.   Any reflux or 
risk factor significant on univariate analysis will be entered into a logistic regression 
model to determine which factors remained independently significant for the incidence 
of either condition.  The results of this multivariate analysis will be presented at the 











TABLE 9.1 13 YEAR INCIDENCE OF C2 VARICOSE VEINS IN RIGHT LEG BY PRESENCE OF REFLUX ≥ 0.5 SECONDS DURATION BY VENOUS SYSTEM 
IN RIGHT LEG AT BASELINE 
 
 13 YEAR INCIDENCE C2 VARICOSE VEINS P VALUE* UNADJUSTED ODDS RATIO a ADJUSTED ODDS RATIO b 
REFLUX AT BASELINE % (95% CI) n (N)    
DEEP REFLUX 1 
















SUPERFICIAL REFLUX 2 
















DEEP + SUPERFICIAL 3 
















% (95% CI) 13 year incidence (95% confidence interval) of C2 varicose veins  
n = number of participants in reflux group at baseline with C2 varicose veins at follow up, (N) = number in reflux group at baseline 
*P value based on chi square test for difference in incidence of C2 varicose veins by presence of reflux ≥ 0.5s in venous system at baseline 
a
 Unadjusted odds ratio = crude odds ratio with no adjustments for age and sex 
b
 Adjusted odds ratio = adjusted for age and sex 
1
 Deep reflux = reflux ≥ 0.5s in CFV, FV origin, FV lower thigh, POP upper or POP lower and no reflux in GSV origin, GSV lower thigh or SSV 
2
 Superficial reflux= reflux ≥ 0.5s in GSV origin, GSV lower thigh or SSV and no reflux in CFV, FV origin, FV lower thigh, POP upper or POP lower 
3
 Combined reflux = reflux ≥ 0.5s in CFV, FV origin, FV lower thigh, POP upper or POP lower and reflux ≥ 0.5s  in GSV origin, GSV lower thigh or SSV 
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TABLE 9.2 13 YEAR INCIDENCE OF C2 VARICOSE VEINS IN LEFT LEG BY PRESENCE OF REFLUX ≥ 0.5 SECONDS DURATION BY VENOUS SYSTEM  
IN LEFT LEG AT BASELINE 
 
 13 YEAR INCIDENCE C2 VARICOSE VEINS P VALUE* UNADJUSTED ODDS RATIO a ADJUSTED ODDS RATIO b 
REFLUX AT BASELINE % (95% CI) n (N)    
DEEP REFLUX 1 
















SUPERFICIAL REFLUX 2 
















DEEP + SUPERFICIAL 3 
















% (95% CI) 13 year incidence (95% confidence interval) of C2 varicose veins 
n = number of participants in reflux group at baseline with C2 varicose veins at follow up, (N) = number in reflux group at baseline 
*P value based on chi square test for difference in incidence of C2 varicose veins by presence of reflux ≥ 0.5s in venous system at baseline 
a
 Unadjusted odds ratio = crude odds ratio with no adjustments for age and sex 
b
 Adjusted odds ratio = adjusted for age and sex 
1 
Deep reflux = reflux ≥ 0.5s in CFV, FV origin, FV lower thigh, POP upper or POP lower and no reflux in GSV origin, GSV lower thigh or SSV 
2
 Superficial reflux= reflux ≥ 0.5s in GSV origin, GSV lower thigh or SSV and no reflux in CFV, FV origin, FV lower thigh, POP upper or POP lower 
3
 Combined reflux = reflux ≥ 0.5s in CFV, FV origin, FV lower thigh, POP upper or POP lower and reflux ≥ 0.5s in GSV origin, GSV lower thigh or SSV 
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TABLE 9.3 13 YEAR INCIDENCE OF C2 VARICOSE VEINS IN RIGHT LEG BY PRESENCE OF REFLUX ≥ 0.5 SECONDS DURATION BY VEIN SEGMENT IN 
RIGHT LEG AT BASELINE 
 
 13 YEAR INCIDENCE C2 VARICOSE VEINS P VALUE* UNADJUSTED ODDS RATIO a ADJUSTED ODDS RATIO b 
REFLUX AT BASELINE % (95% CI) n (N)    
CFV 1 

































FV LOWER  
















POP ABOVE KNEE 3 
















POP BELOW KNEE  
















% (95% CI) 13 year incidence (95% confidence interval) of C2 varicose veins 
n = number of participants in reflux group at baseline with C2 varicose veins at follow up, (N) = number in reflux group at baseline 
*P value based on chi square test for difference in incidence of C2 varicose veins by presence of reflux ≥ 0.5s in vein segment at baseline 
a
 Unadjusted odds ratio = crude odds ratio with no adjustments for age and sex 
b
 Adjusted odds ratio = adjusted for age and sex 
1
 CFV = common femoral vein 
2
 FV = femoral vein 
3
 POP = popliteal vein  
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TABLE 9.3 13 YEAR INCIDENCE OF C2 VARICOSE VEINS IN RIGHT LEG BY PRESENCE OF REFLUX ≥ 0.5 SECONDS DURATION BY VEIN SEGMENT IN 
RIGHT LEG AT BASELINE 
 
 13 YEAR INCIDENCE C2 VARICOSE VEINS P VALUE* UNADJUSTED ODDS RATIO a ADJUSTED ODDS RATIO b 
REFLUX AT BASELINE % (95% CI) n (N)    
GSV ORIGIN 1 
















GSV THIGH  
















SSV THIGH 2 
















% (95% CI) 13 year incidence (95% confidence interval) of C2 varicose veins 
n = number of participants in reflux group at baseline with C2 varicose veins at follow up, (N) = number in reflux group at baseline 
*P value based on chi square test for difference in incidence of C2 varicose veins by presence of reflux ≥ 0.5s in vein segment at baseline 
a
 Unadjusted odds ratio = crude odds ratio with no adjustments for age and sex 
b
 Adjusted odds ratio = adjusted for age and sex 
1
 GSV = great saphenous vein 
2
 SSV = short saphenous vein 
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TABLE 9.4 13 YEAR INCIDENCE OF C2 VARICOSE VEINS IN LEFT LEG BY PRESENCE OF REFLUX ≥ 0.5 SECONDS DURATION BY VEIN SEGMENT IN 
LEFT LEG AT BASELINE 
 
 13 YEAR INCIDENCE C2 VARICOSE VEINS P VALUE* UNADJUSTED ODDS RATIO a ADJUSTED ODDS RATIO b 
REFLUX AT BASELINE % (95% CI) n (N)    
CFV 1 

































FV LOWER THIGH  
















POP ABOVE KNEE 3 
















POP BELOW KNEE  
















% (95% CI) 13 year incidence (95% confidence interval) of C2 varicose veins 
n = number of participants in reflux group at baseline with C2 varicose veins at follow up, (N) = number in reflux group at baseline 
*P value based on chi square test for difference in incidence of C2 varicose veins by presence of reflux ≥ 0.5s in vein segment at baseline 
a
 Unadjusted odds ratio = crude odds ratio with no adjustments for age and sex 
b
 Adjusted odds ratio = adjusted for age and sex 
1
 CFV = common femoral vein 
2
 FV = femoral vein 
3
 POP = popliteal vein  
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TABLE 9.4 13 YEAR INCIDENCE OF C2 VARICOSE VEINS IN LEFT LEG BY PRESENCE OF REFLUX ≥ 0.5 SECONDS DURATION BY VEIN SEGMENT IN 
LEFT LEG AT BASELINE 
 
 13 YEAR INCIDENCE C2 VARICOSE VEINS P VALUE* UNADJUSTED ODDS RATIO a ADJUSTED ODDS RATIO b 
REFLUX AT BASELINE % (95% CI) n (N)    
GSV ORIGIN 1 
















GSV THIGH  
















SSV THIGH 2 
















% (95% CI) 13 year incidence (95% confidence interval) of C2 varicose veins 
n = number of participants in reflux group at baseline with C2 varicose veins at follow up, (N) = number in reflux group at baseline 
*P value based on chi square test for difference in incidence of C2 varicose veins by presence of reflux ≥ 0.5s in vein segment at baseline 
a
 Unadjusted odds ratio = crude odds ratio with no adjustments for age and sex 
b
 Adjusted odds ratio = adjusted for age and sex 
1
 GSV = great saphenous vein 
2
 SSV = short saphenous vein 
 226 
TABLE 9.5 13 YEAR INCIDENCE OF C2 VARICOSE VEINS BY GRADE IN RIGHT LEG ACCORDING TO NUMBER OF VEIN SEGMENTS WITH REFLUX ≥ 
0.5 SECONDS DURATION AT BASELINE IN RIGHT LEG 
 
 13 YEAR INCIDENCE OF C2 VARICOSE VEINS  
NUMBER OF VEIN SEGMENTS ANY GRADE GRADE 1 GRADE 2 GRADE 3 
WITH REFLUX AT BASELINE % (95% CI) N % (95% CI) N % (95% CI) N % (95% CI) N 
DEEP VEINS         
0 (n=443) 9.5 (6.9-12.7) 42 8.6% (6.1-11.6) 38 0.7% (0.2-1.8) 3 0.22% (0.1-1.1) 1 
1 (n=59) 16.9 (8.6-30.2) 10 17.6% (7.4-28.0) 9 2.0% (0.8-8.3) 1 0% (0) 0 
2 (n=32) 18.8 (7.6-39.0) 6 15.6% (5.7-34.6) 5 3.1% (0.2-15.4) 1 0% (0) 0 
≥ 3 (n=17) 35.3 (14.3-73.4) 6 23.1% (7.5-56.8) 4 15.4% (2.0-38.9) 2 0% (0) 0 
P VALUE* <0.001  0.14  0.48  0.10  
SUPERFICIAL VEINS         
0 (n=419) 8.8 (6.3-12.0) 37 7.9% (5.5-10.9) 33 0.7% (0.2-1.9) 3 0.2% (0.1-1.1) 1 
1 (n=33) 36.4 (19.7-61.8) 12 33.3% (17.5-57.9) 11 3.0% (0.2-14.9) 1 0% (0) 0 
2 (n=7) 42.9 (10.9-116.6) 3 28.6% (4.8-94.3) 2 14.3% (0.7-70.4) 1 0% (0) 0 
P VALUE* <0.001  0.28  0.39  0.13  
% (95% CI) 13 year incidence (95% confidence interval) of C2 varicose veins 
N = number of participants in reflux group at baseline with C2 varicose veins at follow up, (n) = number in reflux group at baseline 
*P value based on linear test for trend for association between number of vein segments with reflux ≥ 0.5 s at baseline and incidence of new C2 varicose veins at follow up. 
 227 
TABLE 9.6 13 YEAR INCIDENCE OF C2 VARICOSE VEINS BY GRADE IN LEFT LEG ACCORDING TO NUMBER OF VEIN SEGMENTS WITH REFLUX ≥ 
0.5 SECONDS DURATION AT BASELINE IN LEFT LEG 
  
 13 YEAR INCIDENCE OF C2 VARICOSE VEINS  
NUMBER OF VEIN SEGMENTS ANY GRADE GRADE 1 GRADE 2 GRADE 3 
WITH REFLUX AT BASELINE % (95% CI) N % (95% CI) N % (95% CI) N % (95% CI) N 
DEEP VEINS         
0 (n=466) 11.4 (8.6-14.8) 53 10.1 (7.5-13.3) 47 1.3 (0.5-2.7) 6 0 0 
1 (n=47) 4.3 (0.7-14.0) 2 4.3 (0.7-14.0) 2 0 0 0  0 
2 (n=24) 33.3 (15.5-63.6) 8 29.2 (12.7-57.7) 7 0 0 4.2 (0.2-20.5) 1 
≥ 3 (n=14) 14.3 (2.4-47.2) 2 14.3 (2.4-47.2) 2 0 0 0  0 
P VALUE* 0.15  0.13  0.34  0.10  
SUPERFICIAL VEINS         
0 (n=430) 10.7 (7.9-14.1) 46 9.8 (7.1-13.1) 42 0.7 (0.2-1.9) 3 0.2 (0.1-1.1) 1 
1 (n=33) 21.2 (9.3-41.9) 7 21.2 (9.3-41.9) 7 0 0 0 0 
2 (n=16) 37.5 (15.2-78.0) 6 18.8 (4.8-51.0) 3 18.8 (4.8-51.0) 3 0 0 
P VALUE* <0.001  0.37  0.06  0.18  
% (95% CI) 13 year incidence (95% confidence interval) of C2 varicose veins 
N = number of participants in reflux group at baseline with C2 varicose veins at follow up, (n) = number in reflux group at baseline 
*P value based on linear test for trend for association between number of vein segments with reflux ≥ 0.5 s at baseline and incidence of new C2 varicose veins at follow up. 
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TABLE 9.7 13 YEAR INCIDENCE OF C2 VARICOSE VEINS IN RIGHT LEG BY REFLUX ≥ 0.5 S IN VEIN SEGMENTS IN RIGHT LEG AT BASELINE  
 13-YEAR INCIDENCE OF C2 VARICOSE VEINS   
 ANY GRADE GRADE 1 GRADE 2 GRADE 3 P VALUE* 
REFLUX AT BASELINE % (95% CI) N % (95% CI) N % (95% CI) N % (95% CI) N  
DEEP VEINS          
1 CFV (n=25) 16.0 (5.1-38.6) 4 16.0 (5.1-38.6) 4 0 0 0 0 0.72 
2 FV origin (n=30) 23.3 (10.2-46.1) 7 20.0 (8.1-41.6) 6 2.0 (0.2-16.4) 1 0  0 0.33 
3 FV lower thigh (n=25) 28.0 (12.2-55.4) 7 20.0 (7.3-44.3) 5 8.0 (1.3-26.4) 2 0 0 0.003 
4 POP upper (n=46) 26.1 (14.1-44.3) 12 19.6 (9.5-35.9) 9 6.5 (1.7-17.8) 3 0 0 <0.001 
5 POP lower (n=52) 23.1 (12.5-39.2) 12 15.4 (7.1-29.2) 8 7.7 (2.4-18.6) 4 0  0 0.001 
SUPERFICIAL VEINS          
6 GSV origin (n=7) 42.9 (10.9-116.7) 3 28.6 (4.8-94.3) 2 16.7 (0.7-70.4) 1 0 0 0.002 
7 GSV lower thigh (n=30) 33.3 (16.9-59.4) 18 33.3 (16.9-59.4) 10 6.7 (1.1-22.0) 2 0 0 <0.001 
8 SSV (n=10) 30.0 (7.6-81.6) 3 30.0 (7.6-81.6) 3 0 0 0 0 0.15 
% (95% CI) 13 year incidence (95% confidence interval) of C2 varicose veins 
N = number of participants in reflux group at baseline with C2 varicose veins at follow up, (n) = number in reflux group at baseline 
*P value based on linear test for trend for association between number of vein segments with reflux ≥ 0.5 s at baseline and incidence of new C2 varicose veins at follow up. 
1 
CFV = common femoral vein 
2
 FV origin = femoral vein at origin 
3
 FV lower thigh = femoral vein in the lower third of the thigh 
4
 POP upper = popliteal vein above the knee 
5 
POP lower = popliteal vein below the knee 
6
 GSV junction = great saphenous vein at the saphenofemoral junction 
7
 GSV lower thigh = great saphenous vein in the lower third of the thigh 
8
 SSV = small saphenous vein 
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TABLE 9.8 13 YEAR INCIDENCE OF C2 VARICOSE VEINS IN LEFT LEG BY REFLUX ≥ 0.5 S IN VEIN SEGMENTS IN LEFT LEG AT BASELINE  
 13-YEAR INCIDENCE OF C2 VARICOSE VEINS   
 ANY GRADE GRADE 1 GRADE 2 GRADE 3 P VALUE* 
REFLUX AT BASELINE % (95% CI) n % (95% CI) n % (95% CI) n % (95% CI) n  
DEEP VEINS          
1 CFV (n=25) 8.0  (1.3-26.4) 2 8.0 (1.3-26.4) 2 0 0 0 0 0.50 
2 FV origin (n=14) 14.3 (2.4-47.2) 2 14.3 (2.4-47.2) 2 0  0 0  0 0.92 
3 FV lower thigh (n=21) 19.0 (6.1-45.6) 4 19.0 (6.1-45.6) 4 0 0 0 0 0.48 
4 POP upper (n=41) 17.4 (9.1-37.1) 8 17.1 (7.5-33.8) 7 0 0 2.4 (0.1-12.0) 1 0.05 
5 POP lower (n=39) 20.5 (9.5-38.9) 8 17.9 (7.8-35.5) 7 0  0 2.6 (0.1-12.6) 1 0.04 
SUPERFICIAL VEINS          
6 GSV origin (n=16) 37.5 (15.2-80.0) 6 18.7 (4.8-51.0) 3 18.7 (4.8-51.0) 3 0 0 <0.001 
7 GSV lower thigh (n=40) 27.5 (14.5-47.8) 11 20.0 (9.3-38.0) 8 7.5 (1.9-20.4) 3 0 0 <0.001 
8 SSV (n=9) 22.2 (3.7-73.4) 2 22.2 (3.7-73.4) 2 0 0 0 0 0.54 
% (95% CI) 13 year incidence (95% confidence interval) of C2 varicose veins 
N = number of participants in reflux group at baseline with C2 varicose veins at follow up, (n) = number in reflux group at baseline 
*P value based on linear test for trend for association between number of vein segments with reflux ≥ 0.5 s at baseline and incidence of new C2 varicose veins at follow up. 
1 
CFV = common femoral vein 
2
 FV origin = femoral vein at origin 
3
 FV lower thigh = femoral vein in the lower third of the thigh 
4
 POP upper = popliteal vein above the knee 
5 
POP lower = popliteal vein below the knee 
6
 GSV origin = great saphenous vein at the saphenofemoral junction 
7
 GSV lower thigh = great saphenous vein in the lower third of the thigh 
8
 SSV = small saphenous vein 
 230 
TABLE 9.9 13 YEAR INCIDENCE OF C3-C6 CVI IN RIGHT LEG AT FOLLOW UP BY PRESENCE OF REFLUX ≥ 0.5 SECONDS IN RIGHT LEG AT BASELINE 
 
 13 YEAR INCIDENCE C3-C6 CVI P VALUE* UNADJUSTED ODDS RATIO a ADJUSTED ODDS RATIO b 
REFLUX AT BASELINE % (95% CI) n (N)    
DEEP REFLUX 1 
















SUPERFICIAL REFLUX 2 
















DEEP + SUPERFICIAL 3 
















% (95% CI) 13 year incidence (95% confidence interval) of C3-C6 CVI 
n = number of participants in reflux group at baseline with C3-C6 CVI at follow up, (N) = number in reflux group at baseline 
*P value based on chi square test for difference in incidence of C3-C6 CVI by presence of reflux ≥ 0.5s in venous system at baseline 
a
 Unadjusted odds ratio = crude odds ratio with no adjustments for age and sex 
b
 Adjusted odds ratio = adjusted for age and sex 
1 
Deep reflux = reflux ≥ 0.5s in CFV, FV origin, FV lower thigh, POP upper or POP lower and no reflux in GSV origin, GSV lower thigh or SSV 
2
 Superficial reflux= reflux ≥ 0.5s in GSV origin, GSV lower thigh or SSV and no reflux in CFV, FV origin, FV lower thigh, POP upper or POP lower 
3
 Combined reflux = reflux ≥ 0.5s in CFV, FV origin, FV lower thigh, POP upper or POP lower and reflux ≥ 0.5s in GSV origin, GSV lower thigh or SSV 
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TABLE 9.10 13 YEAR INCIDENCE OF C3-C6 CVI IN LEFT LEG AT FOLLOW UP BY PRESENCE OF REFLUX ≥ 0.5 SECONDS IN LEFT LEG AT BASELINE 
 
 13 YEAR INCIDENCE C3-C6 CVI P VALUE* UNADJUSTED ODDS RATIO a ADJUSTED ODDS RATIO b 
REFLUX AT BASELINE % (95% CI) n (N)    
DEEP REFLUX 1 
















SUPERFICIAL REFLUX 2 
















DEEP + SUPERFICIAL 3 
-  No  
- Yes 
 













% (95% CI) 13 year incidence (95% confidence interval) of C3-C6 CVI 
n = number of participants in reflux group at baseline with C3-C6 CVI at follow up, (N )= number in reflux group at baseline 
*P value based on chi square test for difference in incidence of C3-C6 CVI by presence of reflux ≥ 0.5s in venous system at baseline 
a
 Unadjusted odds ratio = crude odds ratio with no adjustments for age and sex 
b
 Adjusted odds ratio = adjusted for age and sex 
1 
Deep reflux = reflux ≥ 0.5s in CFV, FV origin, FV lower thigh, POP upper or POP lower and no reflux in GSV origin, GSV lower thigh or SSV 
2
 Superficial reflux= reflux ≥ 0.5s in GSV origin, GSV lower thigh or SSV and no reflux in CFV, FV origin, FV lower thigh, POP upper or POP lower 
3
 Combined reflux = reflux ≥ 0.5s in CFV, FV origin, FV lower thigh, POP upper or POP lower and reflux ≥ 0.5s  in GSV origin, GSV lower thigh or SSV 
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TABLE 9.11 13 YEAR INCIDENCE OF C3-C6 IN RIGHT LEG BY PRESENCE OF REFLUX ≥ 0.5 SECONDS DURATION BY VEIN SEGMENT IN RIGHT LEG AT 
BASELINE 
 
 13 YEAR INCIDENCE C3-C6 CVI P VALUE* UNADJUSTED ODDS RATIO a ADJUSTED ODDS RATIO b 
REFLUX AT BASELINE % (95% CI) n (N)    
CFV 1 

































FV LOWER THIGH  
















POP ABOVE KNEE 3 
















POP BELOW KNEE  
















% (95% CI) 13 year incidence (95% confidence interval) of C3-C6 CVI 
n = number of participants in reflux group at baseline with C3-C6 CVI up, N = number in reflux group at baseline 
*P value based on chi square test for difference in incidence of C3-C6 CVI by presence of reflux ≥ 0.5s in vein segment at baseline 
a
 Unadjusted odds ratio = crude odds ratio with no adjustments for age and sex 
b
 Adjusted odds ratio = adjusted for age and sex 
1
 CFV = common femoral vein 
2
 FV = femoral vein 
3
 POP = popliteal vein  
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TABLE 9.11 13 YEAR INCIDENCE OF C3-C6 IN RIGHT LEG BY PRESENCE OF REFLUX ≥ 0.5 SECONDS DURATION BY VEIN SEGMENT IN RIGHT LEG AT 
BASELINE 
 
 13 YEAR INCIDENCE C3-C6 CVI P VALUE* UNADJUSTED ODDS RATIO a ADJUSTED ODDS RATIO b 
REFLUX AT BASELINE % (95% CI) n (N)    
GSV ORIGIN 1 
















GSV THIGH  
















SSV THIGH 2 
















% (95% CI) 13 year incidence (95% confidence interval) of C3-C6 CVI 
n = number of participants in reflux group at baseline with C3-C6 CVI at follow up, (N) = number in reflux group at baseline 
*P value based on chi square test for difference in incidence of C3-C6 CVI by presence of reflux ≥ 0.5s in vein segment at baseline 
a
 Unadjusted odds ratio = crude odds ratio with no adjustments for age and sex 
b
 Adjusted odds ratio = adjusted for age and sex 
1
 GSV = great saphenous vein 
2
 SSV = short saphenous vein 
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TABLE 9.12 13 YEAR INCIDENCE OF C3-C6 IN LEFT LEG BY PRESENCE OF REFLUX ≥ 0.5 SECONDS DURATION BY VEIN SEGMENT IN LEFT LEG AT 
BASELINE 
 
 13 YEAR INCIDENCE C3-C6 CVI P VALUE* UNADJUSTED ODDS RATIO a ADJUSTED ODDS RATIO b 
REFLUX AT BASELINE % (95% CI) n (N)    
CFV 1 

















-  No  
- Yes 
 













FV LOWER THIGH  
















POP ABOVE KNEE 3 
















POP BELOW KNEE  
















% (95% CI) 13 year incidence (95% confidence interval) of C3-C6 CVI 
n = number of participants in reflux group at baseline with C3-C6 CVI up, N = number in reflux group at baseline 
*P value based on chi square test for difference in incidence of C3-C6 CVI by presence of reflux ≥ 0.5s in vein segment at baseline 
a
 Unadjusted odds ratio = crude odds ratio with no adjustments for age and sex 
b
 Adjusted odds ratio = adjusted for age and sex 
1
 CFV = common femoral vein 
2
 FV = femoral vein 
3
 POP = popliteal vein  
 235 
TABLE 9.12 13 YEAR INCIDENCE OF C3-C6 IN LEFT LEG BY PRESENCE OF REFLUX ≥ 0.5 SECONDS DURATION BY VEIN SEGMENT IN LEFT LEG AT 
BASELINE 
 
 13 YEAR INCIDENCE C3-C6 CVI P VALUE* UNADJUSTED ODDS RATIO a ADJUSTED ODDS RATIO b 
REFLUX AT BASELINE % (95% CI) n (N)    
GSV ORIGIN 1 
















GSV THIGH  
















SSV THIGH 2 
















% (95% CI) 13 year incidence (95% confidence interval) of C3-C6 CVI 
n = number of participants in reflux group at baseline with C3-C6 CVI at follow up, (N) = number in reflux group at baseline 
*P value based on chi square test for difference in incidence of C3-C6 CVI by presence of reflux ≥ 0.5s in vein segment at baseline 
a
 Unadjusted odds ratio = crude odds ratio with no adjustments for age and sex 
b
 Adjusted odds ratio = adjusted for age and sex 
1
 GSV = great saphenous vein 
2




CHAPTER 10: RISK FACTORS AND INCIDENCE OF C2 VARICES AND C3-C6 CVI 
 
 
10.1 CHAPTER OUTLINE 
 
This chapter presents results of the univariate analysis on the association of various 
risk factors and the incidence of C2 varicose veins and C3-C6 CVI.  Risk factors 
measured in the Edinburgh Vein Study include body mass index (BMI), family history of 
venous disease, medical history of venous conditions, pregnancy, oestrogen use 
including oral contraceptives and hormone replacement therapy (HRT), smoking, 
mobility at work, bowel habit and physical activity.   
 
The incidence of C2 varices is the proportion of cases who developed new C2 varices at 
follow up in those initially free from C2 varices at baseline.  The incidence of C3-C6 CVI 
is the proportion of new cases of C3-C6 CVI at follow up in those initially free from C2 
varices and C3-C6 CVI at baseline.  Therefore participants with C2 varicose veins at 
baseline whose symptoms worsened to C3-C6 CVI at follow up are not included as 
incident cases as they have not developed new disease but rather their existing venous 
disease has progressed.   Also, it is important to consider that some new cases of C2 
varicose veins or C3-C6 CVI may not have been identified as surgery after the initial 
examination may have eradicated signs of venous disease.  Of the 555 participants free 
from C2-C6 disease at baseline, only 2 had surgery between the two stages of the study.  
However, despite treatment, both of these participants had C2 varicose veins at the 
follow up examination and therefore already included as incident cases. 
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The 13 year incidences of C2 varices and C3-C6 CVI are presented separately according 
to risk factor at baseline, with adjustments made for age and sex where appropriate. 
Changes in risk factors during follow up are also tested for their association with the 
incidence of these conditions.  Bowel habit was measured at baseline only while 
physical activity was measured only at follow up.  For these two risk factors, data is 
presented but changes during the follow up period cannot be measured.    
 
Any risk factor found to be significant for the development of either C2 varices or C3-C6 
CVI was entered with significant reflux results (presented in chapter 9) into a 
multivariate analysis to determine those factors that remained independently 
associated with incidence of either condition.  The results of the multivariate analysis 
are presented at the end of this chapter. 
 
10.2 BODY MASS INDEX 
 
10.2.1 Baseline and follow up 
The mean (SD) BMI of participants increased from 25.6 (4.4) kg/m2 at baseline to 27.5 
(4.8) kg/m2 at follow up (p<0.001).  Figure 10.1 displays the BMI category of 
participants at both stages of the study, based on the World Health Organisation 
classification.  Few participants were classified as being underweight.  The proportion 
of participants classified as a normal weight decreased from 49.0% to 30.1%, while the 
proportion classified as overweight increased from 36.7% at baseline to 44.5% at 
follow up.  Moreover, the number of participants who were classified almost doubled 
from 12.9% at baseline to 24.6% at follow up. 
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Change in BMI was assessed by comparing BMI groups at baseline and follow up.   Of 
the 870 participants with BMI measurements at both baseline and follow up, 520 
(59.8%) participants stayed within the same BMI category; 4 (0.5%) underweight, 229 
(26.3%) normal weight, 193 (22.2%) overweight and 94 (10.8%) obese.  A total of 308 
(35.4%) participants increased by one or more BMI categories: 9 (1.0%) participants 
went from being underweight at baseline to a normal weight at follow up, 179 (20.6%) 
went from being a normal weight to overweight, 16 (1.8%) went from being a normal 
weight to obese and 104 (12.0%) went from being overweight to obese.  A total of 42 
(4.8%) participants decreased by one or more BMI categories; 3 (0.3%) went from a 
normal weight at baseline to underweight at follow up, 22 (2.6%) went from 
overweight to a normal weight, 2 (0.2%) went from obese to a normal weight and 15 
(1.7%) went from obese to overweight.   
 
10.2.2 Incidence of C2 varicose veins  
To examine the association between BMI and incidence of C2 varicose veins, 555 
participants free of varices at baseline were selected.  Of these, 8 (1.4%) were 
underweight at baseline, 278 (50.1%) normal weight, 196 (35.3%) overweight and 73 
(13.2%) obese.  Table 10.1 shows that the incidence of C2 varices at follow up was 25% 
(95% CI 4.2-82.6), 16.5% (95% CI 12.3-21.9), 19.4% (95% CI 13.9-26.3) and 20.5% 
(95% CI 11.9-33.1) in participants who were underweight, normal weight, overweight 
and obese at baseline respectively (p trend=0.43).  There were no significant 
differences in the incidence according to change in BMI from baseline to follow up.  The 
13-year incidence was 17.9% (95% CI 13.7-33.1) in participants who stayed in the 
same BMI group, 16.9% (95% CI 12.0-23.2) in those whose BMI group increased, and 
26.1% (95% CI 10.6-54.3) in those whose BMI group decreased from baseline to follow 
up (p trend=0.55). 
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10.2.3 Incidence of C3-C6 chronic venous insufficiency 
Of 546 participants free of CVI at baseline, 8 (1.5%) were underweight, 277 (50.7%) 
were normal weight, 189 (34.6%) were overweight and 72 (13.2%) were obese.  None 
of the participants who were underweight at baseline developed CVI.  Increased BMI at 
baseline was significantly associated with development of C3-C6 CVI at follow up 
(p<0.001) [Table 10.2].  This association remained significant after adjusting for age 
and sex.  Participants who were overweight at baseline were 1.3 (95% CI 1.1-1.6) times 
more likely to have C3-C6 CVI at follow up.  In obese participants, the odds were even 
higher at 4.5 (95% CI 3.3-6.9).  Change in BMI was not associated with the development 
of C3-C6 CVI.  The 13-year incidence was 10.1% (95% CI 7.0-14.1), 7.5% (95% CI 4.4-
12.1), and 13.0% (95% CI3.3-35.5) in those whose BMI group stayed the same, 
increased and decreased from baseline to follow up (p trend=0.55). 
 
10.3  FAMILY HISTORY 
 
10.3.1 Baseline and follow up 
At baseline, 392 (45.6%) out of 860 participants reported a positive maternal or 
paternal family history of chronic venous disease (CVD)  In those 392 participants, 
62.2% had a maternal family history, 22.5% had a paternal family history and 15.3% 
had a history in both parents.  At follow up, 373 (43.9%) of 852 participants reported a 
family history, 60.9% in the mother only, 22.5% in the father only and 16.6% in both 




10.3.2 Incidence of C2 varicose veins 
Family history of CVD in either first-degree relative was associated with incidence of C2 
varicose veins [Table 10.3].  The 13-year incidence was 23.3% (95% CI 17.5-30.4) and 
14.8% (95% CI 11.0-19.5) in those with and without a family history respectively 
(p=0.09). After adjusting for age and sex, those with a family history in either parent 
were 1.7 (95% CI 1.1-2.7) times more likely to develop C2 varices at follow up.  
Participants with a maternal history had a significantly higher incidence (23.2%, 95% 
CI 16.6-31.5) than those with no maternal history (15.7%, 95% CI 12.1-20.1) (p=0.04) 
and this remained significant after adjusting for age and sex (OR 1.6, 95% CI 1.0-2.6).  
Paternal family history was not associated with the incidence of C2 varices (p=0.20).  
Fewer participants reported a paternal family history (n=88) and this small sample 
may have contributed to the lack of a significant association.  Changes in family history 
from baseline to follow up and incidence of C2 varices was not analysed due to the fact 
that this is relatively constant, as reflected in the equal proportions of participants 
reporting this at baseline and follow up (45.6% and 43.9% respectively).   
 
10.3.3 Incidence of C3-C6 chronic venous insufficiency 
Table 10.4 shows that family history of CVD was not a significant risk factor for the 
incidence of C3-C6 CVI.   Among participants with no family history, the incidence of 
C3-C6 CVI was 8.2% (95% CI 5.4-11.8) compared to 10.7% (95% CI 6.9-15.8) in 
participants with a history of CVD in either mother or father (p=0.40).  When analysed 
separately, neither maternal (p=0.20) nor paternal (p=0.80) family history were 
associated with the development of C3-C6 CVI. 
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10.4 MEDICAL HISTORY 
 
10.4.1 Baseline and follow up 
In the questionnaires at both baseline and follow up, participants were asked to report 
previous medical history of conditions which have been linked to CVD.  These include 
deep vein thrombosis (DVT), phlebitis, swollen leg (post-operatively, post-pregnancy 
or other), fractured leg, inguinal hernia and pulmonary embolism.  Certain conditions 
such as white leg of pregnancy and arthritis were measured at follow up only.  Data on 
the prevalence of these conditions at baseline and follow up are shown in Table 10.5.  
The number of participants affected by conditions such as DVT, phlebitis, hernia and 
pulmonary embolism were small.  From baseline to follow up, there was a slight 
increase in the prevalence of these conditions, although the increase was not 
statistically significant.  The number of participants reporting a swollen leg post 
pregnancy decreased from 35.4% at baseline to just 7.8% at follow up.  The same was 
true for swollen legs caused by other reasons, with 21.9% of participants reporting a 
history of this condition at baseline compared to just 1.8% at follow up.  Almost a third 
(32.2%) of participants at baseline reported having haemorrhoids.   
 
10.4.2 Incidence of C2 varicose veins 
The 13-year incidence of C2 varicose veins by medical history at baseline is shown in 
Table 10.6.  History of DVT was significantly associated with increased incidence of C2 
varices (p=0.02).  The incidence was 17.6% (95% CI 14.4-21.4) in those with no DVT 
compared to 50.0% (95% CI 18.3-110.8) in those with a previous DVT (p=0.02).  
However this association was not significant after adjusting for age (OR 3.5, 95% CI 1.0-
12.4). It should be noted that only 10 participants had a DVT at baseline, 5 of whom 
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went on to develop C2 varices.  For phlebitis, the incidence was 42.9% (95% CI 17.4-
89.1) compared to 17.4% (95% CI 14.2-21.2) in participants with and without this 
condition respectively (p=0.03).  Again this association diminished after adjusting for 
age and sex (OR 2.8, 95% CI 0.9-8.4). Other medical conditions such as swollen leg, 
fractured leg, hernia, haemorrhoids and pulmonary embolism, were not associated 
with incidence of C2 varicose veins (all p≥0.05). 
 
10.4.3 Incidence of C3-C6 chronic venous insufficiency 
Table 10.7 presents the 13-year incidence of C3-C6 CVI by history of medical conditions 
at baseline.  The incidence of CVI was significantly higher in those with an inguinal 
hernia (26.7%, 95% CI 12.4-50.6) compared to those with no history of this condition 
(8.2%, 95% CI 5.9-10.9) (p=0.001).  After adjusting for age and sex, participants with a 
history of inguinal hernia at baseline were over 3 times more likely to develop C3-C6 
CVI at follow up (OR 3.1, 95% CI 1.3-7.8).  Other medical conditions such as history of 
DVT, phlebitis, haemorrhoids, swollen or fractured leg and pulmonary embolism were 





10.5.1 Baseline and follow up  
Data on pregnancy was collected via the study questionnaire.  At baseline, 23.5% of the 
490 female participants had never been pregnant, 40.6% had been pregnant 1-2 times, 
21.8% had been pregnant 3 times and 14.1% had been at least 4 times.  At follow up, 
the proportion of participants who had been pregnant 1-2 times, 3 times and ≥4 times, 
increased to 42.9%, 25.5% and 16.6% respectively (Figure 10.2] 
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10.5.2 Incidence of C2 varicose veins 
Table 10.8 displays the 13-year incidence of C2 varicose veins by number of 
pregnancies at baseline.  The incidence of C2 varicose veins in those never pregnant 
(n=90) was 16.7% (95% CI 9.7-26.9), 16.3% (95% CI 10.5-24.3) in those with 1-2 
pregnancies (n=135), 20.0% (95% CI 11.1-33.3) in those with 3 pregnancies (n=65) 
and highest in those with ≥4 pregnancies (n=44) with an incidence of 27.3% (95% CI 
14.8-46.4) (p trend=0.14).  Change in the number of pregnancies from baseline to 
follow up and the association with incidence of C2 varicose veins was measured.  A 
total of 307 women were free of varicose veins at baseline and had complete pregnancy 
data at both stages of the study.  The 13-year incidence of varicose veins was 20.7% 
(95% CI 15.6-27.0) in those with no further pregnancies, 13.3% (95% CI 4.2-32.2) with 
one further pregnancy, 7.1% (95% CI 0.4-35.2) with 2 further pregnancies and 22.2% 
(95% CI 3.7-73.4) in those who had 3 further pregnancies between the baseline and 
follow up phases of the study.  However the numbers are very small with only 7 women 
in total experiencing one or more pregnancies during the follow up period of the study.   
 
10.5.3 Incidence of C3-C6 chronic venous insufficiency 
Of the 331 female participants free of CVI at baseline, 89 (26.9%) had never been 
pregnant, 134 (40.5%) had been pregnant 1-2 times, 65 (19.6%) had been pregnant 3 
times and 43 (13.0%) had been pregnant at least 4 times.  The 13-year incidence of C3-
C6 CVI by number of pregnancies at baseline is shown in Table 10.9.  There was no 
association between number of pregnancies and incidence of CVI.  The incidence was 
5.6% (95% CI 2.1-12.4) in those never pregnant,  9.0% (95% CI 4.8-15.2) in those 
pregnant 1-2 times, 9.2% (95% CI 3.7-19.2) in those who had been pregnant 3 times 
and 9.3% (95% CI 3.0-22.4) in those who had been pregnant at least 4 times (p=0.42).   
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Pregnancy during the follow up period of the study was not associated with incidence 
of CVI.  The incidence of CVI in female participants who had not been pregnant between 
baseline and follow up was 8.5% (95% CI 5.4-12.7), 3.3% (95% CI 0.2-16.4) in those 
who had had one further pregnancy, and 11.1% (95% CI 0.6-54.8) in those who had 
been pregnant three times between baseline and follow up (p=0.88).   
 
10.6 ORAL CONTRACEPTIVE  
 
10.6.1 Baseline and follow up 
The proportion of oral contraceptive users was similar at both stages of the study: 
73.3% and 75.3% ever having used oral contraceptives at baseline and follow up 
respectively.  Of the 354 users at baseline, 57 (16.1%) were current users while the 
remaining 297 (83.9%) used oral contraceptives before taking part in the baseline 
study.  Of the 354 users at follow up, 19 (5.4%) were current users while the remaining 
335 (94.6%) had taken oral contraceptives before the follow up.   
 
10.6.2 Incidence of C2 varicose veins 
Incidence of C2 varicose veins was not associated with oral contraceptive use at 
baseline (p=0.50).  The 13-year incidence of C2 varices was 22.2% (95% CI 13.2-35.3) 
in female participants who had never used oral contraceptives (n=72) compared to 
17.4% (95% CI 12.9-23.1) in participants who had ever used oral contraceptives 





10.6.3 Incidence of C3-C6 chronic venous insufficiency 
Women who had never been on oral contraceptives appeared to be more likely to 
develop C3-C6 CVI at follow (p=0.001).  The 13 year incidence of CVI was 18.1% (95% 
CI 10.0-30.1) in women who had never been on oral contraceptives (n=72) compared 
to just 5.5% (95% CI 3.1-9.0) in women who had previously used oral contraceptives 
(n=255).  However, after adjusting for age, this association was no longer significant 
(OR 0.5, 95% CI 0.2-1.2).   
 
10.7 HORMONE REPLACEMENT THERAPY 
 
10.7.1 Baseline and follow up 
At baseline, 95 out of 486 (19.3%) female participants had ever been on HRT.  At follow 
up the proportion of HRT users increased to 33.0% (155 out of 470)  Of the 95 HRT 
users at baseline, 58 (61.1%) were using HRT at that time and the remaining 37 
(38.9%) used HRT prior to the baseline study.  Among 155 HRT users at follow up, 18 
(11.6%) were taking HRT during the study while the remaining 137 (88.4%) were on 
HRT before taking part in the follow up study. 
 
10.7.2 Incidence of C2 varicose veins 
HRT use was associated with an increased incidence of C2 varicose veins (p=0.03).  The 
13-year incidence of varicose veins was 16.5% (95% CI 12.2-21.9) in female 
participants who had never been on HRT (n=273) compared to 29.8% (95% CI 18.0-
46.8) in HRT users (n=57).  After adjustments were made for age, the association was 
no longer significant.  The odds ratio for developing C2 varices was 1.5 (95% CI 0.7-3.0) 
in women who had used HRT at baseline. 
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10.7.3 Incidence of C3-C6 chronic venous insufficiency 
The incidence of C3-C6 CVI was similar in women regardless of previous HRT use 
(P=0.50).  The incidence was 8.5% (95% CI 5.5-12.5) in women who had never used 
HRT (n=271) compared to 7.1% (95% CI 2.3-17.2) in previous HRT users (n=56) 
(p=0.50).  After adjusting for age, the odds of developing C3-C6 CVI with previous HRT 
use were 0.4 (95% CI 0.1-1.3). 
 
10.8 MOBILITY AT WORK 
 
10.8.1 Baseline and follow up 
Mobility at work was split into four categories at baseline: sitting, standing, walking 
and lifting heavy objects at work.  The responses were merged to form two categories 
so that for each type of activity at work, the response was less than 50% of the time at 
work and more than 50% of the time spent at work.  Of the 880 participants at baseline, 
389 (44.2%) spent more than 50% of their day at work sitting, 262 (29.8%) standing, 
242 (27.5%) walking whilst 109 (12.4%) spent more than 50% of their working day 
lifting heavy objects. 
 
At follow up, the questionnaire was adapted slightly from that administered at baseline.  
Participants were asked to answer which one of the four activities from sitting, 
standing, walking and lifting heavy objects, best reflected their working day.  Of the 848 
participants with completed data for this risk factor, 254 (30.0%) reported that they 
sat at work most of the day, 474 (55.9%) stood, 100 (11.8%) walked at work whilst the 




10.8.2 Incidence of C2 varicose veins 
The 13-year incidence of C2 varicose veins by mobility at work at baseline is displayed 
in Table 10.10.  There were no significant associations between type of work and 
incidence of varicose veins at follow up (all p≥0.05).  The age-and sex-adjusted odds 
ratios of developing C2 varices in those who spent > 50% of their working day sitting, 
standing, walking or heavy lifting were 0.9 (95% CI 0.6-1.5), 1.0 (95% CI 0.6-1.6), 0.9 
(95% CI 0.6-1.6) and 1.3 (95% CI 0.7-2.4) respectively. 
 
10.8.3 Incidence of C3-C6 chronic venous insufficiency 
Table 10.11 shows the 13-year incidence of C3-C6 CVI by type of work at baseline.  Like 
C2 varicose veins, there was no significant association between type of work at baseline 
and incidence of CVI at follow up (all p≥0.05).  In participants who were sedentary at 
work and sat for more than 50% of the time, the 13-year incidence of C3-C6 CVI was 
7.6% (95% CI 4.7-11.7).  The incidence of C3-C6 CVI in participants who stood, walked 
and did heavy work was 9.0% (95% CI 5.0-14.9), 10.6% (95% CI 6.1-17.0) and 10.4% 














10.9.1 Baseline and follow up 
Figure 10.3 shows the smoking status of participants at the baseline and follow up 
stages of the study.  At baseline, of the 877 participants with complete data on smoking, 
465 (53.0%) had never smoked, 228 (26.0%) were ex-smokers and 184 (21.0%) were 
current smokers.  Of the 184 current smokers, 168 (91.3%) smoked cigarettes whilst 
16 (8.7%) smoked cigars or pipes.  At follow up, smoking data was available for 847 
participants.  Of these, 478 (56.4%) reported to never have smoked, 264 (31.2%) had 
previously smoked but had since stopped and 105 (12.4%) were current smokers.  Of 
the 105 current smokers, 99 (94.3%) smoked cigarettes whilst 6 (5.7%) smoked cigars 
or pipes.  When analysing changes in smoking status from baseline to follow up 844 
participants had complete smoking data for both stages of the study.  Of the 454 
participants who had never smoked at baseline, 2 were current smokers and 7 were ex-
smokers at follow up.  Of the 172 smokers at baseline, 96 were still smoking at follow 
up whilst 64 had since given up smoking.  Of the 218 ex-smokers at baseline, 193 were 
still ex-smokers whilst 7 had started smoking again at follow up. 
 
10.9.2 Incidence of C2 varicose veins 
Smoking was not significantly associated with increased incidence of C2 varicose veins 
(p trend=0.93).  The 13-year incidence was 18.8% (95% CI 14.3-24.3) in non-smokers 
(55 out of 292), 17.5% (95% CI 11.6-25.4) in ex-smokers (25 out of 143) and 17.8% 
(95% CI 11.3-26.7) in those who smoked at baseline (21 out of 118).   The age- and sex-
adjusted odds ratios were 1.0 (95% CI 0.6-1.7) for ex-smokers and 0.9 (95% CI 0.5-1.5) 
for current smokers. 
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10.9.3 Incidence of C3-C6 chronic venous insufficiency 
There was no significant association between smoking and the development of C3-C6 
CVI at follow up (p trend=0.82).  The incidence of CVI was 9.3% (95% CI 6.3-13.4%) in 
non-smokers (27 out of 290), 8.5% (95% CI 4.6-14.5) in ex-smokers (12 out of 141) 
and 9.7% (95% CI 5.1-16.9%) in current smokers (11 out of 113).  The age-and sex 
adjusted odds ratios were 1.2 (95% CI 0.6-2.6) and 1.8 (95% CI 0.4-1.7) in ex-smokers 
and smokers respectively. 
 
10.10 BOWEL HABIT 
 
10.10.1 Baseline 
Bowel habit was recorded at the baseline phase of the study only.  Participants were 
asked, on average, how many days per week they opened their bowels and how many 
times per day.  Among 879 participants at baseline, the mean (SD) number of days per 
week they opened their bowels was 6.2 (1.4) and the mean (SD) number of times per 
day was 1.3 (0.6).  Participants were also asked if they had to strain to start and finish a 
bowel movement, with the option of two responses, “only occasionally” or “half of the 
time or nearly always”.  Seven hundred and fifty six (86.0%) participants occasionally 
had to strain to start a bowel movement compared to 123 (14.0%) who had to strain 
half of the time.  To finish a bowel movement, 795 (90.8%) only occasionally had to 







10.10.2 Incidence of C2 varicose veins  
There was no significant association between straining to start a bowel movement and 
the incidence of C2 varices.  The incidence was 18.0% (95% CI 14.4-22.1) in 
participants who occasionally strained to start a bowel movement and 18.5% (95% CI 
10.6-30.6) in those who strained half of the time (p=0.88).  The-age and sex-adjusted 
odds ratio was 1.0 (95% CI 0.5-1.9).  Straining to finish a bowel movement was not 
associated with C2 varices.  The incidence was 18.4% (95% CI 14.9-22.5) in 
participants who occasionally strained to finish compared to 15.5% (95% CI 7.6-28.5) 
in participants who strained to finish a bowel movement half of the time (p=0.59).  The 
age- and sex-adjusted odds ratio was 0.7 (95% CI 0.3-1.5). 
 
Frequency of bowel movements was also compared.  On average, the mean (SD) 
number of bowel movements was 6.2 (SD) days per week in those with no varicose 
veins compared to 6.1 (1.5) in participants with varicose veins (p=0.71).   Bowel 
movements per day were also similar in the two groups: mean (SD) 1.3 (0.6) and 1.3 
(0.5) in those with and without varicose veins respectively (p=0.3).   
 
10.10.3 Incidence of C3-C6 chronic venous insufficiency 
Like C2 varicose veins, bowel habit had no significant effect on the development of C3-
C6 CVI at follow up.  The 13-year incidence of CVI in those who occasionally strained to 
start a bowel movement was 9.1% (95% CI 6.7-12.2) compared to 9.3% (95% CI 4.1-
18.5) in those who strained half of the time (p=0.96).   The incidence was 9.3% (95% CI 
6.8-12.3) in those who occasionally strained to finished compared to 8.6% (95% CI 3.1-




The frequencies of bowel movements were compared in participants with and without 
CVI at follow up.  The mean (SD) number of days per week the bowels moved was 6.1 
(1.5) in participants with no CVI at follow up compared to 6.2 (1.3) in those with CVI at 
follow up (P=0.8).  There was no difference between number of times per day the 
bowels moved, with a mean (SD) of 1.3 (0.5) times per day in those with no CVI and 1.4 
(0.7) times per day in those with CVI at follow up (p=0.2). 
 
10.11 PHYSICAL ACTIVITY 
 
10.11.1 Follow up 
Physical activity was measured in the follow up questionnaire only.  Participants were 
given examples of light, moderate and strenuous activity and asked to report how many 
times a week they participated in each activity during summer and winter.  Light 
activity included walking, gardening, light DIY and yoga.  Moderate activity included 
badminton, cycling, golf, jogging, swimming and tennis while strenuous activity 
included competitive running, field sports, sports training and squash.  On average, the 
mean (SD) number of times participants performed light activities was 6.5 (6.7) times a 
week.  For moderate and strenuous activity, the mean (SD) was 2.3 (4.0) and 0.4 (1.4) 
respectively.   A more detailed summary is provided in Figure 10.4, which shows the 
mean number of times per week each activity was performed in summer and winter.  
Light and moderate physical activities were performed more often in summer than in 
winter whilst there was no difference in strenuous activity. 
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10.11.2 Prevalence of C2 varicose veins 
Of the 555 participants free of varicose veins at baseline, physical activity data was 
available for 533 at follow up   For 435 participants with no C2 varices at follow up, the 
mean (SD) number of times they took part in light activity was 6.4 (6.5) compared to 
6.0 (6.9) in 98 participants with new trunk varicose veins at follow up (p=0.53).  
Moderate activity was completed a mean of 2.1 (3.1) and 2.3 (3.7) times per week in 
those with and without C2 varices respectively (p=0.54).  Participants who did not have 
varicose veins were more likely to participate in strenuous physical activity (p<0.001).  
At follow up, strenuous physical activity was performed 0.4 (1.3) times per week in 434 
participants with no trunk varicose veins compared to 0.2 (0.7) times per week in 98 
participants with varicose veins at follow up.  It is worth noting these results are 
merely measuring the level of physical activity in those with and without C2 varicose 
veins at follow up.  Associations between physical activity and incidence of varicose 
veins cannot be determined because baseline data on levels of physical activity are not 
available. 
 
10.11.3 Prevalence of C3-C6 chronic venous insufficiency 
Participants with CVI exercised less than those with no CVI (p=0.007).  In 477 
participants with no CVI at follow up, the mean (SD) number of times they took part in 
light activity was 6.3 (6.3) compared to 6.6 (8.8) in 47 participants with CVI at follow 
up (p=0.8).  The mean (SD) number of times per week moderate activity was 
undertaken was 2.2 (3.2) in those with no CVI compared to 1.9 (3.9) in those with CVI 
at follow up (p=0.6).  At follow up, strenuous physical activity was performed 0.4 (1.3) 
times per week in participants with no CVI compared to 0.1 (0.2) times per week in 
those with CVI at follow up.    
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 10.12 MULTIVARIATE ANALYSIS 
Univariate analysis on the association of reflux ≥ 0.5 seconds at baseline with new C2 
varices at follow up determined that reflux in the superficial veins alone or 
accompanied by reflux in the deep veins, was significant in the development of C2 
varices (Chapter 9).  Univariate analysis in this chapter has shown that family history of 
CVD was the only risk factor significantly associated with the incidence of C2 varicose 
veins.  These three factors were entered into a logistic regression model with 
adjustments for age and sex.  Results showed that superficial reflux only (OR 2.97, 95% 
CI 1.52-5.81), combined reflux (OR 4.24, 95% CI 1.92-9.37) and family history of CVD 
(OR 1.73, 95% CI 1.04-2.88) at baseline all remained significantly associated with the 
incidence of C2 varicose veins at follow up. 
 
Reflux at baseline was not significantly associated with the incidence of C3-C6 CVI at 
follow up.  However, two risk factors showed a significant association on univariate 
analysis: obesity and inguinal hernia.   These two factors were entered into a logistic 
regression model with age and sex.  Both inguinal hernia and obesity remained 
significant risk factors for the incidence of C3-C6 CVI with adjusted odds ratios of 3.6 










 10.13 CHAPTER SUMMARY 
 
This study examined risk factors measured at baseline and measured their association 
with the development of C2 varicose veins and C3-C6 chronic venous insufficiency at 
follow up.  Family history, in particular maternal family history of chronic venous 
disease, was significantly associated with the incidence of C2 varicose veins.  However, 
it was not associated with the development of C3-C6 CVI.  On the other hand, obesity 
was a significant risk factor for the development of C3-C6 CVI but not for C2 varicose 
veins.  Participants classified as obese at baseline were almost four times more likely to 
develop CVI at follow up than those of a normal weight.  The incidence of C2 varicose 
veins appeared to increase with number of pregnancies.  Although this trend was not 
significant, the lack of statistical association must be interpreted with caution due to 
the small numbers in this study.  History of DVT and phlebitis were associated with 
incidence of C2 varicose veins, although these associations reduced and became non-
significant after adjusting for age and sex.  Moreover, those with an inguinal hernia at 
baseline were more likely to develop C3-C6 CVI at follow up.  However, caution must be 
exercised in interpreting these results on history of medical conditions as the number 
of participants with these conditions was probably too small to estimate the incidence 
of CVD with precision.  Smoking, mobility at work and bowel habits at baseline showed 






FIGURE 10.1 BODY MASS INDEX AT BASELINE AND FOLLOW UP 
 
Underweight = BMI <18.50 kg/m
2
, normal weight = BMI 18.50-24.99 kg/m
2
, overweight = BMI 25.00-29.99 kg/m
2
, obese = BMI ≥ 30 kg/m
2 
0 
  10 
  20 
  30 
  40 
  50 
  60 
Underweight Normal weight Overweight Obese 
Body mass index 
 




TABLE 10.1 13 YEAR INCIDENCE OF C2 VARICOSE VEINS AT FOLLOW UP ACCORDING TO BODY MASS INDEX (BMI) AT BASELINE AND 
SUBSEQUENT CHANGES TO BMI DURING FOLLOW UP 
 
 13 YEAR INCIDENCE C2 VARICOSE VEINS  P TREND * UNADJUSTED OR a ADJUSTED OR b 
BODY MASS INDEX (BMI)  % (95% CI) n (N)  (95% CI) (95% CI) 
BMI GROUP AT BASELINE c      
Underweight  25.0 (4.2-82.6) 2 (8) 0.43 1.60 (0.12-3.04) 1.66 (0.13-3.46) 
Normal weight  16.5 (12.3-21.9) 46 (278)              1.00              1.00 
Overweight  19.4 (13.9-26.3) 38 (196)  1.72 (0.14-3.71) 1.69 (0.13-3.62) 
Obese  20.5 (11.9-33.1) 15 (73)  1.78 (0.14-4.23) 1.69 (0.12-3.84) 
CHANGE BASELINE TO FOLLOW UP d      
BMI group stayed the same  17.9 (13.7-23.0) 57 (318)              1.00              1.00 
BMI group increased  16.9 (11.9-23.3) 35 (207) 0.80 0.93 (0.59-1.48) 1.02 (0.64-1.63) 
BMI group decreased  26.1 (10.6-54.3) 6 (23)  1.62 (0.61-4.28) 1.20 (0.44-3.30) 
n= number of participants in BMI group at baseline with C2 varices at follow up, (N) = number of participants in BMI group at baseline 
*
 P value based on test for linear association between BMI and incidence of C2 varicose veins at follow up. p<0.05 denotes statistical significance 
a
 Unadjusted odds ratio = crude odds ratio for the risk of developing C2 varicose veins, with no adjustment for age or sex 
b
 Adjusted odds ratio =  odds ratio for the risk of developing C2 varicose veins, adjusted for age and sex 
c
 BMI group at baseline: underweight = BMI < 18.5 kg/m
2
, normal weight = BMI 18.5-24.99 kg/m
2
, overweight = BMI 25.0-29.99 kg/m
2




 Change in BMI group from baseline to follow up.  
Incidence of C2 varicose veins based on the number of new cases of C2 varicose veins at follow up divided by the number of participants free from C2 varicose veins at baseline. 
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TABLE 10.2 13 YEAR INCIDENCE OF C3-C6 CHRONIC VENOUS INSUFFICIENCY AT FOLLOW UP ACCORDING TO BODY MASS INDEX (BMI) AT 
BASELINE AND SUBSEQUENT CHANGES TO BMI DURING FOLLOW UP 
 
 13 YEAR INCIDENCE C3-C6 CVI  P TREND * UNADJUSTED OR a ADJUSTED OR b 
BODY MASS INDEX (BMI)  % (95% CI) n  (N)  (95% CI)  (95% CI) 
BMI GROUP AT BASELINE c      
Underweight  0.0 0 (8) <0.001 - - 
Normal weight  6.1 (3.7-9.6) 17 (277)  1.00 1.00 
Overweight    8.5 (5.0-13.4) 16 (189)  1.49 (0.11-3.24) 1.33 (1.14-1.64) 
Obese    23.6 (14.2-37.0) 17 (72)  4.99 (0.14-7.45) 4.49 (3.26-6.92) 
CHANGE BASELINE TO FOLLOW UP d      
BMI group stayed the same  10.1 (7.0-14.1) 32 (316) 0.55 1.00 1.00 
BMI group increased    7.5 (4.4-12.1) 15 (200)  0.72 (0.38-1.37) 0.87 (0.45-1.68) 
BMI group decreased  13.0 (3.3-35.5) 3 (23)  1.33 (0.38-4.73) 0.93 (0.25-3.45) 
n= number of participants in BMI group at baseline with C3-C6 CVI at follow up, (N) = number of participants in BMI group at baseline 
*
 P value based on test for linear association between BMI and incidence of C3-C6 CVI at follow up   p<0.05 denotes statistical significance 
a
 Unadjusted odds ratio = crude odds ratio for the risk of developing C3-C6 CVI, no adjustment for age or sex 
b
 Adjusted odds ratio =  odds ratio for the risk of developing C3-C6 CVI, adjusted for age and sex 
c
 BMI group at baseline: underweight = BMI < 18.5 kg/m
2
, normal weight = BMI 18.5-24.99 kg/m
2
, overweight = BMI 25.0-29.99 kg/m
2




 Change in BMI group from baseline to follow up.  





TABLE 10.3 13 YEAR INCIDENCE OF C2 VARICOSE VEINS AT FOLLOW UP BY FAMILY HISTORY OF VENOUS DISEASE AT BASELINE 
 
 13 YEAR INCIDENCE C2 VARICOSE VEINS  P VALUE * UNADJUSTED OR b ADJUSTED OR c 
FAMILY HISTORY AT BASELINE a % (95% CI) n/N  (95% CI)  (95% CI) 
ANY FH       
No           14.8 (11.0-19.5) 48 (324) 0.09 1.00 1.00 
Yes   23.3 (17.5-30.4) 51 (219)  1.75 (1.13-2.71) 1.74 (1.11-2.71) 
MATERNAL FH        
No  15.7 (12.1-20.1) 59 (375) 0.04 1.00 1.00 
Yes 23.2 (16.6-31.5) 38 (164)  1.62 (1.02-2.55) 1.64 (1.03-2.61) 
PATERNAL FH      
No  17.5 (13.9-21.8) 78 (445) 0.20 1.00 1.00 
Yes  24.4 (15.1-37.3) 19 (78)  0.72 (0.38-1.37) 0.87 (0.45-1.68) 
n= number of participants with family history at baseline and C2 varicose veins at follow up, (N)=number of participants with family history at baseline 
*
P value based on chi square test for association between family history of CVD at baseline and incidence of C2 varicose veins at follow up.   p<0.05 denotes statistical significance 
a
 Family history of C2-C6 chronic venous disease in either mother or father 
b
 Unadjusted odds ratio = crude odds ratio for the risk of developing C2 varicose veins with no adjustment for age or sex 
c 
Adjusted odds ratio =  odds ratio for the risk of developing C2 varicose veins, adjusted for age and sex 





TABLE 10.4 13 YEAR INCIDENCE OF C3-C6 CHRONIC VENOUS INSUFFICIENCY AT FOLLOW UP BY FAMILY HISTORY OF VENOUS DISEASE AT 
BASELINE 
 
 13 YEAR INCIDENCE C3-C6 CVI  P VALUE * UNADJUSTED OR b ADJUSTED OR c 
FAMILY HISTORY AT BASELINE a % (95% CI) n/N  (95% CI)  (95% CI) 
ANY FH       
No 8.2 (5.4-11.8) 26/319 0.40 1.00 1.00 
Yes  10.7 (6.9-15.8) 23/215  1.35 (0.75-2.43) 1.36 (0.74-2.49) 
MATERNAL FH        
No  8.1 (5.6-11.4) 30/370 0.20 1.00 1.00 
Yes 11.9 (7.4-18.2) 19/160  1.53 (0.83-2.80) 1.61 (0.86-3.01) 
PATERNAL FH      
No  8.9 (6.4-12.0) 39/438 0.80 1.00 1.00 
Yes  10.4 (4.8-19.7) 8/77  1.19 (0.53-2.65) 1.18 (0.52-2.68) 
n= number of participants with family history at baseline and C3-C6 CVI at follow up, (N)=number of participants with family history at baseline 
*
P value based on chi square test for association between family history of CVD at baseline and incidence of C3-C6 CVI at follow up.   p<0.05 denotes statistical significance 
a
 Family history of C2-C6 chronic venous disease in either mother or father 
b
 Unadjusted odds ratio = crude odds ratio for the risk of developing C3-C6 CVI with no adjustment for age or sex 
c 
Adjusted odds ratio =  odds ratio for the risk of developing C3-C6 CVI, adjusted for age and sex 





TABLE 10.5 HISTORY OF MEDICAL CONDITIONS AT BASELINE AND FOLLOW UP 
 
 BASELINE FOLLOW UP P VALUE 
MEDICAL CONDITION AT BASELINE % n % n  
Deep vein thrombosis 2.5 22 3.4 29 0.32 
Phlebitis 4.7 41 5.2 44 0.45 
Swollen leg post operatively 6.3 53 4.6 39 <0.001 
Swollen leg post pregnancy* 35.4 135 7.8 37 <0.001 
Swollen leg other 21.9 165 1.8 15 <0.001 
Broken leg 9.4 82 8.9 76 0.54 
Hernia 6.0 53 6.9 59 0.48 
Haemorrhoids 32.2 283 - - - 
Pulmonary embolism 0.6 5 1.5 13 0.38 
Arthritis - - 27.2 231 - 
White leg of pregnancy** - - 0.6 3 - 
% (n) based on number of participants with a history of the medical condition at baseline and at follow up. 
a
 P value based on difference in prevalence of medical conditions between baseline and follow up 
*Swollen leg post pregnancy based on 381 female participants at baseline and 476 female participants at follow up 




TABLE 10.6 13 YEAR INCIDENCE OF C2 VARICOSE VEINS AT FOLLOW UP BY HISTORY OF MEDICAL CONDITIONS AT BASELINE 
 
 13 YEAR INCIDENCE C2 VARICOSE VEINS  P VALUE * UNADJUSTED OR a ADJUSTED OR b 
MEDICAL CONDITION AT BASELINE  % (95% CI) n (N)  (95% CI)  (95% CI) 
DEEP VEIN THROMBOSIS      
No 17.6 (14.4-21.5) 96 (544) 0.02 1.00 1.00 
Yes  50.0 (18.3-110.8) 5 (10)  4.67 (1.32-16.44) 3.46 (0.96-12.45) 
PHLEBITIS        
No  17.4 (14.2-21.2) 94 (539) 0.03 1.00 1.00 
Yes 42.9 (17.4-89.1) 6 (14)  3.55 (1.20-10.47) 2.78 (0.92-8.42) 
PULMONARY EMBOLISM      
No  18.1 (14.8-22.0) 100 (551) 0.33 1.00 1.00 
Yes  50.0 (2.5-246.6) 1 (2)  4.51 (0.28-72.72) 3.89 (0.24-63.14) 
HAEMORRHOIDS      
No  18.3 (14.3-23.0) 69 (377) 0.95 1.00 1.00 
Yes 18.1 (12.6-25.2) 32 (177)  0.99 (0.62-1.57) 0.81 (0.50-1.31) 
INGUINAL HERNIA      
No  17.9 (14.6-21.9) 94 (524) 0.62 1.00 1.00 
Yes 23.3 (10.2-46.2) 7 (30)  1.39 (0.58-3.34) 1.21 (0.49-2.96) 
SWOLLEN LEG       
No  16.9 (13.6-20.8) 86 (509) 0.22 1.00 1.00 
Yes 27.6 (12.8-52.4) 8 (29)  1.87 (0.80-4.37) 1.83 (0.78-4.34) 
FRACTURED LEG      
No  18.4 (14.9-22.4) 92 (501) 0.95 1.00 1.00 
Yes  18.0 (8.8-33.0) 9 (50)  0.98 (0.46-2.08) 0.99 (0.46-2.14) 
n= number of participants with medical condition at baseline and C2 varicose veins at follow up, (N) = number of participants medical condition at baseline 
*
P value based on chi square test for association between medical condition at baseline and incidence of C2 varicose veins at follow up.   p<0.05 denotes statistical significance 
a
 Unadjusted odds ratio = crude odds ratio for the risk of developing C2 varicose veins with no adjustment for age or sex 
b 
Adjusted odds ratio =  odds ratio for the risk of developing C2 varicose veins adjusted for age and sex 
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TABLE 10.7 13 YEAR INCIDENCE OF C3-C6 CHRONIC VENOUS INSUFFICIENCY AT FOLLOW UP BY MEDICAL CONDITIONS AT BASELINE 
 
 13 YEAR INCIDENCE C3-C6 CVI  P VALUE * UNADJUSTED OR a ADJUSTED OR b 
MEDICAL CONDITION AT BASELINE  % (95% CI) n (N)  (95% CI)  (95% CI) 
DEEP VEIN THROMBOSIS      
No 9.1 (6.8-12.0) 49 (536) 0.58 1.00 1.00 
Yes  11.1 (0.6-54.8) 1 (9)  1.24 (0.15-10.14) 0.80 (0.09-6.82) 
PHLEBITIS        
No  8.7 (6.4-11.4) 46 (531) 0.10 1.00 1.00 
Yes 23.1 (5.9-62.8) 3 (13)  3.16 (0.84-11.90) 2.37 (0.60-9.43) 
PULMONARY EMBOLISM      
No  9.2 (6.9-12.1) 50 (542) 0.82 1.00 1.00 
Yes  0 0 (2)  0 0 
HAEMORRHOIDS      
No  8.6 (6.0-12.1) 32 (370) 0.54 1.00 1.00 
Yes 10.3 (6.3-15.9) 18 (175)  1.21 (0.66-2.22) 0.95 (0.50-1.79) 
INGUINAL HERNIA      
No  8.2 (5.9-10.9) 42 (515) 0.01 1.00 1.00 
Yes 26.7 (12.4-50.6) 8 (30)  4.09 (1.72-9.76) 3.14 (5.9-10.9) 
SWOLLEN LEG       
No  8.9 (6.6-11.8) 45 (504) 0.62 1.00 1.00 
Yes 4.0 (0.2-19.7) 1 (25)  0.43 (0.06-3.22) 0.38 (0.05-2.92) 
FRACTURED LEG      
No  8.7 (7.4-13.0) 43 (493) 0.58 1.00 1.00 
Yes 12.2 (5.0-25.5) 6 (49)  1.46 (0.59-3.63) 1.49 (0.59-3.80) 
n= number of participants with medical condition at baseline and C3-C6 CVI at follow up, (N) = number of participants medical condition at baseline 
*
P value based on chi square test for association between medical condition at baseline and incidence of C3-C6 CVI at follow up.   p<0.05 denotes statistical significance 
a
 Unadjusted odds ratio = crude odds ratio for the risk of developing C3-C6 CVI with no adjustment for age or sex 
b 
Adjusted odds ratio =  odds ratio for the risk of developing C3-C6 CVI, adjusted for age and sex 
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TABLE 10.8 13 YEAR INCIDENCE OF C2 VARICOSE VEINS AT FOLLOW UP ACCORDING TO PREGNANCY AT BASELINE  
 
 13 YEAR INCIDENCE C2 VARICOSE VEINS  P TREND * UNADJUSTED OR a ADJUSTED OR b 
PREGNANCY  % (95% CI) n (N)  (95% CI)  (95% CI) 
NUMBER OF PREGNANCIES AT BASELINE       
0           16.7 (9.7-26.9) 15 (90) 0.14 1.00 1.00 
1-2   16.3 (10.5-24.3) 22 (135)  0.97 (0.48-2.00) 0.63 (0.29-1.37) 
3  20.0 (11.1-33.3)  13 (65)  1.25 (0.55-2.85) 0.72 (0.29-1.75) 
≥ 4 27.3 (14.8-46.4)   12 (44)  1.88 (0.79-4.45) 1.05 (0.41-2.67) 
PREGNANCIES DURING FOLLOW UP        
0 20.7 (15.6-27.0) 52 (251) 0.26 1.00 1.00 
1 13.3 (4.2-32.2) 4 (30)  0.23 (0.03-1.84) 0.43 (0.05-3.71) 
2 7.1 (0.4-35.2) 1 (14)  0.12 (0.01-1.73) 0.32 (0.20-5.48) 
3  22.2 (3.7-73.4) 2 (9)  0.43 (0.04-4.64) 1.35 (0.11-17.30) 
n= number of participants by number of pregnancies at baseline and C2 varicose veins at follow up, (N) = number of participants by number of pregnancies at baseline 
*
P value based on chi square test for linear association between number of pregnancies at baseline and incidence of C2 varicose veins at follow up. p<0.05 denotes statistical 
significance 
a
 Unadjusted odds ratio = crude odds ratio for the risk of developing C2 varicose veins with no adjustment for age or sex 
b 
Adjusted odds ratio =  odds ratio for the risk of developing C2 varicose veins, adjusted for age and sex 




TABLE 10.9 13 YEAR INCIDENCE OF C3-C6 CHRONIC VENOUS INSUFFICIENCYAT FOLLOW UP ACCORDING TO PREGNANCY AT BASELINE 
 
 13 YEAR INCIDENCE C3-C6 CVI  P TREND * UNADJUSTED OR a ADJUSTED OR b 
PREGNANCY  % (95% CI) n (N)  (95% CI)  (95% CI) 
NUMBER OF PREGNANCIES AT BASELINE       
0           5.6 (2.1-12.4) 5 (89) 0.42 1.00 1.00 
1-2   9.0 (4.8-15.2) 12 (134)  1.65 (0.56-4.86) 0.89 (0.28-2.79) 
3  9.2 (3.7-19.2)  6 (65)  1.71 (0.50-5.86) 0.78 (0.21-2.85) 
≥ 4 9.3 (3.0-22.4)   4 (43)  1.72 (0.44-6.77) 0.71 (0.67-3.04) 
PREGNANCIES DURING FOLLOW UP        
0 8.5 (5.4-12.7) 21 (248) 0.88 1.00 1.00 
1 3.3 (0.2-16.4) 1 (30)  0.14 (0.01-2.67) 0.39 (0.02-8.54) 
2 0 0 (14)  0 0 
3  11.1 (0.6-54.8) 1 (9)  0.50 (0.02-10.25) 0.43 (0.01-18.76) 
n= number of participants by number of pregnancies at baseline and C3-C6 CVI follow up, (N) = number of participants by number of pregnancies at baseline 
*
P value based on chi square test for linear association between number of pregnancies at baseline and incidence of C3-C6 CVI at follow up.   p<0.05 denotes statistical significance 
a
 Unadjusted odds ratio = crude odds ratio for the risk of developing C2 varicose C3-C6 CVI  adjusted for age and sex. 





TABLE 10.10 13 YEAR INCIDENCE OF C2 VARICOSE VEINS AT FOLLOW UP ACCORDING TO MOBILITY AT WORK AT BASELINE 
 
 13 YEAR INCIDENCE C2 VARICOSE VEINS  P VALUE * UNADJUSTED OR a ADJUSTED OR b 
MOBILITY AT WORK AT BASELINE  % (95% CI) n (N)  (95% CI)  (95% CI) 
SITTING      
< 50% of the day 18.8 (14.3-24.1) 57 (304) 0.71 1.00 1.00 
> 50% of the day  17.5 (12.9-23.3) 44 (251)  0.92 (0.60-1.42) 0.95 (0.61-1.48) 
STANDING        
< 50% of the day 18.3 (14.4-22.8) 74 (405) 0.94 1.00 1.00 
> 50% of the day 18.0 (12.1-25.8) 27 (150)  0.98 (0.60-1.60) 0.99 (0.61-1.63) 
WALKING      
< 50% of the day 18.3 (14.5-22.8) 75 (410) 0.95 1.00 1.00 
> 50% of the day  18.1 (12.0-26.1) 26 (144)  0.98 (0.60-1.61) 0.95 (0.58-1.56) 
HEAVY LIFTING      
< 50% of the day 17.1 (14.2-21.7) 86 (486) 0.42 1.00 1.00 
> 50% of the day 14.9 (12.6-35.0) 15 (69)  1.29 (0.70-2.40) 1.31 (0.70-2.45) 
n= number of participants in mobility at work group at baseline and C2 varicose veins at follow up, (N) = number of participants in mobility at work group at baseline 
*
P value based on chi square test for association between mobility at work at baseline and incidence of C2 varicose veins at follow up.   p<0.05 denotes statistical significance 
a
 Unadjusted odds ratio = crude odds ratio for the risk of developing C2 varicose veins with no adjustment for age or sex 
b 
Adjusted odds ratio =  odds ratio for the risk of developing C2 varicose veins adjusted for age and sex 
Incidence of C2 varicose veins based on the number of new cases of C2 varicose veins at follow up divided by the number of participants free from C2 varicose veins at baseline. 
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TABLE 10.11 13 YEAR INCIDENCE OF C3-C6 CHRONIC VENOUS INSUFFICIENCY AT FOLLOW UP ACCORDING TO MOBILITY AT WORK AT BASELINE 
 
 13 YEAR INCIDENCE C3-C6 CVI  P VALUE * UNADJUSTED OR a ADJUSTED OR b 
MOBILITY AT WORK AT BASELINE  % (95% CI) n/N  (95% CI)  (95% CI) 
SITTING      
< 50% of the day 10.4 (7.2-14.6) 31/297 0.32 1.00 1.00 
> 50% of the day  7.6 (4.7-11.7) 19/249  0.71 (0.39-1.29) 0.75 (0.41-1.38) 
STANDING        
< 50% of the day 9.2 (6.6-12.6) 37/401 0.92 1.00 1.00 
> 50% of the day 9.0 (5.0-14.9) 13/145  0.97 (0.50-1.88) 0.94 (0.48-1.87) 
WALKING      
< 50% of the day 8.7 (6.1-11.9) 35/403 0.51 1.00 1.00 
> 50% of the day  10.6 (6.1-17.0) 15/142  1.24 (0.66-2.35) 1.18 (0.62-2.27) 
HEAVY LIFTING      
< 50% of the day 9.0 (6.6-12.0) 43/479 0.70 1.00 1.00 
> 50% of the day 10.4 (4.6-20.7) 7/67  1.18 (0.51-2.75) 1.15 (0.48-2.74) 
n= number of participants in mobility at work group at baseline and C3-C6 CVI at follow up, (N) = number of participants in mobility at work group at baseline 
*
P value based on chi square test for association between mobility at work at baseline and incidence of C3-C6 CVI at follow up.   p<0.05 denotes statistical significance 
a
 Unadjusted odds ratio = crude odds ratio for the risk of developing C3-C6 CVI with no adjustment for age or sex 
b 
Adjusted odds ratio =  odds ratio for the risk of developing C3-C6 CVI adjusted for age and sex 
Incidence of C3-C6 CVI based on the number of new cases of C3-C6 CVI at follow up, divided by the number of participants free from C2 varices and C3-C6 CVI at baseline. 
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FIGURE 10.3 CHANGES IN SMOKING STATUS FROM BASELINE TO FOLLOW UP 
 
 History of medical conditions at baseline and follow up stages of the study in 880 participants 
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Light activity  Moderate activity  Strenuous activity 
Level of physical activity 
Mean number 
of times per 
week 
Summer Winter 
Light physical activity = walking, gardening, light DIY, yoga 
Moderate physical activity = badminton, cycling, golf, jogging, swimming, tennis 
Strenuous physical activity = competitive running, fields sports, sports training, squash 
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CHAPTER 11: RISK FACTORS AND INCIDENCE OF VENOUS REFLUX 
 
 
11.1 CHAPTER OUTLINE 
 
This chapter examines the association between risk factors for venous disease at 
baseline and the development of venous reflux ≥ 0.5s duration at follow up.  Risk 
factors measured in the Edinburgh Vein Study include body mass index (BMI), 
pregnancy, oestrogen use including oral contraceptives (OC) and hormone replacement 
therapy (HRT), smoking, family history of venous disease, mobility at work, history of 
medical conditions associated with venous disease, physical activity and bowel 
movement.  For each risk factor measured at baseline, the incidence of deep only, 
superficial only and combined deep and superficial reflux at follow up, is presented.  
Where possible, changes in risk factors during the follow up period are examined to 
check for any association with the development of venous reflux at follow up.  Bowel 
movement was measured at baseline only while physical activity was measured at 
follow up only.  Changes to these two risk factors during the follow up period could not 




11.2 BODY MASS INDEX (BMI) 
 
Body mass index (BMI) at baseline was not significantly associated with venous reflux 
≥0.5s duration at follow up.  The incidence of all reflux was 0% in those who were 
underweight (n=3), 9.6% (95% CI 5.5-15.7) in those who were normal weight (n=153), 
17.5% (95% CI 11.0-26.6) in those who were overweight (n=116) and 11.6% (95% CI 
4.3-25.8) in participants who were obese (n=44) at baseline (p trend=0.25).   
Furthermore, when analysed as a continuous variable, BMI at baseline did not differ 
significantly between those who developed reflux at follow up (mean (SD) 26.2 (4.1) 
kg/m2) and those who did not (mean (SD) 25.6 (4.2) kg/m2) (p=0.43).  Table 11.1 
provides a detailed summary of the incidence of reflux by vein segments by BMI group 
at baseline.  No participant who was underweight at baseline developed deep, 
superficial or combined reflux at follow up.  When reflux was categorised according to 
venous system affected, the number of participants was small, and incidence of deep 
(p=0.29), superficial (p=0.49) and combined reflux (p=0.20) was not associated with 
BMI group at baseline. 
 
Figure 11.1 shows that change in BMI group during follow up was not significantly 
associated with incidence of any reflux (p=0.29), deep reflux only (p=0.49), superficial 
reflux only (p=0.13) nor combined reflux (p=0.54).  When analysed as a continuous 
variable, there were no significant differences between the mean change in BMI during 
follow up in those with any reflux (p=0.44), deep reflux only (p=0.37), superficial reflux 




11.3 FAMILY HISTORY OF VENOUS DISEASE 
 
Of 184 participants with no family history, 21 developed reflux ≥0.5 s duration at 
follow up, giving a 13 year incidence of 11.4% (95% CI 7.2-17.1).  Of the 114 
participants with a maternal or paternal family history, 17 developed reflux at follow 
up giving an incidence of 14.9% (95% CI 9.0-23.4).  The chi square test showed there 
was no significant association between family history and incidence of reflux (p=0.48).  
Incidence of reflux by specific vein segments, according to family history at baseline is 
presented in Table 11.2.  When analysed by venous system affected, family history of 
venous disease was not associated with increased incidence of reflux (all p≥0.50). 
 
11.4 MEDICAL HISTORY 
 
Table 11.3 presents the 13 year incidence of deep, superficial and combined venous 
reflux ≥0.5s duration according to history of medical conditions at baseline.  None of 
the conditions were associated with incidence of deep or superficial venous reflux.  
However, history of DVT was associated with increased incidence of combined venous 
reflux.  Among participants with no DVT at baseline, the incidence of combined reflux 
was 1.0% (95% CI 0.2-2.7) at follow up compared to 33.3% (95% CI 1.7-164.4) in those 
with a history of DVT (p=0.04).  However, it should be noted that the number of 
participants with a history of DVT was very small (n=3), probably accounting for the 








The 13-year incidence of venous reflux ≥0.5s duration was 17.4% (95% CI 8.1-33.0) in 
women who had never been pregnant (n=46), 13.4% (95% CI 6.6-24.7) in women who 
had 1-2 pregnancies (n=67), 13.2% (95% CI 4.8-29.2) in those with 3 pregnancies 
(n=38) and 12.5% (95% CI 3.2-34.0) in women who had been pregnant at least 4 times 
at baseline (n=24) (p trend=0.55).   The incidence of venous reflux in specific vein 
segments by pregnancy at baseline is presented in Table 11.4.  Very few women 
developed deep reflux (n=4) or combined reflux (n=2) and neither were associated 
with pregnancy (p=0.32 and p=0.74 respectively).  The incidence of superficial reflux 
was higher in those with a previous pregnancy but this association was not statistically 
significant (p=0.85).   
 
Pregnancy during the 13 year follow up was not associated with development of 
venous reflux.  The incidence was 14.0% (95% CI 8.7-21.4) in women with no further 
pregnancies (n=136), 0% in those with 1 or 2 further pregnancies (n=16), 80.0% (95% 
CI 25.4-193.0) in those with 3 further pregnancies (n=5) and 50.0% (95% CI 2.5-246.6) 
in those with 4 further pregnancies (n=2) between baseline and follow up (p 
trend=0.56).  It should be noted that only 23 women experienced one or more 
pregnancies during follow up, thus accounting for the high incidence and wide 
confidence intervals.  When analysed by type of reflux, pregnancy during the follow up 
period had no significant effect on the incidence of deep venous reflux (p=0.75), 





11.6 ORAL CONTRACEPTIVE USE 
 
Oral contraceptive use at baseline was not associated with the development of venous 
reflux ≥0.5s duration, with an overall incidence of 19.5% (95% CI 9.1-37.0) in female 
participants who had never used oral contraceptives (n=123) compared to 11.5% (95% 
CI 6.3-19.6) in previous oral contraceptive users (n=44) (p=0.32).  Oral contraceptive 
use remained insignificant for the development of deep (p=0.35), superficial (p=0.06) 
and combined reflux (p=0.72).  Additionally change in oral contraceptive use during 
follow up was not associated with venous reflux (p=0.55) (data not shown). 
 
11.7 HORMONE REPLACEMENT THERAPY (HRT) 
 
Previous HRT users (n=41) appeared to be more likely to develop venous reflux ≥0.5s 
duration at follow up with an incidence of 30.8% (95% CI 9.8-74.2) compared to 12.7% 
(95% CI 7.7-19.6) in non HRT users (n=127).  However, this finding did not reach 
statistical significance.  The incidence of deep (p=0.31), superficial (p=0.40) and 
combined reflux (p=0.16) did not differ significantly according to HRT use at baseline 










11.8 MOBILITY AT WORK 
 
Baseline mobility at work had no significant effect on incidence of venous reflux ≥0.5s 
duration at follow up (p=0.55).  Results in Table 11.5 show that the 13-year incidence 
of deep, superficial and combined reflux was similar in all participants regardless of 




There was no significant association between smoking at baseline and reflux, with an 
incidence of 13.6% (95% CI 8.7-20.2) in those who had never smoked (n=162), 13.6% 
(95% CI 7.1-23.6) in ex-smokers (n=81) and 9.5% (95% CI 3.9-19.8) in current 
smokers (n=63) (p trend=0.89).  Table 11.6 displays incidence of reflux by vein 
segment and shows that smoking was not significantly associated with the 
development of deep (p=0.42), superficial (p=0.79) or combined reflux (p=0.65).  
Incidence of reflux did not differ significantly in participants who had either started 











11.10 BOWEL HABIT 
 
Bowel habit at baseline was not significantly associated with incidence of venous reflux 
≥0.5s duration at follow up.  The incidence of venous reflux was 12.8% (95% CI 9.0-
17.7) in those who had to strain to start a bowel movement only occasionally compared 
to 12.2% (95% CI 4.5-27.0) in those who had to strain more than half of the time 
(p=0.91).  For straining to finish a bowel movement, the incidence of reflux at follow up 
as 12.4% (95% CI 8.7-17.1) in those who strained to finish only occasionally compared 
to 16.1% (95% CI 5.9-35.7) in those who had to strain to finish more than half of the 
time (p=0.36).  Neither isolated deep (p=0.38), superficial (p=0.60) nor combined 
reflux (p=0.39) were associated with strained bowel movement. 
 
11.11 PHYSICAL ACTIVITY 
 
Activity levels did not differ significantly in participants with and without venous reflux 
at follow up.  Light exercise was performed a mean (SD) 6.8 (6.5) times per week in 
those with no reflux compared to 6.4 (9.6) in participants with reflux (P=0.83).  At 
follow up, moderate physical activity was performed 2.9 (6.7) and 2.4 (3.6) times per 
week in those with and without reflux (p=0.66).  Strenuous physical activity was 
performed to the same extent in all participants, with a mean of 0.5 (1.2) times per 
week in all participants regardless of venous reflux at follow up (p=0.84).  Physical 
activity levels did not differ significantly in participants with and without isolated deep, 




11.12 CHAPTER SUMMARY 
 
This chapter has discussed the incidence of deep, superficial and combined venous 
reflux ≥ 0.5s duration in association with risk factors measured at baseline.  Changes in 
risk factors during the 13-year follow up period of the study were also analysed to 
determine their effect on the incidence of venous reflux.  The only risk factor which 
appeared to be associated with venous reflux was history of DVT at baseline, although 
the numbers with DVT were too small to draw any meaningful conclusions.  Body mass 
index, family history of venous disease, mobility at work, pregnancy, female hormone 
use, smoking and bowel movement at baseline appeared to have no impact on the 
incidence of venous reflux at follow up.   
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TABLE 11.1 13 YEAR INCIDENCE OF REFLUX ≥ 0.5 SECONDS DURATION AT FOLLOW UP BY BODY MASS INDEX (BMI) GROUP AT BASELINE 
 13 YEAR INCIDENCE OF REFLUX ≥ 0.5 SECONDS  
 NORMAL WEIGHT (N = 150) a OVERWEIGHT (N = 114) a OBESE (N = 43) a P VALUE* 
PATTERN OF REFLUX % (95% CI) n % (95% CI) n % (95% CI) n  
DEEP REFLUX  ONLY b 1.3 (0.2-4.4) 2 5.3 (2.1-10.9) 6 0 0 0.64 
CFV origin 0.7 (0.03-3.3) 1 0 0 0 0  
FV lower thigh 0 0 0.9 (0.04-4.3) 1 0 0  
POP lower 0.7 (0.03-3.3) 1 1.7 (0.3-5.8) 2 0 0  
POP upper + lower 0 0 2.6 (0.7-7.2) 3 0 0  
SUPERFICIAL REFLUX ONLY c 8.8 (4.5-15.6) 10 10.5 (5.7-17.9) 12 11.6 (4.3-25.8) 5 0.20 
GSV origin 0 0 0.9 (0.04-4.3) 1 2.3 (0.1-11.5) 1  
GSV lower thigh 1.4 (0.2-4.5) 2 5.3 (2.1-10.9) 6 4.6 (0.8-15.4) 2  
SSV 1.4 (0.2-4.5) 2 0.9 (0.04-4.3) 1 0 0  
GSV origin + GSV lower thigh 1.4 (0.2-4.5) 2 2.6 (0.7-7.2) 3 2.3 (0.1-11.5) 1  
GSV lower thigh + SSV 1.4 (0.2-4.5) 2 0.9 (0.04-4.3) 1 0 0  
GSV origin + GSV lower thigh + SSV 1.4 (0.2-4.5) 2 0 0 2.3 (0.1-11.5) 1  
a
 Normal weight = BMI 18.50-24.99 kg/m
2
, Overweight = BMI 25.00-29.99 kg/m
2
, obese = BMI ≥ 30 kg/m
2 
% (95% CI) = 13-year incidence of reflux ≥ 0.5 seconds duration by vein segment affected according to BMI group at baseline 
n = number of participants with no reflux at baseline but reflux in vein segment at follow up according to BMI group at baseline 
* P value based on chi square test for linear trend for difference in incidence of venous reflux by BMI group at baseline 
b
 Deep reflux only = reflux ≥ 0.5s in CFV, FV or POP + no reflux in GSV or SSV at follow up, based on 309 participants: 150 normal weight, 114 overweight, 42 obese 
c
 Superficial reflux only = reflux ≥ 0.5s in GSV or SSV + no reflux in CFV, FV or POP at follow up, based on 306 participants: 146 normal weight, 114 overweight, 43 obese
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TABLE 11.1 13 YEAR INCIDENCE OF REFLUX ≥ 0.5 SECONDS DURATION AT FOLLOW UP BY BODY MASS INDEX (BMI) GROUP AT BASELINE 
(CONTINUED) 
 13 YEAR INCIDENCE OF REFLUX ≥ 0.5 SECONDS  
 NORMAL WEIGHT (N = 150) a OVERWEIGHT (N = 114) a OBESE (N = 43) a P VALUE* 
PATTERN OF REFLUX % (95% CI) n % (95% CI) n % (95% CI) n  
COMBINED REFLUX b 1.4 (0.2-4.5) 2 1.8 (0.3-5.8) 2 0 0 0.70 
POP upper + GSV lower thigh 0.7 (0.03-3.4) 1 0 0 0 0  
POP lower + SSV 0.7 (0.03-3.4) 1 0 0 0 0  
POP upper + GSV lower thigh + SSV 0 0 0.9 (0.04-4.3) 1 0 0  
a
 Normal weight = BMI 18.50-24.99 kg/m
2
, Overweight = BMI 25.00-29.99 kg/m
2
, obese = BMI ≥ 30 kg/m
2 
% (95% CI) = 13-year incidence of reflux ≥ 0.5 seconds duration by vein segment affected according to BMI group at baseline 
n = number of participants with no reflux at baseline but reflux in vein segment at follow up according to BMI group at baseline 
* P value based on chi square test for linear trend for difference in incidence of venous reflux by BMI group at baseline 
b
 Combined reflux = reflux ≥0.5s in CFV, FV or POP + reflux  ≥ 0.5s in GSV or SSV at follow up, based on 304 participants: 146 normal weight, 113 overweight, 42 obese 
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Any venous reflux Deep reflux only Superficial reflux only Combined reflux 
BMI stayed the same BMI increased BMI decreased 
Any venous reflux = reflux ≥ 0.5s in any one of CFV, FV, POP, GSV or SSV in any leg at follow up 
Deep reflux only = reflux ≥ 0.5s in CFV, FV or POP + no reflux in GSV or SSV at follow up 
Superficial reflux only = reflux ≥ 0.5s in GSV or SSV + no reflux in CFV, FV or POP at follow up 
Combined reflux = reflux ≥ 0.5s in CFV, FV or POP + reflux ≥ 0.5 s in GSV or SSV at follow up 
 
 
13 year incidence 
(%) 
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TABLE 11.2 13 YEAR INCIDENCE OF REFLUX ≥ 0.5 SECONDS AT FOLLOW UP, ACCORDING TO FAMILY HISTORY OF VENOUS DISEASE AT BASELINE 
 13 YEAR INCIDENCE OF REFLUX ≥ 0.5 SECONDS  
 NO FAMILY HISTORY (N=184) FAMILY HISTORY (N=114) P VALUE* 
PATTERN OF REFLUX % (95% CI) n % (95% CI) n  
DEEP REFLUX ONLY a 2.2 (0.7-5.2) 4 3.4 (1.1-8.2) 4 0.40 
CFV origin 0.5 (0.1-2.7) 1 0 0  
FV lower thigh 0 0 0.9 (0.04-4.3) 1  
POP lower 1.1 (0.2-3.6) 2 0.9 (0.04-4.3) 1  
POP upper + lower 0.5 (0.1-2.7) 1 1.7 (0.3-5.8) 2  
SUPERFICIAL REFLUX ONLY b 2.7 (1.0-6.0) 15 6.0 (3.1-10.4) 11 0.34 
GSV origin 1.1 (0.2-3.6) 2 0 0  
GSV lower thigh 2.7 (1.0-6.0) 5 3.5 (1.1-8.5) 4  
SSV 0.5 (0.1-2.7) 1 1.7 (0.3-5.8) 2  
GSV origin + GSV lower thigh 1.1 (0.2-3.6) 2 3.5 (1.1-8.5) 4  
GSV origin + SSV 0 0 0 0  
GSV lower thigh + SSV 1.6 (0.4-4.4) 3 0 0  
GSV origin + lower thigh + SSV 1.1 (0.2-3.6) 2 0.9 (0.04-4.3) 1  
% (95% CI) = 13-year incidence of reflux by vein segment affected according to family history of venous disease at baseline in either first-degree relative 
n = number of participants with no reflux at baseline but reflux in each vein segment at follow according to family history of venous disease at baseline 
*P value based on test for chi squared test for difference in incidence of venous reflux in any leg at follow up according to family history of venous disease at baseline 
a
 Deep reflux only = reflux ≥ 0.5s in CFV, FV or POP + no reflux in GSV or SSV at follow up, based on 301 participants: no family history (184), family history of venous disease (114) 
b
 Superficial reflux = reflux ≥ 0.5s in GSV or SSV + no reflux in CFV, FV or POP at follow up, based on 298 participants: no family history (184), family history of venous disease (114) 
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TABLE 11.2 13 YEAR INCIDENCE OF REFLUX ≥ 0.5 SECONDS AT FOLLOW UP, ACCORDING TO FAMILY HISTORY OF VENOUS DISEASE AT BASELINE 
(CONTINUED) 
 13 YEAR INCIDENCE OF REFLUX ≥ 0.5 SECONDS  
 NO FAMILY HISTORY (N=184) FAMILY HISTORY (N=114) P VALUE* 
PATTERN OF REFLUX % (95% CI) n % (95% CI) n  
COMBINED REFLUX a 1.1 (0.2-3.6) 2 1.8 (0.3-5.8) 2 0.50 
POP lower + GSV lower thigh 0 0 0.9 (0.04-4.3) 1  
POP lower + SSV 0 0 0.9 (0.04-4.3) 1  
POP upper + GSV lower thigh + SSV 0.5 (0.1-2.7) 1 0 0  
CFV + POP upper + lower + GSV origin + GSV lower thigh 0.5 (0.1-2.7) 1 0 0  
% (95% CI) = 13-year incidence of reflux by vein segment affected according to family history of venous disease at baseline in either first-degree relative 
n = number of participants with no reflux at baseline but reflux in each vein segment at follow according to family history of venous disease at baseline 
*P value based on test for chi squared test for difference in incidence of venous reflux in any leg at follow up according to family history of venous disease at baseline 
a








TABLE 11.3 13 YEAR INCIDENCE OF REFLUX ≥ 0.5 SECONDS DURATION AT FOLLOW UP BY HISTORY OF MEDICAL CONDITIONS AT BASELINE 
 
  13 YEAR INCIDENCE OF REFLUX ≥ 0.5 SECONDS
 DEEP REFLUX ONLY  a SUPERFICIAL REFLUX ONLY b COMBINED REFLUX c 
MEDICAL CONDITION % (95% CI) n (N) P value* % (95% CI) n (N) P value* % (95% CI) n (N) P value* 







































































































































% (95% CI) = 13-year incidence of reflux at follow up by history of medical condition at baseline 
n = number of participants with venous reflux at follow up, (N) = number of participants with history or no history of medical condition at baseline 
a 
Deep reflux only = reflux ≥ 0.5 s in CFV, FV or POP + no reflux in GSV or SSV at follow up 
b 
Superficial reflux only = reflux ≥ 0.5 s in GSV or SSV + no reflux in CFV, FV or POP at follow up 
c 
Combined reflux = reflux ≥ 0.5 s in CFV, FV or POP + reflux ≥ 0.5 s in GSV or SSV at follow up 
*P value based on chi square test for difference in incidence of reflux in participants by history of medical conditions at baseline. 
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TABLE 11.3 13 YEAR INCIDENCE OF REFLUX ≥ 0.5 SECONDS DURATION AT FOLLOW UP BY HISTORY OF MEDICAL CONDITIONS AT BASELINE 
(CONTINUED) 
  13 YEAR INCIDENCE OF REFLUX ≥ 0.5 SECONDS
 DEEP REFLUX ONLY  a SUPERFICIAL REFLUX ONLY b COMBINED REFLUX c 
MEDICAL CONDITION % (95% CI) n (N) P value* % (95% CI) n (N) P value* % (95% CI) n (N) P value* 












































































































% (95% CI) = 13-year incidence of reflux at follow up by history of medical condition at baseline 
n = number of participants with venous reflux at follow up, (N) = number of participants with history or no history of medical condition at baseline 
a 
Deep reflux only = reflux ≥ 0.5 s in CFV, FV or POP + no reflux in GSV or SSV at follow up 
b 
Superficial reflux only = reflux ≥  0.5 s in GSV or SSV + no reflux in CFV, FV or POP at follow up 
c 
Combined reflux = reflux ≥ 0.5 s in CFV, FV or POP + reflux ≥ 0.5 s in GSV or SSV at follow up 
*P value based on chi square test for difference in incidence of reflux in participants by history of medical conditions at baseline. 
Swollen leg post pregnancy based on 138 women free of venous reflux at baseline 
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TABLE 11.4 13 YEAR INCIDENCE OF REFLUX ≥ 0.5 SECONDS DURATION AT FOLLOW UP, BY NUMBER OF PREGNANCIES AT BASELINE 
 
 13 YEAR INCIDENCE OF REFLUX ≥ 0.5 SECONDS  
 0 PREGNANCIES  1-2 PREGNANCIES 3 PREGNANCIES ≥ 4 PREGNANCIES P VALUE* 
PATTERN OF REFLUX  % (95% CI) n % (95% CI) n % (95% CI) n % (95% CI) n  
DEEP REFLUX ONLY a 4.3 (0.7-14.4) 2 1.4 (0.1-7.0) 1 2.6 (0.1-13.0) 1 0 0 0.32 
CFV origin 2.2 (0.1-10.7) 1 0 0 0 0 0 0  
FV lower thigh 2.2 (0.1-10.7) 1 0 0 0 0 0 0  
POP lower 0 0 0 0 2.6 (0.1-13.0) 1 0 0  
POP upper + lower 0 0 1.4 (0.1-7.0) 1 0 0 0 0  
SUPERFICIAL REFLUX ONLY b 10.9 (4.0-24.1) 5 11.9 (5.5-22.7) 8 7.9 (2.0-21.5) 3 12.5 (3.2-34.0) 3 0.85 
GSV origin 0 0 1.5 (0.1-7.4) 1 0 0 0 0  
GSV lower thigh 4.3 (0.7-14.4) 2 3.0 (0.5-9.9) 2 2.6 (0.1-13.0) 1 12.5 (3.2-34.0) 3  
SSV 2.2 (0.1-10.7) 1 0 0 2.6 (0.1-13.0) 1 0 0  
GSV origin + GSV lower thigh 2.2 (0.1-10.7) 1 3.0 (0.5-9.9) 2 0 0 0 0  
GSV lower thigh + SSV 2.2 (0.1-10.7) 1 1.5 (0.1-7.4) 1 2.6 (0.1-13.0) 1 0 0  
GSV origin + GSV lower thigh + SSV 0 0 3.0 (0.5-9.9) 2 0 0 0 0  
COMBINED REFLUX c 2.2 (0.1-10.7) 1 0 0 2.6 (0.1-13.0) 1 0 0 0.74 
POP lower + GSV thigh 2.2 (0.1010.7) 1 0 0 0 0 0 0  
POP lower + SSV 0 0 0 0 2.6 (0.1-13.0) 1 0 0  
% (95% CI) = 13-year incidence of reflux by vein segment affected according to number of pregnancies at baseline 
n = number of participants with no reflux at baseline but reflux in vein segment at follow up according to number of pregnancies at baseline 
* P value based on linear trend for test for difference in incidence of venous reflux by number of pregnancies at baseline 
a
 Deep reflux only = reflux ≥ 0.5s in CFV, FV or POP + no reflux in GSV or SSV at follow up, based on 179 females:  
b
 Superficial reflux only = reflux ≥ 0.5s in GSV or SSV + no reflux in CFV, FV or POP at follow up,  based on 175 females 
c
 Combined reflux =  reflux ≥ 0.5s in CFV, FV or POP + reflux ≥ 0.5s in GSV or SSV at follow up 
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TABLE 11.5 13 YEAR INCIDENCE OF REFLUX ≥ 0.5 SECONDS DURATION AT FOLLOW UP BY MOBILITY AT WORK AT BASELINE 
  13 YEAR INCIDENCE OF REFLUX ≥ 0.5 SECONDS
 DEEP REFLUX ONLY  a SUPERFICIAL REFLUX ONLY b COMBINED REFLUX c 
MOBILITY AT WORK % (95% CI) n (N) P value* % (95% CI) n (N) P value* % (95% CI) n (N) P value* 
SITTING 
< 50% of the time 


























< 50% of the time 


























< 50% of the time 



























< 50% of the time 

























% (95% CI) = 13-year incidence of reflux at follow up by mobility at work based on % of time spent sitting, standing, walking and lifting heavy objects 
n = number of participants with venous reflux at follow up, (N) = number of participants spending <50% and >50% of time at work sitting, standing, walking and lifting heavy objects 
a
 Deep reflux only = reflux ≥ 0.5 s in CFV, FV or POP + no reflux in GSV or SSV at follow up 
b 
Superficial reflux only = reflux ≥ 0.5 s in GSV or SSV + no reflux in CFV, FV or POP at follow up 
c 
Combined reflux = reflux ≥ 0.5 s in CFV, FV or POP + reflux ≥ 0.5 s in GSV or SSV at follow up 
* P value based on chi square test for difference between incidence of venous reflux in participants according to mobility at work at baseline 
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TABLE 11.6 13 YEAR INCIDENCE OF REFLUX ≥ 0.5 SECONDS DURATION AT FOLLOW UP, ACCORDING TO SMOKING STATUS AT BASELINE 
 
 13 YEAR INCIDENCE OF REFLUX ≥ 0.5 SECONDS  
 NEVER SMOKED (N = 163 ) EVER SMOKED  (N = 184) P VALUE* 
PATTERN OF REFLUX % (95% CI) n % (95% CI) n  
DEEP REFLUX ONLY a 3.1 (1.1-6.8) 5 1.2 (0.06-5.9) 1 0.42 
CFV origin 0.6 (0.03-3.0) 1 0 0  
POP lower 1.2 (0.2-4.0) 2 0 0  
POP upper + lower 1.2 (0.2-4.0) 2 1.2 (0.06-5.9) 1  
SUPERFICIAL REFLUX ONLY b 9.9 (5.9-15.7) 16 9.6 (4.5-18.3) 8 0.79 
GSV origin 0 0 2.4 (0.4-8.4) 2  
GSV lower thigh 2.5 (0.8-6.0) 4 4.8 (1.5-11.6) 4  
SSV 1.9 (0.5-5.0) 3 0 0  
GSV origin + GSV lower thigh 3.1 (1.1-6.8) 5 0 0  
GSV origin + SSV 0 0 0 0  
GSV lower thigh + SSV 1.2 (0.2-4.1) 2 1.2 (0.06-5.9) 1  
GSV origin + lower thigh + SSV 1.2 (0.2-4.1) 2 1.2 (0.06-5.9) 1  
COMBINED REFLUX c 0.6 (0.03-3.1) 1 2.4 (0.4-8.1) 2 0.65 
POP lower + SSV 0 0 1.2 (0.06-6.0) 1  
POP lower + GSV lower thigh + SSV 0.6 (0.03-3.1) 1 0 0  
CFV + POP upper + lower + GSV origin + GSV lower thigh 0 0 1.2 (0.06-6.0) 1  
% (95% CI) = 13-year incidence of reflux by vein segment affected according to smoking status at baseline 
n = number of participants with no reflux at baseline but reflux in vein segment at follow up according to smoking status at baseline 
a
 Deep reflux only = reflux ≥ 0.5 s in CFV, FV or POP + no reflux in GSV or SSV at follow up, based on 247 participants: never smoked (163) ever smoked (84) 
b
 Superficial reflux only = reflux ≥ 0.5s in GSV or SSV + no reflux in CFV, FV or POP at follow up,  based on 245 participants: never smoked (162), ever smoked (83) 
c
 Combined reflux = reflux ≥ 0.5s in CFV, FV or POP + reflux ≥ 0.5s in GSV or SSV at follow up, based on 243 participants: never smoked , ever smoked  




CHAPTER 12: DISCUSSION 
 
 
12.1 CHAPTER OUTLINE 
 
The Edinburgh Vein Study Follow up is one of the few large scale population-based 
cohort studies recently conducted to investigate the incidence of C2 varicose veins, C3-
C6 chronic venous insufficiency, venous reflux ≥ 0.5 seconds duration and associated 
risk factors.  This chapter begins by discussing the recruitment process, the response 
achieved and the representativeness of the study sample.  The limitations of the study, 
including the diagnosis of CVD and measurement of reflux, are presented.  It then 
proceeds to explore the main findings of the follow up study including the prevalence of 
CVD, incidence of C2 varicose veins and C3-C6 CVI and reflux.  Risk factors measured in 
this study are discussed and compared with results from other studies.  The public 
health implications of the results of this study are then considered. Finally the 










12.2 RECRUITMENT AND RESPONSE 
 
12.2.1 Recruitment 
The key process in recruitment was to obtain current contact details for all surviving 
baseline participants.   This was done through Practitioner Services Division (PSD), a 
division of NHS National Services Scotland (NHS NSS).  PSD act as data custodians for 
the Community Health Index (CHI), a database in which every patient registered in 
Scotland is allocated a unique identifying number.   CHI is linked to the National Health 
Services Central Register (NHSCR), which contains details on every patient born in 
Scotland.  For patients who have moved away from Scotland but remain in the UK, the 
NHSCR identifies the health authority where that individual is registered with a GP.  
The CHI and NHSCR are updated and synchronised every week and therefore it was the 
most effective way to retrieve up-to-date contact details for all participants.   
 
The initial search of CHI retrieved addresses for all surviving baseline participants 
residing in Scotland. However, individuals may have moved house but not yet 
registered with another general practitioner located in the catchment area of their new 
address.  In such cases, CHI would not have updated and the address retrieved by the 
search would have been inaccurate.  It was assumed that any individual who did not 
respond to the study invitation could potentially have moved address.  For these 
individuals, addresses provided by CHI were checked against GP practice registers.  
However, if the individual had not registered with another GP, the current practice 
would have been unaware that the patient had changed address.  There was no way to 
overcome this and therefore it was accepted that some individuals would probably not 
receive their study invitation.  
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For individuals not living in Scotland but elsewhere in the UK, only the health authority 
where the individual was registered with a general practitioner was provided.  Due to 
confidentiality regulations, health authorities would not release the individuals’ contact 
details but agreed to send the study invitation to them.  This method did result in some 
individuals travelling from England to take part in the follow up study but it was not as 
fruitful as hoped.  With no contact details and reliant upon a third party passing on 
information, it was impossible to determine if these individuals received a study 
invitation. However, this was the only way in which individuals living outside Scotland 
could be contacted.   
 
Intensive efforts were made to try to recruit as many people as possible to the follow 
up study.  An administrative assistant was employed to trace individuals and send 
study invitations.  Individuals were sent two invitation letters before attempts were 
made to contact them by telephone, made at different times of the day to try to improve 
response.  If the individual could still not be reached, contact was made with the 
general practice to check if they were still registered as a patient there.  A second 
search of CHI was performed in case the individual’s details had changed since the first 
search.  To try to maximise participation in the follow up study, appointment times 
from 7.30 am to 3.30 pm were offered to participants.  Where there was demand, 
evening clinics were arranged to accommodate individuals who could not attend 
during the day.  Participants were reimbursed travel costs and recompensed for loss of 






With any long term follow up study, it is important to keep good relations with the 
study community.  Written reminders have been proven to increase the response rate 
in cohort studies (Edwards 2002, Ronckers 2004).  Therefore, at year 6 of the 13-year 
follow up, newsletters were sent to all baseline participants outlining the key results in 
a language that the lay participant would understand.  It was hoped that, through 
highlighting the importance of the research and acting as a prompt for the follow up 
study, the newsletter would maximise participation at a later date. 
 
12.2.2 Response 
Individuals were classified into 5 groups based on response.  “Participants” were those 
who agreed to take part in the study and underwent a follow up examination.  
“Refusals” comprised individuals who replied declining to participate in the study.  
“Withdrawals” were those who initially agreed to take part in the follow up study but 
subsequently failed to attend their appointment.  “No response” comprised any 
individual who did not reply to the study invitation and could not be contacted by 
telephone.  This group included those who may have moved address and also those 
who did not respond to the study invitation passed on by the heath authority.  
Assuming that the address from CHI was accurate and that the health authority passed 
on the invitation, it was presumed that these individuals received the invite to take part 
but chose not to respond.  However with no contact details for these individuals, this 
cannot be determined.  Finally, “unable to trace” were cases where the health authority 
did not confirm whether the individual was registered there and so it was known that 





The response rate at follow up was based on the number of participants who were 
eligible to take part.  Individuals who had died or emigrated since taking part at 
baseline were not included.  The sample size calculation at baseline assumed that 50% 
of the cross-sectional study participants would be followed up.  Therefore, the response 
rate of 60.4% at follow up was adequate to measure the incidence of varicose veins and 
CVI with the required precision.  Given the length of the follow up and the current 
climate and sceptical attitudes of the population to participating in research, the 
response rate achieved was deemed satisfactory.  
 
The response rate of 60.4% was higher than the 53.8% response achieved at the cross-
sectional study at baseline.   However a higher response to follow up would be expected 
as participants were known volunteers who had previously been examined at the 
baseline study.   Another reason for the higher response to follow up could be that 
those who took part at baseline, particularly those with C2 varicose veins or C3-C6 CVI 
may have been eager to discover if their disease had changed over the 13 years.  The 
follow up appointment comprised of a duplex ultrasound scan to check for venous 
reflux, a procedure not routinely conducted if an individual consults their GP about 
CVD.  Therefore the individual may have felt that this was a rare opportunity to have a 
thorough examination of their leg veins.  The fact that the results of the examination 








Individuals who refused to take part in the study (n=172) were sent a questionnaire to 
determine their venous disease status and ascertain the reason for their refusal.  Of the 
98 who completed the questionnaire, 58% stated that the reason they did not want to 
participate was that they did not have venous disease so they felt research was not 
relevant to them.  The information sheet sent with the letter of invitation highlighted 
the importance of the research even in those without venous disease.  Lack of time was 
the second most common reason for refusing to take part in the follow up study (22%).  
Early morning and evening appointments were offered to accommodate individuals 
who could not attend during working hours.   
 
12.3 REPRESENTATIVENESS OF THE STUDY SAMPLE 
 
12.3.1 Study population 
Participants in the follow up study were from higher social classes than non-
participants.  There is a commonly accepted observation that people who take part in 
research studies tend to be more affluent.  The relationship between social class and 
health has many influencing factors but generally speaking those in lower social classes 
eat a poorer diet, exercise less and are more likely to smoke than those in higher social 
classes.  Consequently they may be less inclined to take part in a research study into a 
disease.  However, with no evidence that neither social class nor mobility at work are 
associated with the development of C2 varicose veins or C3-C6 CVI, the higher 





Follow up study participants were also more likely to be non-smokers than non-
participants.  The Tampere study also reported that those lost to follow up were more 
likely to be smokers (Ahti 2009).  Smokers take less interest in their health and would 
possibly be less likely to participate in a research study on venous disease.  
Furthermore, smoking is associated with social class.  The prevalence of smoking is 
higher in manual compared to non-manual socioeconomic groups (National Institute 
for Clinical Excellence 2013).  As the follow up study sample contained a higher 
proportion of non-manual workers, it would be expected that a higher proportion of 
study participants would be non-smokers.  However as there was no association 
between smoking and CVD in this study or indeed other studies, the higher proportion 
of non-smokers in this sample would not have affected the results of the study. 
 
Follow up participants reported previous varicose vein surgery more often than non-
participants.  This would be expected as individuals with surgically treated veins would 
have an increased incentive to take part.  Interestingly, family history of CVD at 
baseline did not affect whether an individual took part in the follow up study.  It was 
thought that individuals with a history of venous disease in their family would have 
been more likely to participate in the study.  However, participants and non-
participants reported a similar prevalence of family history at baseline.  Family history 
may have changed during follow up and relatives may have developed new venous 
disease.  This could have provided an added incentive for taking part in the study.  On 
the other hand, those with no change in family history may have been less inclined to 
take part.  There was no way to clarify this theory.  Attempts were made to contact the 
“refusals” and “withdrawals” to determine family history.  However, as 22% of eligible 
participants did not respond to study invitations or phone calls, family history at follow 
up could not be determined in a large proportion of non-participants.  
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Other risk factors at baseline such as obesity, history of medical conditions and 
pregnancy were equally distributed between participants and non-participants, 
indicating that there was no significant difference in proposed risk between those who 
did and did not take part in the follow up study.  
 
There were no significant differences between the baseline prevalence of C2 varicose 
veins and C3-C6 CVI in participants and non-participants of the follow up study. 
Furthermore, the prevalence of venous reflux ≥ 0.5 seconds duration at baseline was 
similar between the two groups.  With the exception of swollen legs, participants and 
non-participants did not differ in the reported frequency of symptoms of CVD at 
baseline. These findings suggest that the final study sample was representative of the 
baseline study population with regards to CVD. 
 
12.3.2 Population of Edinburgh 
An important issue in any study is whether the study participants are representative of 
the wider population.  Follow up participants were compared to the population of 
Edinburgh in terms of age, sex and social class.  Participants were slightly older than 
the population of Edinburgh.  Given that the prevalence of CVD increases with age, the 
final study sample would be likely to include a higher proportion of people with CVD 








The proportion of women in the study sample was 4% higher than the proportion of 
women living in Edinburgh.  Some studies have shown an increased prevalence of 
varicose veins in women compared to men but the results are variable.  Conversely, at 
the baseline phase of the study, the prevalence was higher in men.  However as the 
proportion of women in the study was only marginally higher than the general 
population, it was unlikely to affect the representativeness of the study sample.  
Participants in the follow up study tended to be less deprived than the population of 
the City of Edinburgh.  However, there is no evidence that CVD is linked to social class 
and so the inclusion of fewer deprived individuals is unlikely to affect the results of the 
study. 
 
12.4 LIMITATIONS OF THE STUDY 
 
12.4.1 Loss to follow up 
The response rate achieved at follow up in the Edinburgh Vein Study was 60%.  
Strenuous efforts were undertaken to maximise participation but despite these, 40% of 
the study population did take part in the follow up study because they refused, did not 
respond to the invitation, withdrew from the study or were unable to trace.  Loss to 
follow up is a common and inevitable problem in prospective cohort studies.  It is an 
important problem as non-responders may be different from those who participate, 
thus introducing bias and threatening the validity of the study results.  Various 
comparisons were made between participants and non-participants to check the 
representativeness of the study sample to the study population.  Comparisons included 
age, sex, prevalence of CVD and reflux, previous treatment and family history of CVD 
and other risk factors such as BMI, pregnancy, smoking and medical history. 
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Results of these comparisons showed that participants in the follow up study were 
older than non-participants (47 years and 42 years respectively).  While the mean 
difference in age was small, it was statistically significant (p<0.001) and given that the 
incidence and prevalence of both varicose veins and CVI have been shown to increase 
with age, it is likely that the final study sample may contain a higher proportion of 
people with venous disease.   
 
Participants in the follow up study were more likely to have had treatment for varicose 
veins than non-participants.  Consequently it would be expected that participants may 
have had more symptoms of varicose veins at baseline.   However this was not the case.   
There were no significant differences between participants and non-participants in 
terms of the prevalence of either C2 varicose veins or C3-C6 CVI at baseline.   Some 
participants free from disease at baseline may have developed varicose veins during 
the 13 years, thus providing an incentive to take part in the follow up study.  While this 
could account for the lack of statistical difference in prevalence between participants 
and non-participants, it does not account for the significantly higher treatment rate at 
baseline between the two groups.  It is important to note that when comparing the 
prevalence of varicose veins between participants and non-participants, this measure is 
at baseline and does not take into account changes during the follow up.  Attempts 
were made to measure varicose veins at follow up by sending questionnaires to those 
who refused to take part in (n=172), did not respond (n=321) or withdrew (n=69) from 
the follow up study.  Of the 562 non-participants who were sent a questionnaire, only 
98 (17%) completed it.  With the varicose vein status unknown in the majority of non-
participants (83%) it cannot be ruled out that the final study sample may contain a 
higher proportion of people with varicose veins than the study population. 
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12.4.2 Classification of chronic venous disease 
At baseline, the Basle system was used to classify CVD as it is was the most widely 
accepted method at that time.  However, during the follow up the CEAP system was 
developed and has since become the gold standard method.  To ensure direct 
comparison between results at baseline and follow up, and to permit comparisons with 
other studies that have used the CEAP classification, both the Basle and CEAP were 
used at follow up.  Despite the use of a standardized classification system to diagnose 
CVD, there were issues around observer error and reliability, which will now be 
addressed. 
 
Variation between classification of baseline and follow up observers 
Given that different observers classified CVD at the two stages of the study, it was 
imperative to check for variations between observers at baseline and follow up.  A 
sample of 100 baseline participants was chosen by selecting every 15th participant from 
the study list.  Photographs of this sample were analysed by observers at follow up.  
Observers classified CVD independently and were blinded to the classification awarded 
by the baseline observers. Results of agreement suggested that the variability between 










Classification at examination and using photographs 
Classification of CVD was based predominantly on examination of the participant and 
supported with photographic evidence, where available.  Comparison of the two 
methods identified four discrepancies.   C1 telangiectases and reticular veins and C3 
corona phlebectatica were classified at a higher grade based on photographic evidence.  
Conversely, C2 varicose veins were classified at a higher grade upon examination.  
However, photographic evidence was only available on 77% of follow up participants.  
Although the preference was to use examination rather than photographic data 
because the former was more complete, the results of the comparison between the 
examination and photographic methods indicated that amendments would improve the 
accuracy of the data to be included in the statistical analysis, the observer variability 
and the validity of the study results.  Therefore classification of C1 telangiectases and 
reticular veins and C3 corona phlebectatica were based on photographic evidence, 
where available.  
 
Inter-observer variability at follow up 
Despite regular quality control measures during data collection, a limitation of this 
study was some degree of inconsistency between observers in the classification of 
disease on clinical examination.  Analysis showed that one observer reported fewer 
mild C2 varicose veins at examination. However, when this observer’s classification 
based on photographic evidence was compared to the other observers, no significant 
difference in the prevalence of mild C2 veins was found, suggesting an under-reporting 
at examination.  As a result, amendments were made so that for participants examined 
by this observer, a grade 0 C2 vein at examination was changed to a grade 1 (mild), if 
that was the finding on the photographic evidence.  Analysis also highlighted an over- 
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reporting of C4 venous eczema at examination by another observer.  Consequently, an 
amendment was made so that the classification of C4 eczema was based on 
photographic evidence for this observer.  Photographs were taken at both stages of the 
study to ensure that there was supporting evidence available on the classification of 
disease.  Since photographs were not available for all participants, they could not be 
substituted completely for clinical examination data but were used where feasible to 
correct known misclassifications.  It was considered that this approach provided the 
most valid assessment of venous disease, particularly as the appraisal of photographs 
were made independently by two observers, blind to the results of the clinical 
examination. 
 
Intra-observer variability at follow up 
Forty-nine participants had CVD classified by the same observer who completed the 
first classification.  A minimum period of 12 weeks was allowed between appointments 
so that the observer would be unaware of the classification at the first examination.  
However the sample was not large enough to identify discrepancies during the study.  
Only when comparing prevalence between observers at the end of the study was it 
clear that there was an under-reporting of C2 varicose veins upon examination by one 
observer.  This is not uncommon in epidemiological studies where observers “drift” 
over time.  Fortunately photographs provided back up to highlight and investigate such 
problems.  As there were known intra observer errors, it was considered that 
amending the errors based on the photographic evidence would result in a more 




12.4.3 Measurement of venous reflux 
While duplex scanning has become the method of choice for investigation of venous 
reflux, debate surrounding the optimum position and technique still exists.  Currently 
there is no systematic consensus agreement on how duplex ultrasound for CVD is best 
performed.  Most observers (Coleridge-Smith 2006, Labropoulos 2005,  Nicolaides  
2000) recommend examining the patient in a standing position but others have 
suggested that a reverse Trendelenburg is also adequate (Bonfield 2012).  Reflux > 0.5 
seconds is generally used but a definitive cut off point for all segments has not been 
agreed.  Labropoulos et al. suggest a cut-off point of > 1 second for popliteal segments 
(Labropoulos 2003).  Furthermore while the pneumatic cuff is the most reproducible 
method to elicit reflux, the Valsalva manoeuver is recommended for measuring 
incompetence in the saphenofemoral junction (Coleridge-Smith 2006). 
 
Ideally duplex ultrasound would have been combined with a global measure of venous 
function of the limb such as plethysmography.  This combination has been deemed to 
be the most accurate means of measuring reflux (Coleridge-Smith 2006).   However, as 
the study examination lasted an hour, it was felt that asking participants to extend their 










To ensure that the ultrasound scans were performed in a standardised manner, a 
protocol was designed detailing the technique for measuring reflux in specific vein 
segments [Appendix 15].  The four observers at follow up were initially trained 
together by experienced vascular scientists and a consultant radiologist.  All observers 
underwent a practical exam, in which they were required to perform a duplex 
ultrasound on a volunteer, while being assessed by a vascular scientist.  Only when 
observers passed this exam were they deemed competent enough to conduct 
ultrasound scans in the study.   
 
Every participant was examined on a table tilted to an angle of 45 degrees.  An 
automated rapid inflation/deflation cuff was used to elicit reflux as it provides a 
standard stimulus to evaluate reflux parameters (Labropoulos 2005).  The calf veins 
were not examined at baseline and therefore were not examined at follow up.  It has 
been shown that calf veins have a role in popliteal reflux (Allan 2000).  However, with 
no reflux measures for the calf veins at baseline, data at follow up would be of limited 
use.  While this may leave some questions unanswered, it was considered that duplex 
scanning of the calf and perforator veins would be difficult for the research team to 










Inter-observer variability at follow up 
Inter-observer agreement ranged from 83-98% for measures of reflux in the deep veins 
and 79-95% for the superficial veins.  The poorest agreement was for reflux in the GSV 
in the lower third of the thigh.  This segment is acknowledged as difficult to measure 
due to the anatomical variations around the knee (Cavezzi 2006).  Furthermore, 
according to a consensus document on duplex ultrasound for the investigation of CVD, 
the GSV in the thigh is often “accompanied by parallel veins of different length that are 
so large that they may be confused with the GSV itself or considered to be the double 
saphenous veins” (Cavezzi 2006).   Inter observer agreement was lower for the SSV.  
Observers at baseline also had difficulty in measuring reflux in this segment.  Over a 
quarter (26%) of baseline participants were recorded as having missing reflux SSV 
measurements, as observers were not confident that they had correctly identified the 
vein.  The SSV is prone to anatomical variations including a missing vein or a double or 
triple duplicated vein.  The SSV was a difficult segment to measure at both stages of the 
study and so the results must be interpreted with caution. 
 
Intra-observer variability at follow up  
Intra-observer variability ranged from 70-100%, which indicates that each observer 
achieved similar reflux results at two different ultrasound examinations.  The 
agreement was poorest for the GSV upper and lower calf.  As these vein segments are 
located distally, the pneumatic compression device could not be used.   Rather, foot 
compressions were performed where the observer squeezed the foot to initiate blood 
flow.  Unlike the pneumatic calf compression, which was set at a standard pressure, the 
pressure applied to the foot may have varied with each compression.  This variability 
may have accounted for the lower level of agreement for these vein segments.  
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Cut-off point for venous reflux 
At baseline and follow up, abnormal venous reflux was defined as reflux ≥ 0.5 seconds 
duration.  However, there is debate over what constitutes significant reflux.  While 
some authors use duration of reverse flow of greater than 0.5 seconds as a definition 
for significant reflux, others argue that this definition would include individuals with 
normally functioning veins, and use a value of greater than 1 second duration, 
particularly for the popliteal veins (Labropoulos 2003).  Determining which cut-off 
point to use is a complex issue.  Using reflux duration ≥ 0.5 decreases the specificity, 
and could result in a larger proportion of normal veins determined to be incompetent, 
while using a reflux duration > 1.0 second decreases the sensitivity, and risks 
diagnosing a larger proportion of incompetent veins as normal (Evans  2002).   
 
It was intended to analyse the relationship between the duration of reflux ≥ 0.5 seconds 
and > 1.0 second at baseline and the incidence of C2 varicose veins and C3-C6 CVI at 
follow up.  However the number of participants who developed any reflux ≥ 0.5 
seconds at follow up was too small for the analysis to provide any meaningful results.  
Severity of reflux is thought to be an important factor in the progression of CVD to and 










12.4.4 Limited power 
One of the limitations of this study is that although the follow up study sample of 880 
participants exceeded the 750 assumed in the sample size calculation, when incident 
cases were split into subgroups for analysis the numbers were small, thus limiting the 
power of the study to detect true differences.  This was a particular problem when 
analysing venous reflux.  Although the overall incidence of venous reflux was 12%, 
when split according to vein segment affected, the numbers with reflux in certain 
segments were very small.  Consequently important risk factors may not have been 
identified.  Furthermore the true association between the prevalence of venous reflux 
at baseline and the incidence of varicose veins at follow up may not have been detected.  
This was also the case for pregnancy and the incidence of varicose veins where data 
identified it as a risk factor but the association was not statistically significant due to 
small numbers.  Only 47 of the 334 women in the study had one or more pregnancies at 
baseline.  When split further to test the trend for number of pregnancies, the subgroups 
became smaller still and while a linear trend was noted, the trend was not statistically 
significant (p=0.42).  Therefore, in this study non-significant results must not be 
discounted but interpreted with caution.  It is imperative to look at the number of cases 
on whom associations are being tested and consider that that the lack of a statistical 






12.4.5 Multiple testing 
Data in this study underwent multiple statistical testing.  One problem of performing 
multiple tests is that inevitably there will be type I errors.  Type I errors occur when the 
true null hypothesis is incorrectly rejected.  Consequently an association is observed 
when in truth there is none (false positive).  Methods to adjust for type I errors include 
the Bonferroni correction.  However it is a conservative measure and increases the 
probability of producing false negatives, where there is an effect but it is not identified 
as statistically significant.  Multiple test correction was not performed in this study and 
therefore it should be acknowledged that some of the statistically significant results 
may not be true associations but occurred by chance alone.  As such the results should 
be interpreted with caution. 
 
12.5 PREVALENCE OF C1-C6 CHRONIC VENOUS DISEASE AT FOLLOW UP 
 
The prevalence of C2 varicose veins increased from 36.9% at baseline to 39.2% at 
follow up.  The proportion of mild cases decreased but the proportion of moderate and 
severe C2 varices increased.  As the severity was based on the highest grade, this 
finding suggests that those with mild varicose veins at baseline deteriorated to 
moderate or severe varicose veins over the 13 years.  Clinical manifestations of C3-C6 
CVI also increased during follow up, particularly mild forms such as C3 corona 
phlebectatica (16.7%) and C4a pigmentation (5.5%).  Given that CVD represents a 
spectrum of conditions of increasing severity associated with age, it would be expected 
that the prevalence of C3-C6 CVI would increase as some individuals with C2 varicose 
veins at baseline would have deteriorated during the 13 years.  Severe CVI including C5 
healed and C6 active venous ulceration remained uncommon with a prevalence of only 
0.8% at follow up. 
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Overall, the prevalence of C1 telangiectases decreased from 92% at baseline to 85% at 
follow up while the prevalence of C1 reticular veins decreased further from 90% to 
70% over the 13 year period.  While the prevalence of moderate and severe C1 veins 
increased during the 13 years, the decrease in mild telangiectases and reticular veins 
accounted for the lower prevalence observed at follow up.  The increase in the 
proportion of moderate and severe veins suggests some progression from baseline.  
However, given that the prevalence of C2 varicose veins has been associated with age, it 
would have been expected that the prevalence of these conditions would also have 
increased over the 13-year follow up.  
 
It was postulated that varicose vein surgery may have improved the appearance of mild 
C1 veins.  To test this theory, participants who had surgery between baseline and 
follow up examinations were excluded.  However this had little effect on the 
prevalence.  Only 6.6% of the follow up participants reported using compression 
stockings which could not account for the improvement in mild C1 veins.  A possible 
explanation could be that mild C1 telangiectases and reticular veins were misclassified 
either at baseline or follow up.  The prevalence of both these conditions was estimated 
at over 90% at baseline.  Estimates from other studies suggest that the prevalence is 
approximately 80% (Evans 1994).  Therefore it is possible that C1 mild veins were over 
reported at baseline.  Alternatively, observers at follow up could have under reported 
the prevalence of these conditions.  Results suggested that the agreement between the 
observers at baseline and follow up were tolerable.  Clearly some observer variability 
existed, as it would be unlikely that a mild C1 reticular vein would simply disappear 




12.5.1 Age differences 
At follow up, the prevalence of both C2 varicose veins and C3-C6 CVI increased linearly 
with age, regardless of sex.  Other evidence suggests that, on balance, the prevalence of 
CVD increases with age (Abramson 1981,  Arnoldi  1958, Beaglehole 1975, Canonico 
1998, Coon 1973, Criqui 2003, Evans 1999, Franks 1992, Guberan 1973, Komsuoglu 
1994, Maffei 1986, Mekky 1969, Sisto 1995,  Stanhope  1975,  Widmer  1978).  It has 
been postulated that ageing is associated with a change in size and elasticity of the 
venous wall, thus predisposing to varicose veins (Clarke 1992).   
 
12.5.2 Sex differences 
C1 telangiectases were more prevalent in women (90.2%) than in men (79%).  The 
prevalence of C2 varicose veins was 40.0% (95% CI 35.3-44.5) in men compared to 
38.6 (95% 34.4-42.9) in women (p=0.67)  This was an interesting finding as baseline 
results suggested a statistically significantly higher prevalence of C2 varicose veins in 
men (39.7%) compared to women (32.2%).  Evidence from previous studies of varicose 
veins suggested a higher prevalence in women (Abramson 1981, Beaglehole 1975, 
Coon 1973, Criqui 2003, Franks 1992, Komsuoglu 1994, Kontosic 2000, Laurikka 1993, 
Leipnitz 1989, Maffei 1986, Novo 1988, Sisto 1995) although the magnitude of 
difference varied between studies (See Chapter 2, Tables 2.1 and 2.2). The prevalence 
of C3-C6 CVI was similar between men and women at follow up (p>0.05).   At baseline, 
the prevalence of CVI was similar between men and women, suggesting that during 
follow up, venous disease developed at a similar rate between sexes.  However the 




12.6 PREVALENCE OF VENOUS REFLUX AT FOLLOW UP 
 
At baseline, the prevalence of deep venous reflux only (without superficial reflux) was 
significantly higher in men (25.2%, 95% CI 20.6-30.6) than in women (14.4%, 95% CI 
11.3-18.1) (p<0.001).  Conversely superficial reflux (without deep reflux) was more 
common in women (20.3%, 95% CI 16.3-25.1) than in men 11.6, (95% CI 8.4-15.6) 
(p=0.02).  The prevalence of combined deep and superficial reflux did not differ 
between genders (20.0%, 95% CI 15.8-25.0 in men and 16.5%, 95% CI 37.1-58.0 in 
women (p=0.22).  At follow up, men no longer had a statistically higher prevalence of 
deep venous reflux (p=0.75).  However, the trend for a higher prevalence of isolated 
superficial venous reflux in women remained (p<0.001).   
 
The Bochum Study also found that women had a significantly higher prevalence of 
superficial reflux (Schultz-Ehrenburg 1992). While it has been hypothesized that men 
may have larger deep veins which take longer for the valves to close completely (Allan 
2000), there is no known anatomical reason why women should have a higher 











Analysis of the data showed that individuals with isolated superficial reflux at baseline 
were more likely to have C2 varicose veins at follow up.  Moreover, those with 
combined deep and superficial reflux were at an even greater risk of developing C2 
varicose veins at follow up.  In particular, reflux in the GSV at the origin and in the 
lower third of the thigh were the key vein segments identified as contributing to the 
development of C2 varicose veins.  This is supported by Labropoulos et al. who 
identified that above knee GSV reflux was the contributing factor to the prevalence of 
varicose veins without skin changes (Labropoulos 1997).  As the majority of new C2 
veins were classified as mild, it was not possible to conduct an analysis on the effect of 
reflux on the severity of C2 veins.  However, results on the prevalence at baseline 
suggested a higher prevalence of reflux in participants with more severe varices.   
 
Deep venous reflux appeared to be associated with the development of C3-C6 CVI.  This 
association did not reach statistical significance, possibly due to the small number of 
participants developing CVI during follow up.  Despite the lack of statistical association, 
the trend cannot be ignored, particularly when other studies have shown deep venous 
reflux to be an important cause of venous ulceration (MacEnroe 1988, Raju 1983).  
Furthermore it has been shown that that popliteal vein reflux reduces the healing of 







12.7 INCIDENCE OF C2 VARICOSE VEINS AND C3-C6 CVI AT FOLLOW UP 
 
Results from the Edinburgh Vein Study Follow Up suggest that approximately 1.4% of 
the general population will develop C2 varicose veins each year, the majority of which 
are mild.  The incidence reported in this study is lower than in the Framingham Study, a 
longitudinal study with a follow up every 2 years over a 16-year period in the USA 
(Brand 1988).  The annual incidence of varicose veins was 4.6%.  However the 
Framingham Study was conducted before the introduction of a standard classification 
system.  Although varicose veins were defined as “the presence of distended and 
tortuous veins, clearly visible in the lower limbs with the subject standing”, the lack of 
precise and reliable criteria for diagnosis is a drawback in any epidemiological study.  
In the Bonn Vein Study II, where 1,978 of 3,072 participants were re-examined after a 
6.6-year follow up, the incidence of varicose veins was 2.1% per year (Rabe 2010).  
However the methods of derivation of incidence were not reported and it is not clear if 
the incident cases in this study were free of varicose veins at baseline.  The Tampere 
Study reported an incidence of 1.3% per year (Mäkivaara 2004).  However varicose 
veins were based on self-diagnosis via a questionnaire and only 2.4% of the study 
sample underwent physical examination to confirm the diagnosis.  The Bochum Study 
examined school children on three occasions over an eight-year period and used the 
CEAP classification system to diagnose varicose veins (Schultz-Ehrenburg 1992)  None 
of the children aged 10-12 years had varicose veins at the first examination. The 
incidence was 1.7% at age 14-16 years and 3.3% by age 18-20 years.   However given 
that the prevalence of varicose veins is strongly associated with age, it would be 
expected that the incidence of varicose veins in children as young as 10-16 years would 
be low and not comparable with an adult population. 
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The annual incidence rate of CVI in the Edinburgh Vein Study Follow Up was 0.7%, 
0.4% alone and 0.3% with combined development of C2 veins.  The Bonn Vein Study 
however, found a much higher incidence rate of 2.0% per year (Rabe 2010).  Again the 
calculation of incidence in the Bonn Vein Study II is questioned.  Results seem to 
suggest that new cases of CVI at follow up may have had a less severe class of CVI at 
baseline.  If this is the case then the results reported in this study are not real incidence 
but are actually rates of progression of disease   When considering the incidence of CVI, 
it is important to emphasise the difference between the true incidence of CVI and 
natural progression of disease.  The CEAP classification system represents a range of 
symptoms which increase in severity from C1-C6 classes.   C2 varicose veins, if left 
untreated, can lead to more severe symptoms of CVI.  As such, when an individual with 
C2 varices develops symptoms of CVI, it is deemed to be progression of venous disease.   
In the Edinburgh Vein Study the incidence of CVI was based on the number of 
participants with no C2 varices or CVI at baseline.   Consequently participants with C2 
varicose veins at baseline and C3-C6 CVI at follow up were not included as incident 
cases of CVI.  The incidence was calculated in this way as such participants are not true 
incident cases but rather cases where existing venous disease has progressed to more 










When conducting a prospective cohort study to determine the incidence of varicose 
veins or CVI, it is important to consider that participants free from these conditions at 
the initial examination, may have developed symptoms and had subsequent treatment 
(surgery or sclerotherapy) during the follow up period.  Consequently these 
participants may have had no evidence of C2-C6 disease at the follow up examination 
and therefore would not be included as incident cases.  However, in the Edinburgh Vein 
Study, the questionnaire enquired about treatment for varicose veins including the type 
and year of procedure.  Therefore, any participant free from disease at baseline who 
had venous surgery between baseline and follow up could be identified and included as 
an incident case.  Of the 555 participants with no C2-C6 disease at baseline only 2 had 
surgery during the 13 year follow up and both of these participants had signs of C2 
varicose veins at the follow up examination.    Therefore it is considered that the 
incidence calculated in this study is the true incidence of C2 varicose veins and C3- C6 
CVI.  Other studies on incidence of varicose veins and CVI do not address this problem 
and therefore the incidence reported may not actually be the true incidence of disease 
(Brand 1988, Mäkivaara 2004, Rabe 2010, Schultz-Ehrenburg 1992) 
 
12.7.1 Age differences 
Results of this study indicate that the incidence of C2 varicose veins and C3-C6 CVI 
increases significantly with age.  After adjusting for sex, participants aged 45-54 years 
at baseline were 2.6 times more likely to develop C2 varicose vein at follow up 13 years 
later than those aged 18-24 years.  The odds were higher still in those aged 55-64 years 
(OR 3.2, 95% CI 1.6-6.4) compared to 18-24 year olds.  For C3-C6 CVI the risk was 
approximately 2 fold in those aged 35-44 years, 7 fold in those aged 45-54 years and 9 
fold in those aged 55-64 years at baseline compared to 18-24 year olds.   The 
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Edinburgh Vein Study is the first to produce convincing evidence that the risk of 
acquiring both C2 varicose veins and C3-C6 CVI increases with age, a finding which 
would be expected in a chronic degenerative condition.  These results are in keeping 
with the Bochum Study, where incidence of varicose veins also increased with age 
(Schultz-Ehrenburg 1992).  However, it should be noted that participants in that study 
were school children aged 10-12 years at baseline, who were followed up over a 20 
year period.  In the Framingham Study, the incidence of varicose veins did not increase 
significantly with age (Brand 1988).   
 
12.7.2 Sex differences 
Results from the Edinburgh Vein Study suggest that the incidence of C2 varicose veins 
is similar between men and women.  The age-adjusted 13 year incidence was 15.2% 
(95% CI 10.4-20.0) and 17.4% (95% CI 13.1-21.7) (p=0.72).  There were also no 
observed sex differences in the incidence of C3-C6 CVI between men and women.   The 
13 year incidences were 10.7% (95% CI 7.2-15.5) and 8.1% (95% CI 5.7-11.6) in men 
and women respectively (p=0.32).   These findings concur with the Bonn Vein Study II, 
which also found no gender difference (Rabe 2010).  Evidence from other studies 
indicates a higher incidence in women.  The Framingham Study reported annual rates 
of 2.6% in women and 1.9% in men (Brand 1988), while the Tampere Varicose Vein 
Study reported rates of 19.2/1000 person-years and 8.5/1000 person-years in women 
and men respectively (Laurikka 2002).  However, the Tampere Study obtained 
information on CVD via postal questionnaire and may have had a biased response by 
gender.  The Bochum Study found no significant gender differences but only 136 




12.8 INCIDENCE OF VENOUS REFLUX AT FOLLOW UP 
 
The 13 year incidence of venous reflux ≥ 0.5 seconds duration was 12.7%, 8.8% in the 
superficial system only, 2.6% in the deep system only and 1.3% in both the deep and 
superficial systems.  The GSV was the most common vein to develop reflux with a 13 
year incidence of 4.6% (95% CI 2.6-7.5), 3.9% (95% CI 2.1-6.7) and 0.3% (95% CI 0.02-
1.6) in the right, left and both legs respectively. 
 
The incidence of venous reflux did not differ by gender and was not associated with age 
either for individual vein segments or for the whole venous system.  It is interesting to 
note that age was a significant risk factor for the development of C2 varicose veins and 
C3-C6 CVI but not for the development of venous reflux.   
 
12.9 RISK FACTORS FOR C2 VARICOSE VEINS, C3-C6 CVI AND VENOUS REFLUX  
 
12.9.1 Body mass index 
In this study, increased body mass index was not associated with the incidence of C2 
varicose veins (p=0.43) or venous reflux ≥ 0.5 s duration (p>0.50).  However, it was a 
significant risk factor for the development of C3-C6 CVI (p trend<0.001).  Participants 
who were overweight at baseline were 1.3 (95% CI 1.1-1.6) times more likely to have 
C3-C6 CVI at follow up.  The risk in those who were obese was higher still at 4.5 (95% 
CI 3.3-6.9).  Our findings concur with the Bonn Vein Study II, where obese participants 
had a significantly higher risk of developing oedema and skin changes associated with 
CVI (Rabe 2010).  The Framingham Study found that obesity was significantly 
associated with increased incidence of varicose veins in women but not in men (Brand 
1988). Obesity has also been associated with the prevalence of CVI.  A case-control 
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study in New Zealand found that the prevalence of CVI was significantly higher in obese 
patients compared to non-obese, after adjusting for age, previous history of DVT, 
prevalence of deep venous reflux and other risk factors (van Rij 2008).  
 
Evidence on the association of obesity and the prevalence of C2 varices is conflicting.  
Several studies found an association between obesity and varicose veins while others 
did not.   Results indicate that obesity may be a significant risk factor in women only 
(Brand 1988, Iannuzzi 2002, Lee 2003,  Widmer  1978).  However, in the Basle 
(Widmer  1978) and Framingham (Brand 1988) studies, the associations were not 
significant after adjusting for age.  Furthermore, studies did not adjust for parity.  Given 
that parous women tend to have a higher body weight than nulliparous women, it is 
likely that this could act as a confounding factor in the association between obesity and 
the prevalence of C2 varices.   
 
It is unlikely that obesity could be a risk factor for one sex but not for the other.  
However, an important question is whether obesity is a primary risk factor for CVD or 
whether it just accelerates the development or severity of disease.  Abdominal 
pressures are increased in obese patients and it has been hypothesized that this could 
impede venous flow from the legs, thus causing reflux (Wall 2011).  This follow up 
study showed no significant association between obesity and the incidence of venous 
reflux ≥ 0.5 seconds duration.  However, the sample of participants who developed 
reflux was too small to draw any meaningful conclusions from.  Further evidence is 
required to clarify the effect of obesity on the development of C2 varicose veins, C3-C6 





12.9.2 Family history  
Results from this follow up study showed that family history of C2-C6 venous disease 
was a significant risk factor for the incidence of C2 varices (p=0.009).  After adjusting 
for age and sex, those with a family history in either first degree relative were 1.7 (95% 
CI 1.1-2.7) times more likely to develop C2 varices than those with no family history of 
CVD.  The association was significant for maternal (p=0.04) but not for paternal family 
history (p=0.20).  There is no known anatomical or genetic reason why maternal family 
history would increase the risk of developing varicose veins but paternal history would 
not.  One explanation for the lack of association on the paternal side is that participants 
may have been more aware of varicose veins in their mother than in their father.  In 
this study, paternal family history was reported approximately half as frequently as 
maternal family history.  Yet there was no significant difference in the prevalence of C2 
varices in men and women.  This suggests that the lack of a statistical association is not 
a true finding but rather a consequence of underreporting in this study. 
 
The only other study to examine the effect of family history on the incidence of CVD 
was the Tampere Study, where the odds ratio of developing varicose veins was 1.6 
(95% CI 1.1-2.3).  However, only 2.4% of the study sample was examined for C2 
varices.   Several cross-sectional studies have estimated the effect of family history on 
the prevalence of CVD but the magnitude of risk has varied widely (Carpentier 2004, 
Criqui 2003).  It has been postulated that genetics may have a role in the pathogenesis 
of C2 varices and C3-C6 CVI (Krysa 2012).  However, positive family history does not 
automatically mean a genetic cause.  The family often share the same environment and 




The design of this follow up study provided a unique opportunity to measure the effect 
of family history on CVD.  Only those who did not have C2 varicose veins at baseline 
were included in the incidence study.  Family history was elicited at baseline and 
therefore it was unaffected by the participant’s own varicose vein status during follow 
up.  Therefore the potential for recall bias was minimized.  However, it is important to 
acknowledge that family history was determined based on information obtained from 
study participants themselves, without consulting or examining relatives.  It is possible 
that patients with varicose veins were more likely to be aware of any relatives who also 
suffer from the condition.  Ideally, the evaluation of family history in the aetiology of 
CVD would involve studying a number of families of several generations, with family 
members examined at the same age.  However, such a methodology was not feasible in 
the present study. 
 
12.9.3 Medical history 
This follow up study measured the association between medical conditions including 
DVT, pulmonary embolism, phlebitis, hernia, haemorrhoids, swollen and fractured leg 
and the development of CVD and venous reflux.  However, none of these conditions 
were associated with the incidence of C2 varicose veins at follow up (all p>0.05).  
Inguinal hernia was the only medical condition identified as a significant risk factor in 
the development of C3-C6 CVI (p=0.01).  After adjusting for age and sex, participants 
with a history of hernia at baseline were over three times more likely to have C3-C6 CVI 





Deep vein thrombosis is an established contributing factor to the development of 
varicose veins.  The thrombus can either damage the valves directly thus causing reflux 
or it can impede the vein wall and cause it to dilate and become varicose (Ibrahim 
1996).  Phlebitis, or inflammation of the vein, often occurs after a DVT and is also 
associated with CVD (Meissner 2002).  It is interesting to note that in this study, both 
conditions were associated with an increased incidence of C2 varices (both p<0.05).  
However, after adjusting for age and sex, the associations were no longer significant.  
This could be explained by the small number of participants with a history of these 
conditions.  A larger subgroup with a history of DVT or phlebitis is required to estimate 
the true association with the incidence of varicose veins.  There has been little research 
linking inguinal hernia with CVI, yet it was a significant risk factor in this study.  Again, 
there were very few participants with a hernia at baseline and therefore the sample is 
too small to draw any meaningful conclusions.  
 
12.9.4 Pregnancy 
Results of this follow up indicated a trend where the incidence of C2 varices increased 
linearly with number of pregnancies.  Although not statistically significant (p=0.14) this 
could have been due to the small numbers in this study.  Only 62 of 332 women 
developed C2 varices during follow up.  Therefore the proportion of incident cases on 
whom to test the effect of parity was very small.  The Tampere Study was considerably 
larger than the Edinburgh Vein Study (n=2,854 women).  The estimated risk of 
developing varicose veins was 2-fold in women with 3 or more pregnancies compared 
to nulliparous women. However, as previously discussed, a major limitation of the 
Tampere Study was that venous status was based on self-diagnosis.  Nevertheless, 
despite this limitation, evidence from both the Edinburgh Vein Study and Tampere 
Study suggests that the incidence of varicose veins is higher in multiparous women. 
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Prevalence studies suggest that parity is a risk factor for varicose veins (Abramson 
1981,  Kakande  1981, Komsuoglu 1994, Novo 1988, Stvrtinova 1991,  Widmer  1978).  
The Basle Study demonstrated a significantly higher age-adjusted prevalence of trunk 
varices in parous women compared with nulliparous women (Widmer  1978). Evidence 
also points towards a positive relationship between prevalence and an increasing 
number of pregnancies (Beaglehole 1975, Hirai 1990, Laurikka 1993, Maffei 1986, 
Novo 1988,  Sadick  1992, Sisto 1995).   In the Tampere study, the prevalence of 
varicose veins in women with 0, 1, 2, 3 and 4 or more pregnancies were 32%, 38%, 
43%, 48% and 59% respectively (Laurikka 2002).  
 
There are several physiological changes during pregnancy which could contribute to 
the development of varicose veins.  Hormone levels, in particular oestrogen and 
progesterone, increase dramatically and evidence has shown that the varicose part of 
the saphenous vein contains more oestrogen and progesterone receptors (Masiah 
1999).  Secondly, blood flow and volume increase, which can lead to subsequent vein 
dilatation (Cordts 1996, Sparey 1999).  Results on the reversibility of pregnancy-
induced dilated veins are conflicting.  One study found that although the diameter of 
competent and incompetent GSV and SSV increased during pregnancy,  they decreased 
during the postpartum period to return to their baseline values (Boivin 2000).  A more 
recent study found that vein dilation is not fully resolved after delivery, suggesting that 
during pregnancy structural changes in the vein walls may be permanent and even 
deteriorate in subsequent pregnancies (Pemble 2007).  This could explain the 




12.9.5 Oral contraceptive use  
In this study, oral contraceptive use was not significantly associated with an increased 
incidence of CVD (P>0.05).  These results concur with the Tampere Study, which is the 
only other study to date to measure the effect of oral contraceptive use on the incidence 
of C2 varices (Laurikka 2002).  Interestingly, in both the Edinburgh Vein Study and 
Tampere Study, the incidence of C2 varicose veins was lower in women who had 
previously used oral contraceptives. Although age was a confounding factor in both 
studies, the lower incidence observed could also be explained by the fact that general 
practitioners may be less likely to prescribe oral contraceptives to women with C2 
varicosities due to the proven thrombotic risk associated with the contraceptive pill 
and the belief that this risk is increased in those with varicose veins.  This theory is 
supported by results from the EVS follow up, where, after adjusting for age, oral 
contraceptive use was twice as high in female participants free from varicosities than 
those with C2 varicose veins.  Widmer et al reported no difference in the prevalence of 
trunk varices in women aged 25-44 years when comparing oral contraceptive users 
(current or ex) with those who had never used contraceptives (Widmer  1978).  It must 
be noted that the Basle study was conducted in 1978, at which time the oral 








12.9.6 Hormone replacement therapy 
Follow up data suggested that the incidence of C2 varicose veins was higher in women 
who had been on HRT.  However this association diminished after adjusting for age as a 
confounding factor.  The Tampere Study also found that after accounting for age, HRT 
use did not increase the risk of developing varicose veins or CVI.  Few studies have 
examined the relationship between hormonal medication and the prevalence of CVD.  
 
12.9.7 Mobility at work 
Mobility at work was not a significant risk factor for the incidence of C2 varicosities, C3-
C6 CVI nor venous reflux ≥ 0.5 seconds duration in this study.  Evidence on the effect of 
mobility at work on prevalence of CVD is conflicting.  Some studies reported that 
participants who stood for prolonged periods of time were at increased risk of varicose 
veins (Abramson 1981, Brand 1988,  Kakande  1981, Lee 2003, Pinto 1995,  Sadick  
1992, Sisto 1995) while other studies found no evidence (Maffei 1986, Scott 1995, 
Stvrtinova 1991).  Results should be interpreted with caution given the difficulty in 
ascertaining participants’ work place posture, particularly over many year of work.  
Although standing may be an aggravating factor for varicose veins, it is unlikely to be a 
primary cause.  There is no evidence that Africans, for example, stand for less time than 
Europeans, yet the prevalence of CVD in the former is considerably less than in the 









Smoking was not a risk factor for developing C2 varicose veins, C3-C6 CVI or venous 
reflux in this study.  The Tampere Study showed that smoking did not increase the 
incidence of varicose veins (OR 1.3, 95% CI 0.9-1.8).   However, a significant association 
was found in those who reported smoking at least 15 cigarettes per day (OR 1.8, 95% 
CI 1.1-2.8).  As mentioned previously, the results of this study should be interpreted 
with caution because the accuracy of the diagnosis of varicose veins is questionable 
given that venous disease was based on self-diagnosis. 
 
Smoking is one of the most common risk factors measured in prevalence studies but 
none have found any significant association (Brand 1988, Kröeger 2004, Lee 2003, 
Scott 1995, Sisto 1995).  A case control study in France reported a dose-effect relation 
of tobacco smoking on CVI, with an adjusted odds ratio of 1.4 (95% CI 0.9-2.2) for 10-
19 cigarettes per day to 2.1 (95% CI 1.4-3.2) for ≥ 20 cigarettes per day in men and 
from 1.8 (95% CI 1.3-2.3) to 2.4 (95% CI 1.7-3.4) in women, respectively compared to 
non-smokers (Gourgou 2002).  There are obvious issues in measuring smoking habits.  
Recall bias, particularly when measuring cigarette packets smoked over a lifetime, is 
common.  Furthermore, legislation prohibiting smoking in public places has led to the 
widespread belief that it is a socially unacceptable behaviour.  Therefore there is a 






12.10 PUBLIC HEALTH IMPLICATIONS OF THE EDINBURGH VEIN STUDY 
 
The Edinburgh Vein Follow Up Study has estimated that approximately 1.4% of the 
general population will develop C2 varicose veins every year.  In Edinburgh, which has 
a population of approximately half a million people, this equates to 7,000 new cases of 
varicose veins a year.  While the majority of new C2 varices are mild, over time they 
may progress to more severe conditions of CVI.  Venous ulceration is a chronic 
condition which places major demands on nursing service and incurs a large cost to the 
NHS.  The question must be asked if it is worth operating on varicose veins to prevent 
more severe complications.  There are four important issues to consider when making 
this assessment: health service utilisation and provision, and the effectiveness and cost-
effectiveness of treatment.   
 
12.10.1 Health service utilisation 
The Edinburgh Vein Follow Up Study determined that varicose veins affect 
approximately 40% of the population and that the prevalence increases with age.  If 
this proportion of patients presented for treatment then the demand on the NHS, in 
terms of primary care appointments and surgical workload, would be huge.  However 
not all patients with varicose veins seek treatment.  In the EVS questionnaire 
administered at follow up, only 20% of participants reported that they had consulted a 
doctor about their varicose veins.  Yet twice this proportion of participants was found 
to have C2 varices upon examination.  The appearance of the leg is one of the most 
common reasons to seek treatment (Bradbury 1999).  Cosmetic motives may account 
for the higher GP consultation rates for women than for men (Simpson 2004).  
Furthermore, women are more likely to have had treatment for varicose veins than 
men (53% and 29% respectively) (Sisto 1995).   
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12.10.2 Health service provision  
The prevalence of C2 varicose veins has logistic implications for the provision of 
services for assessment and treatment.   Assessment and diagnosis of C2 varices or C3-
C6 CVI is made based on the signs observed by the GP and the symptoms reported by 
the patient.  However, a patient diagnosed with C2 varicose veins is not necessarily 
referred for further assessment with a vascular surgeon.  NICE published guidelines for 
appropriate referral from general practice to specialist services for varicose veins, and 
advised that patients with varicose veins should only be referred if troublesome 
symptoms were severely impacting quality of life (National Institute for Clinical 
Excellence 2001).   Other factors which influence referral for further assessment 
include patient preference, risk of complications, policies of local health care providers 
and waiting lists for treatment (Simpson 2004).   
 
Varicose veins incur long waiting lists for assessment and treatment.  A survey of 
members of the Vascular Surgical Society of Great Britain and Ireland, reported that the 
median waiting time to be seen in a vascular clinic was 12 weeks (Lees 1999).   The 
mean waiting time for surgery in NHS England (2002-3) was approximately 216 days, 
(Michaels 2006).  Waiting lists remain long despite the rapid growth of varicose vein 
day surgery in recent years and the subsequent decrease in length of stay for these 
patients (Simpson 2004).  Varicose veins are generally perceived as low priority.  A 
study which rated waiting lists by expected level of benefit to the patient ranked 






Private health care is an option for patients who can afford it.  For patients seeking 
treatment for cosmetic reasons, this may be the only option due to NHS restrictions on 
surgery for cosmetic complaints.  Many private hospitals offer non-surgical removal of 
varicose veins.  Approved by NICE, laser treatment is an attractive treatment option as 
it requires only a local anaesthetic, can be performed as a day case without hospital 
admission and evidence has shown that it has a faster recovery time than conventional 
surgery (Eberhardt 2005) 
 
The number of varicose veins operations performed in Scotland has decreased.  
According to the Information Services Division (ISD), 4,435 varicose vein operations 
were performed throughout hospitals in Scotland in 2006/2007.  By 2010/2011 the 
figure was 3,574, equivalent to a decrease of 19.4% over 4 years.   Several factors could 
account for this decrease.  Firstly, as the NICE guidelines only recommend referring 
those with severe varicose veins, NHS health boards now request a higher threshold of 
clinical severity before surgery is considered.  Secondly, varicose vein operations are 
rarely urgent and may therefore tend to be cancelled due to lack of time or scarce 
resources.   Thirdly the introduction of laser treatment particularly in private health 
care may result in fewer patients seeking NHS treatment.   It is vital that health 
authorities determine the adequate level of treatment which should be provided in 








12.10.3 Effectiveness of treatment 
Treatment of varicose veins is intended to prevent complications such as CVI and 
venous ulceration and to relieve symptoms.  However, there is no national consensus as 
to which varicose veins should be treated based on site of incompetence or severity.  
Additionally there is no strict guideline as to which treatment should be offered.  Many 
studies have examined the effectiveness of different treatment for varicose veins and it 
is out with the scope of this thesis to examine this.  A key question in measuring the 
effectiveness of treatments is can they prevent progression to venous ulceration.  Long-
term epidemiological and clinical studies are required to demonstrate the benefits of 
surgery over new treatments such as laser therapy and radiofrequency ablation.   
 
12.10.4 Cost-effectiveness 
The cost effectiveness of varicose treatment was assessed within a randomised clinical 
trial (REACTIV trial).  Economic analysis determined that standard surgical treatment 
of varicose veins by ligation and stripping is a cost effective treatment for varicose 
veins, with an ICER well below the threshold normally considered appropriate for 
funding of treatments within the NHS.   
 
12.11 THE FUTURE 
Varicose veins are an important problem and in an ageing population, the incidence 
and prevalence is likely to rise.  It is important to identify patients at risk of progressing 
so that proven effective and cost-effectives treatment can be applied to halt 
deterioration to more serious disease.  The Edinburgh Vein Follow Up Study has also 
examined the progression of CVD.  Results could aid the design of a clinical decision 
tool which may assist clinicians in deciding who should be offered treatment.    
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Chronic venous disease (CVD) is a term covering the spectrum of disease ranging from 
C2 varicose veins to C3-C6 chronic venous insufficiency (CVI).  The Edinburgh Study 
was a population based cohort in which the baseline sample underwent a 13 year 
follow up examination to measure the prevalence and incidence of CVD, venous reflux 
and risk factors associated with these conditions. The following conclusions can be 
drawn from the study: 
 
13.1.1 Prevalence of chronic venous disease  
 The prevalence of C2 varicose veins increased from baseline to follow up. 
o The number of cases of mild C2 varicose veins decreased from 30.8% 
(95% CI 27.8-33.9) at baseline to 21.8% (95% CI 19.2-24.7) at  follow 
up (p<0.001), possibly due to observer error.   
o The number of moderate cases of C2 varices increased from 5.8% (95% 
CI 4.4-7.5) at baseline to 11.1% (95% CI 9.2-13.4) at follow up, while the 
number of severe C2 varices increased from 0.3% (95% CI 0.1-1.0) at 
baseline to 6.3% (95% CI 4.8-8.1) at follow up (both p<0.001), 
suggesting deterioration in C2 varices during the 13-year follow up. 
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 The prevalence of C2 varicose veins increased with age from 14.3% (95% CI 
4.0-40.0) in those aged 25-34 years to 50.6 (95% CI 45.3-55.9) in those aged 
over 65 years (p<0.001). 
 The prevalence of C2 varicose veins was similar in men (40.0%, 95% CI 35.3-
44.5) and women (38.6%, 95% CI 34.4-42.9) (p=0.67). 
 C2 varicose veins affected the right (29.6%, 95% CI 26.7-32.8) and left (28.7%, 
95% CI 25.9-31.8) legs in equal proportions (p=0.57). 
 C2 varicose veins were not associated with social class (p=0.79). 
 C1 telangiectases were significantly more common in women (90.2%, 95% CI 
87.3-92.5) than in men (79.0%, 95% CI 74.7-82.7) (p<0.001).   
o Mild C1 telangiectases were more common in men (65.9%, 95% CI 91.1-
70.4) than in women (62.2%, 95% CI 57.9-66.4) (p=0.001). 
o Moderate C1 telangiectases were more common in women (23.3%, 95% 
CI 19.7-27.2) than in men (11.0%, 95% CI 8.3-14.5) (p<0.001).  Severe 
C1 telangiectases were also more prevalent in women (4.7%, 95% CI 
3.2-6.9) than in men (2.1%, 1.0-4.0) (p<0.001).  
 The prevalence of C3-C6 CVI increased from baseline to follow up  (p<0.001)  
o The most common form of CVI was C3 corona phlebectatica (16.7%, 
95% CI 14.4-19.3). 
 The prevalence of C3-C6 CVI increased with age, from 7.1% (95% CI 1.3-31.5) 
in those aged 25-34 years to 32.6% (95% CI 27.9-37.8) in those aged over 65 
years (p<0.001). 
 The prevalence of C3-C6 CVI did not differ by gender (p=0.18) nor social class 
(p=0.79)._ 
 Clinical signs of C3-C6 CVI affected the left leg (17.6%, 95% CI 15.2-20.3) more 
often than the right leg (16.7%, 95% CI 14.4-19.3) (p<0.001). 
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13.1.2 Incidence of C2 varicose veins and C3-C6 chronic venous insufficiency 
 The 13 year incidence of C2 varicose veins was 18.2% (95% CI 15.2-21.6).   
o Approximately 1.4% (95% CI 1.1-1.7) of the study sample developed 
new C2 varicose veins each year.  
o The majority (87%) of new C2 varices were classified as mild. 
 The incidence of C2 varices increased with age in women (p<0.001) but not in 
men (p=0.23) 
 The incidence of C2 varicose veins was similar in men (10.7%, 95% CI 7.2-15.5) 
and women (8.1%, 95% CI 5.7-11.6) (p=0.32). 
 The incidence of C2 varicose veins was similar in the right (11.9%, 95% CI 9.5-
14.9) and left leg (11.7%, 95% CI 9.3-14.7) (p=0.52). 
 Social class had no significant effect in the development of C2 varices (p=0.95). 
 The 13 year incidence of C3-C6 CVI was 9.2% (95% CI 7.0-11.9). 
o Annual incidence rate of 0.7% (95% CI 0.5-0.9). 
o Majority of new cases of CVI were C3 corona phlebectatica (5.3%, 95% 
CI 3.7-7.5). 
o Only 0.5% (95% CI 0.2-1.6) of study participants developed a C5 or C6 
venous ulcer during the 13 year follow up. 
 The incidence of C3-C6 CVI increased with age in men and women (p<0.001) 




13.1.3 Prevalence and incidence of venous reflux ≥ 0.5 seconds duration 
 The prevalence of venous reflux ≥ 0.5 seconds duration at follow up was 23.8% 
(95% CI 20.7-27.3), 6.5% (95% CI 4.9-8.3) and 11.0% (95% CI 9.0-13.5) in the 
superficial, deep and combined systems.   
o Reflux was most common in the great saphenous vein (21.6%, 95% CI 
18.7-24.9). 
o Superficial reflux was more common in women (28.15, 95% CI 23.6-
33.3) than in men (18.4%, 95% CI 14.4-23.1) (p<0.001). 
o The prevalence of superficial reflux increased with age (p<0.001). 
 The incidence of venous reflux was 2.6% (95% CI 1.2-4.9), 8.8% (95% CI 5.9-
12.7) and 1.3% (95% CI 0.4-3.2) in the deep, superficial and combined venous 
systems respectively. 
o Age was not associated with the incidence of reflux (p>0.05). 
o New cases of venous reflux affected men (10.7, 95% CI 6.1-17.5) and 
women (14.2%, 95% CI 9.5-20.8) equally (p=0.45). 
 
13.1.4 Prevalence of venous reflux and incidence of C2-C6 CVD 
 The risk of developing C2 varicose veins was lowest in those with no reflux and 
increased linearly in those with deep (OR 1.1, 95% CI 0.5-2.4), superficial (OR 
2.6, 95% CI 1.2-6.0) and combined (OR 4.0, 95% CI 1.3-17.3) reflux respectively. 
 Venous reflux was not associated with the incidence of C3-C6 CVI (OR 1.9, 95% 




13.2.4 Risk factors for the incidence of C2-C6 CVD 
 There was no association between BMI and C2 varicose veins (p=0.43) but 
obese patients were over 4 times more likely to develop C3-C6 CVI (OR 4.5, 
95% CI 3.3-6.9). 
 Pregnancy appeared to increase the risk of developing C2 varicose veins 
(p=0.14) but was not associated with C3-C6 CVI (p=0.42). 
 Family history of venous disease increased the likelihood of developing C2 
varices (OR 1.7, 95% CI 1.1-2.7) but was not a risk factor for C3-C6 CVI (OR 1.3, 
95% CI 0.7-2.5). 
 
13.3 RECOMMENDATIONS FOR FUTURE RESEARCH 
 
 Further research, based on a larger sample size, is required to clarify the risk 
factors for incidence of C2 varicose veins and C3-C6 CVI.  This could be achieved 
by combining all population studies on venous disease in a meta-analysis.  The 
quality of each study and the sample size would be taken into account and 
weighted accordingly.  The overall estimate of effect would identify the most 
important risk factors associated with the development of C2 varices and C3-C6 
CVI, and may inform measures to permit disease progression 
 
 The role of venous reflux ≥ 0.5 seconds duration in the development of C2 
varicose veins and C3-C6 CVI remains unclear due to the small numbers in this 
study.  Further large scale cohort studies where the sample is followed up over 
a long period of time are required to clarify the association between venous 
reflux and the aetiology of C2 varices and C3-C6 CVI. 
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 Further studies are required to determine the extent to which venous reflux ≥ 
0.5 seconds duration is a predictor of C2 varicose vein and C3-C6 CVI 
progression.  The Edinburgh Vein Follow Up Study has examined this 
relationship.  Results will be used to design a clinical scoring tool to help 
clinicians in deciding who would benefit most from treatment to slow or halt 
disease progression. 
 
 Further work is required on the correlation between symptoms, quality of life 
and venous disease.  The questionnaire at both the baseline and follow up 
stages of the study enquired about symptoms of venous disease, while quality 
of life was measured in follow up participants only.  Analysis of this data is 
already planned for this study population and will help to measure the quality 
of life in patients with chronic venous disease and identify those whose 
symptoms may be relieved by treatment. 
 
 Family and genetic studies are required to determine the extent to which 
venous disease is an inherited or an acquired condition.  Blood samples from all 
baseline EVS participants are stored and awaiting genetic analysis. 
 
 Future studies are required in order to clarify the cut-off point at which 
duration of reflux becomes clinically significant in different specific vein 
segments. This will help the interpretation of results not only in clinical 
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BASLE CLASSIFICATION OF VENOUS DISEASE  
 
AUTHOR CLASS DEFINITION 
Widmer 1978 1* Hyphenweb: intradermal venectasis 
 2* 
Reticular varices: dilated tortuous veins, not belonging to the main trunk or its major 
branches 
 3* 
Trunk varices: dilated, tortuous trunks of the long or short saphenous vein and their 
branches of the first or second order 
  
Chronic venous insufficiency: 
Categorised into grades I, II and II according to the presence of dilated subcutaneous veins, 
skin changes and ulceration. 
 




















The CEAP is based on clinical signs (C), etiology (E), anatomic distribution of disease (A) and 
underlying pathophysiologic findings (P).   
 
CLASS    CLINCAL SIGNS 
C0    No visible or palpable signs of venous disease. 
C1    Telangiectases or reticular veins. 
C2    Varicose veins (diameter of 3mm or more). 
C3 Oedema or corona 
C4a Skin changes (pigmentation, venous eczema)   
C4b Skin changes (lipodermatosclerosis, atrophie blanche) 
C5 Skin changes as defined above with healed ulceration 





C1 Telangiectases: Permanently dilated intradermal venules less than 1mm in 
size (also called spider veins and thread veins). 
C1 Reticular veins: Permanently dilated bluish subdermal vein, usually 1mm to 
less than 3mm in diameter.   
C2 Varicose veins: Subcutaneous dilated vein 3mm in diameter or larger, 
measured in upright position.   
C3 Corona: Fan-shaped pattern of numerous small intradermal veins 
on the medial or lateral aspects of the ankle and foot.   
C3 Oedema: Perceptible increase in volume of fluid in subcutaneous 
tissue characterised by indentation with pressure, usually 
occurring in the ankle region. 
C4a Pigmentation: Brownish darkening of the skin.  Usually occurs in the ankle 
region but may extend to the leg and the foot.  An early 
skin change. 
C4a Eczema: Dermatitis which may progress to blistering, weeping or 
scaling eruption of the skin of the leg.  Often located near 
varicose veins but may be located anywhere in the leg.   
Usually caused by chronic venous insufficiency. 
C4b Lipodermatosclerosis: Localised chronic inflammation of the skin and 
subcutaneous tissue, sometimes associated with scarring.  
Acute inflammation and tenderness.  Sign of severe venous 
disease. 
C4b Atrophie blanche: Localised, often circular whitish and atrophic skin areas 
surrounded by dilated capillary spots.  Sign of severe CVD, 
and not to be confused with healed ulcer scars.  Scars of 
healed ulceration may also exhibit atrophic skin with 
pigmentary changes, but are distinguishable by history of 
ulceration. 
C5 + C6 Ulcer Full thickness chronic defect of skin, most frequently in 











VENOUS CLINICAL SEVERITY SCORE (VCSS) 
ATTRIBUTE ABSENT = 0 MILD = 1 MODERATE =2 SEVERE = 3 
Pain None Occasional, not restricting 
activity or requiring 
analgesics 
Daily, moderate activity 
limitation, occasional analgesics 
Daily, severe limiting activities 
or requiring regular use of 
analgesics 
Varicose veins a None Few, scattered, isolated 
branch VVs 
Multiple: single segment GS or 
LS distribution involving calf 
only 
Extensive: multi segmental GS 
and LS distribution, involving 
calf and thigh 
Venous oedema b None Evening ankle oedema only Afternoon oedema, above ankle Morning oedema above ankle 
requiring activity change 
Skin pigmentation c None or focal, low 
intensity (tan) 
Diffuse, but limited tin area 
and old (brown) 
Diffuse over most of gaiter 
distribution (lower 1/3) or 
recent pigmentation (purple) 
Wider distribution (above 
lower 1/3) and recent 
pigmentation 
Inflammation None Mild cellulitis, limited to 
marginal area around ulcer 
Moderate cellulitis, involves 
most of gaiter area (lower 1/3) 
Severe cellulitis (lower 1/3 and 
above) or significant venous 
eczema 
Induration None Focal, circum-malleolar ( ≤5 
cm) 
Medial or lateral, less than 
lower third of leg 
Entire lower third of leg or 
more 
No. of active ulcers 0 1 2 ≥ 2 
Active ulceration, 
duration 
None < 3 months >3 months, < 1 years Not healed > 1 year 
Active ulcers, size d None < 2 cm diameter 2-6 cm diameter > 6 cm diameter 
Compressive therapy e Not used or not 
compliant 
Intermittent use of stockings Wears elastic stockings most 
days 
Full compliance: stockings + 
elevation 
a “Varicose” veins must be > 4 mm diameter so that differentiation is between C1 and C2 venous pathology.   
b Presumes venous origin by characteristics eg, Brawny (not pitting or spongy) oedema, with significant effect of standing/limb elevation and/or other clinical evidence of venous aetiology, ie, varicose veins.  
Oedema must be regular finding, eg, daily occurrence.  Occasional or mild oedema does not qualify 
c Focal pigmentation over varicose veins does not qualify 





VENOUS SEGMENTAL DISEAESE SCORE (VSDS) 
 REFLUX  OBSTRUCTION † 
½ Lesser saphenous  ‡ 
1 Greater saphenous 1 Greater saphenous (only if thrombosed or previously excised in 
association with superficial femoral-popliteal occlusion) 
½ Perforators, thigh  ‡ 
1 Perforators, calf  ‡ 
2 Calf veins, multiple (PT alone = 1) 1 Calf veins, multiple 
2 Popliteal vein 2 Popliteal vein 
1 Superficial femoral vein 1 Superficial femoral vein 
1 Profunda femoris vein 1 Profunda femoris vein 
1 Common femoral vein 2 Common femoral vein 
  1 Iliac vein 
  1 Inferior vena cava 
10 Maximum reflux score § 10 Maximum obstruction score § 
 
As determined by appropriate venous imaging (phlebography or Duplex scan) 
† The excision, ligation, or traumatic obstruction of deep venous segments counts toward obstruction points just as much as their thrombosis 
‡ Normally there are no valves above the CFV so no reflux points are assigned to them.  In addition, perforator interruption and saphenous ligation/excision (with the single exception noted) do not count in 
the obstruction score, but as a reduction of the reflux score 
§ Not all of the 11 segments can be involves in reflux or obstruction.  10 is the maximum score which can be assigned, and this might be achieved by complete reflux at all segmental level 





VENOUS DISABILITY SCORE (VDS) 
0 asymptomatic 
1 Asymptomatic but able to carry out usual activities* without compressive therapy 
2 Can carry out usual activities* only with compression and/or limb elevation 
3 Unable to carry out usual activities* even with compression and/or limb elevation 
 
*Usual activities = patient activities before onset of disability from venous disease 



























Research project:  Edinburgh Vein Study  
 
In 1994-1996 you very kindly participated in our research study and had a clinical 
examination of your legs in the University of Edinburgh.  We are writing to invite you to 
take part in a follow-up study to try and find out more about the on-going state of health of 
veins in the legs as people get older. 
 
The first stage of the study in which you took part was extremely successful resulting in 
worldwide interest in our findings on the causes of diseases affecting veins in the leg.  
Enclosed is a copy of the newsletter with the main results from the first stage.  This follow 
up study will also provide new and important information which will lead to a greater 
understanding of how we can prevent venous diseases and their serious complications in 
the future. 
 
Taking part in the study will require you to attend an appointment on one occasion to have 
an examination of the veins in your legs.  These tests are painless and do not involve any 
foreseeable risk.  Appointments will be held at the Wellcome Trust Clinical Research Facility 
at the Western General Hospital, Edinburgh.  More detailed information is given in the 
accompanying patient information sheet.   
 
We are able to arrange an appointment at a time convenient for you.  We can reimburse 
travel and accommodation expenses from within the UK and, if appropriate, provide 
assistance in seeking and taking time off work.  We will also advise your General 
Practitioner of any clinically significant information that comes to light. 
 
We very much hope you will accept our invitation to take part in this research and would be 
grateful if you would return the enclosed reply slip in the pre-paid envelope.  We will then 
contact you at a later date to arrange an appointment. 
 
If you would like any further information, please do not hesitate to contact the study co-



















EDINBURGH VEIN STUDY 




Title of study: Lifestyle and clinical factors determining progression of venous disease in 
the legs: Edinburgh Vein Study. 
 
In 1994-1996 you very kindly participated in the Edinburgh Vein Study and had a clinical 
examination of your legs in the University of Edinburgh.  You are being invited to take part 
in a follow-up study.  Before you decide it is important for you to understand why the 
research is being done and what it will involve.  Please take time to read the following 
information carefully and talk to others about the study if you wish.  Ask us if there is 
anything that is unclear or if you would like more information.   
 
What is the purpose of the study? 
 
Diseases of veins in the legs are very common affecting about one third of the adult 
population.  We know very little about how and why people develop varicose veins over 
time and why some patients develop serious complications such as a leg ulcer.  This study 
will address these questions and the results will help us lead to the development of 
measures to prevent this condition and its complications in the future. 
 
Why have I been chosen? 
 
You were one of the 1566 original participants in the Edinburgh Vein Study.  We would like 
to examine you again as part of the follow-up study to review your condition.  Since this is a 
follow up study, we would like to examine everyone who participated originally.  It is 
equally important for us to examine you whether or not you have had varicose veins. 
 
Do I have to take part? 
 
Taking part is entirely your own decision.  If you decide to take part, you will be given this 
information sheet to keep and will be asked to sign a consent form when you attend for 
your examination.  At any time during the examination, you are free to withdraw without 
having to give a reason.  A decision to withdraw at any time, or a decision not to take part, 







What will happen to me if I take part? 
 
You will be invited to attend the Wellcome Trust Clinical Research Facility at the Western 
General Hospital, Edinburgh on one occasion only for a detailed examination of the veins in 
your legs.  The tests are painless and do not involve any risk.  No injections or blood tests 
are carried out.    
 
You will have an ultrasound scan of your legs so that we can see the blood flowing in your 
veins.  The scan is performed while you are in a standing position, but resting against a bed 
which is tilted at an angle.  Gel needs to be applied to the skin of your leg.  This may feel 
cold and sticky but not unpleasant.  Your calf and thigh muscles will be squeezed gently to 
see in which direction the blood is flowing.  The scan is not painful but does require you to 
be still for a short period of time.  If you feel tired at any time, you can rest and restart 
when you feel ready.  
 
We will examine your legs and take three colour photographs of them to look for any 
varicose veins.  You will also have your height and weight measured and asked to fill in a 
questionnaire about your past medical history, smoking and exercise etc.  If you are unsure 
of any of the questions, you can discuss this with the research staff at your appointment at 
the clinic.  The appointment should take around one hour.  Refreshments will be served 
during your visit. 
 
What do I have to do? 
 
There are no special arrangements for the examination.  You would simply have to attend 
an appointment at the Wellcome Trust Clinical Research Facility at the Western General 
Hospital, Edinburgh.  Ideally you should wear loose or easily removable clothing below the 
waist.  We shall pay any travel and accommodation expenses which you incur. 
 
What are the possible disadvantages and risks of taking part? 
 
There are no foreseeable risks in taking part in this study.  You will be required to stay 
reasonably still for about half an hour during the scan but you will be free to move around 
at any time if you feel the need. 
 
What are the possible benefits of taking part? 
 
There are no direct benefits to you in taking part as the investigations are unlikely to affect 
any treatment you are having.  The research should hopefully benefit others in the future 







Will my taking part in the study be kept confidential? 
 
Yes.  All information which is collected about you during the course of the research will be 
kept strictly confidential and will only be available to the principal researchers.  The 
information is essentially of a technical nature understood by specialists.  Your General 
Practitioner will be informed of any clinically significant results. 
 
What will happen to the results of the research study? 
 
The results of the study will not be able to identify any individual patient.  The results will 
be published in medical scientific journals and a report sent to the Scottish Executive.  We 
shall send you a newsletter describing the results in due course. 
 
Who is organising and funding the research? 
 
The study is being organised by the Wolfson Unit for Prevention of Peripheral Vascular 
Diseases in the University of Edinburgh.  The study is being funded by the Chief Scientist 
Office in the Scottish Executive. 
 
Who has reviewed this study? 
 
This study has been reviewed and approved by independent referees approved by the Chief 
Scientist Office and by the Lothian Health Research Ethics Committee. 
 
Contact for further information 
 
Miss Lindsay Robertson 
Wolfson Unit for Prevention of Peripheral Vascular Diseases 
Public Health Sciences 




Tel: 0131 650 4555 
E-mail: Lindsay.Robertson@ed.ac.uk 
 
We hope that you will agree to take part in this study and if so, you will be given a copy of 


















EDINBURGH VEIN STUDY 
MAIN RESULTS 
 
 Varicose veins occur in around one third of men and women aged 18-64 years. 
 Small ‘spidery’ varicose veins occur in over 80% of the population. 
 The presence of varicose veins increases with age and occurs equally in all 
socioeconomic groups. 
 Varicose veins, especially mild ones, are slightly more common in men than in 
women.  Earlier studies suggested that men were not affected so much, but 
perhaps changes in lifestyle are increasing the risk for men. 
 Individuals with varicose veins are more likely to have disturbances in blood flow in 
their leg. 
 In men, these disturbances in flow are more likely to affect the deep veins in the 
leg, while in women the veins nearer the surface are more likely to be affected. 
 Individuals with varicose veins are only slightly more likely to experience symptoms 
in their legs, such as heaviness, aching and itching than people without varicose 
veins. 
 The occurrence of varicose veins in women is not strongly related to number of 
previous pregnancies. 
 There is no strong link between the amount of fibre consumed in the diet, different 
bowel habits and risk of developing varicose veins. 
 The risk of having varicose veins is related to some underlying differences in certain  
 factors involved in blood clotting 
 
These results are important in helping us to build up a picture of the frequency of 
varicose veins in the population and in understanding why they occur.  However, 
more research is still required.  The follow-up study we are conducting will help 
us to understand why people develop varicose veins and identify steps to try and 
















EDINBURGH VEIN STUDY 
 










I would like to take part in the Edinburgh Vein Study follow-up:    Please tick one box 
 Yes    No 
    
If you would like more information first: 
 
Please contact: 
Miss Lindsay Robertson 
Wolfson Unit for Prevention of Peripheral Vascular Disease 
Public Health Sciences 















































Research project:  Edinburgh Vein Study  
 
Further to our recent telephone conversation, I am writing to confirm that your 
appointment for the Edinburgh Vein Study has been arranged for (insert date) at the 
Wellcome Trust Clinical Research facility, Western General Hospital, Edinburgh. I have 
enclosed a map to help you find your way to the clinic. The examination will take 
approximately one hour fifteen minutes. Please note that you may withdraw at any point 
during the examination if you wish so. I shall be pleased to reimburse any travelling 
expenses that you incur. 
 
I also enclose a study questionnaire and would be grateful if you could complete as much of 
it as you can and take it with you to the appointment. If you have difficulty in answering any 
of the questions, you can discuss them with the study nurses at the clinic.  
 
If this appointment becomes unsuitable for any reason, please telephone a member of the 











Miss Lindsay Robertson   































             
 Study no: ………… 
 






The information you give in this questionnaire will be treated as strictly confidential and 
will only be seen by the study team The results of the research will appear only in the form 
of general statistics from which it will be impossible to identify you as an individual. 
 
 
Please complete the following: 
 
 








Please complete this questionnaire and bring it along with you to your appointment. 
 
 
If you have difficulty in answering any of the questions you will have a chance to discuss 


















1. Please tick one                                          Male                       Female   
 
 
                                                                                   Day           Month         Year 
             









3. In general, would you say your health is: (Please tick one box) 
 
Excellent      Fair   
 
 Very good      Poor   
      
 Good 
 
           
  
 
4. Compared to one year ago, how would you rate your health in general now? 
(Please tick one box) 
 
Much better than one year ago 
Somewhat better than one year ago 
About the same as one year ago 
Somewhat worse than one year ago 
Much worse than one year ago 
 
  





Study no: ………… 
 
 
5. The following questions are about activities you might do during a typical day.  
Does your health now limit you in these activities?  If so, how much?  
 
           (Please tick one box for each statement) 
 
    
         Yes, 
limited  
      a lot 
 
       Yes,   
limited 
   a little 
       Not 
limited      
    at all 
5a. Vigorous activities, such as running, lifting  




     
5b. Moderate activities, such as moving  a table, 
       pushing a vacuum cleaner, bowling, or       
       playing golf 
   
    
5c. Lifting or carrying groceries 
   
     
5d. Climbing several flights of stairs 
   
     
5e. Climbing one flight of stairs 
   
 
5f.  Bending, kneeling, or stooping 
   
 
5g. Walking more than a mile 
   
 
5h. Walking several hundred yards 
   
 
5i.  Walking 100 yards 
   
 
5j.  Bathing or dressing yourself 










 Study no: ………… 
 
 
6. During the past 4 weeks, have you had any of the following problems with your work 
or other regular daily activities as a result of your physical health?   
 
              (Please tick one box for each statement) 
 
    Yes        No 
6  6a.    Cut down on the amount of time you spent on work or other   
7           activities 
8  
  
6b.    Accomplished less than you would like   
 
6c.    Were limited in the kind of work or other activities 
  
 
6d.    Had difficulty performing the work or other activities    




7. During the past 4 weeks, have you had any of the following problems with your work 
or other regular daily activities as a result of any emotion problems (e.g. feeling 
depressed or anxious)?  
 
      (Please tick one box for each statement) 
 
 YYes               No 
        7a. Cut down on the amount of time you spent on work or other      




    
        7b. Accomplished less than you would like 
  
    




8. During the past 4 weeks, to what extent has your physical or emotional problems 
interfered with your normal social activities with family, friends, neighbours or 
groups?                     
           (Please tick one box) 
 
 
Not at all       Quite a bit 
 
Slightly        Extremely 
 






         Study no: ………… 
 
 




 None       Moderate 
  
Very mild      Severe 
 
               Mild      Very severe 
 
 
10.     During the past 4 weeks, how much did pain interfere with your normal work        
           (including both work outside the home and housework)? (Please tick one box) 
 
 
Not at all       Quite a bit 
 





11.    These questions are about how you feel and how things have been with you during           
         the past 4 weeks.  Please give the one answer that is closest to the way you have  
          been feeling for each item. 
 
(Please tick one box for each statement) 
   
 
All  of 
the      
 time 
 Most of        
  the 
time 
A   good 
bit  of 
the time 
 Some of 
     the 
    time 
A little 
of          
the time 
None of                   
    the  
    time 
    11a. Did you feel full     
             of life? 
      
    11b. Have you been   
             a very nervous  
             person? 
      
    11c. Have you felt     
             so down in the  
             dumps that  
             nothing could  
             cheer you up? 









11d. Have you felt   
          calm and  
         peaceful? 
 
All  of 
the      
 time 
  
Most of        
  the 
time 
 
A   good 




     the 
    time 
 
A little 
of          
the time 
 
None of                   
    the  
    time 
11e. Did you have a     
         lot of energy?                  
 
 
     
11f. Have you felt  
        downhearted      
        and blue? 
 
 
     
11g. Did you feel worn  
         out? 
        
11h. Have you been a  
         happy person? 
      
 11i. Did you feel  
         tired? 




12. During the past 4 weeks, how much of the time has your physical health or emotional 
problems interfered with your social activities (like visiting friends, relatives etc.)  
(Please tick one box) 
 
         
All of the time      A little of the time  
            
Most of the time      None of the time 
         









13. How TRUE or FALSE is each of the following statements for you? 
 
(Please tick one box for each statement) 
 
 
           
Definitely     
   true 
         
Mostly  
      true 
        
  Don’t  
  know 
    
 Mostly           
  false 
     
Definitely         
     false 
       13a.  I seem to get sick  
                a little easier than  
                other people 
        
  
       13b. I am as healthy     
               as anybody I know 
     
  
       13c. I expect my  
                health to get  
               worse 
       
     
      13d. My health is  
               excellent 







14. During the past 4 weeks, how often have you had any of the following leg 
problems? 
 
 (Please tick one box for each statement) 
  
           
Every 
day 
       
Several         
times a   
 week 
        
About 
 once a     
 week             
         
Less than 
once a      
week 
      
 Never 
     
        14a. Heavy legs 
     
 
        14b. Aching legs 
     
       
        14c. Swelling 
     
     
        14d. Night cramps 
     
    
        14e. Heat or burning  
                 sensation 





     
 
 
         
         14f. Restless legs 
        
Every 
day 
       
Several         
times a   
 week 
        
About 
 once a     
 week             
         
Less than 
once a      
week 
      
 Never 
 
        14g. Throbbing 
     
 
        14h. Itching 
     
 
        14i. Tingling sensation  
               (e.g. pins and needles) 




15. At what time of day is your leg problem most intense? 
 
 
 On waking      During the night 
 
 At mid-day      At any time of day 
 





16. Compared to one year ago, how would you rate your leg problem in general now? 
 
Much better than one year ago 
 
Somewhat better than one year ago 
 
About the same now as one year ago 
 
Somewhat worse than one year ago 
 
Much worse now than one year ago 
 










17. The following items are about activities that you might do in a typical day.  Does your 
leg problem now limit you in these activities?  If so, how much? 
 
 (Please tick one box for each statement) 
        
        
           I do not   
      work 
    YES, 
limited     
    a lot 
YES, limited   
a little 
NO, Not 
limited at  
all 
     17a. Daily activities at work     
     17b. Daily activities at home (e.g.    
              housework, ironing,  odd jobs, 




     17c. Social or leisure activities in which  
              you are standing for long periods of  
              time (e.g. shopping, public transport) 
   
     17d. Social or leisure activities in which  
              you are sitting for long periods of  
              time  (e.g. cinema, theatre, travelling) 




18. During the past 4 weeks, have you had any of the following problems with your  
               work or other regular daily activities as a result of your leg problem? 
 
                  Yes      No 
  
 Cut down the amount of time you spent on work or  
other activities 
 
 Accomplished less than you would like 
 
 Were limited in the kind of work or other activities 
 
    Had difficulty performing the work or other activities  








19. During the past 4 weeks, to what extent has your leg problem interfered with your  
normal social activities with family, friends, neighbours or groups?   
(Please tick one box) 
 
 
 Not at all      Quite a bit  
 






20. How much leg pain have you had during the past 4 weeks? (Please tick one box) 
 
  
 None       Moderate 
 
 Very mild      Severe 
  




21. These questions are about how you feel and how things have been with you during  
the past 4 weeks as a result of your leg problem.  For each question, please give 
one answer that comes closest to the way you have been feeling.  How much of the 
time during the past 4 weeks –  
 





  All of 
    the   
   time 
 Most of  
 the 
time 
A good  
 bit of 
the time 
Some of 
    the     
  time 
  A little 
of  
the time            
 None of  
  the 
time 
        21a. Have you felt  
                 concerned      
                about the   
                appearance  
                of your leg(s)? 
      
        21b. Have you felt  
                irritable? 
        21c. Have you felt  
                a burden to  
                your family or  
                friends? 





         
 
  All of 
    the   
   time 
 Most of  
 the 
time 
A good  
 bit of 
the time 
Some of 
    the     
  time 
  A little 
of  
the time            
 None of  
  the 
time 
        21d. Have you             
                been worried  
                about          
                bumping into  
                things? 
      
        21e. Has the  
                 appearance  
                 of your leg(s)  
                 influenced           
                 your choice of  
                clothing? 








22. Have you ever been told by a doctor that you had any of the following? 
 
 
         Left Leg     Right Leg         No 
 
a. Varicose veins 
 
b. Leg ulcer 
 
c. Phlebitis / vein inflammation 
 
 
d. Swollen leg either i) following pregnancy 
 
       ii) following operation 
 




e. White leg of pregnancy 
 
 
f. Deep vein thrombosis (clot in the leg) 
 
g. Fractured / broken leg 





                  
                     Yes              No 
 
h. Hernia (lump in the groin) 
 
















         Varicose veins         Leg ulcer 
 
    Mother 
 
    Father 
 
    Brother / sister 
 
    Grandparents 
 
    Other relatives 







If you have not had varicose veins, then women go to question 27 and men go to 
question 31a.  
 
 
24. How old were you when you first developed varicose veins?       
years 







           
 
25. Have you had the following treatments for varicose veins? (Please tick) 
 
 




b. Injection of veins 
 




If you have never had an operation or injections for your varicose veins (i.e. you 





26a. Have your varicose veins come back since they  










26b. Have you had your varicose veins treated by operation or injection more than 
once?           






26c. In which hospitals have you had treatment for varicose veins? 
 















Men omit this section and go to Question 31a 
 
 
27. What age did you go through: 
 
 Menarche (i.e. started your periods)     years 
 
Menopause (i.e. periods stopped)     years 
 
    (if you are still having periods, put a 0 in the box) 
  
 






28b. How many times have you been pregnant? (include any current pregnancy and  
              miscarriages) 
 




28c. Did any varicose veins first develop during pregnancy?            Yes           No    




 If you’ve never had varicose veins please tick here    
            
 
 
28d. If yes, during which pregnancy did they develop?          pregnancy 
 













If yes, for how many years in total?             years 









 If yes, what is the name of the pill? 
 
(If you don’t know the exact name, do you take it every day or do you only take it 3 
weeks out of 4?) 
 




















If yes, what is the name of the tablets you  























31a. Do you smoke at present?             Yes         No 
    
 





31b. What do you usually smoke now?    Cigarettes 
  
         Pipe 
 
         Cigars 
 








31d. For how many years of your life have you    years 





31e. How many cigarettes have you smoked per day on average during the period you 
have smoked? 
         
          cigarettes per day
             
  
Now proceed to 31j. 
 
 
31f. Have you ever smoked cigarettes regularly?           Yes         No 
   
   
   
  








31g. How many cigarettes per day did you smoke on average while you were a smoker?    
 
                cigarettes per day




31h. For how many years did you smoke cigarette   years 
           
  
         
 
31i. How long is it since you gave up smoking cigarettes?    years 
 
                          
 
31j. Are you exposed to cigarette smoke at home or at work?   Yes           No 
 








The following section gives examples of the sort of activities you might do now. 
 
 
Light activity   Moderate activity         Strenuous activity 
 
Ballroom dancing  Badminton          Basketball 
Bowling      Cricket           Competitive cycling 
Light DIY   Cycling (to work, shops etc)        Competitive swimming 
Light gardening       Heavy DIY          Competitive running 
Horse riding   Golf           Field sports 
Sailing    Jogging                        Sports training 
Walking (to work, shops etc) Swimming               Squash 
Yoga    Tennis           Football 
Other activities of    Other activities of         Other activities of 
similar intensity       similar intensity               similar intensity 
 










32. In a typical week during the last year, on how many occasions would you take part 
for more than 20 minutes each time: 
 
              Insert none if appropriate 
 
 
 In light activity?  In summer    
 times 
 (see above)   In winter      
 
 
In moderate activity  In summer    
 times 
 (see above)   In winter      
 
 
In strenuous activity  In summer    
 times 




33. Which of the following best describes your daily work or other daytime activity at 
the present time? 
 
(Please tick one box only) 
 
 
         I am usually sitting during the day and  
        do not walk about much 
      e.g. office workers, drivers 
         I stand or walk quite a lot during the  
         day, but do not have to carry of lift  
         things very often 
  
 e.g. housewives, shop  
          assistants 
         
           I usually lift or carry light loads and  
          have to climb stairs and /or hills often 
    
e.g. postmen, packers 
         
          I do heavy work and carry heavy loads 
  
e.g. building, mining and  

































Research project:  Edinburgh Vein Study  
 
 
Sometime during the past three months you received an invitation to take part in the 
Edinburgh Vein Study.  We understand that you decided not to do so. 
 
The Edinburgh Vein Study is one of the most important of its kind to be carried out in the 
UK. The results of the study, conducted in 1992-1994, were published in scientific papers 
and you may have seen some that were presented in a BBC Healthcheck Watchdog 
programme. The follow-up study will provide important information about the ongoing 
state of health of veins in the legs as people get older.  
 
However, to complete the study we need to know if those who took part were similar to 
those who did not and for this we need your help.  
 
We would therefore be most grateful if you would fill in the short form enclosed. Please fill 
in the form even if you don’t have any problems with your legs and return it in the prepaid 
envelope. It should take only a couple of minutes to complete and will help us considerably,  
 
Once we’ve received your form we will not contact you again. 
 






                                
 
Miss Lindsay Robertson   Professor erry Fowkes 
Research Fellow    Professor of Epidemiology 










     Study Number    ………. 
 
 




Any information you give in this form is strictly confidential. The results of the research will 




Name:   
 
 
Please fill in this form by ticking the appropriate boxes. 
 
 
1. Have you ever been told by a doctor that you have had any of the following? 
 
          Yes  No 
 
Varicose veins   
     
    Leg ulcer 
 
    Vein inflammation/phlebitis   
   
           
Yes No 
 




3. Have you ever had any of the following treatment for varicose veins? 
          Yes No 
           
    Operation 
 
    Injection of veins 
 








4. Please say why you were unable to take part in the study. 
   (Please tick all the reasons which apply) 
             
    Not interested in study 
 
    Study waste of time 
 
    Too busy 
 
    Clinic times inconvenient 
 
    Worried about examination or results 
 
    Housebound 
 
    Feel unhealthy so don’t need to take part 
 
    Already seeing doctor about veins 
 
    Forgot about invitation/appointment 
 
    Object to invasion of privacy 
 





























Title of Study:  Edinburgh Vein Study – lifestyle and clinical factors determining 
progression of venous disease in the legs. 
 
 
Name of Researcher: Miss Lindsay Robertson 
   Wolfson Unit for Prevention of Peripheral Vascular Diseases 
   Public Health Sciences 
   University of Edinburgh 
   Teviot Place 
   Edinburgh 
   EH8 9AG 
   Tel: 0131 650 4555 
 
 
                   
                                      Please initial 
 
 
1. I confirm that I have read and understood the information sheet for the 
above study.  I have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily. 
2. I understand that my participation is voluntary and that I am free to withdraw 
at any time, without giving any reason, without my medical care or legal 
rights being affected. 
3. I understand that relevant sections of any of my medical notes and data 
collected during the study may be looked at by the principal investigators or 
by regulatory authorities where it is relevant to my taking part in this 
research.  I give permission for these individuals to have access to my 
records. 
4. I agree to have my legs photographed for the purpose of the study. 
5. I understand that my General Practitioner will be informed of any clinically 
significant information that comes to light as a result of this study. 








Name of investigator                  Date                       Signature of investigator 
 
















Participant name………………………………………        Study Number…………………. 
 
EDINBURGH VEIN STUDY 
 
HEIGHT AND WEIGHT RECORDING FORM 
 
            Day  Month          Year 
 
Date of examination     …………      /    …………   /    ………..   
 
Time of examination     ………… am / pm 
 
HEIGHT (without shoes)   . cms 
 
WEIGHT (without shoes)   . kgs 
 










White Caucasian    Chinese  
 






















Participant name …………………………………………                    Study number………………. 
 
EDINBURGH VEIN STUDY 
DUPLEX SCANNING RECORDING FORM 
 
Have you ever been investigated for recurrent blackouts or fainting?          YES   /   NO 
Are you currently taking any medication for high blood pressure?               YES   /   NO 
 
 RIGHT LEFT 
PROCEDURES Operations Injections Operations Injections 
Great saphenous vein YES  /  NO YES  /  NO YES  /  NO YES  /  NO 
Small saphenous vein YES  /  NO YES  /  NO YES  /  NO YES  /  NO 
 
 REFLUX 











DEEP        
CFV       
FV origin       
FV lower 1/3        
POP above knee       
POP below knee       
SUPERFICIAL        
GSV origin       
GSV lower 1/3 
thigh 
      
GSV upper calf       
GSV lower calf       
SV       












Participant name………………………………………….                Study number…………… 
 
 
EDINBURGH VEIN STUDY 
 
LEG EXAMINATION FORM 
 
 
BACK OF LEGS FRONT OF LEGS 
LEFT RIGHT LEFT RIGHT 
C0 Venous disease     
C1a Telangiectases  
(1,2,3) 
    
C1b Reticular varices  
(1,2,3) 
    
C2 Trunk varices  
(1,2,3) 
    
C3 Oedema     
C3 Corona     
C4a1 Pigmentation     
C4a2 Eczema     
C4b1 
Lipodermatosclerosis 
    
C4b2 Atrophie blanche     
C5 Healed ulcer     
C6 Active ulcer     





Do you currently suffer from swollen ankles?         YES / NO               RIGHT / LEFT / BOTH
          
Number of standard photographs taken:                3 / 6 / _____ if other, specify the number 
 







































To identify points and patterns of venous reflux in the deep and superficial veins of the legs. 
 
PREPARATION 
1. Make sure the probe is clean.  Set the rapid air source to a pressure of 110 mmHg. 
2. The scanner is set up so that all scans are conducted within the venous section of 
the peripheral vascular protocol.  If the setup is changed, use the SCANHEAD 
button to bring up the protocols.  Select the L7-438mm probe, “peripheral 
vascular” and “venous”. 
3. Enter the participant’s name, study ID no and date of birth using the PATIENT DATA 
button and save.   
4. Explain the procedure to the patient.  Document any previous blackouts, 
medication for high blood pressure or medical conditions.  Ask them to notify you 
immediately if they feel faint.  Ask the patient to disrobe from the waist down. 
5. The participant should be asked to lie flat on the tilt-table with one pillow under 
their head.  Once they are comfortable, the tilt-table should be raised in a reverse 
fashion to a near-standing position (45°).  For participants who find it difficult to 
weight-bear for long periods, the tilt-table can be reduced to a 30° angle.  If the 
participant is unable to tolerate this then the scan should be abandoned since 
significant reflux may not be observed if the angle is <30°.  The participant should 
then be encouraged to take most of their weight on their opposite leg with the leg 
to be scanned relaxed to the side with the knee slightly bent. 
 
HOLDING THE PROBE 
It is important to hold the probe the correct way.  If scanning in transverse, the leading 
edge should always be to the participant’s right hand side i.e. facing you.  If scanning 
longitudinally, the leading edge should be pointing towards the participant’s heart.  When 
not using the probe (i.e. between reflux measurements), take it down and place it back on 







IMAGING THE VEINS 
Start by measuring the deep veins: 
Deep veins: 
Each deep vein (CFV, FV and POP) is accompanied by its artery.  The artery usually lies 
underneath the vein but it is vital to check this.  Locate deep veins in transverse view in 
black and white.  Use the colour function to check for venous or arterial blood flow.  This 
button shows the flow of blood in the veins as blue and the flow of blood in the arteries as 
red.  Squeeze the calf to initiate flow.  If you are on the vein, you should see a short burst of 
blue representing the blood being squeezed out.  If you see red, you are focussing on the 
artery and will need to readjust the probe until you are satisfied that you are on the vein. 
 
6. Begin in cross-section by imaging the sapheno-femoral junction (SFJ), also known as 
the “Mickey Mouse” configuration. Note that in patients who have had varicose 
vein surgery, the GSV may not be present if it has been previously tied or stripped. 
7. Check for a thrombus by pushing the probe (perpendicular to the body) firmly until 
the vein walls collapse completely (arteries cannot be compressed so the CFA will 
remain open).  If the walls cannot be compressed, the patient may have had a 
thrombus in their leg (invite back for a second scan with Paul Allan). 
8. Still in a longitudinal view, move the probe upwards until you can see the CFV just 
above the SFJ.   
9. Take a measurement of reflux.  Go into colour flow and pulsed Doppler mode.  
Place the Doppler cursors on the walls of the vein segment.  Inflate the pneumatic 
cuff to the pre-set pressure of 110 mmHg.  Check that the compression augments 
venous outflow and observe for signs of reflux. Measure the reflux time by placing 
the calipers at the start and end of the spectra.  Wait a minimum of 5 seconds 
between calf compressions to take another reflux measure.  Record both reflux 
times. 
10. Move the probe down until you can see the SFV 2cm below the SFJ.  Take 2 
measurements of reflux (Step 9). 
11. Follow the SFV down to the lower third of the thigh and take 2 measurements of 





12. Ask the patient to turn towards you in order for you to scan the popliteal (POP) vein 
behind the knee.  In transverse view, image the sapheno-popliteal junction (SPJ).  
Note that in patients you have had varicose vein surgery, the SSV may be missing.   
13. Turn the probe longitudinally and move upwards so that you can image the POP 
vein above the knee crease.  Take 2 measurements of reflux (Step 9). 
14. Move the probe down the leg to the POP vein below the knee crease.  Take 2 
measurements of reflux (Step 9). 
 
Superficial veins: 
The superficial veins will appear much higher on the screen as they are so close to the skin.  
It is important to hold the probe very lightly when scanning the superficial veins to avoid 
closing the vein walls.  When imaging the GSV and SSV, the image often resembles an eye.  
If you press the probe lightly, the vein walls should close to make it look as though the eye 
is winking at you.  Also, often when scanning the superficial veins, you may see the deep 
veins further down the screen.  Use the depth button to reduce the depth so that you’re 
imaging the superficial veins only. 
15. In transverse, go back to viewing the SFJ. 
16. Turn longitudinally and follow the GSV down to just below the junction.  Take 2 
measurements of reflux (Step 9). 
17. Still in longitudinal, follow the GSV down to the lower third of the thigh.  Take 2 
measurements of reflux (Step 9). 
18. Follow the GSV down to the upper calf.  Take 2 measurements of reflux (Step 9). 
19. Follow the GSV down to the lower calf  Note that, as the probe is close to the ankle, 
you will have to squeeze the foot to initiate blood flow rather than squeezing the 
calf. 
 
IMPROVING THE PICTURE QUALITY 
DEPTH – To get a clear picture, the depth should be reduced when imaging superficial veins     
and increased when imaging deep veins. 
FOCUS – To get the best image, the focus should point towards the vein being scanned. 







IF THE PARTICIPANT FEELS UNWELL 
If any participant feels faint, dizzy, sick, or starts yawning repeatedly while standing on the 
couch, ask them to COUGH HARD, lower the couch immediately so that the participant is 




Anyone we suspect having a deep vein thrombosis (i.e. absent or diminished flow in the 
deep veins or a non-compressible vein) should be asked to come back to be scanned by Dr 
P Allan.  Inability to detect flow in the superficial veins does not carry the significance and 


























Dear Dr  
 
Re: Participant name, address, date of birth 
 
The above patient was seen on ………. as part of the Edinburgh Vein Follow Up Study.  I 
enclose a copy of the subject information sheet for your information.  Also attached is a 
report of our findings on this patient.  The leg examination consisted essentially of visual 
inspection of the legs.  The Duplex scan demonstrates points of incompetence of the 
venous valves in the legs.  Please bear in mind that this information is based on a 
classification for the purposes of research and is not intended to be a clinical diagnosis. 
 
Patients inquiring about varicose veins were given an information leaflet produced by the 
Health Education Board for Scotland on “Help and Advice on Leg Problems – Varicose 
Veins”, and advised to discuss the matter with their general practitioner if more 
information was desired. 
 
 
I hope this information may be of help.  If you need any more information, please do not 















EDINBURGH VEIN FOLLOW-UP STUDY 
 
RESULTS OF STUDY EXAMINATION 
 
 
Study no:    
 
Name:    
 
Address:     
 
Date of birth:   
 
Height:      
 
Weight:     
 
BMI:     
 
 
CLASSIFICATION OF VENOUS DISEASE 
(Grading = Absent / Mild / Moderate / Severe) 
 
 RIGHT LEFT 
SPIDER VEINS mild mild 
RETICULAR VARICES moderate absent 
TRUNK VARICES mild severe 
CHRONIC VENOUS INSUFFICIENCY absent absent 
 
 
DUPLEX SCAN – INCOMPETENCE OF VENOUS VALVES 
(Grading for incompetence = Absent / Mild / Moderate / Severe) 
 
 RIGHT LEFT 
DEEP VEINS absent moderate 
GREAT SAPHENOUS VEIN mild mild 

















KAPPA SCORES AND LEVEL OF AGREEMENT 
 
KAPPA STATISTIC 
Studies that measure agreement between two or more observers should include a test statistic 
that takes into account the fact that observers will sometimes agree or disagree merely by 
chance.  The kappa statistic (K) assesses the reliability of agreement between observers when 
assigning categorical ratings to a number of items.  The measure calculates the degree of 
agreement in classification over that which would be expected by chance and is scored as a 
number between 0 and 1, thus giving a quantitative measure of the magnitude of agreement 
between observers.  To assist in converting the kappa value to a qualitative value of the level 
of agreement, Altman (1991) provided the following guidance for interpreting the kappa 
statistic.   
 
Value of K    Strength of agreement 
<0.20      Poor 
0.21-0.04      Fair 
0.41-0.60      Moderate 
0.61-0.80      Good 









The kappa statistic alone is appropriate if the items in cross tabulation are relatively balanced.  
However, if the prevalence of a condition is very high or low, the value of kappa may indicate a 
low level of reliability even when the observed proportion of agreement is high.  In these 
instances the kappa value alone is insufficient.  Therefore it is recommended that kappa values 
should always be reported with level of agreement to provide a clearer picture of agreement 
between observers (Sim & Wright 2005).    
 
 
LEVEL OF AGREEMENT 
Level of agreement is measured by taking the proportion of participants correctly identified at 
the same grade of clinical disease between observers or classification method.  For example, 
when comparing two different observers, the proportion of participants correctly identified as 
having grade 1 varicose veins by observer 1 is compared to those identified as having grade 1 
varicose veins by observer 2.  The proportion for each grade of disease is measured and then 
added up to form the level of agreement. In a similar manner, level of agreement can be 
calculated for the presence or absence of venous reflux determined by two different observers 
or by one observer on two different ultrasound examinations.  When discussing quality control 
measures in this study the kappa values and level of agreement are reported, where possible.  
For conditions where the cross tabulation was asymmetrical e.g. one observer found cases of 
reflux and the other did not, the kappa statistic could not be calculated and therefore only the 
level of agreement is presented. 
 
 
